Previous O O
hospital O O
course O O
( O O
per O O
H&P O O
): O O

Deep B-test O
tendon I-test O
reflexes I-test O
were O O
1-2+ O O
and O O
symmetric O B-problem
bilaterally O I-problem
. O O

Abdomen O O
: O O
soft O O
, O O
nondistended B-problem O
. O O

3. O O
Coronary B-problem B-treatment
artery I-problem I-treatment
disease I-problem I-treatment
with O O
a O O
history O O
of O O
angina B-problem O
in O O
the O O
distant O O
past O O
. O O

2017-09-03 O O
GLUCOSE B-test B-test
- O O
206 O O
* O O
UREA B-test B-test
N I-test O
- O O
28 O O
* O O
CREAT B-test B-test
- O O
1.8 O O
* O O
SODIUM B-test B-test
- O O
135 O O
POTASSIUM B-test B-test
- O O
4.1 O O
CHLORIDE B-test B-test
- O O
85 O O
* O O
TOTAL B-test B-test
CO2 I-test I-test
- O O
42 O O
* O O
ANION B-test O
GAP I-test O
- O O
12 O O

Her O O
lungs O O
revealed O O
coarse B-problem O
bilateral I-problem O
rhonchi I-problem O
from O O
base O O
to O O
midline O O
. O O

The O O
patient O O
was O O
discharged O O
on O O
Tenormin B-treatment B-test
, O O
25 O O
mg O O
PO O O
qd O O
; O O
Bactrim B-treatment B-treatment
DS I-treatment O
, O O
one O O
PO O O
bid O O
x5 O O
days O O
. O O

15. O O
Florinef B-treatment B-test
Acetate I-treatment I-test
0.1 O O
mg O O
p.o. O O
q.d. O O

The O O
patient O O
tolerated O O
the B-treatment O
procedure I-treatment O
well O O
. O O

1. O O
Left B-problem B-problem
transverse I-problem I-problem
mid I-problem I-problem
shaft I-problem I-problem
radial I-problem I-problem
fracture I-problem I-problem
with O O
ulnar B-problem O
displacement I-problem O
status O O
post O O
left B-treatment B-problem
radial I-treatment I-problem
open I-treatment I-problem
reduction I-treatment I-problem
and O O
internal B-treatment B-problem
fixation I-treatment I-problem
. O O

Epicardial B-treatment B-test
pacing I-treatment I-test
wires I-treatment O
were O O
removed O O
on O O
post-op O O
day O O
four O O
. O O

On O O
the O B-test
lower O I-test
extremity O I-test
, O O
could O O
wiggle B-test O
toes I-test O
, O O
flexor B-test B-test
and O O
plantar B-test B-treatment
, O O
3+/5 O O
, O O
quadriceps O B-treatment
4/5 O O
on O O
the O O
left O O
. O O

No O O
beta B-treatment O
blockers I-treatment O
were O O
given O O
. O O

She O O
was O O
discharged O O
on O O
06/16/2001 O O
at O O
12:00 O O
pm O O
in O O
stable O O
condition O O
. O O

08/20/2000 O O
9:25 O O
A O O

SOCIAL O O
HISTORY O O
: O O

He O O
was O O
initially O O
placed O O
on O O
Ceftriaxone B-treatment B-treatment
, O O
Levaquin B-treatment B-treatment
, O O
and O O
Flagyl B-treatment O
in O O
the O O
ICU O O
but O O
then O O
changed O O
to O O

There O O
were O O
no O O
wheezes B-problem O
or O O
rhonchi B-problem O
. O O

The O O
patient O O
is O O
alert O O
and O O
oriented O O
and O O
has O O
a B-treatment O
sling I-treatment O
for O O
his B-problem B-problem
left I-problem I-problem
humeral I-problem I-problem
fracture I-problem I-problem
. O O

( O O
End O O
of O O
Report O O
) O O

T O O
: O O
2012-05-19 O O
05:00 O O

There O O
was O O
no O O
dysarthria B-problem B-problem
. O O

FYFEZEISLEITZ O O
, O O
MATA O B-problem
Dictation O I-problem
ID O O
5149122 O O

9. O O
Propranolol B-treatment B-treatment
10 O O
mg O O
Tablet O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Tablet O O
PO O O
BID O O
( O O
2 O O
times O O
a O O
day O O
) O O
. O O

Disp O O
:* O O
30 O O
Tablet O O
(s)* O O
Refills O O
:* O O
0 O O
* O O

Pt O O
was O O
note O O
started O O
on O O
ASA B-treatment O
as O O
she O O
does O O
not O O
tolerate O O
this O O
well O O
, O O
BB B-treatment O
was O O
also O O
not O O
started O O
given O O
SBPs B-test O
in O O
the O O
110s O O
. O O

Please O O
continue O O
to O O
take O O
this B-treatment O
medication I-treatment O
as O O
prescribed O O
. O O

md O O
aware O O

Aspirin B-treatment B-test
325 O O
mg O O
p.o. O O
q. O O
day O O
, O O
Capoten B-treatment B-test
25 O O
mg O O
p.o. O O
q.8h. O O
, O O
NPH B-treatment B-test
insulin I-treatment I-test
28 O O
units O O
q.a.m. O O
and O O
10 O O
units O O
q.p.m. O O
, O O
Regular B-treatment B-test
insulin I-treatment I-test
4 O O
units O O
q.a.m. O O
and O O
4 O O
units O O
q.p.m. O O
, O O
simvastatin B-treatment B-test
20 O O
mg O O
p.o. O O
q. O O
day O O
, O O
digoxin B-treatment B-treatment
0.25 O O
mg. O O

Mild B-problem O
posterior I-problem B-problem
mitral I-problem I-problem
valve I-problem I-problem
prolapse I-problem I-problem
with O O
mild B-problem B-problem
mitral I-problem I-problem
regurgitation I-problem I-problem
. O O

SLAINEAEE O B-test
S O I-test
CHABECHIRD O I-test
, O O
JR O O
, O O
M.D. O O

Alkaline B-test B-test
phosphatase I-test I-test
169 O O
. O O

GLUCOSE B-test B-test
- O O
116 O O
* O O
UREA B-test B-test
N I-test O
- O O
14 O O
CREAT B-test B-test
- O O
1.0 O O
SODIUM B-test B-test
- O O
137 O O
POTASSIUM B-test B-test
- O O
4.5 O O
CHLORIDE B-test B-test
- O O
105 O O
TOTAL B-test B-test
CO2 I-test I-test
- O O
20 O O
* O O
ANION B-test O
GAP I-test O
- O O
17 O O

4. O O
Metoprolol B-treatment B-test
Tartrate I-treatment I-test
25 O O
mg O O
Tablet O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Tablet O O
PO O O
TID O O
( O O
3 O O
times O O
a O O
day O O
). O O

2012-06-07 O O
09:55 O O
PM O O
BLOOD B-test B-test
PT B-test I-test
- O O
12.8 O O
PTT B-test B-test
- O O
25.7 O O
INR(PT) B-test B-treatment
- O O
1.0 O O

2013-05-18 O O
06:00 O O
PM O O
PLT B-test O
SMR I-test O
- O O
NORMAL O O
PLT B-test O
COUNT I-test O
- O O
216 O O

843566350 O O
RWH O O

Pulmonary B-test B-test
consult I-test I-test
was O O
done O O
, O O
and O O
it O O
was O O
felt O O
that O O
the O O
patient O O
should O O
undergo O O
a B-test B-treatment
formal I-test I-treatment
sleep I-test I-treatment
study I-test I-treatment
, O O
full B-test O
PFTs I-test O
, O O
and O O
a B-test B-treatment
repeat I-test I-treatment
CT I-test I-treatment
scan I-test I-treatment
in O O
1 O O
year O O
to O O
assess O O
for O O
pulmonary B-problem O
nodule I-problem O
that O O
was O O
seen O O
. O O

14. O O
Plavix B-treatment B-treatment
75 O O
mg O O
p.o. O O
q. O O
day O O
times O O
30 O O
days O O
. O O

On O O
5-9-92 O O
the B-problem O
right-sided I-problem O
symptoms I-problem O
worsened O O
and O O
she O O
also O O
had O O
some B-problem O
elements I-problem O
of I-problem O
aphasia I-problem B-problem
. O O

Abd B-test O
CT I-test B-treatment
performed O I-treatment
09-01 O O
showed O O
multiple B-problem B-treatment
calcifications I-problem I-treatment
in I-problem O
the I-problem O
body I-problem O
and I-problem O
tail I-problem O
of I-problem O
the I-problem O
pancreas I-problem O
with O O
a B-problem B-problem
larger I-problem I-problem
cystic I-problem I-problem
lesion I-problem I-problem
in I-problem O
the I-problem O
tail I-problem O
of I-problem O
the I-problem O
pancreas I-problem O
. O O

During O O
this O O
admission O O
, O O
the O O
patient O O
was O O
started O O
on O O
Baclofen B-treatment B-treatment
10 O O
mg O O
p.o. O O
t.i.d. O O
for O O
spasticity B-problem O
. O O

Discharge O O
Summary O O

He O O
had O O
flatus O O
on O O
postoperative O O
day O O
# O O
3 O O
. O O

Extremities O O
: O O

The O O
remaining O O
unit O O
of O O
autologous B-treatment B-problem
packed I-treatment I-problem
red I-treatment I-problem
blood I-treatment I-problem
cells I-treatment I-problem
was O O
transfused O O
. O O

likely O O
exacerbation B-problem O
possibly O O
from O O
URI B-problem O
/ O O
pneumonia B-problem B-problem
. O O

The O O
abdomen O O
was O O
soft O O
, O O
nontender B-problem O
, O O
nondistended B-problem O
. O O

She O O
developed O O
additional B-problem B-problem
abdominal I-problem I-problem
tenderness I-problem I-problem
and O I-problem
distention B-problem I-problem
. O O

HISTORY O O
OF O O
PRESENT O O
ILLNESS O O
: O O

He O O
did O O
undergo O O
a B-test O
CT-guided I-test O
aspiration I-test O
/ I-test O
biopsy I-test O
at I-test O
the I-test O
L3-4 I-test O
disc I-test O
space I-test O
on O O
2020-03-11 O O
and O O
the O O
pt O O
was O O
transferred O O
to O O
Mediplex O O
Rehab O O
Hospital O O
immediately O O
following O O
this O O
. O O

You O O
were O O
treated O O
with O O
blood B-treatment B-problem
thinners I-treatment I-problem
. O O

Room O O
: O O

1. O O
Vascular B-treatment B-problem
catheter I-treatment I-problem
tip I-treatment I-problem
terminates O I-problem
in O I-problem
proximal O I-problem
right O I-problem
atrium O I-problem
. O O

His B-test B-test
vital I-test I-test
signs I-test I-test
were O O
stable O O
. O O

The O O
patient O O
was O O
moving O O
all O O
four O O
extremities O O
with O O
ease O O
. O O

DISCHARGE O O
DIAGNOSES O O
: O O

The O O
patient O O
required O O
2 O O
units O O
of O O
fresh B-treatment O
frozen I-treatment O
plasma I-treatment O
on O O
the O O
night O O
following O O
surgery B-treatment O
, O O
and O O
1 O O
unit O O
of O O
platelets B-treatment O
on O O
postop O O
day O O
1 O O
, O O
but O O
otherwise O O
required O O
no O O
blood B-treatment B-problem
products I-treatment I-problem
following O I-problem
the B-treatment I-problem
liver I-treatment I-problem
transplant I-treatment I-problem
. O O

3. O O
Vertebral B-treatment B-treatment
Spacer I-treatment I-treatment
at I-treatment O
L3-L4 I-treatment O
. O O

No O O
palmar B-problem B-problem
erythema I-problem I-problem

Transdermal B-treatment B-problem
nitroglycerin I-treatment I-problem
caused O I-problem
headache B-problem I-problem
. O O

emergency B-treatment B-test
CABG I-treatment I-test
X O O
3 O O
( O O
2017-06-13 O O
)( O O
LIMA B-treatment O
to I-treatment O
LAD I-treatment O
, O O
SVG B-treatment O
to I-treatment O
ramus I-treatment O
, O O
SVG B-treatment O
to I-treatment O
OM I-treatment O
) O O

A B-problem O
1.8 I-problem O
cm I-problem O
exophytic I-problem O
renal I-problem O
cyst I-problem O
is O O
seen O O
on O O
the O O
left O O
. O O

Echocardiogram B-test O
showed O O
normal O O
right O O
ventricular O O
and O O
left O B-problem
ventricular O I-problem
size O I-problem
and O O
systolic O B-problem
function O I-problem
. O O

Serial B-test O
cardiac I-test O
enzymes I-test O
negative O O
. O O

Neurological B-test B-test
examination I-test I-test
revealed O O
that O O
the O O
patient O O
was O O
quite B-problem O
sedated I-problem O
at O O
this O O
time O O
having O O
received O O
some O B-problem
medications B-treatment I-problem
. O O

The B-treatment O
Feeney I-treatment O
Gann-Burlington I-treatment O
drain I-treatment O
on O O
postoperative O O
day O O
number O O
demonstrated O O
medial B-test O
output I-test O
of O O
780 O O
with O O
lateral B-test O
output I-test O
of O O
150 O O
. O O

Apgars B-test O
were O O
8 O O
at O O
one O O
minute O O
and O O
8 O O
at O O
five O O
minutes O O
. O O

The O O
patient O O
will O O
follow O O
up O O
with O O
his O B-problem
oncologist O I-problem
. O O

9. O O
Left B-problem B-problem
femoral I-problem I-problem
AV I-problem I-problem
fistula I-problem I-problem
2017-04-19 O O

INDICATION O O
: O O
Postoperative B-problem O
fever I-problem O
. O O

PCP O O
Name O O
: O O

The B-problem O
patient I-problem O
&apos;s I-problem B-problem
pain I-problem I-problem
was O O
initially O O
controlled O O
with O O
IV B-treatment B-problem
pain I-treatment I-problem
medications I-treatment I-problem
but O O
at O O
the O O
time O O
of O O
discharge O O
to O O
the O O
rehab O O
facility O O
he O O
was O O
able O O
to O O
control O B-problem
his B-problem I-problem
pain I-problem I-problem
on O O
po B-treatment O
pain I-treatment B-problem
medications I-treatment I-problem
. O O

8) O O
Fosamax B-treatment B-treatment
10 O O
mg O O
p.o. O O
q. O O
day O O
. O O

Spontaneous O O
Condition O O
: O O

He O O
tolerated O O
the B-treatment O
procedure I-treatment O
well O O
with O O
no O O
complications B-problem B-treatment
except O I-treatment
postoperatively O I-treatment
, O O
his O O
voice O O
was O O
hoarse B-problem O
. O O

Admission O O
Date O O
: O O

He O O
lives O O
at O O
home O O
with O O
his O O
wife O O
. O O

Because O O
it O O
would O O
be O O
ideal O O
to O O
place O B-treatment
a B-treatment I-treatment
mechanical I-treatment I-treatment
valve I-treatment I-treatment
if O I-treatment
valve B-treatment I-treatment
replacement I-treatment I-treatment
rather O I-treatment
that O I-treatment
commissurotomy B-treatment I-treatment
is O O
needed O O
, O O
she O O
was O O
seen O O
by O O
Dr. O O
Ca O O
Shuff O O
of O O
ENT O O
for O O
her O O
history O O
of O O
epistaxis B-problem B-problem
. O O

Sex O O
: O O

2. O O
K-Dur B-treatment O
20 O O
mg O O
PO O O
q.day O O
, O O

The O O
patient O O
is O O
to O O
be O O
discharged O O
to O O
home O O
. O O

Over O O
the O O
next O O
several O O
days O O
, O O
her O B-treatment
activity O I-treatment
level O I-treatment
was O O
increased O O
with O O
the O O
assistance O O
of O O
Physical O O
Therapy O O
and O O
the O O
nursing O O
staff O O
. O O

Digoxin B-treatment B-test
0.125 O O
, O O
discontinued O O
one O O
month O O
prior O O
to O O
admission O O
, O O
Toprol B-treatment B-test
XL I-treatment I-test
100 O O
mg O O
daily O O
, O O
Trazodone B-treatment B-test
50 O O
mg O O
once O O
daily O O
, O O
Lipitor B-treatment B-test
10 O O
mg O O
daily O O
, O O
Diovan B-treatment B-test
40 O O
mg O O
daily O O
, O O
Atrovent B-treatment B-treatment
/ O I-treatment
Albuterol B-treatment I-treatment
prn O O
, O O
Pulmicort B-treatment B-treatment
, O O
Coumadin B-treatment B-treatment
2.5 O O
mg O O
daily O O
, O O
Vitamin B-treatment B-treatment
E I-treatment O
, O O
Vitamin B-treatment B-treatment
C I-treatment I-treatment
, O O
iron B-treatment B-problem
supplement I-treatment I-problem
. O O

( O O
End O O
of O O
Report O O
) O O

T B-test O
97.8 O O
, O O
HR B-test B-test
53 O O
, O O
BP B-test B-test
156/58 O O
, O O
RR B-test O
16 O O
, O O
O2 B-test O
sat I-test O
94% O O
on O O
2.5 O O
L O O

The O O
pt O O
was O O
given O O
ceftriaxone B-treatment O
/ O O
azithromycin B-treatment B-problem
/ O I-problem
vancomycin B-treatment I-problem
in O I-problem
Deanna O I-problem
. O O

1. O O
Percutaneous B-treatment B-treatment
transluminal I-treatment I-treatment
coronary I-treatment I-treatment
angioplasty I-treatment I-treatment
and O O
coronary B-treatment B-treatment
atherectomy I-treatment I-treatment
of I-treatment I-treatment
the I-treatment I-treatment
left I-treatment I-treatment
anterior I-treatment I-treatment
descending I-treatment I-treatment
, O O
8-17-93 O O
, O O

OTHER O O
DIAGNOSIS O O
; O O
Conditions O B-treatment
, O O
Infections O B-treatment
, O O
Complications O B-treatment
, O O
affecting O B-treatment
Treatment O I-treatment
/ O I-treatment
Stay O I-treatment
Obesity B-problem I-treatment
HTN B-problem I-treatment
High B-problem I-treatment
Cholesterol I-problem I-treatment
Tobacco O I-treatment
Fhx O I-treatment
of O I-treatment
CAD B-problem I-treatment
ETT B-treatment I-treatment
12/94 O O
( O O
- O O
) O O
ischemia B-problem B-test
ECHO B-test I-test
02/89 O O
nl B-test O
ETT I-test O
03/89 O O
, O O
07/90 O O
c O O
/ O O
w O O
ND B-problem O
ische I-problem O

2014-10-21 O O
08:10 O O
PM O O

Social O O
History O O
: O O

Fall B-problem O
was O O
witnessed O O
by O O
daughter O O
. O O

His B-test B-test
blood I-test I-test
pressure I-test I-test
was O O
114 O O
to O O
123/62 O O
. O O

Following O O
evaluation B-test B-treatment
and O O
treatment B-treatment B-treatment
, O O
the O O
patient O O
&apos;s O O
disposition O O
at O O
the O O
end O O
of O O
the O O
visit O O
was O O
ADMITTED O O
AS O O
AN O O
INPATIENT O O
TO O O
RO O O
WOODMA O B-problem
HEALTHCARE O I-problem
. O O

No O O
intraspinal B-problem B-problem
lesions I-problem I-problem
are O O
identified O O
. O O

Lab O O
values O O
: O O

She O O
also O O
has O O
a O O
history O O
of O O
uterine B-problem O
fibroids I-problem O
, O O
status O O
post O O
total B-treatment B-problem
abdominal I-treatment I-problem
hysterectomy I-treatment I-problem
. O O

Cesarean B-treatment B-test
section I-treatment I-test
x O O
2 O O
, O O
dilatation B-treatment B-treatment
and I-treatment O
curettage I-treatment O
x O O
1 O O
, O O
neck B-treatment O
fusion I-treatment O
after O O
motor O O
vehicle O O
accident O O
, O O
shoulder B-treatment O
surgery I-treatment O
after O O
motor O O
vehicle O O
accident O O
. O O

White B-test B-test
blood I-test I-test
cell I-test I-test
count I-test I-test
7.8 O O
with O O
86% O O
polymorphonuclear B-test B-test
cells I-test I-test
, O O
11.1 O O
lymphocytes B-test B-test
, O O
hemoglobin B-test B-test
14.3 O O
, O O
hematocrit B-test B-test
40.5 O O
, O O
MCV B-test B-test
88 O O
, O O
INR B-test B-test
1.0 O O
, O O
PTT B-test B-test
24.7 O O
, O O
PT B-test B-test
12.3 O O
, O O
platelet B-test B-test
count I-test I-test
295,000 O O
, O O
glucose B-test B-test
81 O O
, O O
BUN B-test B-test
15 O O
, O O
creatinine B-test B-test
0.8 O O
, O O
sodium B-test B-test
142 O O
, O O
potassium B-test B-test
4.2 O O
, O O
chloride B-test B-test
104 O O
, O O
CO2 B-test O
26 O O
, O O
calcium B-test B-test
9.3 O O
, O O
phosphate B-test B-test
4.8 O O
, O O
magnesium B-test B-treatment
2.3 O O
. O O

The O O
patient O O
was O O
admitted O O
for O O
work-up B-test O
of O O
his B-problem B-problem
cholestatic I-problem I-problem
jaundice I-problem I-problem
picture I-problem I-problem
along O O
with O O
work-up B-test O
for O O
his B-problem B-treatment
pulmonary I-problem I-treatment
process I-problem I-treatment
and O O
treatment B-treatment O
of O O
both O O
. O O

2013-05-18 O O
06:00 O O
PM O O
HYPOCHROM B-test B-test
- O O
1 O O
+ O O
ANISOCYT B-test O
- O O
NORMAL O O
POIKILOCY B-test O
- O O
NORMAL O O
MACROCYT B-test O
- O O
NORMAL O O
MICROCYT B-test O
- O O
NORMAL O O
POLYCHROM B-test O
- O O
NORMAL O O

2) O O
Paroxysmal B-problem B-problem
atrial I-problem I-problem
fibrillation I-problem I-problem
. O O

Discharge O O
Date O O
: O O

He O O
will O O
need O O
follow-up B-test O
bloodwork I-test O
as O O
an O O
outpatient O O
. O O

The O O
lungs O O
were O O
clear O O
to O O
auscultation B-test B-treatment
bilaterally O I-treatment
, O O
without O O
rales B-problem O
or O O
wheezes B-problem O
. O O

DD O O
: O O

The O O
patient O O
was O O
also O O
covered O O
with O O
Erythromycin B-treatment B-treatment
and O O
Gentamicin B-treatment B-treatment
for O O
coverage O O
of O O
community B-problem B-treatment
acquired I-problem I-treatment
pneumonias I-problem I-treatment
and O O
gram B-problem O
negative I-problem O
rods I-problem O
. O O

T O O
: O O

4. O O
Status O O
post O O
ileostomy B-treatment O
without O O
evidence O O
of O O
small-bowel B-problem B-problem
obstruction I-problem I-problem
. O O

Mother O O
with O O
pacemaker B-treatment O
, O O
alive O O
at O O
91 O O
years O O
old O O
. O O

CMED O O
: O O
A+Ox3 O O
, O O
mood O O
" O O
great O O
," O O
affect O O
approp O O
, O O
speech B-problem B-treatment
stuttering I-problem I-treatment
, O O
linear O B-treatment
TP O I-treatment
, O O
no O O
SI B-problem O
or O O
HI B-problem O

# O O
DMI B-problem O
: O O
Pt O O
on O O
sliding B-treatment O
scale I-treatment O
as O O
inpatient O O
and O O
taking O O
NPH B-treatment O
2 O O
units O O
BID O O
at O O
home O O
. O O

Report O O
: O O

Lungs O O
: O O
CTAB O O
post O O

MEDICATIONS B-treatment O
ON I-treatment O
ADMISSION I-treatment O
: O O

2. O O
Clonazepam B-treatment B-test
1 O O
mg O O
QAM O O
, O O
1 O O
mg O O
Q3PM O O
, O O
2 O O
mg O O
PO O O
QHS O O

POSTPARTUM O O
RETURN O O
APPOINTMENT O O
( O O
DAYS O O
) O O
: O O

Additionally O O
, O O
there O O
is O O
diminished B-problem O
color I-problem O
flow I-problem O
with O O
confluence O B-problem
of O I-problem
the O I-problem
hepatic O I-problem
veins O I-problem
. O O

2012-06-07 O O
09:55 O O
PM O O
BLOOD B-test B-test
ALT B-test I-test
- O O
44 O O
* O O
AST B-test B-test
- O O
31 O O
AlkPhos B-test B-test
- O O
36 O O
* O O
TotBili B-test B-treatment
- O O
0.2 O O

JOB O O
#: O O

She O O
was O O
maintained O O
on O O
intravenous B-treatment B-treatment
heparin I-treatment I-treatment
and O O
was O O
brought O O
back O O
to O O
the B-test O
cardiac I-test B-problem
catheterization I-test I-problem
laboratory I-test I-problem
on O O
08-18-93 O O
for O O
a B-test B-problem
relook I-test I-problem
coronary I-test I-problem
angiography I-test I-problem
. O O

2013-05-23 O O
01:08 O O
PM O O
1.22 O O

Provider O O
Number O O
: O O

GOINGNETHBUMPS O B-test
, O O
NANSO O O
R. O O
, O O
M.D. O O
( O O
HK18 O O
) O O
02/14/02 O O
08:39 O O
AM O O

There O O
were O O
no O O
ST B-problem O
or I-problem O
T I-problem O
wave I-problem O
changes I-problem O
. O O

MEDICATIONS O O
ON O O
DISCHARGE O O
: O O

3/24/1997 O O
12:00:00 O O
AM O O

7lb O O
0 O O
oz O O
3175 O O
grams O O

The O O
patient O O
is O O
a O O
78-year-old O O
female O O
who O O
has O O
had O O
osteoarthritis B-problem B-treatment
and O O
noted O O
the O O
sudden O O
onset O O
of O O
left B-problem B-treatment
knee I-problem I-treatment
pain I-problem I-treatment
in O O
09/89 O O
. O O

- O O
F O O
: O O

****** O O
DISCHARGE O O
ORDERS O O
****** O O

Report O O
Status O O
: O O

Benzodiazapine B-problem O
Overdose I-problem O

She O O
denied O O
fevers B-problem O
, O O
chills B-problem O
or O O
sweats B-problem O
. O O

There O O
is O O
moderate B-problem B-problem
pulmonary I-problem I-problem
artery I-problem I-problem
systolic I-problem I-problem
hypertension I-problem I-problem
. O O

The O O
patient O O
feels O O
this O O
is O O
secondary O O
to O O
her B-problem O
hemorrhoids I-problem O
, O O
although O O
it O O
does O O
not O O
clearly O O
localize O O
to O O
the O O
rectum O O
. O O

FEN O O
: O O
house O O
diet O O

2013-05-24 O O
12:52 O O
AM O O
147 O O
* O O

Refills O O
: O O
*2* O O

DISCHARGE O O
PATIENT O O
ON O O
: O O

Bactrim B-treatment B-test
DS I-treatment I-test
tabs I-treatment I-test
, O O
one O O
tablet O O
p.o. O O
q. O O
day O O
for O O
ten O O
days O O
. O O

General O O
: O O
sleepy B-problem O
, O O
arouses O O
to O O
voice O O
but O O
limited O O
participation O O
with O O
physical B-test B-problem
exam I-test I-problem

Delivery O O
: O O

Speaks O O
in O O
full O O
sentences O O
. O O

Over O O
the O O
past O O
four O O
weeks O O
, O O
the O O
patient O O
reported O O
progressive B-problem O
shortness I-problem O
of I-problem O
breath I-problem O
and O O
mid B-problem O
thoracic I-problem B-problem
back I-problem I-problem
pain I-problem I-problem
. O O

4. O O
Hypertension B-problem B-problem

12. O O
Tylenol B-treatment B-test
325 O O
mg O O
, O O
one O O
to O O
two O O
tablets O O
q. O O
four O O
to O O
six O O
hours O O
p.r.n. O O

T O O
: O O

0-3054851 O O
WEBCtug O O
Tel O O

Hep B-problem O
C I-problem O

2013-05-24 O O
12:52 O O
AM O O
22 O O
65 O O
* O O
739 O O
* O O
52 O O
81 O O
1.0 O O

1. O O
Cardiovascular O O
: O O

He O O
has O O
a B-problem O
chronic I-problem O
cough I-problem O
with O O
clear B-problem O
sputum I-problem O
. O O

GLUCOSE B-test B-test
- O O
193 O O
* O O
UREA B-test B-test
N I-test O
- O O
23 O O
* O O
CREAT B-test B-test
- O O
1.2 O O
SODIUM B-test B-test
- O O
138 O O
POTASSIUM B-test B-test
- O O
4.6 O O
CHLORIDE B-test B-test
- O O
101 O O
TOTAL B-test B-test
CO2 I-test I-test
- O O
21 O O
* O O
ANION B-test B-test
GAP I-test I-test
- O O
21 O O
* O O

RF O O
: O O

The B-test O
patient I-test O
&apos;s I-test O
liver I-test O
enzymes I-test O
were O O
noted O O
to O O
be O O
elevated O O
mid O O
way O O
through O O
her B-treatment O
hospital I-treatment O
course I-treatment O
, O O
to O O
about O O
three O O
times O O
normal O O
, O O
especially O O
the O O
SGOT B-test O
and O O
SGPT B-test O
. O O

Admission O O
Date O O
: O O

Weight B-test O
: O O

the O O
right O B-problem
inguinal O I-problem
region O I-problem
. O O

CONDITION O O
ON O O
DISCHARGE O O
: O O

His O B-test
skin O I-test
was O O
clear O O
, O O
without O O
rashes B-problem O
. O O

10. O O
Flomax B-treatment B-treatment
0.4 O O
mg O O
po O O
every O O
day O O
. O O

GLOTZASRHALT O O
, O O
SHIRLH O O

none O O
. O O

Dispo O O
- O O
to O O
rehab O O
when O O
resp B-problem O
status I-problem O
improved O O
, O O
PT O O
consulted O O

5. O O
History O O
of O O
Streptococcemia B-problem B-treatment
in O O
the O O
year O O
2008 O O
; O O
source O O
was O O
unclear O O
but O O
presumed O O
to O O
be O O
urinary O O
. O O

MEDICATIONS O O
ON O O
ADMISSION O O
: O O

Early O O
on O O
post-op O O
day O O
two O O
Ms. O O
Bridge O O
had O O
an O O
episode O O
of O O
aphasia B-problem B-problem
. O O

GOINGNETHBUMPS O B-test
, O O
NANSO O O
R. O O
, O O
M.D. O O

Secondary O O
diagnosis O O
: O O

The O O
patient O O
remained O O
stable O O
through O O
2010-06-29 O O
at O O
which O O
point O O
she O O
was O O
sent O O
to O O
the O O
operating O O
room O O
to O O
undergo O O
a B-treatment B-problem
left I-treatment I-problem
radial I-treatment I-problem
fracture I-treatment I-problem
open I-treatment I-problem
reduction I-treatment I-problem
and O O
internal B-treatment B-problem
fixation I-treatment I-problem
procedure I-treatment I-problem
. O O

The O O
patient O O
&apos;s O O
gait O O
remained O O
wide O O
based O O
and O O
shuffling O O
and O O
requiring O O
assist O O
. O O

There O O
was O O
no O O
evidence O O
of O O
MVP B-problem O
. O O

history O O
, O O
physical B-test B-treatment
, O O
neuro B-test O
exam I-test O
normal O O

Nitroglycerin B-treatment B-test
1 O O
tablet O O
sublingual O O
q. O O
5 O O
minutes O O
X3 O O
p.r.n. O O
chest B-problem B-problem
pain I-problem I-problem
. O O

Type B-problem O
2 I-problem O
Diabetes I-problem O
Mellitus I-problem O

Bowel O O
sounds O O
were O O
present O O
. O O

For O O
deep B-treatment O
vein I-treatment O
thrombosis I-treatment O
prophylaxis I-treatment O
she O O
was O O
treated O O
with O O
subcutaneous B-treatment B-problem
heparin I-treatment I-problem
and O O
for O O
gastrointestinal B-treatment B-problem
prophylaxis I-treatment I-problem
she O O
was O O
treated O O
with O O
Protonix B-treatment B-treatment
. O O

Achest B-test O
x-ray I-test O
done O O
at O O
that O O
time O O
showed O O
left B-problem B-problem
pleural I-problem I-problem
effusion I-problem I-problem
and O O
small B-problem B-treatment
right I-problem I-treatment
pleural I-problem I-treatment
effusion I-problem I-treatment
, O O
not O O
pulmonary B-problem B-treatment
edema I-problem I-treatment
and O O
left B-problem B-problem
lower I-problem I-problem
lobe I-problem I-problem
consolidations I-problem I-problem
. O O

The O O
patient O O
underwent O O
radical B-treatment B-problem
retropubic I-treatment I-problem
prostatectomy I-treatment I-problem
on O O
2012-01-20 O O
. O O

Rectal B-test B-test
exam I-test I-test
was O O
unremarkable O O
with O O
stool B-test O
heme I-test O
negative O O
. O O

EFW B-test O
= O O
7# O O
. O O

The B-test O
electrocardiogram I-test O
showed O O
atrial B-problem B-problem
fibrillation I-problem I-problem
with O O
slow B-problem O
ventricular I-problem O
response I-problem O
and O O
digitalis B-problem O
effect I-problem O
as O O
well O O
as O O
left B-problem B-problem
ventricular I-problem I-problem
hypertrophy I-problem I-problem
. O O

Ranitidine B-treatment B-test
150 O O
mg O O
twice O O
a O O
day O O
, O O
enteric-coated B-treatment B-test
aspirin I-treatment I-test
325 O O
mg O O
once O O
daily O O
, O O
Glucovance B-treatment B-test
5/500 O O
one O O
tablet O O
twice O O
a O O
day O O
, O O
metoprolol B-treatment B-test
25 O O
mg O O
twice O O
a O O
day O O
, O O
Furosemide B-treatment B-test
20 O O
mg O O
once O O
daily O O
for O O
14 O O
days O O
, O O
potassium B-treatment B-treatment
chloride I-treatment I-treatment
20 O O
mEq O O
once O O
daily O O
for O O
14 O O
days O O
, O O
Colace B-treatment B-test
100 O O
mg O O
twice O O
a O O
day O O
, O O
Niferex B-treatment B-test
150 O O
mg O O
once O O
daily O O
, O O
Percocet B-treatment B-treatment
5/325 O O
one O O
to O O
two O O
tablets O O
every O O
four O O
hours O O
as O O
needed O O
, O O
ibuprofen B-treatment B-treatment
400 O O
mg O O
every O O
six O O
hours O O
as O O
needed O O
. O O

No O O
smoking O O
for O O
last O O
5 O O
years O O
. O O

1 O O
VERIFIED O O
BY O O
DILUTION O O

This O O
report O O
was O O
created O O
by O O
DREWEILLTRIEVKEMME O O
, O O
QUELOISEVIER O B-treatment
03/06/2002 O O
06:28 O O
AM O O

Discharge O O
Medications O O
: O O

CIENNE O O
, O O
GUTAOI O O

Sodium B-test B-test
139 O O
, O O
potassium B-test B-test
3.8 O O
, O O
chloride B-test B-test
101 O O
, O O
bicarb B-test B-test
26 O O
, O O
BUN B-test B-test
9 O O
, O O
creatinine B-test B-test
0.7 O O
, O O
glucose B-test B-test
141 O O
, O O
albumin B-test B-test
4.1 O O
, O O
calcium B-test B-test
8.9 O O
, O O
LDH B-test B-test
665 O O
, O O
AST B-test B-test
44 O O
, O O
ALT B-test B-test
of O O
57 O O
, O O
amylase B-test B-test
41 O O
, O O
CK B-test B-treatment
32 O O
. O O

Cranial O O
nerves O O
II O O
through O O
XII O O
are O O
intact O O
. O O

Lactulose B-treatment O
30 O O
cc O O
qid O O
titrated O O
to O O
3-4 O O
BM O O
/ O O
day O O

IMPRESSION O O
: O O

Her O B-test
uterus O I-test
and O O
adnexa O O
were O O
difficult O O
to O O
assess O O
secondary O O
to O O
voluntary B-problem O
tensing I-problem O
of I-problem O
her I-problem B-problem
abdomen I-problem I-problem
. O O

It O O
was O O
thought O O
that O O
the B-problem O
blood I-problem O
in I-problem O
the I-problem O
esophagus I-problem O
was O O
secondary O O
to O O
a O O
possible O O
Mallory-Weiss B-problem O
tear I-problem O
. O O

2018-12-26 O O
10:53 O O
PM O O

In O O
general O O
, O O
patient O O
in O O
no O O
acute B-problem B-problem
distress I-problem I-problem
. O O

She O O
received O O
intermittent O O
doses O O
of O O
Lasix B-treatment B-treatment
to O O
assure O O
overall O O
negative O O
intakes O O
and O O
outputs O O
. O O

Fich B-test B-test
cardiac I-test I-test
output I-test I-test
was O O
3.0 O O
and O O
indexed O O
2.0 O O
. O O

6/5/2002 O O
12:00:00 O O
AM O O

Stable O O
. O O

LABORATORY O O
DATA O O
: O O

COPD B-problem O
flare I-problem O

She O O
is O O
status O O
post O O
left B-treatment B-problem
knee I-treatment I-problem
replacement I-treatment I-problem
and O O
status O O
post O O
multiple B-treatment O
prior I-treatment O
surgeries I-treatment O
and O O
reconstruction B-treatment O
of I-treatment O
the I-treatment O
knee I-treatment O
. O O

Cardiac B-test B-test
monitor I-test I-test
was O O
placed O O
on O O
the O O
patient O O
, O O
given O O
the B-problem O
bigeminy I-problem O
, O O
and O O
he O O
did O O
rule O O
out O O
for O O
myocardial B-problem B-problem
infarction I-problem I-problem
. O O

Please O O
follow O O
up O O
with O O
your O O
primary O O
care O O
physician O O
within O O
the O O
next O O
week O O
. O O

Provider O O
: O O
Joe O O
Kari O O
, O O
MD O O
Phone O O
:( O O
625 O O
) O O
747-8259 O O

DIAGNOSIS O O
: O O

Atonic B-problem O
bladder I-problem O
with O O
suprapubic B-treatment B-problem
catheter I-treatment I-problem
. O O

EJEAN O O
NADARC O B-problem
FREIERMCHIRD O I-problem
, O O
M.D. O O

The O O
patient O O
was O O
admitted O O
on O O
February O O
23 O O
, O O
1999 O O
to O O
Eifro O O
Medical O O
Center O O
because O O
of O O
failure B-problem O
to I-problem O
thrive I-problem O
and O O
decreased B-problem B-problem
hematocrit I-problem I-problem
. O O

2. O O
Status O O
post O O
cholecystectomy B-treatment O
four O O
days O O
prior O O
to O O
admission O O
. O O

Lyme B-test O
capture I-test O
was O O
pending O O
and O O
at O O
the O O
time O O
of O O
discharge O O
. O O

LUPEVICKETTE O B-test
FLOW O I-test
, O O
M.D. O O
YA80 O O
QO567/192247 O O

2) O O
Provider O O
: O O
Peter O O
Helen O O
Braddy O O
, O O
MD O O
Phone O O
: O O
337 O O
2567 O O

The O O
patient O O
had O O
BiPAP B-treatment O
initiated O O
once O O
she O O
reached O O
the O O
unit O O
, O O
but O O
did O O
not O O
tolerate O O
it O O
, O O
becoming O B-problem
apneic B-problem I-problem
and O O
obstructing B-problem O
. O O

Her O O
lungs O O
were O O
clear O O
to O O
auscultation B-test B-problem
bilaterally O I-problem
. O O

He O O
has O O
had O O
chronic B-problem B-treatment
bilateral I-problem I-treatment
lower I-problem I-treatment
extremity I-problem I-treatment
swelling I-problem I-treatment
since O I-treatment
his B-treatment I-treatment
transplant I-treatment I-treatment
but O I-treatment
the B-problem I-treatment
right I-problem I-treatment
lower I-problem I-treatment
extremity I-problem I-treatment
swelling I-problem I-treatment
was O O
noticeably O O
increased O O
. O O

Left B-problem O
rib I-problem O
fractures I-problem O
05-22 O O

3. O O
Fatty B-problem O
liver I-problem O
resolved O O
. O O

The B-treatment O
patient I-treatment O
&apos;s I-treatment O
discharge I-treatment O
medications I-treatment O
include O O
the O O
following O O
: O O

5. O O
Hematology O B-treatment
- O O
Most O B-treatment
recent O I-treatment
hematocrit B-test I-treatment
was O O
42.8 O O
on O O
50-05-25 O O
. O O

1+ B-problem O
edema I-problem B-problem
bilaterally I-problem I-problem
. O O

3. O O
Congestive B-problem B-treatment
heart I-problem I-treatment
failure I-problem I-treatment
- O O
During O O
the O O
initial O O
course O O
of O O
the O O
patient O O
's O O
admission O O
, O O
it O O
was O O
unclear O O
as O O
to O O
whether O O
or O O
not O O
he O O
was O O
volume B-problem O
overloaded I-problem O
or O O
volume B-problem O
depleted I-problem O
. O O

DISCHARGE O O
CONDITION O O
: O O

EKG B-test O
was O O
negative O O
for O O
ischemia B-problem B-problem
. O O

Urinary B-problem B-problem
tract I-problem I-problem
infection I-problem I-problem
. O O

5. O O
Right B-treatment B-treatment
coronary I-treatment I-treatment
artery I-treatment I-treatment
stent I-treatment O
in O O
2008 O O
; O O
ejection B-test B-treatment
fraction I-test I-treatment
60 O O
to O O
65% O O
. O O

By O O
the O O
patient O O
and O O
his O O
family O O
&apos;s O O
prior O O
wishes O O
, O O
the O O
patient O O
was O O
extubated O O
. O O

212512774 O O
WGH O O

No O O
hypoglycemia B-problem B-problem
issues I-problem I-problem
noted O O
. O O

Colace B-treatment B-test
100 O O
mg O O
p.o. O O
twice O O
a O O
day O O
. O O

1. O O
End-stage B-problem B-treatment
renal I-problem I-treatment
disease I-problem I-treatment
secondary O O
to O O
type B-problem O
1 I-problem O
diabetes I-problem B-problem
mellitus I-problem I-problem
; O O
status O O
post O O
renal B-treatment O
transplant I-treatment O
in O O
2003 O O
. O O

MEDICATIONS O O
: O O

FINAL O O
DISCHARGE O O
DIAGNOSES O O
: O O

Pertinent O O
Results O O
: O O

disease B-problem B-test
. O O

She O O
should O O
have O O
her B-test O
chem I-test O
7 I-test O
checked O O
next O O
week O O
given O O
the O O
start O O
of O O
her B-treatment O
new I-treatment O
meds I-treatment O
. O O

Allergies O O
: O O

DISPOSITION O O
: O O

As O O
stated O O
the O O
patient O O
was O O
status O O
post O O
endoscopic B-test O
retrograde I-test O
cholangiopancreatography I-test O
with O O
stent O O

5. O O
Colace B-treatment B-treatment
100 O O
milligrams O O
po O O
bid O O
. O O

She O O
has O O
had O O
several B-problem O
prior I-problem O
bleeding I-problem O
events I-problem O
and O O
presented O O
with O O
a B-problem O
subacute I-problem O
bleed I-problem O
in I-problem O
the I-problem O
mid I-problem O
to I-problem O
lower I-problem O
pons I-problem O
. O O

745701560 O O
WGH O O

His B-problem B-test
right I-problem I-test
tib I-problem I-test
/ I-problem I-test
fib I-problem I-test
fracture I-problem I-test
was O O
repaired O O
by O O
Orthopedics O O
on O O
10-27 O O
; O O
postoperatively O O
there O O
were O O
no O O
complications B-problem B-problem
. O O

There O O
are O O
simple B-problem O
atheroma I-problem O
in I-problem O
the I-problem O
descending I-problem O
thoracic I-problem O
aorta I-problem O
. O O

10. O O
Hepatitis B-problem B-problem
B I-problem I-problem
. O O

Musculoskeletal O O
: O O
Has O O
suffered O O
significant B-problem O
deconditioning I-problem O
since O O
admission O O
, O O
but O O
has O O
consisitently O O
recieved O O
PT B-treatment O
. O O

Admission O O
Date O O
: O O

Fortunately O O
, O O
these O O
issues O O
were O O
not O O
active O O
during O O
the O O
present O O
admission O O
. O O

Rectal O O
: O O

Pupils O O
: O O

Extubated O O
early O O
the O O
next O O
morning O O
and O O
chest B-treatment B-problem
tubes I-treatment I-problem
removed O O
. O O

POTENTIALLY O O
SERIOUS O O
INTERACTION O O
: O O

2017-08-15 O O
BLOOD B-test B-problem
CULTURE I-test I-problem
NGTD O I-problem

2/23/1993 O O
12:00:00 O O
AM O O

Cardiac O B-test
and O O
infectious O B-treatment
sources O I-treatment
of O I-treatment
hypotension B-problem I-treatment
were O O
considered O O
, O O
but O O
cardiac B-test B-treatment
enzymes I-test I-treatment
were O O
not O O
changed O O
from O O
prior O O
studies O O
and O O
he O O
had O O
no O O
localizing B-problem B-treatment
signs I-problem I-treatment
of I-problem I-treatment
infection I-problem I-treatment
; O O
blood B-test B-test
cultures I-test I-test
were O O
sent O O
and O O
a B-test B-test
ultrasound I-test I-test
of O O
the B-treatment O
L I-treatment O
arm I-treatment O
AVF I-treatment O
ordered O O
to O O
rule O O
out O O
abscess B-problem O
at I-problem O
the I-problem O
site I-problem O
. O O

Amy O O
3 O O
children O O
, O O
2 O O
daughters O O
and O O
1 O O
son O O
. O O

He O O
presented O O
on O O
2016-11-21 O O
for O O
resection B-treatment B-problem
. O O

mitral B-treatment B-test
valve I-treatment I-test
repair I-treatment I-test
. O O

JVD B-problem O
difficult O O
to O O
access O O
02-23 O O
increased B-problem O
neck I-problem O
girth I-problem O
. O O

4. O O
Baclofen B-treatment B-treatment
10 O O
mg O O
p.o. O O
t.i.d. O O

OPERATIONS O O
AND O O
PROCEDURES O O
: O O

Hearing O O
was O O
diminished B-problem O
for O O
conversational O B-problem
speech O I-problem
. O O

White B-test B-test
blood I-test I-test
cell I-test I-test
count I-test I-test
9.0 O O
, O O
hematocrit B-test B-test
39.3 O O
, O O
platelets B-test B-test
296 O O
, O O
neutrophil B-test B-test
count I-test I-test
82 O O
, O O
lymphocytes B-test B-test
14 O O
, O O
4 O O
monocytes B-test O
, O O
troponin B-test B-treatment
was O O
less O O
then O O
0.3 O O
. O O

Date O O
of O O
Birth O O
: O O

Discharge O O
Date O O
: O O

Levofloxacin B-treatment B-test
500 O O
mg O O
p.o. O O
q. O O
day O O
. O O

The O O
patient O O
was O O
oxygenating O O
well O O
on O O
her B-treatment O
home I-treatment O
O2 I-treatment O
dose I-treatment O
of O O
2 O O
liters O O
per O O
minute O O
. O O

No O O
Restrictions O O

Tiotropium B-treatment O
Bromide I-treatment O

In O O
addition O O
, O O
patient O O
is O O
to O O
have O O
her O O
own O O
appointment O O
with O O
Podiatry O O
. O O

Central B-treatment B-test
Venous I-treatment I-test
Catheter I-treatment I-test
and O O
Swan B-treatment O
Ganz I-treatment O
catheter I-treatment O
placement I-treatment O

She O O
was O O
able O O
to O O
subtract O B-treatment
serial O I-treatment
sevens O I-treatment
, O O
remember O O
three O O
out O O
of O O
three O O
objects O O
after O O
five O O
minutes O O
, O O
and O O
there O O
was O O
notable B-problem O
aphasia I-problem O
or O O
word B-problem O
finding I-problem O
difficulty I-problem O
. I-problem O

Palpation B-test B-treatment
of O I-treatment
the O I-treatment
neck O I-treatment
discloses O I-treatment
a B-problem I-treatment
multinodular I-problem I-treatment
goiter I-problem I-treatment
, O O
larger O O
on O O
the O O
right O O
side O O
, O O
with O O
no O O
associated B-problem B-problem
cervical I-problem I-problem
lymphadenopathy I-problem I-problem
. O O

MEDICATIONS O O
ON O O
ADMISSION O O
: O O

DISCHARGE O O
SUMMARY O O

Allergies B-problem O
included O O
PENICILLIN B-treatment O
and O O
IODINE B-treatment O
. O O

Pcc O O
: O O

PTT B-test O
was O O
27.3 O O
. O O

11. O O
Left B-treatment B-treatment
CMED I-treatment I-treatment
cataract I-treatment I-treatment
surgery I-treatment I-treatment
in O O
2009-10-05 O O
. O O

Sodium B-test B-test
148 O O
, O O
potassium B-test B-test
3.4 O O
, O O
glucose B-test B-test
174 O O
, O O
P02 B-test O
102 O O
, O O
PC02 B-test O
115 O O
, O O
PH B-test B-test
7.11 O O
on O O
40% B-treatment O
02 I-treatment O
. O O

16. O O
Neutra-Phos B-treatment B-treatment
1.25 O O
grams O O
po O O
as O O
needed O O
. O O

The B-test B-test
head I-test I-test
, I-test O
eyes I-test O
, I-test O
ears I-test O
, I-test O
nose I-test O
and I-test O
throat I-test B-problem
examination I-test I-problem
is O O
notable O O
for O O
pupils O O
which O O
have O O
irregular B-problem O
border I-problem O
and O O
are O O
very B-problem O
sluggishly I-problem O
reactive I-problem O
. O O

1 O O
VERIFIED O O

Cardiopulmonary B-test O
exercise I-test O
study I-test O
results O O
are O O
pending O O
. O O

12. O O
Regular B-treatment B-test
insulin I-treatment I-test
5 O O
units O O
q. O O
a.m. O O
and O O
3 O O
to O O
5 O O
units O O
q. O O
p.m. O O

8. O O
Venous B-problem B-problem
stasis I-problem I-problem
. O O

His B-test B-test
saturation I-test I-test
increased O I-test
to O O
87% O O
on O O
a B-treatment B-problem
nonrebreather I-treatment I-problem
. O O

DISCHARGE O O
ACTIVITY O O
: O O

ADMISSION O O
DATE O O
: O O

DIET O O
: O O

Remote O O
tobacco O O
use O O
. O O

He O O
reported O O
that O O
he O O
began O O
with O O
difficulty B-problem O
buttoning I-problem O
his I-problem O
shirt I-problem O
for O O
many O O
years O O
since O O
after O O
a B-problem O
stroke I-problem O
but O O
now O O
reports O O
that O O
on O O
occasion O O
she O O
would O O
ask O O
him O O
why O O
he O O
was O O
doing O O
certain O O
things O O
and O O
he O O
could O O
not O O
give O O
a O B-problem
concrete O I-problem
example O I-problem
. O O

OB O O
Discharge O O
Summary O O

He O O
did O O
travel O O
to O O
the O O
Taheimpromong O O
, O O
last O O
in O O
01/2004 O O
for O O
three O O
weeks O O
. O O

Her O B-test
left O I-test
knee O O
had O O
5 O O
degrees O O
of O O
valgus B-problem O
, O O
120 O O
degrees O O
of O O
flexion O O
, O O
full O O
extension O O
and O O
slight B-problem B-problem
valgus I-problem I-problem
instability I-problem I-problem
. O O

Service O O
: O O

Chief O O
Complaint O O
: O O

Andre O O
R. O O
RATAN O O
, O O
M.D. O O

HISTORY O O
OF O O
PRESENT O O
ILLNESS O O
: O O

Index O O
No. O O
MIEQVK9Q4Z O O

9. O O
Docusate B-treatment B-test
Sodium I-treatment I-test
100 O O
mg O O
Capsule O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Capsule O O
PO O O
BID O O
( O O
2 O O
times O O
a O O
day O O
) O O
. O O

The O O
patient O O
was O O
discharged O O
to O O
home O O
with O O
instructions O O
to O O
return O O
to O O
the O O
hospital O O
on O O
Monday O O
, O O
2012-03-12 O O
, O O
for O O
follow-up O O
and O O
laboratory B-test B-problem
checks I-test I-problem
. O O

1) O O
RIGHT B-problem B-problem
LOWER I-problem I-problem
EXTREMITY I-problem I-problem
PSEUDOMONAS I-problem I-problem
CELLULITIS I-problem I-problem
. O O

- O O
CXR B-test O
no O O
focal B-problem B-treatment
consolidation I-problem I-treatment
or O I-treatment
edema B-problem I-treatment
, O O
old B-problem O
biapical I-problem B-treatment
scarring I-problem I-treatment
ABG B-test I-treatment
7.34/79/74 O O
U B-test O
/ I-test O
A I-test O
negative O O

The O O
patient O O
is O O
allergic B-problem B-treatment
Ampicillin B-treatment I-treatment
, O O
Tylenol B-treatment B-treatment
, O O
Clinoril B-treatment B-treatment
, O O
Biaxin B-treatment B-treatment
, O O
Codeine B-treatment O
, O O
Sulfa B-treatment B-problem
and O I-problem
Aminophylline B-treatment I-problem
. O O

1. O O
No O O
definite B-problem O
pulmonary I-problem O
embolism I-problem O
is O O
identified O O
. O O

labor B-problem O
at I-problem O
term I-problem O

His B-test B-test
white I-test I-test
blood I-test I-test
count I-test I-test
was O O
7100 O O
, O O
hematocrit B-test B-treatment
35.9 O O
, O O
platelet B-test B-treatment
count I-test I-treatment
258,000 O O
. O O

Discharge O O
Condition O O
: O O

The O O
right O B-treatment
upper O I-treatment
extremity O I-treatment
shows O I-treatment
generalized B-problem I-treatment
reduction I-problem I-treatment
in I-problem O
strength I-problem O
, O O
4/5 O O
in O O
all O O
joints O O
. O O

Median O O
Placenta O O
: O O

Report O O
Status O O
: O O

Her B-test B-test
electrocardiogram I-test I-test
revealed O O
normal O O
sinus O O
rhythm O O
, O O
left B-problem B-treatment
atrial I-problem I-treatment
enlargement I-problem I-treatment
, O O
left B-problem B-treatment
axis I-problem I-treatment
deviation I-problem I-treatment
, O O
poor B-problem O
R-wave I-problem O
progression I-problem O
in O O
V1 O O
through O O
V4 O O
, O O
consistent O O
with O O
marked O O
clockwise O O
rotation O O
, O O
cannot O B-problem
rule O I-problem
out O I-problem
an B-problem I-problem
old I-problem I-problem
anteroseptal I-problem I-problem
wall I-problem I-problem
myocardial I-problem I-problem
infarction I-problem I-problem
. O O

His O O
appetite O O
is O O
decreasing O O
somewhat O O
as O O
his B-problem B-treatment
disease I-problem I-treatment
process I-problem I-treatment
progresses O I-treatment
, O O
therefore O O
, O O
we O O
have O O
liberalized O O
his O O
diet O O
for O O
him O O
to O O
take O O
what O O
he O O
wishes O O
. O O

The O O
left O O
ventricular O O
cavity O O
size O O
is O O
normal O O
. O O

She O O
was O O
also O O
given O O
morphine B-treatment O
2 O O
mg O O
x3 O O
, O O
4 O O
mg O O
IV O O
x2 O O
, O O
dolasetron B-treatment B-test
12.5 O O
mg O O
x2 O O
and O O
ativan B-treatment O
1 O O
mg O O
IV O O
x1 O O
. O O

The B-problem O
patient I-problem O
&apos;s I-problem B-problem
abdominal I-problem I-problem
pain I-problem I-problem
should O O
be O O
followed O O
over O O
the O O
next O O
week O O
or O O
so O O
in O O
case O O
it O O
does O O
not O O
respond O O
to O O
Prilosec B-treatment O
. O O

2. O O
Aspirin B-treatment B-treatment
81 O O
mg O O
Tablet O O
, O O
Delayed O O
Release O O
( O O
E.C. O O
) O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Tablet O O
, O O
Delayed O O
Release O O
( O O
E.C. O O
) O O
PO O O
DAILY O O
( O O
Daily O O
). O O

The O O
patient O O
was O O
reportedly O O
alert O O
at O O
scene O O
, O O
and O O
then O O
became O O
unresponsive B-problem O
in O O
route O O
to O O
the O O
hospital O O
. O O

Report O O
Status O O
: O O

Extended O O
Care O O

On O O
11-02 O O
she O O
was O O
brought O O
to O O
the O O
operating O O
room O O
where O O
she O O
underwent O O
a B-treatment B-treatment
coronary I-treatment I-treatment
artery I-treatment I-treatment
bypass I-treatment I-treatment
graft I-treatment I-treatment
x O O
2 O O
. O O

F O O
/ O O
U O O
with O O
Dr. O O
Wierstkotea O O
within O O
1 O O
week O O
. O O

for O O
H.Pylori B-problem B-treatment
. O O

Social O O
History O O
: O O

PRINCIPLE O O
DIAGNOSIS O O
: O O

will O O
monitor O O
. O O

Date O O
of O O
Birth O O
: O O

PAST O O
MEDICAL O O
HISTORY O O
: O O

Pt O O
states O O
he O O
has O O
been O O
receiving O O
chemotherapy B-treatment O
up O O
until O O
1 O O
week O O
ago O O
. O O

2018-03-04 O O
01:02PM O O

- O O
saddle B-problem O
PE I-problem O
, O O
no O O
CD O O
or O O
report O O
sent O O

Because O O
of O O
the B-problem O
tongue I-problem O
injury I-problem O
and O O
tachycardia B-problem O
as O O
well O O
as O O
possible O O
infection B-problem O
given O O
her B-problem O
fevers I-problem O
or O O
chills B-problem O
the O O
GI O O
Service O O
transferred O O
the O O
patient O O
to O O
the O O
CMED O O
CCU O O
for O O
close O O
observation O O
. O O

A O O
, O O
REBAY O O
J O O

Joseph O O
Judy O O
MD O O
35-943 O O

She O O
was O O
transferred O O
in O O
stable O O
condition O O
to O O
the O O
Pasi O O
for O O
further B-treatment B-problem
rehabilitation I-treatment I-problem
therapy I-treatment I-problem
. O O

History O O
of O O
Present O O
Illness O O
: O O

HISTORY O O
AND O O
REASON O O
FOR O O
HOSPITALIZATION O O
: O O

PT B-test B-test
9.5/10.0 O O
, O O
PTT B-test B-treatment
23.9 O O
. O O

8. O O
Paranoia B-problem B-treatment
/ O I-treatment
Depression B-problem I-treatment
, O O
h/o O O
auditory B-problem O
hallucinations I-problem O
, O O
? O O
mania B-problem O

Plan O O
to O O
continue O O
vancomycin B-treatment O
for O O
08-19 O O
day O O
course O O
to O O
treat O O
empiric B-problem B-problem
line I-problem I-problem
infection I-problem I-problem
. O O

Joyce O O
, O O
Catherine O O
PSYCHIATRY O O
CMED O O
CSRU O O
Phone O O
:( O O
405 O O
) O O
582-6811 O O

2019-06-19 O O
07:20 O O
AM O O
BLOOD O B-test
Neuts B-test I-test
- O O
77.0 O O
* O O
Bands B-test B-test
- O O
5.0 O O
Lymphs B-test B-test
- O O
11.0 O O
* O O
Monos B-test B-test
- O O
3.0 O O
Eos B-test B-test
- O O
0 O O
Baso B-test B-test
- O O
0 O O
Atyps B-test B-test
- O O
1.0 O O
* O O
Metas B-test B-test
- O O
2.0 O O
* O O
Myelos B-test B-test
- O O
1.0 O O
* O O

PHYSICAL O O
EXAMINATION O O
: O O

Reason O O
: O O
STUCK O O
BY O O
AUTO O O

2017-08-15 O O
SPUTUM B-test B-treatment
CULTURE I-test I-treatment
- O O
PRELIMINARY O O
{ O O
PSEUDOMONAS B-problem O
AERUGINOSA I-problem O
} O O

Her B-test B-test
blood I-test I-test
pressure I-test I-test
was O O
190/90 O O
when O O
I O O
first O O
saw O O
her O O
on O O
her O O
second O O
hospital O O
day O O
. O O

Anzemet B-treatment O
12.5 O O
IV O O
prn O O

Disp O O
:* O O
30 O O
Tablet O O
(s)* O O
Refills O O
:* O O
0 O O
* O O

NYRI O O
A O O
MEMORY O O
, O O
M.D. O O

MRN O O
: O O

INR B-test B-test
3.5 O O
, O O
PT B-test B-test
32.5 O O
, O O
PTT B-test O
41 O O

Mild B-problem O
ST I-problem O
elevation I-problem O
in I-problem O
V3 I-problem O
. O O

Disp O O
: O O
*60 O O
Tablet( O O
s O O
)* O O

Reason O O
for O O
override O O
: O O

OTHER O O
TREATMENTS O O
/ O O
PROCEDURES O O
( O O
NOT O O
IN O O
O.R. O O
) O O

A O B-test
specimen O I-test
was O O
obtained O O
by O O
fine B-test O
needle I-test O
aspiration I-test O
and O O
the B-test O
pathology I-test O
of O O
this O O
was O O
consistent O O
with O O
adenocarcinoma B-problem B-problem
. O O

2017-06-14 O O
02:06AM O O
BLOOD B-test O

2018-12-26 O O
10:53 O O
PM O O

In O O
the O O
CMED O O
CCU O O
he O O
became O O
hypotensive B-problem O
to O O
SBP B-test O
80 O O
s. O O

JOB O O
#: O O

ALLERGIES O O
: O O

Platelets B-test B-test
were O O
9,000 O O
, O O
hemoglobin B-test B-treatment
9.5 O O
, O O
temperature B-test B-treatment
was O O
100.4 O O
. O O

MCHC B-test B-test
- O O
35.3* O O
RDW B-test B-test
- O O
14.8 O O
Plt B-test B-test
Ct I-test I-test
- O O
214 O O

1. O O
Docusate B-treatment B-test
Sodium I-treatment I-test
100 O O
mg O O
Capsule O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Capsule O O
PO O O
TID O O
( O O
3 O O
times O O
a O O
day O O
) O O
as O O
needed O O
for O O
Constipation B-problem B-problem
. O O

Cardiopulmonary B-treatment B-test
bypass I-treatment I-test
time O O
was O O
234 O O
minutes O O
. O O

She O O
does O O
stairs O O
one O O
at O O
a O O
time O O
and O O
only O O
with O O
help O O
. O O

SIMVASTATIN B-treatment O
and O O
CLARITHROMYCIN B-treatment O

14. O O
Heparin B-treatment B-treatment
Flush I-treatment I-treatment
CVL I-treatment I-treatment
( O O
100 O O
units O O
/ O O
ml O O
) O O
1 O O
ml O O
IV O O
DAILY O O
: O O
PRN O O

8. O O
Back B-problem B-problem
pain I-problem I-problem

Chronic B-problem B-test
Kidney I-problem I-test
disease I-problem I-test
- O O
on O O
hemodialysis B-treatment B-treatment
type B-problem I-treatment
2 I-problem I-treatment
diabetes I-problem I-treatment
hypercholestrolemia B-problem I-treatment
anemia B-problem I-treatment
of I-problem I-treatment
chornic I-problem I-treatment
disease I-problem I-treatment
h/o O O
PE B-problem O
, O O
s/p B-problem O
PEA I-problem O
arrest I-problem O
11-14 O O

CHEST B-test O
( I-test O
PORTABLE I-test O
AP I-test O
) I-test O

G2 O O
T1 O O
P0 O O
A0 O O
L1 O O
Estimated O O

( O O
End O O
of O O
Report O O
) O O

Please O O
see O O
operative O O
note O O
for O O
full O O
details O O
. O O

Dictated O O
By O O
: O O
Carmen O O
Y.R. O O
Martinez O O
, O O
M.D. O O

CML B-problem O
. O O

13. O O
Status B-treatment O
post I-treatment O
tracheostomy I-treatment O
2017-07-21 O O
02-22 O O
failure B-problem O
to I-problem O
wean I-problem O

Please O O
call O O
the O O
surgeon O O
or O O
return O O
to O O
the O O
Emergency O O
Department O O
if O O
you O O
develop O O
chest B-problem B-test
pain I-problem I-test
, O O
shortness B-problem B-treatment
of I-problem I-treatment
breath I-problem I-treatment
, O O
fever B-problem O
greater I-problem O
than I-problem O
101.5 I-problem O
, O O
foul B-problem O
smelling I-problem O
or I-problem O
colorful I-problem B-treatment
drainage I-problem I-treatment
from O I-treatment
your B-problem I-treatment
incisions I-problem I-treatment
, O O
redness B-problem O
or O O
swelling B-problem O
, O O
severe B-problem B-problem
abdominal I-problem I-problem
pain I-problem I-problem
or O O
distention B-problem O
, O O
persistent B-problem B-treatment
nausea I-problem I-treatment
or O O
vomiting B-problem O
, O O
inability B-problem O
to I-problem O
eat I-problem O
or I-problem O
drink I-problem O
, O O
or O O
any O O

REGISTRATION O O
DATE O O
: O O

Diagonal O O
1 O O
also O O
had O O
a B-problem B-problem
99% I-problem I-problem
stenosis I-problem I-problem
. O O

AST B-test O
was O O
25 O O
, O O
alkaline B-test B-test
phosphatase I-test I-test
130 O O
, O O
total B-test B-test
bilirubin I-test I-test
3.2 O O
, O O
albumin B-test B-treatment
3.4 O O
, O O
calcium B-test B-treatment
8.8 O O
. O O

DIET O O
: O O

In O O
summary O O
the O O
patient O O
is O O
a O O
59 O O
year-old O O
female O O
who O O
was O O
admitted O O
to O O
Quincy O O
Medical O O
Center O O
for O O
an B-test B-problem
endoscopic I-test I-problem
retrograde I-test I-problem
cholangiopancreatography I-test I-problem
for O O
possible O O
stent B-treatment O
placement I-treatment O
for O O
a B-problem O
bile I-problem O
leak I-problem O
secondary O O
to O O
cholecystectomy B-treatment O
performed O O
four O O
days O O
prior O O
to O O
admission O O
. O O

CLEV O O
, O O
NISHA O O

She O O
will O O
follow-up O O
with O O
Dr. O O
Koors O O
in O O
approximately O O
five O O
weeks O O
. O O

MCG O O
INH O O
DAILY O O
DIET O O
: O O

DISCHARGE O O
DIAGNOSES O O
: O O

OPERATIVE O O
PROCEDURE O O
: O O

Oxycontin B-treatment B-test
10 O O
mg O O
PO O O
q.day O O
. O O

2. O O
Examination B-test B-treatment
under I-test I-treatment
anesthesia I-test I-treatment
with O O
placement B-treatment O
of I-treatment O
splint I-treatment O
, I-treatment O
right I-treatment B-problem
elbow I-treatment I-problem
. O O

DISCHARGE O O
MEDICATIONS O O
: O O

There O O
were O O
no O O
electrolytes B-problem O
or I-problem O
mineral I-problem O
abnormalities I-problem O
that O O
could O O
explain O B-problem
his B-problem I-problem
delirium I-problem I-problem
. O O

Assumed O O
to O O
be O O
secondary O O
to O O
trauma B-problem O
when O O
moving O O
patient O O
into O O
ambulance O O
. O O

Neck O O
: O O

Adrenal B-problem B-test
insufficiency I-problem I-test
. O O

Tympanic O B-test
membranes O I-test
were O O
noted O O
to O O
be O O
clear O O
. O O

The B-problem B-test
estimated I-problem I-test
blood I-problem I-test
loss I-problem I-test
was O O
minimal O O
and O O
the O O
patient O O
received O O
600 O O
cc. O O
of O O
intravenous B-treatment B-problem
fluid I-treatment I-problem
. O O

The O O
patient O O
is O O
a O O
71-year-old O O
police O O
chief O O
who O O
presents O O
with O O
painless B-problem O
jaundice I-problem O
x1 O O
day O O
. O O

normal O O
pulses O O
, O O
no O O
clubbing B-problem O
, O O
cyanosis B-problem B-problem
or O I-problem
edema B-problem I-problem
. O O

HCV B-problem B-test
cirrhosis I-problem I-test
. O O

The O O
patient O O
has O O
remained O O
stable O O
and O O
is O O
now O O
ready O O
for O O
discharge O O
to O O
home O O
with O O
follow-up O O
in O O
approximately O O
four O O
weeks O O
. O O

Discharge O O
Status O O
: O O

Pertinent O O
Results O O
: O O

4. O O
Acute B-problem B-problem
renal I-problem I-problem
failure I-problem I-problem
. O O

UNDERLYING O O
MEDICAL O O
CONDITION O O
: O O

She O O
is O O
to O O
also O O
call O O
the O O
office O O
if O O
she O O
has O O
any O O
fever B-problem O
greater I-problem O
than I-problem O
101 I-problem O
, O O
bleeding B-problem O
from I-problem O
the I-problem O
surgical I-problem O
wounds I-problem O
, O O
or O O
pus B-problem O
from I-problem O
the I-problem O
wounds I-problem O
. O O

The O O
patient O O
was O O
advised O O
that O O
he O O
needs O O
to O O
speak O O
with O O
his O O
PCP O O
about O O
medication B-treatment O
for I-treatment O
antianxiety I-treatment O
and O O
/ O O
or O O
further B-test O
testing I-test O
or O O
counseling B-treatment O
to O O
help O O
control O O
his B-problem O
anxiety I-problem O
level I-problem O
. O O

In O O
addition O O
, O O
she O O
has O O
some B-problem O
dysphagia I-problem O
, O O
particularly O O
has O O
had O O
some B-problem O
difficulties I-problem O
with I-problem O
swallowing I-problem O
. O O

Admission O O
Date O O
: O O

Provider O O
Number O O
: O O

His O O
postoperative O O
course O O
was O O
remarkable O O
for O O
a B-problem B-treatment
low I-problem I-treatment
grade I-problem I-treatment
temperature I-problem I-treatment
to O O
101.7 O O
. O O

T O O
: O O

Children O O
's O O
Hospital O O
of O O
Waltham O O

2. O O
Severe B-problem B-problem
gait I-problem I-problem
ataxia I-problem I-problem
. O O

HISTORY O O
OF O O
PRESENT O O
ILLNESS O O
: O O

Left B-problem B-test
lower I-problem I-test
lobe I-problem I-test
pneumonia I-problem I-test
, O O
resolving O O
now O O
on O O
oral B-treatment B-problem
antibiotics I-treatment I-problem
. O O

The O O
patient O O
was O O
ultimately O O
deemed O O
ready O O
for O O
discharge O O
on O O
postoperative O O
day O O
8 O O
. O O

2. O O
Asthma B-problem O
. O O

LENTNY O O
FARSTNAPPSSHEE O O
, O O
M.D. O O

BILIARY B-problem O
OBSTRUCTION I-problem O

DD O O
: O O

Quetiapine B-treatment O
was O O
continued O O
however O O
clonipin B-treatment B-treatment
was O O
initially O O
held O O
when O O
she O O
was O O
intubated B-treatment O
on O O
fentynyl B-treatment O
/ O O
versed B-treatment O
. O O

2014-02-21 O O
12:20 O O
PM O O
BLOOD B-test B-problem
Lipase B-test I-problem
- O O
11 O O

Total B-test B-test
bilirubin I-test I-test
was O O
0.8 O O
. O O

L B-problem O
SHOULDER I-problem O
INJ I-problem O

CALCIUM B-test B-test
- O O
9.7 O O
PHOSPHATE B-test B-treatment
- O O
3.9 O O
MAGNESIUM B-test B-treatment
- O O
1.9 O O

DISCHARGE O O
MEDICATIONS O O
: O O

EXTREMITIES O O
: O O

Mild B-problem O
stenosis I-problem B-problem
of I-problem I-problem
the I-problem I-problem
proximal I-problem I-problem
right I-problem I-problem
internal I-problem I-problem
carotid I-problem I-problem
artery I-problem I-problem
. O O

Of O O
note O O
, O O
he O O
was O O
hospitalized O O
at O O
Dana-Farber O O
Cancer O O
Institute O O
from O O
9/25-10/6 O O
with O O
chest B-problem B-test
pain I-problem I-test
, O O
at O O
which O O
time O O
he O O
reportedly O O
had O O
cardiac B-test B-treatment
enzymes I-test I-treatment
, O O
an B-test B-treatment
echocardiogram I-test I-treatment
and O O
a B-test B-problem
pharmacological I-test I-problem
stress I-test I-problem
test I-test I-problem
performed O I-problem
. O O

Physical O O
Exam O O
: O O

BUN B-test B-test
12 O O
, O O
creatinine B-test B-test
0.6 O O
, O O
glucose B-test B-test
92 O O
, O O
uric B-test B-test
acid I-test I-test
3.3. O O
Cholesterol B-test B-test
236 O O
, O O
triglycerides B-test B-test
115 O O
, O O
HDL B-test B-test
99 O O
, O O
LDL B-test B-test
114 O O
, O O
total B-test B-test
protein I-test I-test
6.2 O O
, O O
globulin B-test B-test
2.6 O O
, O O
direct B-test B-test
bilirubin I-test I-test
0 O O
, O O
total B-test B-test
bilirubin I-test I-test
0.2 O O
, O O
alkaline B-test B-test
phosphatase I-test I-test
59 O O
, O O
amylase B-test B-test
64 O O
, O O
SGOT B-test B-test
16 I-test O
, O O
LDH B-test B-test
141 I-test O
, O O
CPK B-test B-treatment
57 O O
. O O

HISTORY O O
OF O O
PRESENT O O
ILLNESS O O
: O O

ED O O
Discharge O O
Summary O O

The O O
patient O O
is O O
retired O O
, O O
lives O O
with O O
his O B-test
wife O O
and O O
one O O
son O O
, O O
who O O
is O O
47 O O
years O O
old O O
and O O
had O O
multiple B-problem B-problem
myeloma I-problem I-problem
and O O
renal B-problem B-problem
failure I-problem I-problem
. O O

motrin B-treatment B-test
600 O O
mg O O
every O O
8 O O
hours O O
for O O
pain B-problem B-treatment
- O O
please O O
take O O
with O O
food O O
in O O
your O O
stomach O O

The O O
patient O O
should O O
also O O
have O O
her B-test B-treatment
potassium I-test I-treatment
levels I-test I-treatment
checked O I-treatment
two O O
times O O
per O O
week O O
to O O
insure O O
that O O
she O O
is O O
not O O
becoming O B-problem
hypokalemic B-problem I-problem
. O O

Total B-test B-test
bilirubin I-test I-test
3.0 O O
, O O
direct B-test B-treatment
bilirubin I-test I-treatment
of O O
2.0 O O
. O O

The O O
patient O O
was O O
aggressively B-treatment O
hydrated I-treatment O
given O O
that O O
she O O
was O O
NPO B-treatment O
. O O

Dr. O O
Linke O O
recommended O O
chemotherapy B-treatment O
with I-treatment O
PFL I-treatment O
. O O

Ext O O
: O O
tr B-problem O
edema I-problem O
, O O
2+ O O
DP B-test O
bilaterally I-test O

Systemic B-test B-test
arterial I-test I-test
resistance I-test I-test
12/81 O O
. O O

There O O
were O O
non-specific B-problem B-problem
ST-T I-problem I-problem
wave I-problem I-problem
abnormalities I-problem I-problem
. O O

PCP O O
notified O O
by O O

Clomipramine B-treatment B-test
100 O O
mg O O
po O O
qhs O O

2017-06-17 O O
05:14AM O O
BLOOD B-test O

DICTATING O O
FOR O O
: O O

DD O O
: O O

Examination B-test O
on O O
presentation O O
to O O
the O O
emergency O O
room O O
revealed O O
the O O
following O O
: O O

SOCIAL O O
HISTORY O O
: O O

He O O
also O O
had O O
significant B-problem B-problem
lower I-problem I-problem
extremity I-problem I-problem
and I-problem O
scrotum I-problem B-problem
edema I-problem I-problem
. O O

3. O O
Feeding B-treatment B-problem
jejunostomy I-treatment I-problem
. O O

4) O O
History O O
of O O
cerebrovascular B-problem B-problem
disease I-problem I-problem
. O O

This B-test B-test
CT I-test I-test
scan I-test I-test
, O O
done O O
also O O
on O O
10/10/97 O O
, O O
again O O
showed O O
the B-problem O
severely I-problem O
comminuted I-problem O
fracture I-problem O
of I-problem O
the I-problem B-problem
proximal I-problem I-problem
left I-problem I-problem
humerus I-problem I-problem
. O O

There O O
is O O
a B-problem B-treatment
small I-problem I-treatment
amount I-problem I-treatment
of I-problem I-treatment
blood I-problem I-treatment
layering I-problem I-treatment
in I-problem I-treatment
both I-problem I-treatment
lateral I-problem I-treatment
ventricles I-problem I-treatment
, O O
and O O
this O O
has O O
decreased O O
since O O
the B-test O
previous I-test O
study I-test O
. O O

The O O
descending O O
thoracic O O
aorta O O
is O O
mildly B-problem O
dilated I-problem O
. O O

Blindness B-problem O
02-26 O O
macular B-problem B-problem
degeneration I-problem I-problem

TO O O
DO O O
/ O O
PLAN O O
: O O

There O O
was O O
also O O
a B-problem O
blowing I-problem O
holosystolic I-problem O
murmur I-problem O
heard O O
at O O
the O O
patient O O
&apos;s O O
apex O O
to O O
axilla O O
. O O

ALLERGIES O O
: O O

The O O
patient O O
was O O
admitted O O
to O O
the O O
Surgical O O
Intensive O O
Care O O
Unit O O
postoperatively O O
. O O

PAST O O
MEDICAL O O
HISTORY O O
: O O

Although O O
there O O
was O O
never O O
any B-problem O
bacteria I-problem O
isolated O O
from O O
the B-test O
blood I-test O
you O O
had O O
some B-problem O
bacteria I-problem O
in I-problem O
the I-problem O
urine I-problem O
which O O
you O O
are O O
being O O
treated O O
for O O
. O O

The O O
patient O O
had O O
completed O O
her B-treatment O
antibiotic I-treatment O
course I-treatment O
while O O
in O O
house O O
. O O

FALC O O
, O O
COLL O O
891-57-52-0 O O
T37 O O

The O O
patient O O
while O O
in O O
bed O O
had O O
her O B-problem
legs O I-problem
elevated O I-problem
. O O

CLOZPLU O B-test
, O O
A O B-test
A O I-test
, O O
M.D. O O
Delivery O O

Disp O O
:* O O
30 O O
Tablet O O
(s)* O O
Refills O O
:* O O
0 O O
* O O

The O O
tip O O
was O O
culture B-test O
negative O O
. O O

5. O O
Hydrochlorothiazide B-treatment B-treatment
, O O
25 O O
mg O O
PO O O
daily O O
. O O

For O O
surgical B-problem B-problem
incision I-problem I-problem
and O O
left O O
arm O O

Dr. O O
Lynn O O
in O O
1-2 O O
weeks O O

There O O
was O O
a B-problem B-problem
left I-problem I-problem
arm I-problem I-problem
pronator I-problem I-problem
. O O

This O O
report O O
was O O
created O O
by O O
POUSSCROOKESSEILLE O O
, O O
VONNELIBRY O B-treatment
10/23/2005 O O
10:51 O O
AM O O

In O O
the O O
subsequent O O
two O O
days O O
, O O
she O O
had O O
several O O
small B-problem O
spells I-problem O
of I-problem O
&quot; I-problem O
imbalance I-problem O
&quot; O O
, O O
particularly O B-treatment
towards O I-treatment
the O I-treatment
right O I-treatment
, O O
and O O
other B-problem B-problem
symptoms I-problem I-problem
included O I-problem
diffuse B-problem I-problem
and I-problem O
mainly I-problem B-treatment
frontal I-problem I-treatment
headaches I-problem I-treatment
and O O
mild B-problem B-problem
neck I-problem I-problem
soreness I-problem I-problem
. O O

MEDICATIONS O O
ON O O
ADMISSION O O
: O O

Calcium B-test B-test
- O O
8.7 O O
Phos B-test B-test
- O O
2.5* O O
Mg B-test O
- O O
2.1 O O

The O O
patient O O
is O O
a O O
63-year-old O O
female O O
with O O
a O O
three-year O O
history O O
of O O
bilateral B-problem B-treatment
hand I-problem I-treatment
numbness I-problem I-treatment
and O O
occasional B-problem B-problem
weakness I-problem I-problem
. O O

FREIERMFUSC O B-test
, O O
SHAIGAYDONA O B-treatment
, O O
M.D. O O
, O O
M.DIV. O O

SPALDFREIERMPLCA O B-test
, O O
IEOLY O O
E O O

The O O
left O O
atrium O O
is O O
mildly B-problem O
dilated I-problem O
. O O

ED O O
Discharge O O
Summary O O

HTN B-problem O
, O O
DM B-problem O

Patient O O
recorded O O
as O O
having O O
No O O
Known B-problem O
Allergies I-problem O
to I-problem O
Drugs I-problem O

He O O
had O O
also O O
some B-problem B-treatment
increased I-problem I-treatment
shortness I-problem I-treatment
of I-problem I-treatment
breath I-problem I-treatment
and O O
a B-problem B-test
10 I-problem O
pound I-problem O
weight I-problem O
gain I-problem O
and O O
new O O
three O O
to O O
four O O
pillow B-problem O
orthopnea I-problem O
with O O
a B-problem O
dry I-problem O
cough I-problem O
. O O

papillary B-problem B-test
carcinoma I-problem I-test
. O O

1) O O
Endotracheal B-treatment O
tube I-treatment O
is O O
slightly O O
proximal O O
in O O
location O B-treatment
, O O
and O O
could O O
be O O
advanced O O
approximately O O
1.5 O O
cm O O
for O O
more O O
optimal O O
placement O O
. O O

T O O
: O O
2011-01-26 O O
11:30 O O

Patient O O
denies O O
night B-problem O
sweats I-problem O
in O O
the O O
past O O
month O O
. O O

She O O
can O O
one O O
walk O O
without O O
difficulties B-problem O
. O O

- O O
glipizide B-treatment O
5 O O
mg O O
po O O
bid O O

Discharge O O
Diagnosis O O
: O O

Hematocrit B-test O
stable O O
. O O

Discharge O O
Date O O
: O O

NO O O
Tifany O B-treatment
, O O
ETOH O O
, O O
OR O O
REC O O
DRUG O O
USE O O
. O O

Stable O O
. O O

9. O O
Valcyte B-treatment B-treatment
450 O O
mg O O
po O O
qod O O
. O O

Results O O
were O O
discussed O O
with O O
Dr. O O
Leanne O O
Vazquez O O
in O O
the O O
early O O
afternoon O O
on O O
2014-10-21 O O
. O O

Pertinent O O
Results: O O

MEDICATIONS O O
ON O O
ADMISSION O O
: O O

Pt B-test O
's I-test B-treatment
blood I-test I-treatment
cultures I-test I-treatment
came O I-treatment
back O I-treatment
positive O I-treatment
for O O
Staph B-problem O
Aureus I-problem O
and O O
Enterococcus B-problem B-treatment
, O O
both O O
were O O
pansensitive O O
. O O

3. O O
Fluids O O
, O O
electrolytes O O
and O O
nutrition O O
: O O

16. O O
Miconazole B-treatment B-treatment
Nitrate I-treatment I-treatment
2 O O
% O O
Cream O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Appl O O
Topical O O
BID O O
( O O
2 O O
times O O
a O O
day O O
). O O

Upon O B-test
arrival O I-test
GCS B-test I-test
15 O O
, O O
alert O O
and O O
oriented O O
x3 O O
. O O

Continued O O
in O O
Melrose-J O O
for O O
comfort O O
per O O
orthopedics O O
. O O

3. O O
Metoprolol B-treatment B-treatment
100 O O
mg O O
twice O O
a O O
day O O
. O O

After O O
removal O O
of O O
tunneled B-treatment O
line I-treatment O
pt O O
was O O
given O O
tube B-treatment O
feeds I-treatment O
while O O
she O O
was O O
intubated B-treatment O
. O O

Per O O
the O O
patient O O
&apos;s O O
wishes O O
, O O
she O O
was O O
transferred O O
to O O
the O O
Windgo O O
Hospital O O
for O O
chemotherapy B-treatment O
. O O

3. O O
Niferex B-treatment O
150 O O
milligrams O O
caplet O O
one O O
cap O O
per O O
day O O
. O O

The O O
patient O O
had O O
a O O
relatively O O
unremarkable O O
course O O
and O O
his O O
neurologic O O
status O O
continued O O
to O O
improve O O
following O O
the B-treatment O
operation I-treatment O
. O O

HISTORY O O
OF O O
PRESENT O O
ILLNESS O O
: O O

Medications O O
on O O
Admission O O
: O O

Righteye B-treatment O
surgery I-treatment O
for O O
glaucoma B-problem O
in O O
05/97 O O
. O O

4. O O
HYPERCHOLESTEROLEMIA B-problem B-problem

He O O
does O O
not O O
have O O
wheezing B-problem O
, O O
claudication B-problem B-problem
or O I-problem
gastrointestinal B-problem I-problem
bleeding I-problem I-problem
. O O

7) O O
Kay B-treatment O
Ciel I-treatment O
20 O O
mEq O O
p.o. O O
q. O O
day O O
. O O

She O O
has O O
a O O
questionable O O
sensitivity B-problem O
to O O
iodine B-treatment O
. O O

In O O
addition O O
, O O
he O O
had O O
slight B-problem O
shortness I-problem O
of I-problem O
breath I-problem O
but O O
denies O O
headache B-problem O
, O O
change B-problem O
in I-problem O
vision I-problem O
, O O
dizziness B-problem B-treatment
, O O
nausea B-problem B-treatment
, O O
vomiting B-problem B-treatment
, O O
abdominal B-problem B-test
pain I-problem I-test
, O O
change B-problem O
in I-problem O
bowel I-problem O
or I-problem O
urinary I-problem B-treatment
habits I-problem I-treatment
, O O
or O O
fevers B-problem O
, O O
chills B-problem B-treatment
, O O
and O O
sweats B-problem O
. O O

There O O
was O O
no O O
obvious O B-problem
segmental B-problem I-problem
wall-motion I-problem I-problem
abnormality I-problem I-problem
. O O

Her B-test O
CXR I-test O
prior O O
to O O
discharge O O
showed O O
mild B-problem B-treatment
pulm I-problem I-treatment
edema I-problem I-treatment
and O O
thus O O
was O O
given O O
40 O O
of O O
lasix B-treatment O
prior O O
to O O
going O O
to O O
rehab O O
. O O

1) O O
Multiple B-problem B-problem
myeloma I-problem I-problem
. O O

Lasix B-treatment B-test
80 O O
mg O O
PO O O
BID O O

G3 O O
T1 O O
P0 O O
A1 O O
L1 O O

Heart O O
: O O
RRR O O
- O O
c/r/m/g B-problem O

11. O O
Docusate B-treatment B-test
Sodium I-treatment I-test
100 O O
mg O O
Capsule O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Capsule O O
PO O O
BID O O
( O O
2 O O
times O O
a O O
day O O
). O O

A B-test B-test
white I-test I-test
blood I-test I-test
cell I-test I-test
count I-test I-test
of O O
14.2 O O
, O O
hematocrit B-test B-test
of O O
35.3 O O
, O O
platelet B-test B-treatment
count I-test I-treatment
of O O
449,000 O O
. O O

Kathy O O
Tillis O O
, O O
M.D. O O

****** O O
END O O
OF O O
DISCHARGE O O
ORDERS O O
****** O O

Signed O O
electronically O O
by O O
: O O
DR. O O
Janice O O
Oconnell O O
on O O
: O O
Kent O O
2019-01-10 O O
3:28 O O
PM O O

Discharge O O
Summary O O

His O B-test
respiratory O I-test
status O O
improved O O
slowly O O
, O O
oxygen B-treatment B-test
was O O
weaned O O
off O O
, O O
and O O
he O O
was O O
discharged O O
on O O
course O O
of O O
Levaquin B-treatment B-problem
. O O

Discharge O O
Date O O
: O O

On O O
hospital O O
day O O
2 O O
she O O
experienced O O
atrial B-problem O
fibrillation I-problem O
with O O
HR B-test O
in O O
the O O
140s O O
. O O

7. O O
Clozapine B-treatment B-treatment
25 O O
mg O O
Tablet O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Tablet O O
PO O O
HS O O
( O O
at O O
bedtime O O
) O O
. O O

Service O O
: O O

OB O O
Discharge O O
Summary O O

It O O
was O O
felt O O
that O O
this O O
potentially O O
had O O
lead O O
to O O
his B-problem O
atrial I-problem O
flutter I-problem O
and O O
atrial B-problem B-problem
fibrillation I-problem I-problem
with O O
rapid B-problem B-problem
ventricular I-problem I-problem
response I-problem I-problem
. O O

The O O
patient O O
had O O
two B-treatment O
drains I-treatment O
placed O O
after O O
a B-treatment O
prolonged I-treatment O
course I-treatment O
and O O
difficult B-treatment B-problem
procedure I-treatment I-problem
. O O

Brief O O
Hospital O O
Course O O
: O O

LVEF B-test O
>70% O O
, O O
LA B-test O
6.1 O O
cm O O
, O O
no O O
regional B-problem B-problem
wall I-problem I-problem
motion I-problem I-problem
abnormality I-problem I-problem
. O O

SOCIAL O O
HISTORY O O
: O O

Discharge O O
Disposition O O
: O O

OTHER O O
TREATMENTS O O
/ O O
PROCEDURES O O
( O O
NOT O O
IN O O
O.R. O O
) O O

Electrocardiogram B-test O
showed O O
atrial B-problem B-problem
fibrillation I-problem I-problem
, O O
moderate B-problem B-treatment
ventricular I-problem I-treatment
response I-problem I-treatment
, O O
incomplete B-problem B-problem
right I-problem I-problem
bundle I-problem I-problem
branch I-problem I-problem
block I-problem I-problem
, O O
right B-problem B-problem
axis I-problem I-problem
deviation I-problem I-problem
, O O
right B-problem B-problem
ventricular I-problem I-problem
hypertrophy I-problem I-problem
and O O
possible O B-problem
apical B-problem I-problem
infarction I-problem I-problem
. O O

It O O
was O O
felt O O
that O O
the O O
patient O O
possibly O O
had O O
a O O
worsening O O
of O O
his B-problem B-problem
coronary I-problem I-problem
artery I-problem I-problem
disease I-problem I-problem
and O O
therefore O O
underwent O O
cardiac B-test B-problem
catheterization I-test I-problem
on O O
01/17/96 O O
. O O

HOSPITAL O O
COURSE O O
: O O

The O O
pneumocephalus B-problem O
adjacent O O
to O O
the B-problem O
linear I-problem O
skull I-problem O
fracture I-problem O
appears O O
to O O
have O O
decreased O O
in O O
size O O
. O O

Sed B-test O
rate I-test O
6 O O
. O O

Per O O
Dr. O O
John O O
C. O O
Corrigan O O
Mental O O
Health O O
Center O O
, O O
at O O
baseline O O
, O O
patient O O
not O O
interactive O O
. O O

2018-12-26 O O
09:44 O O
PM O O

Extremities O O
: O O

Oxygen B-treatment O
2-4 O O
L O O
to O O
keep O O
Sa02 B-test O
greater O O
than O O
or O O
equal O O
to O O
94-95% O O
and O O
wean O O
as O O
tolerated O O
. O O

Not O O
Applicable O O

Brief O O
Hospital O O
Course O O
: O O

FAMILY O O
HISTORY O O
: O O

11. O O
Colace B-treatment B-treatment
100 O O
mg O O
po O O
bid O O
. O O

Neurological B-test B-test
exam I-test I-test
revealed O O
an O O
alert O O
and O O
oriented O O
x O O
3 O O
elderly O O
male O O
. O O

LDH B-test O
806 O O
. O O

Status O O
post O O
placement B-treatment O
of I-treatment O
percutaneous I-treatment B-problem
transhepatic I-treatment I-problem
biliary I-treatment I-problem
drainage I-treatment I-problem
with O O
placement B-treatment O
of I-treatment O
8 I-treatment O
Caucasian I-treatment B-treatment
nephrostomy I-treatment I-treatment
catheter I-treatment I-treatment
in O O
the O O
common O O
bile O O
duct O O
. O O

HULLEKOTE O B-test
, O O
AU O O
329-72-53-3 O O
Z23 O O

The O O
patient O O
requested O O
an O O
outside O O
second O O
opinion O O
, O O
as O O
she O O
was O O
reluctant O O
to O O
undergo O O
hysterectomy B-treatment O
at O O
this O O
time O O
. O O

No O O
Restrictions O O

post O O
partum O O

Post-intubation O B-test
, O O
the B-test O
pt I-test O
's I-test O
BP I-test O
acutely O O
dropped O O
to O O
58/19 O O
in O O
the O O
setting O O
of O O
propofol B-treatment O
. O O

Urology O O
also O O
followed O O
him O O
and O O
kept O O
him O O
on O O
antibiotics B-treatment O
until O O
postoperative O O
day O O
#7 O O
at O O
which O O
point O O
antibiotics B-treatment O
were O O
discontinued O O
. O O

2017-08-12 O O
11:41 O O
PM O O

Her B-test B-test
liver I-test I-test
function I-test I-test
tests I-test I-test
and O O
amylase B-test O
and O O
lipase B-test O
were O O
followed O O
closely O O
. O O

POST-BYPASS B-treatment O
: O O
LV B-test O
and I-test O
RV I-test O
function I-test O
is O O
unchanged O O
. O O

Brief O O
Hospital O O
Course O O
: O O

Sensation O O
was O O
intact O O
to O O
light B-test O
touch I-test O
, O O
pin B-test B-treatment
prick I-test I-treatment
, O O
and O O
proprioception B-test B-treatment
. O O

PAST O O
MEDICAL O O
HISTORY O O
: O O

Tongue O O
was O O
midline O O
. O O

Discharge O O
Date O O
: O O

Sepsis B-problem O
risk I-problem O
factors I-problem O
: O O

The O O
patient O O
presented O O
with O O
a O O
chief O O
complaint O O
of O O
SOB B-problem O
. O O

Admitting B-test B-test
creatinine I-test I-test
was O O
.7 O O
, O O
glucose B-test B-test
131 O O
, O O
white B-test B-test
blood I-test I-test
count I-test I-test
was O O
10,000 O O
, O O
hematocrit B-test B-treatment
was O O
40 O O
, O O
liver B-test O
enzymes I-test O
normal O O
range O O
. O O

Aspirin B-treatment B-test
325 O O
mg O O
PO O O
q.day O O
. O O

Supporting B-treatment O
tubes I-treatment O
and I-treatment O
lines I-treatment O
are O O
in O O
unchanged O O
position O O
and O O
the O O
patient O O
has O O
a B-treatment O
single I-treatment O
lead I-treatment O
pacemaker I-treatment O
projected O O
on O O
the O O
left O O
. O O

He O O
uses O O
alcohol O O
occasionally O O
. O O

Abd O O
: O O

Echo B-test O
: O O

8. O O
Oxybutynin B-treatment B-treatment
Chloride I-treatment I-treatment
5 O O
mg O O
Tablet O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Tablet O O
PO O O
QPM O O
( O O
once O O
a O O
day O O
( O O
in O O
the O O
evening O O
)). O O

Foley B-treatment O
was O O
also O O
discontinued O O
. O O

UA B-test O
showed O O
no O O
white O B-problem
blood O I-problem
cells O I-problem
, O O
positive B-problem B-problem
granular I-problem I-problem
casts I-problem I-problem
. O O

Service O O
: O O

20. O O
Albuterol B-treatment B-treatment
90 O O
mcg/Actuation O O
Aerosol O O
Sig O O
: O O
4-6 O O
Puffs O O
Inhalation O O
Q6H O O
( O O
every O O
6 O O
hours O O
) O O
. O O

WIRES O O
, O O
PEANTSALL O B-problem
A O I-problem

Chest B-test O
x-ray I-test O
. O O

Studies B-test O
on O O
admission O O
revealed O O
the O O
following O O
: O O

None O O
. O O

indicated O O
THIAMINE B-treatment O
( I-treatment O
THIAMINE I-treatment O
HCL I-treatment O
) I-treatment O
100 O O
MG O O
PO O O
QD O O
SIMVASTATIN B-treatment O
40 O O
MG O O
PO O O
QHS O O

The O O
patient O O
denied O O
blurry B-problem O
vision I-problem O
, O O
headache B-problem B-treatment
, O O
nausea B-problem B-treatment
, O O
vomiting B-problem B-treatment
, O O
paresthesias B-problem B-treatment
, O O
pain B-problem B-treatment
in I-problem O
mental I-problem O
status I-problem O
, O O
confusion B-problem B-problem
or O I-problem
seizures B-problem I-problem
. O O

Total B-treatment O
abdominal I-treatment B-problem
hysterectomy I-treatment I-problem
. O O

Complex B-problem B-treatment
tear I-problem I-treatment
involving O I-treatment
the O I-treatment
posterior O I-treatment
Ellison O I-treatment
and O O
body O O
. O O

She O O
will O O
begin O O
weekly O O
follow-up O O
in O O
the O O
Transplant O O
Center O O
. O O

The O O
patient O O
is O O
a O O
58 O O
year O O
old O O
female O O
with O O
a O O
history O O
of O O
Parkinson B-problem B-treatment
&apos;s I-problem I-treatment
disease I-problem I-treatment
for O O
more O O
than O O
twenty O O
years O O
who O O
presented O O
to O O
the O O
Gemenadentoolpai O O
Medical O O
Center O O
with O O
a B-problem B-treatment
revolving I-problem I-treatment
anterolateral I-problem I-treatment
wall I-problem I-treatment
myocardial I-problem I-treatment
infarction I-problem I-treatment
on O O
08-01-93 O O
. O O

The O O
patient O O
had O O
an B-problem B-problem
elevated I-problem I-problem
bilirubin I-problem I-problem
on O O
admission O O
with O O
decreased B-problem O
output I-problem O
of O O
biliary B-treatment B-problem
drain I-treatment I-problem
. O O

Service O O
: O O

10. O O
Protonix B-treatment B-treatment
40 O O
mg O O
q. O O
day O O
. O O

D O O
: O O
2017-01-12 O O
11:35 O O

HISTORY O O
OF O O
PRESENT O O
ILLNESS O O
: O O

# O O
DISPO O O
: O O

3. O O
Right B-test O
ventricular I-test O
chamber I-test O
size I-test O
is O O
normal O O
. O O

Discharge O O
was O O
delayed O O
by O O
one O O
day O O
to O O
ensure O O
patient O O
could O O
tolerate O O
P.O. O O
which O O
patient O O
did O O
without O O
difficulty B-problem O
. O O

Goal O O
INR B-test O
01-31 O O
. O O

Home O O
Under O O
Care O O
Of O O
Home O O
Health O O
Agency O O

Sex O O
: O O

In O O
the O O
Juan O O
, O O
his B-test B-test
VS I-test I-test
were O O
97.8 O O
150/80 O O
88 O O
12 O O
89-94% O O
3L B-treatment O
NC I-treatment O
. O O

The B-test O
cardiac I-test O
monitor I-test O
showed O O
occasional B-problem B-problem
irregularities I-problem I-problem
in O I-problem
a B-treatment I-problem
PACED I-treatment I-problem
rhythm I-treatment I-problem
. O O

The O O
patient O O
did O O
go O O
to O O
operating O O
room O O
on O O
2014-04-04 O O
and O O
the O O
patient O O
had O O
cadaveric B-treatment B-treatment
liver I-treatment I-treatment
transplant I-treatment I-treatment
performed O O
by O O
Dr. O O
Michael O O
Sanders O O
. O O

She O O
had O O
a O O
normal O O
S1 O O
and O O
S2 O O
and O O
regular O O
rate O O
and O O
rhythm O O
with O O
no O O
murmurs B-problem B-problem
. O O

The O O
patient O O
is O O
a O O
retired O O
truck O O
driver O O
. O O

He O O
was O O
diuresed B-treatment O
and O O
ruled O O
out O O
for O O
myocardial B-problem B-problem
infarction I-problem I-problem
. O O

He O O
did O O
not O O
show O O
any O O
episodes O O
of O O
bradycardia B-problem O
throughout O O
the O O
remainder O O
of O O
his B-treatment O
hospital I-treatment O
course I-treatment O
. O O

Coronary B-problem O
Artery I-problem O
Disease I-problem O

DISPOSITION O O
: O O

The O O
right O O
lobe O O
was O O
within O O
normal O O
limits O O
. O O

DICTATING O O
FOR O O
: O O

BRIEF O O
RESUME O O
OF O O
HOSPITAL O O
COURSE O O
: O O

- O O
monitor O O
on O O
tele B-test O
overnight O O

He O O
was O O
diuresed O O
with O O
intravenous B-treatment B-treatment
Lasix I-treatment I-treatment
to O O
which O O
he O O
responded O O
with O O
at O O
lease O O
a O O
2L O O
urine B-test O
output I-test O
on O O
the O O
first O O
day O O
and O O
1.5L O O
the O O
second O O
day O O
. O O

No O O
evidence O O
of O O
extension B-problem B-problem
into I-problem I-problem
the I-problem I-problem
foramina I-problem I-problem
transversaria I-problem I-problem
. O O

PRINCIPAL O O
DISCHARGE O O
DIAGNOSIS O O
; O O

Report O O
Status O O
: O O

therapy B-treatment O
. O O

04/05/1999 O O
3:06 O O

Apgar B-test B-test
scores I-test I-test
were O O
6 O O
at O O
one O O
minute O O
and O O
8 O O
at O O
five O O
minutes O O
. O O

He O O
was O O
given O O
ativan B-treatment O
a O O
total O O
of O O
4 O O
mg O O
of O O
ativan B-treatment B-test
, O O
6 O O
mg O O
of O O
dilaudid B-treatment O
, O O
labetolol B-treatment B-test
20 O O
mg O O
IV O O
x O O
1 O O
and O O
hydralazine B-treatment B-test
10 O O
mg O O
IV O O
x O O
1 O O
without O O
good O O
response O O
( O O
200/99 O O
). O O

69 O O
y/o O O
female O O
wtih O O
PMH O O
significant O O
for O O
ESRD B-problem O
on O O
HD B-treatment O
, O O
type B-problem O
2 I-problem O
DM I-problem O
, O O
and O O
recent B-problem O
PE I-problem O
resulting O O
in O O
PEA B-problem O
arrest I-problem O
admitted O O
through O O
the O O
Juan O O
with O O
sepsis B-problem O
of O O
unknown O O
etiology O O
. O O

PANCREATIC B-problem B-problem
CANCER I-problem I-problem

Vital B-test B-test
signs I-test I-test
temperature B-test I-test
100.6 O O
. O O

STA O O
BODEJOVE O O
, O O
M.D. O O

699905656 O O
SC O O

Tracy O O
Doris O O
MD O O
79-274 O O

There O O
is O O
no O O
pneumothorax B-problem B-problem
. O O

Report O O
Status O O
: O O

STAGE O O
2 O O
OF O O
THE B-treatment O
SURGERY I-treatment O
WILL O O
BE O O
DONE O O
IN O O
3 O O
WEEKS O O
. O O

MEDICATIONS O O
ON O O
DISCHARGE O O
: O O

The O O
patient O O
is O O
, O O
therefore O O
, O O
discharged O O
after O O
a O O
three O O
day O O
hospitalization O O
, O O
with O O
plans O O
for O O
re-admission O O
for O O
the B-treatment B-problem
neuroradiology I-treatment I-problem
procedure I-treatment I-problem
. O O

COPD B-problem O
, O O
Prostate B-problem O
CA I-problem O

ALLERGIES O O
: O O

On O O
the O O
third O O
hospital O O
day O O
the B-problem O
patient I-problem O
's I-problem O
pain I-problem B-treatment
was O O
improving O O
and O O
the B-problem O
rebound I-problem O
was O O
decreasing O O
. O O

PHYSICAL O O
EXAM O O
on O O
admission O O
: O O

Craig O O
Douglas O O
MD O O
10-898 O O

HISTORY O O
AND O O
REASON O O
FOR O O
HOSPITALIZATION O O
: O O

He O O
smokes O O
one O O
pack O O
per O O
day O O
. O O

Batch O O
: O O

Left B-problem B-test
rib I-problem I-test
fracture I-problem I-test
. O O

Albumin B-test B-test
was O O
2.6 O O
. O O

DISCHARGE O O
DIAGNOSES O O
: O O

Discharge O O
Note O O

He O O
identified O O
no O O
bleeding B-problem O
source I-problem O
, O O
but O O
felt O O
that O O
the O O
risk O O
of O O
nasal B-problem O
hemorrhage I-problem O
on O O
Coumadin B-treatment O
could O O
be O O
minimized O O
interventional B-treatment O
neuroradiology I-treatment O
occlusion I-treatment O
of O O
the O O
arteries O O
to O O
the O O
nose O O
bilaterally O O
. O O

He O O
recieved O O
2L B-treatment O
NS I-treatment O
and O O
was O O
started O O
on O O
labetolol B-treatment O
gtt I-treatment O
and O O
BP B-test O
decreased O O
to O O
161/79 O O
. O O

CEALME O B-test
PAIN O I-test
, O O
M.D. O O

Report O O
Status O O
: O O

Discharge O O
Date O O
: O O

Bone O O
marrow O O
transplant O O
service O O

Physical O O
Exam O O
: O O

07/31/2000 O O
07:36 O O
PM O O

2013-05-24 O O
12:52 O O
AM O O
160 O O
* O O
86 O O
* O O
2.6 O O
* O O
148 O O
* O O
4.4 O O
115 O O
* O O
14 O O
* O O
1 O O
23 O O
* O O

SHe O O
has O O
a B-test O
culture I-test O
pending O O
which O O
needs O O
to O O
be O O
followed O O
up O O
at O O
the O O
nursing O O
home O O
and O O
treated O O
if O O
positive B-problem O
. O O

PAST O O
MEDICAL O O
HISTORY O O
: O O

Also O O
, O O
explained O O
which O O
meds B-treatment O
are O O
new O O
. O O

She O O
became O O
more O O
alert O O
during O O
the O O
remainder O O
of O O
the B-test O
exam I-test O
. O O

Pulses B-test O
were O O
2+ O O
bilaterally O O
. O O

There O O
was O O
no O O
rebound B-problem O
or O O
guarding B-problem O
. O O

Ext O O
: O O
no O O
c/c/e B-problem O

ED O O
DISCHARGE O O
NOTIFICATION O O
/ O O
SUMMARY O O

Lescol B-treatment O
40 O O
qd O O

PRINCIPAL O O
PROCEDURE O O
OR O O
OPERATION O O
: O O

PHYSICAL O O
EXAMINATION O O
: O O

HISTORY O O
OF O O
PRESENT O O
ILLNESS O O
: O O

He O O
was O O
out O O
of O O
bed O O
to O O
a O B-problem
chair O I-problem
. O O

TD O O
: O O

MEDICATIONS O O
: O O

TO O O
DO O O
/ O O
PLAN O O
: O O

HOSPITAL O O
COURSE O O
: O O

patient O O
had O O
difficulty B-problem O
with I-problem O
tandem I-problem O
gait I-problem O
and O O
fell O O
forward O O
while O O
standing O O
on O O
his O O
his O O
toes O O
. O O

Report O O
Status O O
: O O

Coronary B-problem B-problem
artery I-problem I-problem
disease I-problem I-problem
requiring O I-problem
surgical B-treatment I-problem
intervention I-treatment I-problem

Lopressor B-treatment O
5 O O
intravenously O O
q.4.h. O O

Edith O O
AI O O
. O O

There O O
was O O
no O O
evidence O O
of O O
any B-problem O
special I-problem O
neglect I-problem O
. O O

Last O O
week O O
it O O
was O O
worse O O
and O O
he O O
was O O
seen O O
in O O
clinic O O
. O O

D O O
: O O
2011-01-25 O O
14:08 O O

She O O
has O O
developed O O
bad B-problem O
thrush I-problem O
in O O
this O O
setting O O
, O O
she O O
is O O
not O O
yet O O
able O O
to O O
swallow O O
and O O
so O O
she O O
is O O
on O O
Nystatin B-treatment O
swish I-treatment O
and I-treatment O
spit I-treatment O
five O O
times O O
a O O
day O O
. O O

In O O
the O O
am O O
, O O
she O O
was O O
found O O
to O O
have O O
a B-test O
hct I-test O
of O O
24 O O
, O O
down O O
from O O
32 O O
and O O
plts B-test O
35 O O
, O O
down O O
from O O
72 O O
. O O

The B-treatment O
regimen I-treatment O
included O O
cyclophosphamide B-treatment O
, O O
daunorubicin B-treatment B-treatment
, O O
prednisone B-treatment O
, O O
Vincristine B-treatment B-treatment
and O O
PEG-asparaginase B-treatment B-problem
. O O

Dr O O
Miller O O
in O O
1 O O
week O O
( O O
262-575-0600 O O
) O O
please O O
call O O
for O O
appointment O O

Completed O O
by O O
: O O
Jane O O
Ashmore O O
MD O O
50-063 O O
2017-08-16 O O
@ O O
0950 O O

3) O O
Anemia B-problem B-treatment
. O O

For O O
follow O O
up O O
, O O
the O O
patient O O
is O O
to O O
call O O
for O O
an O O
appointment O O
with O O
Dr. O O
Sapmal O O
. O O

Spontaneous B-treatment O
Vertex I-treatment O
Vaginal I-treatment O
Delivery I-treatment O

The O O
patient O O
was O O
observed O O
overnight O O
without O O
any B-problem O
problems I-problem O
. O O

Notable O O
for O O
a O O
history O O
of O O
trigeminal B-problem B-problem
neuralgia I-problem I-problem
, O O
left B-treatment B-treatment
shoulder I-treatment I-treatment
surgery I-treatment I-treatment
, O O
fibrocystic B-problem B-treatment
breast I-problem I-treatment
disease I-problem I-treatment
, O O
endometriosis B-problem B-treatment
and O O
status O O
post O O
total B-problem B-problem
abdominal I-problem I-problem
hysterectomy I-problem I-problem
. O O

DISCHARGE O O
SUMMARY O O

DD O O
: O O

High O O
school O O
student O O

Social O O
History O O
: O O

motrin B-treatment B-test
400-600 O O
mg O O
every O O
8 O O
hours O O
as O O
needed O O
for O O
pain B-problem B-problem

Significant O O
for O O
her O O
father O O
, O O
who O O
died O O
at O O
50 O O
years O O
from O O
myocarditis B-problem O
. O O

2. O O
Undesired B-problem O
adiposity I-problem O
. O O

****** O O
DISCHARGE O O
ORDERS O O
****** O O

The O O
patient O O
had O O
no O O
further B-problem B-test
complaints I-problem I-test
and O O
on O O
2012-03-10 O O
, O O
his B-test B-treatment
white I-test I-treatment
blood I-test I-treatment
cell I-test I-treatment
count I-test I-treatment
was O O
2.3 O O
, O O
neutrophils B-test B-test
50% O O
, O O
bands B-test O
2% O O
, O O
lymphocytes B-test B-test
5% O O
, O O
monocytes B-test B-test
40% O O
, O O
and O O
blasts B-test O
1% O O
. O O

2014-03-10 O O
05:25 O O
PM O O
BLOOD B-test B-test
cTropnT B-test I-test
- O O
0.42 O O
* O O

no O O
, O O
tob O O
, O O
no O O
etoh O O
, O O
no O O
drugs O O

ALLERGIES O O
: O O

# O O
Recurrent B-problem O
ascites I-problem O
: O O
On O O
the O O
medical O O
floor O O
, O O
pt O O
had O O
a B-treatment B-treatment
large I-treatment I-treatment
volume I-treatment I-treatment
paracentesis I-treatment I-treatment
( O O
6 O O
liters O O
) O O
followed O O
by O O
replacement B-treatment O
with I-treatment O
albumin I-treatment B-problem
. O O

Yesterday O O
morning O O
, O O
he O O
developed O O
intermittent B-problem B-problem
substernal I-problem I-problem
chest I-problem I-problem
pain I-problem I-problem
with O O
radiation B-problem O
to I-problem O
the I-problem O
left I-problem O
shoulder I-problem O
that O O
worsened O O
with O O
any O O
activity O O
and O O
any O O
motion O O
of O O
his O B-problem
shoulders O I-problem
. O O

DISCHARGE O O
SUMMARY O O
NAME O O
: O O

MEDICATIONS O O
ON O O
ADMISSION O O
: O O

EFW B-test O
= O O
7# O O
. O O

His B-problem B-test
pain I-problem I-test
here O O
has O O
been O O
controlled O O
, O O
initially O O
on O O
Oxycontin B-treatment O
with O O
morphine B-treatment O
for O O
breakthrough B-problem B-problem
pain I-problem I-problem
. O O

He O O
also O O
has O O
a O O
diagnosis O O
of O O
interstitial B-problem B-problem
cystitis I-problem I-problem
and O O
more O O
significantly O O
has O O
a O O
history O O
of O O
coronary B-problem B-treatment
artery I-problem I-treatment
disease I-problem I-treatment
with O O
a B-test B-problem
recent I-test I-problem
catheterization I-test I-problem
, O O
supraventricular B-problem B-treatment
tachycardia I-problem I-treatment
, O O
and O O
a B-problem B-problem
progressive I-problem I-problem
mitochondrial I-problem I-problem
myopathy I-problem I-problem
. O O

The O O
patient O O
was O O
started O O
on O O
Florinef B-treatment O
for O O
concern O O
of O O
adrenal B-problem B-treatment
insufficiency I-problem I-treatment
; O O
however O O
, O O
she O O
was O O
hemodynamically O O
stable O O
that O O
morning O O
and O O
was O O
transferred O O
back O O
out O O
to O O
the O O
floor O O
. O O

Spontaneous O O
Episiotomy O O
: O O

If O O
you O O
need O O
additional O O
information O O
please O O
call O O
639-873-2993 O O
. O O

12. O O
Vicodin B-treatment B-treatment
5-500 O O
mg O O
1-2 O O
Tablets O O
PO O O
every O O
six O O
( O O
6 O O
) O O
hours O O
PRN O O

There O O
is O O
mild B-problem B-problem
regional I-problem I-problem
left I-problem I-problem
ventricular I-problem I-problem
systolic I-problem I-problem
dysfunction I-problem I-problem
. O O

He O O
was O O
given O O
bag B-treatment O
mask I-treatment O
ventilation I-treatment O
with O O
good O O
response O O
. O O

FLANK B-problem O
PAIN I-problem O
URI B-problem O
? O O

Then O O
again O O
on O O
Sunday O O
, O O
3 O O
days O O
PTA O O
, O O
again O O
from O O
sitting O O
to O O
standing O O
heard O O
his O O
knee O O
CMED O O
CCU O O
. O O

Index O O
No. O O
FXZQ7B8JJX O O

She O O
also O O
gets O O
Metamucil B-treatment O
one O O
teaspoon O O
with O O
the O O
first O O
bolus O O
of O O
juice B-treatment O
each O O
day O O
. O O

Head B-test O
CT I-test B-treatment
negative O O
. O O

The B-problem B-test
liver I-problem I-test
laceration I-problem I-test
was O O
stable O O
, O O
no O O
sign O O
of O O
rupture B-problem O
or O O
further B-problem B-problem
complication I-problem I-problem
, O O
did O O
not O O
required O O
surgical B-treatment O
managment I-treatment O
. O O

9lb O O
4 O O
oz O O
4196 O O
grams O O

Multiple O B-test
conversations O I-test
were O O
had O O
with O O
the O O
patient O O
as O O
well O O
as O O
an O O
interpreter O O
stating O O
the O O
importance O O
of O O
not O O
smoking O O
and O O
keeping O O
flames O O
away O O
from O O
his B-treatment O
oxygen I-treatment O
tank I-treatment O
. O O

Lives O O
with O O
son O O
who O O
is O O
very O O
involved O O
and O O
well O O
informed O O
regarding O O
her O O
care O O
needs O O
. O O

Abnormal B-problem O
Pap I-problem O
Test I-problem O
, O O
history O O
of O O

Please O O
conitnue O O
to O O
keep O O
hands O O
elevated O O
in O O
bed O O
until O O
follow O O
up O O
appointment O O
with O O
plastic O B-problem
surgery O I-problem
. O O

HEENT O O
: O O

Stable O O
Patient O O
States O O
Complaint O O
: O O

Date O O
/ O O
Time O O
: O O

This O O
area O O
can O O
be O O
a O O
leading O O
point O O
of O O
obstruction B-problem B-problem
. O O

Echo B-test O
- O O

Attending O O
:Jordan O O
U O O
Kostohryz O O
, O O
M.D. O O

HOSPITAL O O
COURSE O O
AND O O
TREATMENT O O
: O O

CT B-test B-test
of I-test I-test
the I-test I-test
abdomen I-test I-test
and I-test O
pelvis I-test O
showed O O
no O O
evidence O O
of O O
bleed B-problem O
. O O

REc&apos;d O O
duonebs B-treatment O
, O O
solumedrol B-treatment O
125 O O

6. O O
Ileus B-problem O
. O O

OTHER O O
DIAGNOSIS O O
; O O

Service O O
: O O

Admission O O
Date O O
: O O

2. O O
Respiratory O O
: O O

He O O
underwent O O
an B-test B-test
echocardiogram I-test I-test
, O O
which O O
showed O O
an B-test O
EF I-test O
of O O
60% O O
. O O

Ms. O O
Sterpkoteneish O O
is O O
a O O
69-year-old O O
woman O O
, O O
who O O
over O O
the O O
past O O
six O O
months O O
has O O
noted O O
increasing B-problem B-problem
pain I-problem I-problem
in I-problem I-problem
her I-problem I-problem
left I-problem I-problem
upper I-problem I-problem
quadrant I-problem I-problem
radiating O I-problem
to O O
the O O
back O O
. O O

Discharge O O
Diagnosis O O
: O O

The O O
patient O O
was O O
given O O
printed O O
instructions O O
for O O
abdominal B-problem B-problem
pain I-problem I-problem
( O O
English O O
) O O
. O O

388755206 O O
SC O O

He O O
did O O
have O O
burst B-problem O
of I-problem O
atrial I-problem B-treatment
fibrillation I-problem I-treatment
and O O
was O O
started O O
on O O
a B-treatment B-problem
Amiodarone I-treatment I-problem
gtt I-treatment O
. O O

Hypercholesterolemia B-problem O
. O O

TECHNIQUE O O
: O O
Non-contrast B-test B-problem
head I-test I-problem
CT I-test I-problem
. O O

The O O
patient O O
states O O
that O O
he O O
has O O
felt O O
" O O
cloudy B-problem O
" O O
of O O
late O O
which O O
seems O O
to O O
relate O O
to O O
his B-problem B-problem
worsening I-problem I-problem
SOB I-problem I-problem
. O O

PRINCIPAL O O
DIAGNOSIS O O
: O O

11) O O
Axid B-treatment O
150 O O
mg O O
p.o. O O
b.i.d. O O

pt O O
discharged O O
home O O
on O O
01-24 O O
with O O
instructions O O
to O O
complete O O
2 O O
week O O
course O O
of O O
vancomycin B-treatment O
at O O
hemodialysis B-treatment O
for O O
his B-problem B-problem
PORT I-problem I-problem
line I-problem I-problem
infection I-problem I-problem
. O O

DISCHARGE O O
PATIENT O O
ON O O
: O O

Meds B-treatment O
at O O
home O O
: O O
Coumadin B-treatment B-treatment
, O O
Levoxyl B-treatment B-treatment
, O O
Folate B-treatment O
, O O
Colace B-treatment B-treatment
, O O
Byetta B-treatment B-treatment
, O O
Verapamil B-treatment B-treatment
, O O
Lisinopril B-treatment B-treatment
, O O
Pravachol B-treatment B-treatment
, O O
Nexium B-treatment B-treatment
, O O
Lasix B-treatment B-treatment
, O O
Celexa B-treatment O

He O O
has O O
followed O O
this O O
family O O
in O O
the O O
past O O
and O O
will O O
see O O
her O O
in O O
follow-up O O
. O O

He O O
was O O
extubated O O
that O O
night O O
. O O

Sensation O O
is O O
intact O O
bilaterally O O
. O O

2. O O
Marinol B-treatment B-treatment
2.5 O O
mg O O
p.o. O O
b.i.d. O O
before O O
breakfast O O
and O O
dinner O O
. O O

Lungs O O
clear O O
. O O

ADMISSION O O
DATE O O
: O O

Disp O O
:* O O
180 O O
Tablet O O
, O O
Chewable O O
(s)* O O
Refills O O
:* O O
0 O O
* O O

Lungs O O
: O O
breath B-test O
sounds I-test O
clear O O
and O O
equal O O
bilaterally O O
, O O
no O O
retractions B-problem B-problem
. O O

9. O O
Ipratropium B-treatment B-treatment
Bromide I-treatment I-treatment
17 O O
mcg O O
/ O O
Actuation O O
Aerosol O O
Sig O O
: O O
Two O O
( O O
2 O O
) O O
Puff O O
Inhalation O O
Q4-6H O O
( O O
every O O
4 O O
to O O
6 O O
hours O O
) O O
as O O
needed O O
. O O

The O O
patient O O
is O O
a O O
67 O O
year O O
old O O
white O O
male O O
with O O
a O O
recent O O
history O O
of O O
urinary B-problem B-treatment
frequency I-problem I-treatment
Q2-3H O O
, O O
stranguria B-problem B-treatment
, O O
nocturia B-problem B-treatment
x O O
3-4 O O
per O O
night O O
. O O

Abdomen O O
was O O
gravid B-problem O
. O O

Blood B-test O
, I-test O
urine I-test B-treatment
and I-test O
sputum I-test B-problem
culutres I-test I-problem
were O O
sent O O
. O O

Neurological B-test B-test
exam I-test I-test
on I-test O
admission I-test O
revealed O O
he O O
was O O
drowsy B-problem O
but O O
easily O O
arousable O O
to O O
voice O O
, O O
oriented O O
to O O
person O O
, O O
Retelk O O
County O O
Medical O O
Center O O
, O O
and O O
date O O
, O O
able O O
to O O
say O O
no O O
but O O
mildly B-problem B-problem
inattentive I-problem I-problem
during O I-problem
examination B-test I-problem
. O O

She O O
was O O
transferred O O
here O O
for O O
further O O
care O O
. O O

Stable O O
. O O

PT B-test B-test
14.2 O O
, O O
PTT B-test B-test
108.5 O O
, O O
INR B-test O
1.3 O O
. O O

The O O
case O O
was O O
discussed O O
with O O
Dr. O O
Harold O O
from O O
the O O
Falmouth O O
Hospital O O
. O O

She O O
had O O
bilateral B-problem O
upgoing I-problem O
toes I-problem O
. O O

Extremities O O
: O O

Signed O O
electronically O O
by O O
: O O
DR. O O
Ruby O O
von O O
der O O
Smith O O
on: O O
WED O O
2015-12-09 O O
3:34 O O
PM O O

An B-test B-test
MRI I-test I-test
was O O
done O O
and O O
this O O
showed O O
a B-problem O
signal I-problem O
abno I-problem O
in I-problem O
L3 I-problem O
L4 I-problem O
? O O
disciitis B-problem O
vs O O
osteo B-problem O
without O O
a B-problem B-problem
definitive I-problem I-problem
epidural I-problem I-problem
abscess I-problem I-problem
. O O

Right B-treatment B-test
dialysis I-treatment I-test
catheter I-treatment I-test
( O O
2018-11-05 O O
) O O
was O O
changed O O
over O O
a B-treatment O
wire I-treatment O
2019-01-08 O O
. O O

6. O O
Atenolol B-treatment B-treatment
100 O O
mg O O
Tablet O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Tablet O O
PO O O
DAILY O O
( O O
Daily O O
) O O
. O O

He O O
tolerated O O
the B-treatment O
procedure I-treatment O
well O O
. O O

FREIERMPRATL O O
, O O
NI O O
L O O

COURSE O O
IN O O
HOSPITAL O O
: O O

T O O
: O O
2010-10-17 O O
17:21 O O

Batch O O
: O O

DISCHARGE O O
CONDITION O O
: O O

Facial O O
sensation O O
is O O
sensation O O
. O O

1. O O
No O O
evidence O O
of O O
pulmonary B-problem B-problem
embolism I-problem I-problem
. O O

2. O O
Lasix B-treatment B-treatment
. O O

8 O O
. O O

Dictated O O
By O O
: O O
Frances O O
P O O
Sheets O O
, O O
M.D. O O

LABORATORY O O
DATA O O
: O O

Freddy O O
Stephen O O
, O O
M.D. O O

3/6 B-problem O
systolic I-problem B-treatment
ejection I-problem I-treatment
murmur I-problem I-treatment
heard O O
best O O
at O O
the O O
apex O O
. O O

5. O O
The O B-problem
mitral O I-problem
valve O I-problem
leaflets O I-problem
are O I-problem
mildly B-problem I-problem
thickened I-problem I-problem
. O O

5. O O
Dilaudid B-treatment O
4 O O
mg O O
Tablet O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Tablet O O
PO O O
q3-4hr O O
prn O O
. O O

6. O O
There O O
is O O
moderate B-problem B-problem
pulmonary I-problem I-problem
artery I-problem I-problem
systolic I-problem I-problem
hypertension I-problem I-problem
. O O

Given O O
the O O
presence O O
of O O
consolidation B-problem O
on O O
chest B-test B-test
x-ray I-test I-test
, O O
however O O
, O O
and O O
previous O O
history O O
of O O
pneumonia B-problem B-treatment
, O O
the O O
patient O O
was O O
maintained O O
on O O
antibiotics B-treatment B-treatment
of O I-treatment
Zithromax B-treatment I-treatment
500 O O
mg O O
daily O O
and O O
ceftriaxone B-treatment O
. O O

4. O O
hypertrophic B-problem B-problem
obstructive I-problem I-problem
cardiomyopathy I-problem I-problem
, O O

There O O
is O O
no O O
family O O
history O O
of O O
parathyroid B-problem O
or I-problem O
thyroid I-problem O
diseases I-problem O
. O O

IMPRESSION O O
: O O
Linear B-problem B-problem
right I-problem I-problem
temporal I-problem I-problem
calvarial I-problem I-problem
fracture I-problem I-problem
extending O I-problem
into O I-problem
the O I-problem
mastoid O I-problem
process O I-problem
with O O
small B-problem B-problem
associated I-problem I-problem
right I-problem I-problem
posterior I-problem I-problem
convexity I-problem I-problem
subdural I-problem I-problem
hematoma I-problem I-problem
and O O
pneumocephalus B-problem O
. O O

The O B-test
right O I-test
upper O I-test
extremity O I-test
was O O
flaccid B-problem O
and O O
paresthetic B-problem B-problem
. O O

PAST O O
SURGICAL O O
HISTORY O O
: O O

Sensation O O
was O O
intact O O
in O O
the O O
median O O
, O O
radius O B-treatment
, O O
and O O
ulnar-nerve O B-problem
distributions O I-problem
. O O

Type B-problem O
II I-problem O
diabetes I-problem O
. O O

PAST O O
MEDICAL O O
HISTORY O O
: O O

CMED O O
service O O
was O O
consulted O O
and O O
recommended O O
wtd B-treatment O
woulnd I-treatment O
care I-treatment O
and O O
sling B-treatment O
at O O
all O O
times O O
. O O

No O O
retinal B-problem B-problem
hemorrhages I-problem I-problem
. O O

h.pylori B-treatment O
tx I-treatment O
. O O

ACE B-treatment B-test
inhibitors I-treatment I-test
, O O
possible O O
allergy B-problem O
to O O
barium B-treatment O
reported O O
by O O
the O O
patient O O
during O O
a B-treatment O
barium I-treatment O
swallow I-treatment O
25 O O
years O O
ago O O
. O O

The O O
patient O O
was O O
transferred O O
on O O
the O O
evening O O
of O O
2012-05-22 O O
to O O
the O O
ICU O O
given O O
persistent B-problem O
carbon I-problem O
dioxide I-problem O
retention I-problem O
and O O
respiratory B-problem B-problem
acidosis I-problem I-problem
and O O
the B-problem O
intermittent I-problem O
mental I-problem O
status I-problem O
changes I-problem O
. O O

Report O O
Status O O
: O O

Followup B-test O
radiograph I-test O
suggested O O

FAMILY O O
HISTORY O O
: O O

1) O O
HIV B-problem O
positive I-problem O
with O O
a B-test B-treatment
CD4 I-test I-treatment
count I-test I-treatment
of O O
74 O O
. O O

Lungs O O
were O O
clear O O
to O O
auscultation B-test B-problem
. O O

Attending O O
: O O

Admitted O O
for O O
diagnostic B-treatment B-treatment
/ I-treatment I-treatment
therapeutic I-treatment I-treatment
paracentesis I-treatment I-treatment
and O O
then O O
transferred O O
to O O
the O O
ICU O O
for O O
hypotension B-problem O
, O O
confusion B-problem B-treatment
and O O
anemia B-problem B-problem
. O O

Return O O
to O O
the O O
ED O O
for O O
worsening B-problem B-treatment
chest I-problem I-treatment
pain I-problem I-treatment
, O O
shortness B-problem B-treatment
of I-problem I-treatment
breath I-problem I-treatment
, O O
nausea B-problem B-treatment
/ O I-treatment
vomiting B-problem I-treatment
, O O
fever B-problem B-treatment
/ O I-treatment
chills B-problem I-treatment
, O O
weakness B-problem B-treatment
/ O I-treatment
dizziness/numbness B-problem I-treatment
, O O
or O O
any B-problem O
other I-problem O
problems I-problem O
. O O

Disp O O
:* O O
qs O O
* O O
Refills O O
:* O O
2 O O
* O O

ALLERGIES O O
: O O

She O O
required O B-problem
periodic B-treatment I-problem
repletion I-treatment I-problem
of I-treatment I-problem
her I-treatment I-problem
potassium I-treatment I-problem
. O O

3) O O
ONCOLOGY O O
: O O

HEENT O O
: O O

Transferred O O
to O O
floor O O
on O O
day O O
of O O
admission O O
with O O
no O O
acute B-problem O
medical I-problem O
issues I-problem O
; O O
awaiting O O
psych B-test O
eval I-test O
. O O

PAST O O
MEDICAL O O
HISTORY O O
: O O

PRINCIPAL O O
PROCEDURE O O
OR O O
OPERATION O O
: O O

Discharge O O
Date O O
/ O O
Time O O
: O O

Height B-test O
5 O O
&apos; O O
1 O O
&quot; O O
, O O
weight B-test O
138 O O
lb. O O

POSTPARTUM O O
RH O O
IMMUNE O O
GLOBULIN O O
: O O

Her O O
abdomen O O
was O O
benign O O
. O O

He O O
was O O
transferred O O
to O O
the O O
Ro O O
Woodma O O
Healthcare O O
for O O
further B-treatment O
cardiac I-treatment O
care I-treatment O
. O O

PLAN O O
FOR O O
FOLLOWUP O O
: O O

2) O O
Linear B-problem B-problem
right I-problem I-problem
temporal I-problem I-problem
calvarial I-problem I-problem
fracture I-problem I-problem
extending O I-problem
into O I-problem
the O I-problem
mastoid O I-problem
with O O
a B-problem B-treatment
small I-problem I-treatment
right I-problem I-treatment
posterior I-problem I-treatment
convexity I-problem I-treatment
subdural I-problem I-treatment
hematoma I-problem I-treatment
and O O
pneumocephalus B-problem O
; O O
see O O
head B-test O
CT I-test B-problem
report O I-problem
. O O

The B-test O
left I-test O
ventricular I-test O
cavity I-test O
is O O
small O O
. O O

Vitals B-test O
: O O
99.3 O O
67 O O
( O O
60-70 O O
) O O
99/53 O O
( O O
90-100 O O
s) O O
96% O O
on O O
RA O O
3.7L O O
+ O O
LOS O O

Discharge O O
Medications O O
: O O

General B-test B-test
exam I-test I-test
revealed O O
a O O
well-developed O O
, O O
well-nourished O O
gentleman O O
in O O
no O O
acute B-problem B-problem
distress I-problem I-problem
. O O

His B-treatment B-test
NPH I-treatment I-test
was O O
recently O O
increased O O
today O O
( O O
10/23/97 O O
) O O
to O O
24 O O
units O O
in O O
the O O
a.m. O O
and O O
14 O O
units O O
in O O
the O O
p.m. O O
with O O
CZI B-treatment B-problem
sliding-scale I-treatment I-problem
coverage I-treatment I-problem
. O O

1. O O
Small B-problem B-treatment
cirrhotic I-problem I-treatment
liver I-problem I-treatment
with O O
what O O
appears O O
to O O
be O O
a B-treatment B-problem
portocaval I-treatment I-problem
shunt I-treatment I-problem
. O O

PAST O O
MEDICAL O O
HISTORY O O
: O O

She O O
denies O O
any O O
fevers B-problem O
or O O
chills B-problem O
. O O

She O O
had O O
a B-problem B-problem
mildly I-problem I-problem
widened I-problem I-problem
right I-problem I-problem
palpable I-problem I-problem
fissure I-problem I-problem
. O O

7/31/2000 O O
12:00:00 O O
AM O O

Healthy-appearing O O
woman O O
, O O
in O O
no O O
acute B-problem B-problem
distress I-problem I-problem
. O O

Urinalysis B-test O
was O O
within O O
normal O O
limits O O
with O O
6 O O
to O O
10 O O
red B-test O
blood I-test B-problem
cells I-test I-problem
. O O

Telephone O O
#: O O

Fluticasone B-treatment O
/ O O
Salmeterol B-treatment O

IMPRESSION O O
: O O
No O O
new B-problem O
cortical I-problem B-problem
territorial I-problem I-problem
infarction I-problem I-problem
or O O
hemorrhage B-problem O
is O O
identified O O
. O O

Vital B-test B-test
signs I-test I-test
, O O
stable O O
. O O

Override O O
added O O
on O O
12/06/05 O O
by O O
BELB O O
, O O
BRITHERL O B-treatment
, O O
M.D. O O
on O O
order O O
for O O
ZOCOR B-treatment O
PO I-treatment O
( O O
ref O O
# O O
33033281 O O
) O O

She O O
received O O
a O O
total O O
of O O
4 O O
liters O O
of O O
NS B-treatment O
then O O
was O O
started O O
on O O
levophed B-treatment O
for O O
continued B-problem O
hypotension I-problem O
. O O

Abd O O
: O O
soft O O
, O O
+distension B-problem B-treatment
with O O
tympany B-problem O
, O O
no O O
HSM B-problem O
, O O
hyperactive B-problem O
BS I-problem O

His O B-test
liver O I-test
was O O
10 O O
cm O O
and O O
was O O
felt O O
three O O
finger O O
breadths O O
below O O
the O O
costal O O
margin O O
. O O

1. O O
Carotid B-problem B-problem
stenosis I-problem I-problem
. O O

Dicatated O O
By O O
: O O

Sex O O
: O O

Labs O O
on O O
admission O O
: O O

11/16/2005 O O
12:00:00 O O
AM O O

Her O O
gait O O
was O O
notable O O
for O O
requiring O O
assist O O
. O O

Discharge O O
Date O O
: O O

Treatment O O
Rendered O O
: O O

INTRAUTERINE B-problem O
PREGNANCY I-problem O
AT I-problem O
23 I-problem O
WEEKS I-problem O
. O O

Overall B-test B-problem
left I-test I-problem
ventricular I-test I-problem
systolic I-test I-problem
function I-test I-problem
is O O
mildly B-problem O
depressed I-problem O
. O O

Dictated O O
By O O
: O O
Lloyd O O
U. O O
King O O
, O O
M.D. O O

CT B-test B-problem
C-SPINE I-test I-problem
W/O O I-problem
CONTRAST O I-problem

ADMISSION O O
DATE O O
: O O

Urinalysis B-test O
from O O
October O O
21 O O
, O O
is O O
positive O O
for O O
Citrobacter B-problem O
susceptible O O
to O O
ciprofloxacin B-treatment B-treatment
, O O
gentamycin B-treatment B-treatment
, O O
nitrofurantoin B-treatment B-treatment
, O O
tetracycline B-treatment B-treatment
and O O
Bactrim B-treatment B-treatment
. O O

888428725 O O
RWH O O

WBC B-test B-test
- O O
11.4* O O
RBC B-test B-test
- O O
3.61* O O
Hgb B-test B-test
- O O
11.4* O O
Hct B-test B-test
- O O
32.6* O O
MCV B-test B-test
- O O
90 O O
MCH B-test B-treatment
- O O
31.7 O O

DISCHARGE O O
PATIENT O O
ON O O
: O O

455343475 O O
PUMC O O

23. O O
Gabapentin B-treatment B-treatment
300 O O
mg O O
Capsule O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Capsule O O
PO O O
BID O O
( O O
2 O O
times O O
a O O
day O O
) O O
. O O

The O O
patient O O
has O O
not O O
obtained O O
gynecologic B-treatment O
care I-treatment O
for O O
32 O O
years O O
until O O
April O O
2004 O O
when O O
an O O
increase O O
in O O
abdominal B-problem O
GERD I-problem O
and O O
urinary B-problem B-treatment
symptoms I-problem I-treatment
lead O O
her O O
to O O
initial O B-treatment
consultation O I-treatment
with O O
Dr. O O
Lentny O O
Farstnappsshee O O
in O O
Gobrew O O
Street O O
, O O
Denlandcobridclevena O B-treatment
, O O
West O B-problem
Virginia O I-problem
28880 O O
. O O

Well-appearing O O
female O O
without O O
distress B-problem O
on O O
admission O O
to O O
the O O
Newborn O O
Intensive O O
Care O O
Unit O O
. O O

CXR B-test O
also O O
showed O O
small B-problem B-treatment
pleural I-problem I-treatment
effusion I-problem I-treatment
and O O
attempt O O
was O O
made O O
to O O
tap B-treatment O
it O O
, O O
but O O
pt O O
did O O
not O O
tolerate O O
the B-treatment O
procedure I-treatment O
and O O
asked O O
that O O
it O O
be O O
deferred O O
. O O

Cardiac O O
: O O

It O O
was O O
believed O O
that O O
a B-test O
troponin I-test O
on O O
admission O O
in O O
addition O O
to O O
the B-problem O
wall I-problem O
motion I-problem O
abnormalities I-problem O
she O O
underwent O O
a B-problem O
non-Q I-problem O
wave I-problem O
myocardial I-problem O
infarction I-problem O
prior O O
to O O
resulted O O
in O O
her B-problem B-problem
current I-problem I-problem
cardiac I-problem I-problem
failure I-problem I-problem
. O O

4. O O
Ativan B-treatment B-treatment
1 O O
mg O O
Tablet O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Tablet O O
PO O O
q6h O O
prn O O
. O O

DISCHARGE O O
MEDICATIONS O O
: O O

TR O O
: O O

Signed O O
electronically O O
by O O
: O O
DR. O O
Kevin O O
Arthur O O
on O O
: O O
Tony O O
2012-01-27 O O
6:52 O O
AM O O

DIFFERENTIAL B-test O
Neuts B-test O
Bands B-test O
Lymphs B-test O
Monos B-test O
Eos B-test O
Baso B-test O
Atyps B-test O
Metas B-test O

- O O
Procrit B-treatment B-treatment
40,000 O O
units O O
SC O O
q O O
Friday O O

PHYSICAL O O
EXAMINATION O O
: O O

Pertinent O O
Results O O
: O O

Disp O O
: O O
*28 O O
Capsule O O
, O O
Sustained O O
Release( O O
s O O
)* O O

He O O
was O O
therefore O O
transferred O O
to O O
Saints O O
Medical O O
Center O O
for O O
endoscopic B-test B-problem
retrogram I-test I-problem
cholangiopancreatography I-test I-problem
. O O

Chest O O
clear O O
to O O
auscultation B-test B-treatment
bilateral O I-treatment
, O O
S1 O O
S2 O O
normal O O
and O O
with O O
no O O
murmors B-problem B-problem
. O O

Sex O O
: O O

The O O
patient O O
was O O
discharged O O
home O O
early O O
from O O
this O O
admission O O
due O O
to O O
family O O
needs O O
. O O

PERCOCET B-treatment B-test
, O O
IV B-treatment O
Contrast I-treatment O
, O O
LISINOPRIL B-treatment O
, O O
ATENOLOL B-treatment O

15. O O
Dolasetron B-treatment B-treatment
Mesylate I-treatment I-treatment
12.5 O O
mg O O
IV O O
Q8H O O
: O O
PRN O O

Anesthesia O O
: O O

Discharge O O
Status O O
: O O

Temperature B-test B-test
35.4 O O
Celsius O B-treatment
, O O
blood B-test B-test
pressure I-test I-test
116/63 O O
, O O
pulse B-test B-test
105 O O
, O O
respiratory B-test B-treatment
rate I-test I-treatment
18 O O
, O O
oxygen B-test B-treatment
saturation I-test I-treatment
98% O O
on O O
room O O
air O O
. O O

Gastritis B-problem O
and O O
duodenitis B-problem O
. O O

10. O O
Gastrointestinal B-problem O
bleed I-problem O

RIGHT B-problem O
HIP I-problem O
, I-problem O
OSTEOARTHRITIS I-problem O
. O O

Signed O O
electronically O O
by O O
: O O
DR. O O
Jermaine O O
X O O
Reynolds O O
on O O
: O O
Andrea O O
2016-06-30 O O
3:46 O O
PM O O

1 O O
+ O O
DP B-test O
pulses I-test O
BL O O

ASSESSMENT O O
: O O

10. O O
Epogen B-treatment O
5000 O O
units O O
two O O
times O O
weekly O O
, O O
on O O
Monday O O
and O O
Thursday O O
. O O

Follow O O
up O O
Service O O
: O O

The O O
patient O O
was O O
given O O
250 O O
cc O O
of O O
normal B-treatment O
saline I-treatment O
and O O
her B-test B-treatment
blood I-test I-treatment
pressure I-test I-treatment
responded O O
coming O O
back O O
up O O
to O O
the O O
high O O
90 O O
s. O O

He O O
had O O
a O O
history O O
of O O
alcohol O O
abuse O O
but O O
has O O
been O O
sober O O
for O O
30 O O
years O O
. O O

Physical O O
Exam O O
: O O

HISTORY O O
OF O O
PRESENT O O
ILLNESS O O
: O O

PRINCIPAL O O
DIAGNOSIS O O
: O O

On O O
the O O
night O O
of O O
05-01 O O
, O O
the O O
patient O O
complained O O
of O O
increased B-problem B-problem
vomiting I-problem I-problem
. O O

6. O O
Type B-problem O
1 I-problem O
diabetes I-problem B-treatment
mellitus I-problem I-treatment
with O O
triopathy B-problem O
, O O
retinopathy B-problem O
, O O
neuropathy B-problem O
, O O
nephropathy B-problem O
. O O

ABG B-test O
done O O
on O O
FiO2 B-treatment O
100% O O
7.36/66/417/98% O O
. O O

WILL O O
D O O
/ O O
C O O
ORDER O O
BE O O
USED O O
AS O O
THE O O
D O O
/ O O
C O O
SUMMARY O O
: O O

PROSTATE B-problem O
CANCER I-problem O
AND O O
RENAL B-problem O
FAILURE I-problem O

Discharge O O
Status O O
: O O

Acute B-problem O
respiratory I-problem O
failure I-problem O

12/07/2004 O O
22:57 O O

He O O
was O O
started O O
on O O
finsateride B-treatment O
on O O
the O O
day O O
prior O O
to O O
admission O O
. O O

Syncope B-problem O
. O O

Right B-problem O
capsular I-problem B-problem
putamenal I-problem I-problem
hemorrhage I-problem I-problem
. O O

tylenol B-treatment B-test
PRN O I-test
lisinopril B-treatment I-test
5 O O
mg O O
PO O O
qd O O
protonix B-treatment B-treatment
20 O O
mg O O
PO O O
qd O O
artifical B-treatment B-treatment
tears I-treatment I-treatment
bid O I-treatment
metoprolol B-treatment I-treatment
25 O O
mg O O
PO O O
bid O O

Chest B-test B-test
CT I-test I-test
showed O O
bibasilar B-problem B-problem
diffuse I-problem I-problem
infiltrates I-problem I-problem
, O O
PCP B-test O
was O O
negative O O
. O O

The O O
patient O O
was O O
then O O
switched O O
to O O
po B-treatment O
etidronate I-treatment O
. O O

He O O
had O O
5 O O
out O O
of O O
5 O O
strength O O
diffusely O O
, O O
normal O O
deep O O
tendon O O
reflexes O O
and O O
normal O O
sensation O O
. O O

Reason O O
for O O
override O O
: O O

16. O O
medication B-treatment B-problem

Epidural B-treatment O
Vaginal O O
delivery O O
: O O

Chief O O
Complaint O O
: O O

5. O O
Lovenox B-treatment B-test
40 O O
mg O O
/ O O
0.4 O O
mL O O
Syringe O O
Sig O O
: O O
0.4 O O
ML O O
's O O
Subcutaneous O O
once O O
a O O
day O O
for O O
30 O O
days O O
. O O

Ocufen B-treatment B-test
0.03% O O
1 O O
GTT O O
OD O O
t.i.d. O O
Vasotec B-treatment B-test
20 O O
mg. O O
p.o.q. O O
a.m. O O
Prozac B-treatment B-treatment
40 O O
mg.p.o.q. O O
a.m. O O

3. O O
Pramipexole B-treatment B-treatment
0.125 O O
mg O O
Tablet O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Tablet O O
PO O O
TID O O
( O O
3 O O
times O O
a O O
day O O
) O O
. O O

- O O
Albuterol B-treatment B-treatment
/ O O
Atrovent B-treatment O
nebs O O
q4 O O

weeks O O
. O O

He O O
underwent O O
flap B-test O
checks I-test O
every O O
15 O O
minutes O O
initially O O
with O O
a B-treatment B-problem
dextran I-treatment I-problem
infusion I-treatment I-problem
. O O

DD O O
: O O

She O O
was O O
gently O O
diuresed O O
towards O O
her O O
pre-op O O
weight O O
. O O

Discharge O O
Date O O
: O O

Discharge O O
Status O O
: O O

These B-treatment O
dressing I-treatment O
changes I-treatment O
are O O
applied O O
by O O
applying O O
the O O
Xeroform B-treatment O
on O O
Betadine B-treatment O
initially O O
and O O
then O O
changing O O
it O O
with O O
sterile B-treatment O
dry I-treatment O
bandages I-treatment O
. O O

DR. O O
Michael O O
Z O O
Waldroup O O
on O O
: O O

He O O
will O O
need O O
to O O
continue O O
on O O
Lovenox B-treatment O
injections I-treatment O
for O O
at O O
least O O
4-6 O O
weeks O O
. O O

The O O
patient O O
was O O
initially O O
started O O
on O O
nasal B-treatment O
prong I-treatment O
CPAP I-treatment O
at O O
6 O O
and O O
required O O
additional B-treatment O
oxygen I-treatment O
to O O
35% O O
. O O

On O O
post-op O O
day O O
#3 O O
, O O
the B-treatment O
patient I-treatment O
's I-treatment O
pacing I-treatment O
wires I-treatment O
were O O
removed O O
, O O
and O O
his B-treatment B-problem
lopressor I-treatment I-problem
was O O
started O O
. O O

Major O O
Surgical O O
or O O
Invasive O O
Procedure O O
: O O

Abdomen O O
soft O O
, O O
nontender B-problem O
and O O
distended B-problem O
. O O

Admission O O
Date O O
: O O

CONDITION O O
ON O O
DISCHARGE O O
: O O

No O O
carotid B-problem B-treatment
bruits I-problem I-treatment
were O O
noted O O
. O O

Report O O
Status O O
: O O

To O O
home O O
. O O

Non-toxic B-problem O
multinodular I-problem O
goiter I-problem O
. O O

There O O
is O O
also O O
a B-problem B-problem
left I-problem I-problem
occipital I-problem I-problem
scalp I-problem I-problem
contusion I-problem I-problem
but O O
no O O
associated B-problem B-problem
skull I-problem I-problem
fracture I-problem I-problem
. O O

HEENT O O
: O O

Postoperatively O O
, O O
the O O
patient O O
did O O
well O O
and O O
was O O
able O O
to O O
cough O O
and O O
phonate O O
completely O O
with O O
no O O
changes B-problem O
from O O
preoperative O O
. O O

The B-treatment O
percutaneous I-treatment B-treatment
endoscopic I-treatment I-treatment
gastrostomy I-treatment I-treatment
was O O
unsuccessful O B-treatment
, O O
and O O
the B-treatment O
procedure I-treatment O
was O O
converted O O
to O O
an B-treatment O
open I-treatment O
gastrostomy I-treatment O
tube I-treatment O
which O O
then O O
proceeded O O
without O O
complications B-problem O
. O O

CA O O
SHUFF O O
, O O
M.D. O O

Service O O
: O O
CARDIOTHORACIC O B-problem

4. O O
Anterior B-treatment B-problem
instrumentation I-treatment I-problem
L3-L4 I-treatment O
. O O

HOSPITAL O O
COURSE O O
: O O

HOSPITAL O O
COURSE O O
: O O

Code O O
- O O
FC O O

Date O O
of O O
Birth O O
: O O

Follow O O
up O O
Service O O
: O O

She O O
was O O
noted O O
to O O
have O O
mild B-problem B-treatment
cataracts I-problem I-treatment
, O O
possibly O O
due O O
to O O
chronic B-treatment B-treatment
steroids I-treatment I-treatment
, O O
as O O
well O O
as O O
a B-problem B-treatment
subtle I-problem I-treatment
temporal I-problem I-treatment
disc I-problem I-treatment
pallor I-problem I-treatment
OD I-problem O
, O O
possibly O O
due O O
to O O
previous O O
episode O O
of O O
optic B-problem B-problem
neuritis I-problem I-problem
. O O

Family O O
History O O
: O O

Discharge O O
Disposition O O
: O O

2. O O
Levoxyl B-treatment O
50 O O
mcg O O
q.d. O O

REGISTRATION O O
DATE O O
: O O

54 O O
yo O O
F O O
with O O
Crohn B-problem B-treatment
's I-problem I-treatment
s/p O I-treatment
ileostomy B-treatment I-treatment
and O O
subsequent O O
short B-problem O
gut I-problem O
syndrome I-problem O
with O O
port-a-cath B-treatment O
placement I-treatment O
for O O
TPN B-treatment O
who O O
presents O O
with O O
progressive B-problem B-problem
right I-problem I-problem
sided I-problem I-problem
chest I-problem I-problem
pain I-problem I-problem
that O O
comes O O
in O O
waves O O
. O O

The O O
patient O O
was O O
afebrile B-problem O
, O O
her B-test B-treatment
vital I-test I-treatment
signs I-test I-treatment
were O O
stable O O
and O O
she O O
maintained O O
a O O
good O O
urine B-test O
output I-test O
. O O

The O O
patient O O
was O O
found O O
to O O
have O O
stable O O
hemodynamics O O
with O O
appropriate O O
mixed O O
venous B-test O
saturations I-test O
in O O
the O O
70% O O
range O O
. O O

( O O
End O O
of O O
Report O O
) O O

History O O
of O O
Present O O
Illness: O O

Discharge O O
Wt O O
1645 O O
gms O O
. O O

4. O O
SUTENT B-treatment B-treatment
50 O O
mg O O
Capsule O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Capsule O O
PO O O
Every O O
other O O
day O O
: O O
Please O O
restart O O
on O O
Wallace O O
, O O
06-24 O O
. O O

s/p O O
Pedestrian O O
struck O O
by O O
auto O O

Lungs O O
: O O
CTAB O O
, O O
coarse B-problem O

DOCTOR O O
&apos;S O O
DISCHARGE O O
ORDERS O O
: O O

He O O
lives O O
by O O
himself O O
in O O
Tennessee O O
. O O

The O O
patient O O
also O O
complained O O
of O O
intermittent B-problem B-treatment
right I-problem I-treatment
neck I-problem I-treatment
swelling I-problem I-treatment
, O O
and O O
recommendations O O
are O O
to O O
consider O B-problem
a B-test I-problem
CT I-test I-problem
scan I-test I-problem
with I-test O
contrast I-test O
to O O
evaluate O O
nodes B-problem O
in I-problem O
his I-problem O
neck I-problem O
. O O

Sex O O
: O O

The O O
patient O O
was O O
begun O O
on O O
Nafcillin B-treatment O
due O O
to O O
continued O O
spiking O O
. O O

Please O O
stay O O
on O O
top O O
of O O
the B-treatment O
sliding I-treatment O
scale I-treatment O
so O O
that O O
the O O
patient O O
can O O
keep O O
a O B-problem
euglycemic O I-problem
level O I-problem
. O O

His O O
mother O O
is O O
in O O
her O O
50 O O
s O O
and O O
has O O
hypertension B-problem B-problem
. O O

11. O O
status O O
post O O
cataract B-treatment O
surgery I-treatment O
, O O

The B-treatment O
aortic I-treatment O
prosthesis I-treatment O
leaflets I-treatment O
appear O O
to O O
move O O
normally O O
. O O

regular O O
rate O O
and O O
rhythm O O
, O O
without O O
ectopy B-problem O
. O O

5) O O
Prednisone B-treatment O
5 O O
mg O O
p.o. O O
q.o.d. O O

She O O
has O O
been O O
seen O O
by O O
Dr. O O
Tokbelb O O
, O O
her O O
primary O O
care O O
physician O O
in O O
Itgreenredan O O
Hospital O O
, O O
and O O
also O O
Dr. O O
Kotefyfechird O O
, O O
her O B-test
cardiologist O I-test
, O O
and O O
also O O
an O O
endocrinologist O O
at O O
Retelk O O
County O O
Medical O O
Center O O
. O O

His B-test B-test
platelet I-test I-test
count I-test I-test
was O O
267 O O
. O O

NONCONTRAST B-test B-test
CERVICAL I-test I-test
SPINE I-test I-test
CT I-test I-test
: O O
There O O
are O O
minimally B-problem O
displaced I-problem O
and I-problem O
comminuted I-problem B-treatment
fractures I-problem I-treatment
through I-problem I-treatment
the I-problem I-treatment
left I-problem I-treatment
C7 I-problem I-treatment
and I-problem O
T1 I-problem O
transverse I-problem O
processes I-problem O
. O O

2. O O
Cardiomyopathy B-problem B-treatment
. O O

REVIEW O O
OF O O
SYSTEMS O O
: O O

His B-test B-test
blood I-test I-test
cultures I-test I-test
and O O
chest B-test B-treatment
X-ray I-test I-treatment
were O O
negative O O
. O O

The O O
patient O O
was O O
switched O O
to O O
ampicillin B-treatment B-treatment
, O O
gentamicin B-treatment B-treatment
, O O
and O O
clindamycin B-treatment B-treatment
, O O
according O O
to O O
the B-test O
culture I-test O
, O O
Enterococci B-problem B-treatment
and O O
Staphylococcus B-problem O
in O O
the B-problem O
wound I-problem O
. O O

cholecystectomy B-treatment O
, O O
total B-treatment B-problem
abdominal I-treatment I-problem
hysterectomy I-treatment I-problem
, O O
cataract B-treatment B-problem
excision I-treatment I-problem
. O O

Attending O O
: O O

Food O O
/ O O
Drug O O
Interaction O O
Instruction O O

The B-test O
patient I-test O
&apos;s I-test O
admission I-test O
chest I-test O
x-ray I-test O
revealed O O
no O O
infiltrate B-problem O
, O O
no O O
congestive B-problem B-problem
heart I-problem I-problem
failure I-problem I-problem
. O O

Levothyroxine B-treatment O
100 O O
mcg O O
PO O O
daily O O

Chief O O
Complaint O O
: O O

He O O
stayed O O
in O O
the O O
unit O O
for O O
about O O
one O O
day O O
. O O

A/P O O
: O O

Over O O
the O O
past O O
4-5 O O
weeks O O
her B-problem O
functional I-problem O
level I-problem O
has O O
progressively O O
deteriorated O O
. O O

There O O
is O O
no O O
ventricular B-problem B-problem
septal I-problem I-problem
defect I-problem I-problem
. O O

No O O
dictated O O
summary O O

Discharge O O
Diagnosis O O
: O O

Peterson O O
ver O O
Vasquez O O
MD O O
07-506 O O

Past O O
Medical O O
History O O
: O O

Ext O O
: O O

The O O
ventricles O O
, O O
cisterns O B-treatment
and O O
sulci O O
are O O
normal O O
. O O

Provider O O
: O O

In O O
addition O O
, O O
his B-test B-problem
cyclosporin I-test I-problem
levels I-test I-problem
were O O
checked O O
. O O

These O O
were O O
seen O O
best O O
in O O
gradient B-test B-problem
echocardiogram I-test I-problem
images I-test I-problem
. O O

PRIMARY O O
DIAGNOSIS O O
: O O

Retazepine B-treatment B-test
50 O O
mg O O
q O O
h.s. O O

Testosterone B-treatment B-test
4 O O
mg O O
q. O O
24 O O
hours O O
. O O

Pt O O
was O O
therefore O O
discharged O O
home O O
in O O
stable O O
condition O O
, O O
voiding O O
, O O
ambulating O B-treatment
and O O
eating O O
without O O
difficulty O O
. O O

Socially O O
he O O
drinks O O
alcohol O O
. O O

She O O
was O O
able O O
to O O
move O O
all O O
four O O
of O O
her O O
extremities O O
in O O
response O O
to O O
pain B-test B-treatment
. O O

Delivery O O
date O O
: O O

Discharge O O
Diagnosis: O O

PAST O O
MEDICAL O O
HISTORY O O
: O O

HEENT B-test B-test
examination I-test I-test
was O O
normocephalic O O
and O O
atraumatic B-problem B-problem
. O O

Radical B-treatment B-test
retropubic I-treatment I-test
prostatectomy I-treatment I-test
, O O
bilateral B-treatment B-problem
lymph I-treatment I-problem
node I-treatment I-problem
dissection I-treatment I-problem
. O O

Patient O O
continued O O
getting O O
Acyclovir B-treatment O
, O O
Prednisone B-treatment B-treatment
, O O
MMF B-treatment O
one O O
gram O O
b.i.d O O
. O O

The O O
heart O O
is O O
markedly B-problem O
enlarged I-problem O
. O O

Discharge O O
Instructions O O
: O O
may O O
shower O O
, O O
no O O
bathing O O
or O O
swimming O O
for O O
1 O O
month O O
no O O
creams B-treatment B-treatment
, O O
lotions B-treatment B-treatment
or O O
powders B-treatment O
to O O
any B-problem O
incisions I-problem O
no O O
driving O O
for O O
1 O O
month O O
no O O
lifting O O
> O O
10 O O
# O O
for O O
10 O O
weeks O O

Admission O O
Date O O
: O O

Protonix B-treatment B-test
20 O O
mg O O
q. O O
24 O O
hours O O
. O O

Atenolol B-treatment B-test
, O O
25 O O
mg O O
PO O O
qd O O
. O O

ALLERGIES O O
: O O

Allergies O O
: O O

The B-treatment O
intra-aortic I-treatment B-treatment
balloon I-treatment I-treatment
pump I-treatment I-treatment
was O O
discontinued O O
on O O
day O O
two O O
. O O

Food O O
/ O O
Drug O O
Interaction O O
Instruction O O

Patient O O
States O O
Complaint O O
: O O

Followup O O
Instructions O O
: O O

Urology B-test O
consultation I-test O
thinks O O
that O O
cystoscopy B-treatment O
would O O
not O O
add O O
any O O
benefit O O
to O O
the O O
management O O
and O O
only O O
would O O
consider O B-problem
a B-treatment I-problem
right I-treatment I-problem
nephrostomy I-treatment I-problem
if O I-problem
renal B-problem I-problem
function I-problem I-problem
failed O O
to O O
improve O O
. O O

A B-test B-test
bronchoscopy I-test I-test
was O O
done O O
and O O
there O O
was O O
blood B-problem O
found O O
in O O
the O O
upper O O
airways O O
but O O
no O O
evidence O O
of O O
blood B-problem O
in I-problem O
alveoli I-problem O
so O O
it O O
was O O
not O O
felt O O
to O O
be O O
DAH B-problem O
. O O

This O O
is O O
to O O
notify O O
you O O
that O O
your O O
patient O O
, O O
CIENNE O B-treatment
, O O
GUTAOI O O
arrived O O
in O O
the O O
Emergency O O
Department O O
at O O
Well O O
General O O
Hospital O O
on O O
12/19/2006 O O
08:13 O O
PM O O
. O O

IMPRESSION O O
: O O

Argatroban B-treatment B-test
was O O
started O O
abd O O
a B-test O
HIT I-test O
panel I-test O
was O O
sent O O
, O O
HIT B-test O
panel I-test O
was O O
positive B-problem O
. O O

Nicholas B-problem B-test
seizures I-problem I-test
, O O
no O O
LOC B-problem B-treatment
, O O
no O O
head B-problem O
or I-problem O
neck I-problem B-problem
trauma I-problem I-problem
. O O

Patient O O
States O O
Complaint O O
: O O

D O O
: O O
2012-11-12 O O
21:57 O O

The O O
patient O O
was O O
maintained O O
on O O
supplemental B-treatment O
oxygen I-treatment O
and O O
sputum O B-treatment
production O I-treatment
was O O
maximized O O
with O O
the O O
help O O
of O O
an B-treatment B-problem
Acapella I-treatment I-problem
device I-treatment I-problem
and O O
respiratory B-treatment B-problem
therapy I-treatment I-problem
. O O

These O O
findings O O
are O O
consistent O O
with O O
chronic B-problem B-problem
pancreatitis I-problem I-problem
with O O
pseudocyst B-problem O
formation I-problem O

2. O O
Aortic B-problem B-problem
stenosis I-problem I-problem
. O O

PROSTATE B-problem B-test
CANCER I-problem I-test
. O O

Report O O
Status O O
: O O

Maternal O O
transfer O O
: O O

Limited B-test O
examination I-test B-treatment
. O O

PAST O O
MEDICAL O O
HISTORY O O
: O O

Estradialol B-test O
pending O O
. O O

No O O
history O O
of O O
abnormal B-problem B-problem
Pap I-problem I-problem
smears I-problem I-problem
. O O

2017-09-03 O O
CK B-test B-test
- I-test O
MB I-test B-test
- O O
Not O O
Done O O
cTropnT B-test B-treatment
- O O
0.22 O O
* O O

Medications O O
on O O
Admission O O
: O O

He O O
was O O
given O O
Levo B-treatment O
750 O O
mg O O
PO O O
X1 O O
, O O
and O O
Flagyl B-treatment B-test
500 O O
mg O O
PO O O
X1 O O
. O O

Again O O
seen O O
are O O
subtle B-problem O
hypodensities I-problem O
within I-problem O
the I-problem O
periventricular I-problem O
white I-problem O
matter I-problem O
which O O
is O O
an O O
indication O O
of O O
chronic B-problem B-problem
microvascular I-problem I-problem
ischemic I-problem I-problem
changes I-problem I-problem
, O O
stable O O
. O O

Date O O
of O O
Birth O O
: O O

The B-treatment O
Lasix I-treatment B-treatment
drip I-treatment I-treatment
was O O
eventually O O
changed O O
to O O
IV B-treatment O
Lasix I-treatment B-treatment
boluses I-treatment I-treatment
, O O
with O O
a B-treatment B-treatment
net I-treatment I-treatment
diuresis I-treatment I-treatment
of O O
over O O
36 O O
liters O O
for O O
the O O
hospital O O
stay O O
. O O

Insulin-dependent B-problem B-test
diabetes I-problem I-test
mellitus I-problem I-test
, O O
lymphoma B-problem B-treatment
as O O
above O O
, O O
ulcerative B-problem B-problem
colitis I-problem I-problem
, O O
melanoma B-problem O
status O O
post O O
excision B-treatment O
in I-treatment O
right I-treatment B-treatment
upper I-treatment I-treatment
extremity I-treatment I-treatment
, O O
hypertension B-problem B-treatment
, O O
hypothyroidism B-problem B-treatment
, O O
congestive B-problem B-treatment
heart I-problem I-treatment
failure I-problem I-treatment
, O O
and O O
coronary B-problem B-problem
artery I-problem I-problem
disease I-problem I-problem
with O O
bypass B-treatment B-problem
grafting I-treatment I-problem
. O O

Estimated B-problem B-test
blood I-problem I-test
loss I-problem I-test
of O O
300 O O
cc O O
. O O

No O O
lymphadenopathy B-problem O
. O O

Dictated O O
By O O
: O O

Cath B-test O
revealed O O
severe B-problem O
3 I-problem O
vessel I-problem B-problem
disease I-problem I-problem
. O O

Neurosurgery O O
was O O
consulted O O
but O O
due O O
to O O
the B-problem O
severity I-problem O
of I-problem O
the I-problem O
bleed I-problem O
surgery B-treatment O
was O O
not O O
considered O O
an O O
option O O
. O O

2. O O
CMED B-treatment O
CCU I-treatment O
drops I-treatment O
. O O

TR O O
: O O

2019-06-14 O O
10:30 O O
AM O O
BLOOD O B-test
PT B-test I-test
- O O
11.2 O O
PTT B-test B-test
- O O
23.9 O O
INR(PT) B-test B-treatment
- O O
0.9 O O

Presented O O
w O O
/ O O
epigastric B-problem B-treatment
pain I-problem I-treatment
, O O
SOB B-problem O
at O O
work O O
. O O

POSTPARTUM O O
RETURN O O
APPOINTMENT O O
( O O
DAYS O O
) O O
: O O

The O O
patient O O
is O O
status O O
post O O
uterine B-treatment B-treatment
artery I-treatment I-treatment
embolization I-treatment I-treatment
on O O
2009-01-07 O O
secondary O O
to O O
fibroids B-problem O
. O O

CUCHSPARDCAMPMOTTELAMN O O
, O O
LARIN O O

He O O
was O O
taken O O
to O O
Wayskemedcalltown O B-problem
Talmi O I-problem
and O O
transferred O O
to O O
Heaonboburg O O
Linpack O O
Grant O O
Medical O O
Center O O
with O O
a B-test B-problem
computerized I-test I-problem
tomography I-test I-problem
scan I-test I-problem
showing O I-problem
a B-problem I-problem
1x2 I-problem I-problem
thalamic I-problem I-problem
capsular I-problem I-problem
hemorrhage I-problem I-problem
without O I-problem
superficial B-problem I-problem
mass I-problem I-problem
effect I-problem I-problem
. O O

VITALS B-test O
: O O
T B-test O
96.9 O O
, O O
BP B-test B-test
110/70 O O
, O O
HR B-test B-test
84 O O
, O O
RR B-test O
20 O O
, O O
Sat B-test O
97% O O
on O O
4L O O
. O O

ID O O
was O O
consulted O O
who O O
suggested O O
broad B-treatment O
spectrum I-treatment O
antibiotics I-treatment O
if O O
she O O
were O O
to O O
spike B-problem O
. O O

Magnesium B-test B-test
was O O
2.2 O O
. O O

Not O O
reviewed O O
with O O
patient O O
. O O

s/p O O
Pedestrian O O
Struck O O
by O O
Auto O O

After O O
transfer O O
to O O
the O O
floor O O
when O O
she O O
was O O
stable O O
. O O

ANERM O O
, O O
CHRETTA O B-problem

FOLLOW O O
UP O O
APPOINTMENT O O
( O O
S O O
) O O
: O O

He O O
went O O
to O O
the O O
Padrugmoff O O
Hospital O O
Emergency O O
Room O O
after O O
trying O O
nitroglycerin B-treatment O
at O O
home O O
. O O

Lungs O O
: O O
CTA O O
b/l O O

No O O
Restrictions O O

The O O
patient O O
is O O
to O O
return O O
to O O
the O O
ED O O
for O O
recurrent B-problem B-treatment
dizziness I-problem I-treatment
, O O
chest B-problem B-treatment
pain I-problem I-treatment
, O O
shortness B-problem B-problem
of I-problem I-problem
breath I-problem I-problem
or O I-problem
weakness B-problem I-problem
. O O

Age O O
: O O

prednisone B-treatment O
5 O O
mg O O
qday O O

CN O O
02-17 O O
grossly O O
intact O O
. O O

5. O O
Celexa B-treatment B-treatment
10 O O
mg O O
daily O O
. O O

Vasotec B-treatment B-test
40 O O
mg O O
q.day O O
, O O
Soma B-treatment B-test
1 O O
tablet O O
q.day O O
, O O
Demerolprn B-treatment B-treatment
, O O
Clonidine B-treatment B-treatment
. O O

Postoperative B-problem B-test
hypokalemia I-problem I-test
, O O
resolved O O
. O O

Discharge O O
Disposition O O
: O O

PHYSICAL O O
EXAMINATION O O
: O O

On O O
admission O O
, O O
a B-test B-test
CT I-test I-test
scan I-test I-test
of I-test O
the I-test O
head I-test O
with O O
and O O
without O O
contrast O O
was O O
performed O O
, O O
showing O B-treatment
a B-problem I-treatment
missing I-problem I-treatment
posterior I-problem I-treatment
arch I-problem I-treatment
at I-problem O
C-1 I-problem O
and O O
metallic B-treatment B-problem
clips I-treatment I-problem
at I-treatment O
the I-treatment O
craniocervical I-treatment O
junction I-treatment O
consistent O O
with O O
prior B-treatment B-problem
surgical I-treatment I-problem
intervention I-treatment I-problem
. O O

He O O
was O O
initially O O
treated O O
with O O
IV B-treatment B-test
Decadron I-treatment I-test
10 O O
mg O O
up O O
front O O
and O O
then O O
6 O O
mg O O
q6h. O O

The B-problem B-test
pain I-problem I-test
became O O
worse O O
over O O
the O O
next O O
few O O
minutes O O
to O O
07-12 O O
and O O
increased O O
to O O
10-12 O O
while O O
he O O
was O O
in O O
the O O
ambulance O O
. O O

Date O O
/ O O
Time O O
: O O
2019-07-03 O O
3:30 O O

Report O O
Status O O
: O O

The O O
patient O O
's O O
condition O O
on O O
discharge O O
was O O
stable O O
. O O

Recieved O O
nebulizer B-treatment O
treatments I-treatment O
post-op O O
in O O
the O O
ICU O O
, O O
after O O
successfully O O
extubated O O
. O O

The O O
baby O O
is O O
breastfeeding O O
well O O
. O O

Disp O O
:* O O
30 O O
Tablet O O
( O O
s O O
)* O O
Refills O O
:* O O
2 O O
* O O

Allergies O O
: O O

Family O O
History O O
: O O

Call O O
887 O O
415 O O
4220 O O
to O O
schedule O O
an O O
appointment O O
with O O
Orthopedics O O
for O O
late O O
November O O
. O O

The O O
Whidden O O
Memorial O O
Hospital O O
hospital O O
course O O
has O O
been O O
smooth O O
with O O
the O O
patient O O
progressively O O
improving O O
. O O

TO O O
DO O O
/ O O
PLAN O O
: O O

The O O
patient O O
presented O O
initially O O
to O O
Rehab O O
Hospital O O
of O O
the O O
Cape O O
& O O
Islands O O
Hospital O O
at O O
the O O
end O O
of O O
December O O
for O O
abdominal B-problem B-treatment
pain I-problem I-treatment
, O O
and O O
was O O
found O O
to O O
have O O
pancreatitis B-problem B-problem
. O O

Atrial B-problem B-test
fibrillation I-problem I-test
. O O

FAMILY O O
HISTORY O O
: O O

UNIT O O
NUMBER O O
: O O

Losartan B-treatment O
/ O O
Aspirin B-treatment B-problem
/ O I-problem
Lisinopril-Hctz B-treatment I-problem

Her B-treatment B-test
hemovac I-treatment I-test
drains I-treatment I-test
were O O
removed O O
on O O
postoperative O O
day O O
# O O
2 O O
as O O
was O O
her B-treatment B-problem
Foley I-treatment I-problem
catheter I-treatment I-problem
. O O

GLUCOSE B-test B-test
- O O
208 O O
* O O
UREA B-test B-test
N I-test I-test
- O O
21 O O
* O O
CREAT B-test B-test
- O O
1.3 O O
* O O
SODIUM B-test B-test
- O O
138 O O
POTASSIUM B-test B-test
- O O
4.2 O O
CHLORIDE B-test B-test
- O O
104 O O
TOTAL B-test B-test
CO2 I-test I-test
- O O
23 O O
ANION B-test O
GAP I-test O
- O O
15 O O

However O O
, O O
on O O
05-07-92 O O
there O O
was O O
a O O
a O O
question O O
of O O
a B-problem O
new I-problem O
event I-problem O
with O O
addition O O
to O O
the B-problem B-treatment
left I-problem I-treatment
upper I-problem I-treatment
extremity I-problem I-treatment
weakness I-problem I-treatment
, O O
some B-problem B-treatment
noted I-problem I-treatment
right I-problem I-treatment
upper I-problem I-treatment
and I-problem O
right I-problem B-problem
lower I-problem I-problem
extremity I-problem I-problem
discoordination I-problem I-problem
. O O

In O O
John O O
, O O
BP B-test B-test
80/60 O O
, O O
HR B-test O
80 O O
. O O

Sclera O O
were O O
anicteric B-problem O
. O O

Please O O
call O O
gynecology O O
clinic O O
at O O
150-5825 O O
to O O
arrange O O
for O O
follow O O
up O O
. O O

There O O
were O O
no O O
ventricular B-problem B-problem
premature I-problem I-problem
contractions I-problem I-problem
. O O

The O O
patient O O
was O O
started O O
on O O
levofloxacin B-treatment B-treatment
at O O
Newton-Wellesley O O
Hospital O O
for O O
a O O
question O O
of O O
UTI B-problem O
based O O
on O O
U/A B-test O
positive O O
for O O
WBC B-test B-problem
. O O

He O O
was O O
instructed O O
not O O
to O O
restart O O
these O O
until O O
seen O O
by O O
Dr. O O
Ercek O O
. O O

No O O
bruits B-problem O
appreciated O O
. O O

Abdm O O
: O O
soft O O
NT B-problem O
/ O O
ND B-problem O
/ O O
NABS O O

At O O
that O O
time O O
BP B-test O
was O O
attributed O O
to O O
abdominal B-problem B-treatment
pain I-problem I-treatment
and O O
inability O O
to O O
take O O
PO O O
meds O O
d/t O O
nausea B-problem B-problem
/ O I-problem
vomiting B-problem I-problem
. O O

Number O O
of O O
Doses O O
Required O O
( O O
approximate O O
) O O
: O O

The O O
patient O O
is O O
missing B-problem O
many I-problem O
teeth I-problem O
. O O

No O O
dictated O O
summary O O

ALEN O O
L O O
CREDKOTE O O
, O O
M.D. O O

Patient O O
expired O O
after O O
the B-treatment O
endotracheal I-treatment O
tube I-treatment O
was O O
withdrawn O O
at O O
6:40 O O
p.m. O O

Service O O
: O O

His B-test B-test
blood I-test I-test
pressure I-test I-test
was O O
220/110 O O
there O O
. O O

WILL O O
D O O
/ O O
C O O
ORDER O O
BE O O
USED O O
AS O O
THE O O
D O O
/ O O
C O O
SUMMARY O O
: O O

Albumin B-test B-test
2.3 O O
. O O

10. O O
Albuterol B-treatment B-treatment
sulfate I-treatment I-treatment
solution I-treatment I-treatment
q.05-15 O O
h. O O
p.r.n. O O
for O O
shortness B-problem B-problem
of I-problem I-problem
breath I-problem I-problem
. O O

T O O
: O O
2011-12-01 O O
13:20 O O

CT B-test B-problem
HEAD I-test I-problem
W/O I-test I-problem
CONTRAST I-test I-problem

He O O
should O O
also O O
be O O
encouraged O O
to O O
eat O O
as O O
much O O
as O O
possible O O
orally O O
in O O
addition O O
to O O
this B-treatment O
tube I-treatment O
feeds I-treatment O
and O O
aspiration B-treatment B-problem
precaution I-treatment I-problem
should O O
be O O
maintained O O
. O O

PAST O O
MEDICAL O O
HISTORY O O
: O O

He O O
did O O
drink O O
alcohol O O
three O O
drinks O O
per O O
day O O
, O O
no O O
withdrawal B-problem B-problem
symptoms I-problem I-problem
. O O

The O O
patient O O
is O O
discharged O O
to O O
home O O
in O O
good O O
condiiton O O
. O O

During O O
her O O
labor O O
she O O
encountered O O
the O O
following O O
complication O O
( O O
s O O
) O O
: O O

DISCHARGE O O
DATE O O
: O O

- O O
DM B-problem O
with O O
neuropathy B-problem O
. O O

The O O
patient O O
did O O
not O O
have O O
chest B-problem B-treatment
pain I-problem I-treatment
until O I-treatment
approximately O I-treatment
1-1/2 O O
years O O
ago O O
, O O
when O O
he O O
began O O
to O O
have O O
chest B-problem B-treatment
tightness I-problem I-treatment
( I-problem I-treatment
pressure I-problem I-treatment
) I-problem O
approximately O O
every O O
three O O
months O O
with O O
stress B-problem O
. O O

The B-test O
left I-test B-treatment
ventricular I-test I-treatment
inflow I-test I-treatment
pattern I-test I-treatment
suggests O I-treatment
a B-problem I-treatment
restrictive I-problem I-treatment
filling I-problem I-treatment
abnormality I-problem I-treatment
, O O
with O O
elevated B-problem B-problem
left I-problem I-problem
atrial I-problem I-problem
pressure I-problem I-problem
. O O

REVIEW O O
OF O O
SYSTEMS O O
: O O

HISTORY O O
OF O O
PRESENT O O
ILLNESS O O
: O O

He O O
describes O B-problem
mild B-problem I-problem
reflux I-problem I-problem
symptoms I-problem I-problem
at O O
night O O
. O O

FULL O O
CODE O O
. O O

Physical O O
Exam O O
: O O

Pathology B-test O
was O O
reviewed O O
revealing O B-problem
invasive B-problem I-problem
squamous I-problem I-problem
cell I-problem I-problem
carcinoma I-problem I-problem
. O O

Quinine B-treatment B-problem
gives O I-problem
her O I-problem
a B-problem I-problem
rash I-problem I-problem
. O O

It O O
was O O
felt O O
that O O
this B-test O
cardiac I-test B-problem
catheterization I-test I-problem
was O O
not O O
significantly O O
changed O O
from O O
his B-test B-problem
previous I-test I-problem
catheterization I-test I-problem
. O O

Nausea B-problem O
, O O
vomiting B-problem B-treatment
, O O
Abdominal B-problem B-problem
pain I-problem I-problem
, O O
distention B-problem B-problem
. O O

Sex O O
: O O

The O O
past O O
surgical O O
history O O
is O O
negative O O
. O O

OTHER O O
LABORATORIES O O
THAT O O
WERE O O
NOTABLE O O
: O O

Glaucoma B-problem O
. O O

10/24/2001 O O
10:07 O O

2014-04-23 O O
07:56 O O
AM O O

Sex O O
: O O

2/1/2000 O O
12:00:00 O O
AM O O

TD O O
: O O

Bilaterally O O
without O O
stridor B-problem O
. O O

SOCIAL O O
HISTORY O O
: O O

Previously O O
reported O O
interstitial B-problem O
edema I-problem O
has O O
resolved O O
. O O

Cranial O O
nerves O O
II O O
through O O
XII O O
grossly O O
intact O O
with O O
a B-problem O
slight I-problem O
deviation I-problem O
of I-problem O
the I-problem O
uvula I-problem O
and I-problem O
tongue I-problem O
to O O
the O O
right O O
. O O

He O O
has O O
had O O
no O O
significant O O
episode O O
of O O
tachycardia B-problem B-problem
or O I-problem
blood B-problem I-problem
pressure I-problem I-problem
alteration I-problem I-problem
during O O
the O O
final O O
days O O
of O O
hospitalization O O
. O O

There O O
will O O
be O O
further O O
addendum O O
. O O

Soft O O
palate O O
was O O
in O O
the O O
midline O O
and O O
moved O O
upward O O
nicely O O
, O O
but O O
did O O
not O O
respond O O
to O O
gag O O
. O O

Her O B-test
extremities O I-test
were O O
without O O
clubbing B-problem O
, O O
cyanosis B-problem B-treatment
, O O
edema B-problem B-treatment
, O O
or O O
rash B-problem O
; O O
there O O
were O O
some O O
older O O
hematomas B-problem O
in I-problem O
the I-problem O
bilaterally I-problem O
shins I-problem O
. O O

HEENT O O
: O O

Completed O O
by O O
: O O
Bristol O O
MD O O
47-191 O O
2017-10-10 O O
@ O O
1058 O O

7lb O O
4.8 O O
oz O O
3311 O O
grams O O

REGISTRATION O O
DATE O O
: O O

Chest O O
: O O
CTAB O O
- O O
w/r/r B-problem O

Once O O
consent O O
and O O
preoperative B-test B-treatment
evaluation I-test I-treatment
was O O
complete O O
, O O
he O O
was O O
taken O O
to O O
the O O
operating O O
room O O
. O O

he O O
states O O
he O O
gives O O
her O O
one O O
of O O
his O B-treatment
pensions O I-treatment
and O O
she O O
helps O O
him O O
with O O
medicines B-treatment O
etc O O
. O O

5. O O
Gabapentin B-treatment B-test
800 O O
mg O O
PO O O
QAM O O
, O O
1600 O O
mg O O
PO O O
Q3PM O O
, O O
1600 O O
mg O O
PO O O
QHS O O

ADMISSION O O
DATE O O
: O O

5-29-00 O O
: O O

Service O O
: O O

Transmitral B-test B-test
Doppler I-test I-test
and O O
tissue B-test O
velocity I-test O
imaging I-test O
are O O
consistent O O
with O O
Grade B-problem B-problem
III/IV I-problem I-problem
( I-problem I-problem
severe I-problem I-problem
) I-problem I-problem
left I-problem I-problem
ventricular I-problem I-problem
diastolic I-problem I-problem
dysfunction I-problem I-problem
. O O

5. O O
Hypertension B-problem B-treatment
. O O

There O O
is O O
mild B-problem B-problem
symmetric I-problem I-problem
left I-problem I-problem
ventricular I-problem I-problem
hypertrophy I-problem I-problem
. O O

Afib B-problem O
, O O
occasional B-treatment B-treatment
V-paced I-treatment I-treatment
, O O
rate B-test O
83 O O
bpm O O
. O O

The O O
patient O O
has O O
not O O
had O O
an O B-problem
CMED B-test I-problem
examination I-test I-problem
or O O
hearing B-test O
test I-test O
. O O

She O O
has O O
not O O
had O O
any O O
alcoholic O O
beverages O O
during O O
this B-problem O
pregnancy I-problem O
. O O

8. O O
Neoral B-treatment B-treatment
500 O O
mg O O
po O O
bid O O
. O O

CC O O
: O O

No O O
jugular B-problem B-problem
venous I-problem I-problem
distention I-problem I-problem
. O O

The O O
patient O O
underwent O O
an B-test O
adenosine I-test O
stress I-test O
test I-test O
, O O
where O O
he O O
exercised O O
for O O
4 O O
minutes O O
, O O
reaching O O
65% O O
of O O
predicted O O
heart O O
rate O O
. O O

He O O
was O O
subsequently O O
restared O O
on O O
Vancomycin B-treatment B-treatment
for O O
Corynebacterium B-problem O
in O O
blood B-test O
cx I-test O
from O O
Fri O O
; O O
Followup B-test O
cx I-test O
has O O
been O O
NGTD O O
. O O

Morphine B-treatment O
was O O
administered O O
to O O
insure O O
patient O O
's O O
comfort O O
. O O

Dr. O O
______________ O O
consulted O O
on O O
the O O
case O O
. O O

2) O O
Digoxin B-treatment B-treatment
0.125 O O
mg O O
p.o. O O
q. O O
AM O O
. O O

JEMSKOP O O
, O O
COT O O

FOLLOW O O
UP O O
: O O

3. O O
Lasix B-treatment B-treatment
40 O O
mg O O
PO O O
q.day O O
, O O

The O O
mitral O O
valve O O
leaflets O O
are O O
mildly B-problem O
thickened I-problem O
. O O

Admission O O
Date O O
: O O

On O O
admission O O
, O O
electrocardiogram B-test B-treatment
showed O O
less O O
than O O
1 O O
mm. O O
of O O
ST B-problem O
depression I-problem O
in I-problem O
V4 I-problem O
to I-problem O
V6 I-problem O
, O O
which O O
is O O
likely O O
the O O
patient O O
&apos;s O O
baseline O O
. O O

Aspirin B-treatment B-test
325 O O
mg O O
p.o. O O
every O O
day O O
. O O

PT B-test B-test
- O O
12.3 O O
PTT B-test B-test
- O O
26.1 O O
INR B-test O
( I-test O
PT I-test O
)- I-test O
1.0 O O

Prevertebral B-problem O
soft I-problem O
tissue I-problem O
swelling I-problem O
cannot O O
be O O
excluded O O
secondary O O
to O O
intubation B-treatment B-problem
. O O

He O O
is O O
not O O
ambulatory O O
and O O
is O O
very B-problem O
deconditioned I-problem O
secondary O O
to O O
several B-problem O
complications I-problem O
within O O
the O O
past O O
two O O
months O O
related O O
to O O
an B-problem B-problem
AICD I-problem I-problem
pocket I-problem I-problem
infection I-problem I-problem
. O O

Anoxic B-problem O
encephalopathy I-problem O

Signed O O
electronically O O
by O O
: O O
DR. O O
Juan O O
R. O O
RATAN O O
on O O
: O O
TUE O O
2010-03-02 O O
8:13 O O
PM O O

Diastolic B-problem O
rumble I-problem O
at I-problem O
the I-problem O
apex I-problem O
. O O

DISCHARGE O O
SUMMARY O O

Etiology O O
felt O O
most O O
likely O O
demand B-problem O
ischemia I-problem O
in O O
setting O O
of O O
original B-problem O
hypertensive I-problem O
urgency I-problem O
with O O
persistent B-problem B-treatment
elevation I-problem I-treatment
of I-problem O
trop I-problem O
02-08 O O
ESRD B-problem O
. O O

1. O O
Tuberculosis B-problem B-treatment
, O O
mother O O
was O O
treated O O
in O O
2001 O O
according O O
to O O
chart O O
with O O
subsequent O B-problem
negative O I-problem
chest B-test I-problem
x-ray I-test I-problem
, O O
and O O

DISCHARGE O O
INSTRUCTIONS O O
: O O

He O O
subsequently O O
did O O
well O O
, O O
with O O
a B-test B-treatment
repeat I-test I-treatment
hematocrit I-test I-treatment
of O O
34.3 O O
after O O
the B-test O
transfusion I-test O
. O O

He O O
was O O
then O O
transitioned O O
to O O
oral B-treatment O
Lasix I-treatment O
for O O
maintainence O O
. O O

HEENT O O
: O O

She O O
tolerated O O
the B-treatment O
operation I-treatment O
well O O
, O O
and O O
was O O
transferred O O
from O O
the O O
operating O O
room O O
to O O
the O O
Cardiothoracic O O
Intensive O O
Care O O
Unit O O
. O O

ENTERED O O
BY O O
: O O

The B-test B-test
heart I-test I-test
rate I-test I-test
was O O
53 O O
to O O
106 O O
. O O

Dictated O O
By O O
: O O

ABD O O
: O O
Pt O O
very B-problem O
tense I-problem O
in I-problem O
abdomen I-problem O
( O O
states O O
belly O O
is O O
fine O O
, O O
but O O
he O O
is O O
weary O O
of O O
his O O
back O O
). O O

vw O O
/ O O
bmot O O

The O O
patient O O
completed O O
the B-test O
studies I-test O
and O O
to O O
be O O
informed O O
of O O
the O O
results O O
as O O
an O O
outpatient O O
. O O

01/24/05 O O
AT O O
07:00 O O
PM O O

Disp O O
:* O O
50 O O
Tablet O O
(s)* O O
Refills O O
:* O O
0 O O
* O O

PCP O O
Name O O
: O O

GAIT B-problem O
DISORDER I-problem O
. O O

LABORATORIES O O
ON O O
ADMISSION O O
: O O

Apgars B-test O
9,9 O O

Discharge O O
Summary O O

A B-problem B-test
small I-problem I-test
right I-problem I-test
pleural I-problem I-test
effusion I-problem I-test
has O O
decreased O O
in O O
size O O
. O O

Right-sided B-treatment O
PICC I-treatment O
line I-treatment O
with O O
its O O
tip O O
in O O
the O O
distal O O
SVC O O
. O O

ASSOCIATED O O
DIAGNOSIS O O
: O O

( O O
End O O
of O O
Report O O
) O O

ADMISSION O O
DATE O O
: O O

Cardiac B-test B-test
examination I-test I-test
was O O
regular O O
rate O O
and O O
rhythm O O
. O O

Significant O O
for O O
a B-treatment B-treatment
left I-treatment I-treatment
ear I-treatment I-treatment
operation I-treatment I-treatment
approximately O I-treatment
30 O O
years O O
ago O O
with O O
left B-treatment B-treatment
TM I-treatment I-treatment
reconstruction I-treatment I-treatment
in O O
December O O
1999 O O
at O O
Hitch O O
Hospital O O
. O O

DISCHARGE O O
MEDICATIONS O O
: O O

Limited B-test O
examination I-test B-treatment
. O O

Triamterene/hydrochlorothiazide B-treatment B-test
37.5/25 O O
mg O O
one O O
tablet O O
by O O
mouth O O
once O O
daily O O
and O O
lorazepam B-treatment B-treatment
1 O O
mg O O
three O O
times O O
daily O O
as O O
needed O O
( O O
for O O
anxiety B-problem O
) O O
. O O

Delivery O O
date O O
: O O

ALLERGIES O O
: O O

He O O
was O O
weaned O O
from O O
oxygen B-problem O
requirement I-problem O
and O O
was O O
continued O O
on O O
normal B-treatment O
saline I-treatment O
boluses I-treatment O
and O O

MEDICATIONS O O
ON O O
ADMISSION O O
: O O

- O O
If O O
any B-problem O
abdominal I-problem B-treatment
pain I-problem I-treatment
, O O
fever B-problem O
or O O
dizziness B-problem O
, O O
go O O
to O O
the O O
Emergency O O
Room O O

He O O
is O O
a O O
retired O O
painter O O
. O O

5/29/2000 O O
12:00:00 O O
AM O O

CT B-test B-test
OF I-test O
THE I-test O
PELVIS I-test O
WITHOUT I-test O
IV I-test O
CONTRAST I-test O
: O O
As O O
previously O O
noted O O
, O O
there O O
is O O
a B-problem B-treatment
small I-problem I-treatment
amount I-problem I-treatment
of I-problem I-treatment
free I-problem I-treatment
fluid I-problem I-treatment
surrounding O I-treatment
the O I-treatment
right O I-treatment
colon O I-treatment
, O O
tracking O B-treatment
along O I-treatment
the O I-treatment
mesentery O I-treatment
and O O
into O O
the O O
pelvis O O
. O O

White B-test B-test
blood I-test I-test
cell I-test I-test
count I-test I-test
on O O
admission O O
6.1 O O
, O O
INR B-test O
on O O
admission O O
1.0 O O
, O O
relevant B-test B-problem
imaging I-test I-problem
. O O

On O O
postoperative O O
day O O
number O O
17 O O
, O O
the O O
patient O O
was O O
discharged O O
. O O

Carotid O O
pulsations O O
are O O
normal O O
without O O
bruit B-problem O
. O O

Troponin B-test B-test
was O O
0.07 O O
. O O

Sodium B-test B-test
was O O
133 O O
, O O
potassium B-test B-test
was O O
4.2 O O
, O O
chloride B-test B-test
100 O O
, O O
CO2 B-test B-test
19 O O
, O O
BUN B-test B-test
21 O O
, O O
creatinine B-test B-test
1.2 O O
, O O
and O O
glucose B-test B-treatment
122 O O
. O O

Report O O
Status O O
: O O

She O O
is O O
anticoagulated O O
on O O
Coumadin B-treatment B-treatment
and O O
this O O
has O O
been O O
stable O O
. O O

Diagnosis O O
: O O

The B-test O
patient I-test O
urinalysis I-test O
on O O
10/19/97 O O
showed O O
moderate B-problem B-treatment
occult I-problem I-treatment
blood I-problem I-treatment
, O O
pH B-test O
5 O O
, O O
albumin B-test B-test
1+ O O
, O O
white B-test B-test
blood I-test I-test
cells I-test I-test
present O I-test
, O O
2-50 O O
red B-test O
blood I-test B-test
cell I-test I-test
, O O
10-20 O O
white B-test B-test
blood I-test I-test
cells I-test I-test
, O O
few B-problem O
bacteria I-problem B-treatment
, O O
and O O
moderate B-problem B-problem
bladder I-problem I-problem
epithelial I-problem I-problem
cells I-problem I-problem
. O O

13. O O
Heparin B-treatment B-treatment
Flush I-treatment I-treatment
PICC I-treatment I-treatment
( O O
100 O O
units O O
/ O O
ml O O
) O O
2 O O
ml O O
IV O O
DAILY O O
: O O
PRN O O
10 O O
ml O O
NS O O
followed O O
by O O
2 O O
ml O O
of O O
100 O O
Units O O
/ O O
ml O O
heparin B-treatment O
( O O
200 O O
units O O
heparin B-treatment O
) O O
each O O
lumen B-treatment O
Daily O O
and O O
PRN O O
. O O

No O O
observed B-problem O
abnormalities I-problem O

HTN B-problem O
ventral B-problem B-problem
hernia I-problem I-problem
right B-treatment I-problem
nephrectomy I-treatment I-problem
s/p O I-problem
right B-treatment I-problem
facial I-treatment I-problem
plating I-treatment I-problem

Admission O O
Date O O
: O O

12. O O
Fluconazole B-treatment B-treatment
200 O O
mg O O
Tablet O O
Sig O O
: O O
Two O O
( O O
2 O O
) O O
Tablet O O
PO O O
Q24H O O
( O O
every O O
24 O O
hours O O
) O O
for O O
7 O O
days O O
. O O

Graphesthesia O O
was O O
poor O O
in O O
both O O
hands O O
. O O

The O O
patient O O
&apos;s O O
preliminary O O
admitting O O
physician O O
is O O
KOTEDAIZREKE O O
, O O
LILA O O
and O O
the O O
preliminary O O
admitting O O
diagnosis O O
is O O
CP B-problem O
. O O

Vancomycin B-treatment B-test
1 O O
gm O O
IV O O
q O O
36 O O
hours O O
( O O
last O O
dose O O
at O O
2000 O O
on O O
08-13 O O
) O O
. O O

Admission O O
Date O O
: O O

He O O
had O O
guaiac B-problem B-problem
positive I-problem I-problem
stools I-problem I-problem
. O O

Vital B-test B-test
signs I-test I-test
showed O O
his B-test B-treatment
blood I-test I-treatment
pressure I-test I-treatment
to O O
be O O
slightly B-problem O
decreased I-problem O
at O O
120/60 O O
, O O
pulse B-test B-test
64 O O
, O O
respirations B-test B-test
16 O O
, O O
temperature B-test B-test
98.8 O O
, O O
O2 B-test O
sat I-test O
95 O O
. O O

Cardiovascular B-test B-test
examination I-test I-test
is O O
notable O O
for O O
a O B-treatment
regular O I-treatment
rate O I-treatment
and O O
rhythm O O
; O O
no O O
murmurs B-problem B-treatment
, O O
rubs B-problem O
or O O
gallops B-problem O
. O O

Lungs O O
: O O

Lactulose B-treatment O
PRN O O

SC O O
, O O
JUSONKIM O O
N O O

As O O
a O B-test
result O I-test
, O O
the O O
patient O O
was O O
started O O
on O O
Os-Cal B-treatment B-test
250 O O
mg O O
PO O O
q.i.d. O O
On O O
postoperative O O
day O O
number O O
three O O
, O O
her B-test B-treatment
ionized I-test I-treatment
calcium I-test I-treatment
was O O
1.06 O O
and O O
her B-treatment B-test
Os-Cal I-treatment I-test
was O O
increased O O
to O O
500 O O
q.i.d. O O

There O O
was O O
no O O
formal B-test O
strength I-test O
test I-test O
done O O
. O O

Batch O O
: O O

Skin O O
: O O

Left B-test O
ventricular I-test O
wall I-test O
thicknesses I-test O
are O O
normal O O
. O O

2014-02-21 O O
12:20 O O
PM O O
BLOOD B-test B-test
PT B-test I-test
- O O
12.9 O O
PTT B-test B-test
- O O
32.5 O O
INR(PT) B-test B-treatment
- O O
1.1 O O

He O O
was O O
awake O O
, O O
alert O O
, O O
uncomfortable B-problem O
secondary O O
to O O
incisional B-problem O
tenderness I-problem O
at O O
neck B-problem O
site I-problem O
as O O
well O O
as O O
right B-problem B-problem
iliac I-problem I-problem
graft I-problem I-problem
site I-problem I-problem
. O O

1. O O
Phenytoin B-treatment B-treatment
50 O O
mg O O
Tablet O O
, O O
Chewable O O
Sig O O
: O O
Two O O
( O O
2 O O
) O O
Tablet O O
, O O
Chewable O O
PO O O
three O O
times O O
a O O
day O O
for O O
1 O O
months O O
. O O

ee O O
/ O O
bihn O O

UNIT O O
NUMBER O O
: O O

DISCHARGE O O
MEDICATIONS O O
: O O

He O O
will O O
continue O O
Cipro B-treatment O
p.o. I-treatment O
for O O
prophylaxis B-treatment B-problem
. O O

However O O
, O O
her B-test B-test
creatinine I-test I-test
has O O
worsened B-problem O
up O O
to O O
4.2 O O
. O O

CC O O
: O O

Sex O O
: O O

POSTPARTUM O O
MEASLES O O
/ O O
MUMPS O O
/ O O
RUBELLA O O
VACCINE O O
: O O

The O O
cytology O O
for O O
this B-test O
biopsy I-test O
is O O
still O O
pending O O
. O O

Diagnosis O O
: O O

Lives O O
alone O O
in O O
elderly O O
housing O O
, O O
a O O
daughter O O
in O O
the O O
area O O
, O O
two O O
children O O
and O O
exercises O O
two O O
times O O
a O O
week O O
by O O
walking O O
and O O
stretching O O
. O O

Admission O O
Date O O
: O O

ACTIVITY O O
: O O

2017-08-17 O O
EEG B-test O
: O O

9. O O
Hypercholesterolemia B-problem B-treatment
. O O

Home O O
w/ O O
services O O

PAST O O
MEDICAL O O
HISTORY O O
: O O

Peripheral B-test B-test
pulses I-test I-test
were O O
very O O
strong O O
and O O
bounding O O
. O O

No O O
fever B-problem O
, O O
no O O
fetal B-problem B-problem
tachycardia I-problem I-problem
, O O
rupture B-problem O
of I-problem O
membranes I-problem O
at O O
delivery O O
. O O

8. O O
Prevacid B-treatment O
30 O O
mg O O
PO O O
twice O O
a O O
day O O
. O O

Mucous O O
membranes O O
moist O O
. O O

The O O
patient O O
saw O O
her O B-test
PCP O I-test
and O O
was O O
known O O
to O O
have O O
an B-test B-treatment
oxygen I-test I-treatment
saturation I-test I-treatment
of O O
82 O O
to O O
85 O O
percent O O
on O O
room O O
air O O
. O O

FINDINGS O O
: O O
There O O
is O O
a B-problem B-problem
linear I-problem I-problem
nondepressed I-problem I-problem
right I-problem I-problem
temporal I-problem I-problem
calvarial I-problem I-problem
fracture I-problem I-problem
extending O I-problem
into O I-problem
the O I-problem
mastoid O I-problem
process O I-problem
. O O

BREAST O O
FEEDING O O
AT O O
DISCHARGE O O
: O O

PCP O O
Name O O
: O O

3. O O
Cardiovascular O B-treatment
. O O

DICTATING O O
FOR O O
: O O

Patient O O
was O O
started O O
on O O
heparin B-treatment B-treatment
drip I-treatment I-treatment
and O O
bilateral B-test B-treatment
lower I-test I-treatment
extremeties I-test I-treatment
were O O
done O O
which O O
were O O
negative O O
for O O
DVT B-problem O
. O O

HOSPITAL O O
COURSE O O
AND O O
TREATMENT O O
: O O

Infectious O O
Disease O O
: O O

6. O O
Tylenol B-treatment B-treatment
. O O

Trivial B-problem B-test
mitral I-problem I-test
regurgitation I-problem I-test
is O O
seen O O
. O O

3. O O
Lansoprazole B-treatment B-treatment
30 O O
mg O O
Susp O O
, O O
Delayed O O
Release O O
for O O
Recon O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
PO O O
DAILY O O
( O O
Daily O O
). O O

However O O
, O O
her B-test B-problem
urine I-test I-problem
output I-test I-problem
has O O
improved O O
. O O

The O O
patient O O
was O O
also O O
started O O
on O O
Solu-Medrol B-treatment O
IV I-treatment O
for O O
active B-problem B-problem
airway I-problem I-problem
disease I-problem I-problem
component I-problem I-problem
of O I-problem
her B-problem I-problem
shortness I-problem I-problem
of I-problem I-problem
breath I-problem I-problem
. O O

1. O O
She O O
was O O
instructed O O
to O O
have O O
blood B-test O
drawn O O
by O O
the O O
Visiting O O
Nurses O O
Association O O
the O O
day O O
after O O
discharge O O
and O O
then O O
a O O
few O O
days O O
after O O
discharge O O
the O O
same O O
week O O
to O O
have O O
INR B-test O
. O O

PRINCIPAL O O
PROCEDURE O O
: O O

5. O O
Aluminum-Magnesium B-treatment B-treatment
Hydroxide I-treatment I-treatment
225-200 O O
mg/5 O O
mL O O
Suspension O O
Sig O O
: O O
15-30 O O
MLs O O
PO O O
QID O O
( O O
4 O O
times O O
a O O
day O O
) O O
as O O
needed O O
for O O
indigestion B-problem O
. O O

No O O
lifting O O
more O O
than O O
10 O O
pounds O O
for O O
10 O O
weeks O O

Peripheral B-test O
smear I-test O
revealed O O
blasts B-test O
of O O
62% O O
. O O

She O O
is O O
afebrile B-problem O
with O O
stable O O
vital O O
signs O O
. O O

A B-test O
chest I-test B-problem
X-ray I-test I-problem
documented O I-problem
a B-problem I-problem
progressing I-problem I-problem
left I-problem I-problem
lower I-problem I-problem
lobe I-problem I-problem
infiltrate I-problem I-problem
. O O

ED O O
Discharge O O
Summary O O

On O O
standing O O
, O O
she O O
tended O O
to O O
fall O O
to O O
the O O
front O O
, O O
back O O
or O O
sides O O
without O O
trying O O
to O O
stop O O
her O O
fall O O
initially O O
, O O
and O O
extensive B-test O
gait I-test O
testing I-test O
was O O
deferred O O
due O O
to O O
concerns O O
for O O
safety O O
. O O

T O O
: O O
2014-01-24 O O
13:45 O O

Ms. O O
Franklin O B-treatment
is O O
a O O
34 O O
- O O
year-old O O
woman O O
with O O
Bipolar B-problem B-treatment
disorder I-problem I-treatment
and O O
group O O
home O O
resident O O
who O O
by O O
way O O
of O O
EMS O O
for O O
apparent B-problem B-problem
alprazolam I-problem I-problem
overdose I-problem I-problem
. O O

LABORATORY O O
DATA O O
: O O

It O O
was O O
finally O O
under O O
control O O
with O O
high O O
doses O O
of O O
Captopril B-treatment B-treatment
, O O
Nifedipine B-treatment B-treatment
, O O
and O O
hydrochlorothiazide B-treatment O
. O O

The O O
patient O O
was O O
in O O
her O O
usual O O
state O O
of O O
health O O
until O O
about O O
three O O
weeks O O
prior O O
to O O
admission O O
when O O
she O O
began O O
to O O
notice O O
increased B-problem O
weakness I-problem O
and O O
bruising B-problem O
. O O

Right B-problem O
parietal I-problem B-problem
occipital I-problem I-problem
temporal I-problem I-problem
tumor I-problem I-problem
. O O

She O O
was O O
admitted O O
to O O
the O O
hospital O O
for O O
a B-test B-problem
pre I-test I-problem
lung I-test I-problem
transplant I-test I-problem
evaluation I-test I-problem
. O O

Mr. O O
Vazquez O O
is O O
a O O
48 O O
year O O
old O O
man O O
with O O
a O O
history O O
of O O
hepatitis B-problem O
C I-problem O
, O O
bipolar B-problem O
disorder I-problem O
with O O
suicide O O
attempts O O
in O O
the O O
past O O
, O O
recent O O
CMED O O
admit O O
earlier O O
in O O
4/05 O O
who O O
was O O
found O O
alert O O
approximately O O
one O O
hour O O
after O O
taking O O
an O O
unspecified O O
number O O
of O O
pills B-treatment O
. O O

The O O
patient O O
was O O
bolused O O
with O O
intravenous B-treatment B-problem
heparin I-treatment I-problem
due O O
to O O
concern O O
for O O
pulmonary B-problem B-problem
embolism I-problem I-problem
. O O

Admission O O
Date O O
: O O

Postoperative B-test B-test
laboratories I-test I-test
revealed O O
sodium B-test O
was O O
134 O O
, O O
potassium B-test B-test
was O O
4.1 O O
, O O
chloride B-test B-test
was O O
102 O O
, O O
bicarbonate B-test B-test
was O O
28 O O
, O O
blood B-test B-test
urea I-test I-test
nitrogen I-test I-test
was O O
18 O O
, O O
creatinine B-test B-test
was O O
0.8 O O
, O O
and O O
glucose B-test B-treatment
was O O
148 O O
. O O

Multiple O B-test
posterior O I-test
right O I-test
- O O
sided O O
mastoid O O
air O O
cells O O
are O O
opacified B-problem O
with I-problem O
blood I-problem B-problem
. O O

Labs O O
today O O
: O O

4. O O
FEN O O
: O O

MEDICATIONS O O
ON O O
ADMISSION O O
: O O

Report O O
Status O O
: O O

LUNGS O O
: O O
CLEAR O O
TO O O
ASCULATION B-test O

Social O O
History O O
: O O

The O O
patient O O
was O O
therefore O O
referred O O
to O O
the O O
Dr. O O
A O O
Eu O O
Wave O O
. O O

Asthma B-problem O
/ O O
COPD B-problem O
on O O
BiPAP B-treatment O
, O O
history O O
of O O
intubation B-treatment B-problem
. O O

Job O O
# O O
: O O
34705 O O

Do O O
gentle B-treatment O
range I-treatment O
of I-treatment O
motion I-treatment O
exercises I-treatment O
for O O
the O O
next O O
few O O
days O O
. O O

- O O
Call O O
for O O
appointment O O
to O O
( O O
289 O O
) O O
411-5387 O O
for O O
the O B-problem
Trauma O I-problem
Clinic O I-problem
and O O
Abdominal B-test B-problem
CT I-test I-problem
scan I-test I-problem
of I-test O
the I-test O
Abdomen I-test O
in O O
4 O O
weeks O O

Were O O
unremarkable O O
with O O
normal O O
electrolytes B-test O
and O O
complete B-test B-problem
blood I-test I-problem
count I-test I-problem
parameters I-test I-problem
. O O

( O O
End O O
of O O
Report O O
) O O

The O O
patient O O
did O O
well O O
postoperatively O O
and O O
had O O
a O O
regular O O
diet O O
by O O
the O O
third O O
postoperative O O
day O O
. O O

DISCHARGE O O
PATIENT O O
ON O O
: O O

COMPARISON O O
: O O

Chest O O
: O O
HD B-treatment O
line I-treatment O
in O O
place O O
without O O
erythema B-problem O

TD O O
: O O

Gen O O
: O O
comforable O O

Liver O O
and O O
spleen O O
were O O
not O O
palpable O O
. O O

Sister O O
with O O
stomach B-problem B-problem
cancer I-problem I-problem
. O O

ED O O
DISCHARGE O O
NOTIFICATION O O

7. O O
Cataracts B-problem O

Compared O O
with O O
the B-test O
prior I-test O
study I-test O
( O O
images O O
reviewed O O
) O O
of O O
2017-09-04 O O
, O O
there O O
is O O
probably O O
no O O
significant O B-problem
change O I-problem
. O O

PCP O O
Name O O
: O O

CODE O O
STATUS O O
: O O

regular O O
rate O O
and O O
rhythm O O
without O O
murmur B-problem O
. O O

Responsible O O
After O O
Study O O
for O O
Causing O O
Admission O O
) O O
COPD B-problem O
flare I-problem O

General O O
: O O

HABITS O O
: O O

Family O O
History O O
: O O

Disp O O
:* O O
30 O O
Tablet O O
, O O
Delayed O O
Release O O
( O O
E.C. O O
)(s)* O O
Refills O O
:* O O
0 O O
* O O

Room O O
: O O

AZMACORT B-treatment B-test
, O O
CLINDAMYCIN B-treatment B-treatment
, O O
VERSED B-treatment B-treatment
, O O
FENTANYL B-treatment B-treatment
, O O
and O O
MORPHINE B-treatment B-problem
. O O

REASON O O
FOR O O
THIS O O
EXAMINATION O O
: O O

Coumadin B-treatment O
has O O
caused O O
bleeding B-problem O
from I-problem O
the I-problem O
mouth I-problem O
and I-problem O
nose I-problem O
on O O
two O O
occasions O B-treatment
, O O
on O O
one O O
occasion O O
with O O
prothrombin B-test B-treatment
time I-test O
13 O O
, O O
and O O
has O O
been O O
replaced O O
by O O
anti-platelet B-treatment O
agents I-treatment O
. O O

The O O
patient O O
was O O
diagnosed O O
as O O
having O O
an B-problem B-problem
acute I-problem I-problem
myocardial I-problem I-problem
infarction I-problem I-problem
. O O

Discharge O O
Date O O
: O O

There O O
has O O
been O O
almost O O
complete O O
resolution O O
of O O
pulmonary B-problem B-problem
edema I-problem I-problem
. O O

RED B-test O
CELL I-test B-problem
MORPHOLOGY I-test I-problem
Hypochr B-test I-problem
Anisocy B-test I-problem
Poiklo B-test I-problem
Macrocy B-test I-problem
Microcy B-test I-problem
Polychr B-test I-problem

Bisacodyl B-treatment O
prn O O

REASON O O
FOR O O
THIS O O
EXAMINATION O O
: O O

On O O
1/5 O O
, O O
the O O
patient O O
underwent O O
a B-treatment O
local I-treatment O
tumor I-treatment O
debulking I-treatment O
at O O
Bri O O
Health O O
under O O
local B-treatment O
anesthesia I-treatment O
. O O

The O O
patient O O
is O O
an O O
83-year-old O O
female O O
who O O
presents O O
for O O
surgical B-test B-problem
evaluation I-test I-problem
for O O
her B-problem B-problem
hyperparathyroidism I-problem I-problem
. O O

MRN O O
: O O

Resume O O
regular O O
exercise O O

CMED O O
CSRU O O
: O O
Listens O O
and O O
responds O O
to O O
questions O O
appropriately O O
, O O
pleasant O O

No O O
hemoptysis B-problem B-treatment
, O O
hematemesis B-problem B-treatment
, O O
abdominal B-problem B-treatment
pain I-problem I-treatment
, O O
black B-problem O
or I-problem O
tarry I-problem O
stools I-problem O
, O O
dysuria B-problem B-problem
/ O I-problem
frequency/urgency B-problem I-problem
. O O

Emergent O O
Indications O O
: O O

Reason O O
for O O
override O O
: O O

TR O O
: O O

She O O
was O O
told O O
to O O
make O O
an O O
appointment O O
two O O
weeks O O
after O O
her B-treatment O
surgery I-treatment O
for O O
removal B-treatment O
of O O
her B-treatment B-problem
retention I-treatment I-problem
sutures I-treatment I-problem
. O O

The B-treatment B-test
left I-treatment I-test
forearm I-treatment I-test
dressing I-treatment I-test
was O O
noted O O
to O O
be O O
in O O
place O O
, O O
clean O B-treatment
, O O
dry O O
, O O
and O O
intact O O
with O O
no O O
saturation B-problem B-problem
. O O

He O O
also O O
noted O O
a B-problem O
23 I-problem O
pound I-problem O
weight I-problem O
loss I-problem O
in O O
the O O
past O O
11 O O
months O O
despite O O
having O O
an B-problem B-problem
increased I-problem I-problem
appetite I-problem I-problem
. O O

176746010 O O
WGH O O

There O O
she O O
should O O
received O O
physical B-treatment O
therapy I-treatment O
to O O
consist O O
of O O
a B-treatment B-treatment
routine I-treatment I-treatment
post I-treatment I-treatment
total I-treatment I-treatment
hip I-treatment I-treatment
replacement I-treatment I-treatment
rehabilitation I-treatment I-treatment
protocol I-treatment I-treatment
, O O
with O O
emphasis O B-treatment
on O O
gait B-treatment O
training I-treatment O
, O O
partial O B-treatment
weight O I-treatment
bearing O I-treatment
on O I-treatment
the O I-treatment
right O I-treatment
lower O I-treatment
extremity O I-treatment
, O O
using O O
a O O
walker B-treatment O
or O O
crutches B-treatment O
. O O

PROBLEM O O
LIST O O
: O O

The O O
patient O O
was O O
continued O O
on O O
Lipitor B-treatment B-treatment
and O O
aspirin B-treatment B-treatment
, O O
and O O
Plavix B-treatment B-treatment
was O O
added O O
and O O
will O O
be O O
continued O O
for O O
30 O O
days O O
post O O
catheterization B-test B-problem
. O O

Hematocrit B-test O
is O O
37.6 O O
, O O
platelet B-test B-treatment
count I-test I-treatment
is O O
148,000 O O
. O O

There O O
is O O
mild B-problem B-problem
symmetric I-problem I-problem
left I-problem I-problem
ventricular I-problem I-problem
hypertrophy I-problem I-problem
. O O

Electronically O O
signed O O
by O O
Tracy O O
Kimball O O
, O O
MD O O
, O O
Interpreting O B-problem
physician O I-problem

Allergies O O
: O O

1. O O
Diabetes B-problem B-problem
mellitus I-problem I-problem
. O O

Initially O O
on O O
Vanc B-treatment O
and O O
Cipro B-treatment O
on O O
Friday O O
but O O
then O O
seen O O
by O O
ID O O
who O O
reccommended O O
no O O
abx B-treatment O
but O O
a B-test O
bone I-test O
biopsy I-test O
, O O
blood B-test B-problem
cx I-test I-problem
. O O

She O O
is O O
without O O
bruits B-problem O
or O O
JVD B-problem O
. O O

Patient O O
is O O
an B-problem B-problem
insulin I-problem I-problem
dependent I-problem I-problem
diabetic I-problem I-problem
. O O

supple O O
, O O
no O O
bruits B-problem O
. O O

2. O O
Cardiovascular O B-treatment
- O O
The O O
patient O O
has O O
been O O
cardiovascularly O O
stable O O
without O O
murmur B-problem O
. O O

Patient O O
States O O
Complaint O O
: O O

Physical O O
Exam O O
: O O

ADMISSION O O
MEDICATIONS O O
: O O

Discharge O O
Date O O
: O O

Cinpipecoursspi O O
Hospital O O
Health O O
Center O O

However O O
, O O
subsequent O O
it O O
was O O
determined O O
that O O
the B-problem O
patient I-problem O
's I-problem O
hypotension I-problem O
may O O
have O O
been O O
related O O
to O O
his B-problem B-treatment
rapid I-problem I-treatment
ventricular I-problem I-treatment
response I-problem I-treatment
and O O
right B-problem B-problem
heart I-problem I-problem
failure I-problem I-problem
. O O

Report O O
Status O O
: O O

The O O
patient O O
&apos;s O O
postoperative B-test O
Hct I-test O
was O O
34 O O
. O O

PHYSICAL O O
EXAMINATION O O
: O O

2. O O
Diabetes B-problem B-problem
mellitus I-problem I-problem
Type I-problem I-problem
2 I-problem O

Neck O O
supple O O
, O O
carotids O O
without O O
bruits B-problem O
. O O

His B-test B-test
hematocrit I-test I-test
increased O I-test
to O O
about O O
30 O O
, O O
but O O
he O O
continued O O
to O O
have O O
hematuria B-problem O
and O O
his B-test B-problem
renal I-test I-problem
function I-test I-problem
only O O
improved O O
very O O
slowly O O
. O O

She O O
does O O
not O O
drink O O
. O O

Her B-problem B-test
incision I-problem I-test
has O O
remained O O
clean O O
, O O
dry O O
, O O
intact O O
, O O
with O O
staples B-treatment O
removed O O
on O O
POD# O O
27/18 O O
. O O

Epidural O O
Secondary O O
Anesthesia O O
: O O

Allergies O O
: O O

Bowel O O
sounds O O
positive O O
, O O
soft O O
, O O
mildly B-problem O
tender I-problem O
in I-problem O
the I-problem O
epigastrium I-problem O
without O O
hepatosplenomegaly B-problem O
, O O
mass B-problem B-problem
or O I-problem
tenderness B-problem I-problem
. O O

The O O
family O O
decided O O
to O O
pursue O O
comfort B-treatment O
measures I-treatment O
. O O

Standardized O O
Discharge O O
Instructions O O
: O O

NAME O O
: O O

If O O
there O O
is O O
clear B-problem O
drainage I-problem O
from O O
your B-problem O
incisions I-problem O
, O O
cover O O
with O O
a B-treatment O
dry I-treatment O
dressing I-treatment O
. O O

CONTINGENT O O
UPON O O

Given O O
her O O
hx O O
of O O
ileostomy B-treatment O
secondary O O
to O O
crohn B-problem B-treatment
's I-problem I-treatment
disease I-problem I-treatment
and O O
resultant O B-treatment
short B-problem I-treatment
gut I-problem I-treatment
syndrome I-problem I-treatment
, O O
the O O
pt O O
requires O B-problem
nutritional B-treatment I-problem
support I-treatment I-problem
via O I-problem
TPN B-treatment I-problem
. O O

The B-test O
finger-to-nose I-test O
was O O
okay O O
on O O
the O O
right O O
. O O

Please O O
take O O
an B-treatment O
over I-treatment O
the I-treatment O
counter I-treatment O
stool I-treatment O
softener I-treatment O
such O O
as O O
Colace B-treatment O
or O O
a B-treatment O
gentle I-treatment O
laxative I-treatment O
such O O
as O O
Milk B-treatment O
of I-treatment O
Magnesia I-treatment B-problem
if O I-problem
you O I-problem
experience O I-problem
constipation B-problem I-problem
. O O

2. O O
Infertility B-problem O
. O O

No O O
cough B-problem O
. O O

Admission O O
Date O O
: O O

DISCHARGE O O
CONDITION O O
: O O

D O O
: O O

He O O
denies O O
chills B-problem O
, O O
no O O
chest B-problem B-test
pain I-problem I-test
, O O
no O O
LE B-problem O
swelling I-problem O
. O O

Cranial O O
nerves O O
notable O O
for O O
bilateral B-problem B-problem
esotropia I-problem I-problem
. O O

Operative O O
course O O
and O O
recovery O O
were O O
without O O
complication B-problem O
. O O

Hypertension B-problem O
. O O

Full O O
code O O

Social O O
History O O
: O O

He O O
also O O
had O O
a B-problem O
high I-problem O
CO I-problem O
and O O
low B-problem O
SVR I-problem O
suggestive O O
of O O
sepsis B-problem B-treatment
, O O
but O O
he O O
never O O
had O O
an B-problem B-treatment
elevated I-problem I-treatment
WBC I-problem I-treatment
and O O
was O O
afebrile B-problem O
during O O
his O O
entire O O
hospital O O
admission O O
with O O
negative O O
blood B-test B-test
, I-test O
urine I-test B-treatment
, I-test O
wound I-test O
, I-test O
and I-test O
pleural I-test B-problem
fluid I-test I-problem
cultures I-test I-problem
. O O

The O O
patient O O
was O O
also O O
administered O O
adaptive B-treatment O
training I-treatment O
for O O
activities B-treatment O
of I-treatment O
daily I-treatment O
life I-treatment O
and O O
advised O O
regarding O O
wound B-treatment O
care I-treatment O
. O O

Admission O O
Date O O
: O O

45M O O
w/no O O
PMH O O
presented O O
to O O
Chelseahospital O O
after O O
a B-problem O
syncopal I-problem O
episode I-problem O
on O O
the O O
morning O O
of O O
admission O O
. O O

On O O
day O O
of O O
life O O
#1 O O
, O O
caffeine B-treatment B-treatment
was O O
started O O
. O O

The O O
patient O O
describes O B-problem
chest B-problem I-problem
discomfort I-problem I-problem
without O I-problem
any B-problem I-problem
significant I-problem I-problem
EKG I-problem I-problem
changes I-problem I-problem
. O O

She O O
was O O
initially O O
treated O O
nonoperatively O O
with O O
IV B-treatment O
fluids I-treatment O
, O O
antibiotics B-treatment B-treatment
, O O
serial B-test B-problem
exams I-test I-problem
and O O
NGT B-treatment B-problem
decompression I-treatment I-problem
. O O

05/16/2004 O O
12:00:00 O O
AM O O

2018-10-31 O O
06:25 O O
AM O O
BLOOD B-test B-test
WBC B-test I-test
- O O
13.6 O O
* O O
RBC B-test B-test
- O O
2.72 O O
* O O
Hgb B-test B-test
- O O
8.6 O O
* O O
Hct B-test B-test
- O O
24.6 O O
* O O
MCV B-test B-test
- O O
91 O O
MCH B-test B-test
- O O
31.7 O O
MCHC B-test B-test
- O O
35.0 O O
RDW B-test B-test
- O O
14.0 O O
Plt B-test B-test
Ct I-test I-test
- O O
314 O O

On O O
05-05-92 O O
she O O
was O O
noted O O
to O O
convert O O
to O O
atrial B-problem O
fibrillation I-problem O
which O O
resolved O O
spontaneously O O
a O O
few O O
days O O
later O O
. O O

T O O
: O O
2012-05-02 O O
06:55 O O

Beta B-treatment O
blockers I-treatment O
and O O
diuretics B-treatment O
were O O
initiated O O
on O O
post-op O O
day O O
one O O
. O O

1. O O
60-69% B-problem O
stenosis I-problem B-problem
of I-problem I-problem
the I-problem I-problem
right I-problem I-problem
internal I-problem I-problem
carotid I-problem I-problem
artery I-problem I-problem
. O O

Treatment O O
Rendered O O
: O O

TD O O
: O O

She O O
fell O O
on O O
her O O
R O O
side O O
and O O
had O O
a O O
great O O
deal O O
of O O
pain B-problem B-treatment
in I-problem I-treatment
her I-problem I-treatment
R I-problem I-treatment
arm I-problem I-treatment
and I-problem O
hip I-problem O
. O O

eScription O O
document O O
: O O

Waltham-Ludlow B-treatment O
drains I-treatment O
put O O
out O O
on O O
the O O
13th O O
620 O O
and O O
380 O O
. O O

DISCHARGE O O
DIAGNOSES O O
: O O

Carotid O O
pulses O O
bounding O O
very O O
strongly O O
. O O

DISCHARGE O O
FOLLOW O O
UP O O
: O O
The O O
patient O O
is O O
to O O
follow O O
up O O
with O O
Dr. O O
Debra O O
Oneal O O
, O O
his O B-treatment
PCP O I-treatment
and O O
his O O
cardiologist O O
in O O
3 O O
weeks O O
. O O

Stable O O
. O O

ABG B-test O
revealed O O
widened B-problem O
A-a I-problem O
gradient I-problem O
so O O
a B-test O
d-dimer I-test O
was O O
sent O O
which O O
was O O
elevated B-problem O
. O O

nausea B-problem O
and O O
vomiting B-problem O

3. O O
Metoprolol B-treatment B-treatment
25 O O
mg O O
po O O
bid O O
. O O

Guarded B-problem O
, O O
but O O
stable O O
. O O

Date O O
of O O
Birth O O
: O O

professor O O
/ O O
Kyra O O
social O O
worker O O

Anemia B-problem B-test
- O O
The B-test O
patient I-test O
's I-test O
hematocrit I-test O
dropped O O
in O O
the O O
Intensive O O
Care O O
Unit O O
to O O
the O O
mid O O
20s O O
and O O
she O O
received O O
one O O
unit O O
of O O
packed O O

Age O O
: O O

Pt O O
was O O
seen O O
by O O
GI O O
on O O
13 O O
EGD B-test O
was O O
performed O O
HD2 O O
which O O
was O O
negative O O
for O O
gastritis B-problem O
, O O
stricture B-problem O
or O O
ulcer B-problem O
. O O

f O O
/ O O
u O O
with O O
dr. O O
white O O

Size O O
appropriate O O
for O O
gestational O O
age O O
, O O
32 O O
week O O
female O O
. O O

The O O
patient O O
was O O
brought O O
to O O
the O O
operating O O
room O O
on O O
06/30/93 O O
after O O
informed O O
consent O O
was O O
obtained O O
. O O

T O O
: O O

Denies O O
alcohol O O
use O O
. O O

( O O
Part O O
of O O
the O O
patient O O
's O O
chart O O
from O O
the O O
period O O
2013-05-09 O O
to O O
2013-05-23 O O
is O O
currently O O
unavailable O O
, O O
and O O
this O O
dictation O O
will O O
mainly O O
cover O O
the O O
period O O
from O O
2013-05-23 O O
to O O
2013-06-02 O O
) O O

The O O
patient O O
was O O
previously O O
a O O
heavy O O
alcohol O O
user O O
, O O
but O O
had O O
been O O
sober O O
since O O
1996 O O
. O O

He O O
then O O
went O O
to O O
the O O
Operating O O
Room O O
on O O
2016-03-14 O O
where O O
he O O
had O O
resection B-treatment B-treatment
of O I-treatment
the B-problem I-treatment
left I-problem I-treatment
face I-problem I-treatment
squamous I-problem I-treatment
cell I-problem I-treatment
cancer I-problem I-treatment
by O O
Dr. O O
Langhorne O O
and O O
split B-treatment O
thickness I-treatment O
and I-treatment O
full I-treatment O
thickness I-treatment O
skin I-treatment O
grafting I-treatment O
of O O
the B-problem O
defects I-problem O
on O O
2016-03-14 O O
. O O

While O O
in O O
the O O
PACU O O
, O O
Anesthesia O B-treatment
was O O
called O O
because O O
the O O
patient O O
became O O
dyspneic B-problem O
and O O
tachypneic B-problem B-treatment
and O O
his B-test O
SAO2 I-test O
dropped O O
to O O
89% O O
. O O

He O O
was O O
discharged O O
home O O
with O O
a B-treatment B-treatment
Foley I-treatment I-treatment
catheter I-treatment I-treatment
and O O
he O O
will O O
follow-up O O
with O O
Dr. O O
Ross O O
in O O
one O O
to O O
two O O
weeks O O
. O O

She O O
was O O
not O O
a O O
transplant O O
candidate O O
due O O
to O O
her B-problem O
obesity I-problem O
. O O

asa B-treatment O
325 O O
mg O O
qday O O

This O O
revealed O O
some B-problem B-problem
supraglottic I-problem I-problem
edema I-problem I-problem
which O O
revealed O O
with O O
time O O
, O O
without O O
further B-treatment O
intervention I-treatment O
. O O

Pelvic B-test B-test
exam I-test I-test
showed O O
a O B-problem
small O I-problem
mobile O I-problem
uterus O I-problem
. O O

The O O
patient O O
died O O
in O O
hospital O O
. O O

Report O O
any B-problem O
fever I-problem O
greater I-problem O
than I-problem O
101 I-problem O

He O O
was O O
then O O
called O O
out O O
to O O
the O O
medical O O
floor O O
on O O
01-21 O O
. O O

No O O
smoking O O
, O O
alcohol O O
or O O
drugs O O
. O O

Weight B-test O
: O O

She O O
is O O
currently O O
unemployed O O
, O O
but O O
until O O
recently O O
, O O
she O O
was O O
employed O O
at O O
a O O
bank O O
. O O

She O O
was O O
raised O O
in O O
multiple O O
foster O O
care O O
homes O O
because O O
her O O
mother O O
could O O
not O O
care O O
for O O
her O O
. O O

He O O
tolerated O O
this B-treatment O
procedure I-treatment O
well O O
. O O

Sensory B-test B-test
exam I-test I-test
was O O
not O O
remarkable O O
, O O
cerebellar B-test B-problem
exam I-test I-problem
was O O
not O O
possible O O
. O O

On O O
that O O
day O O
he O O
was O O
slightly B-problem O
diaphoretic I-problem O
with O O
some B-problem O
tachycardia I-problem O
to O O
100 O O
. O O

She O O
was O O
pleasant O O
, O O
in O O
no O O
acute B-problem B-test
distress I-problem I-test
; O O
blood B-test B-test
pressure I-test I-test
130/60 O O
; O O
heart B-test B-test
rate I-test I-test
66 O O
; O O
respirations B-test B-treatment
18 O O
; O O
temperature B-test O
98 O O
. O O

The O O
patient O O
was O O
transferred O O
from O O
an O O
outside O O
hospital O O
for O O
a O O
second O O
opinion O O
regarding O O
workup B-test O
of O O
his B-problem B-problem
pancreatic I-problem I-problem
cancer I-problem I-problem
. O O

Service O O
. O O

ENTERED O O
BY O O
: O O

Mild B-problem O
irreg. I-problem O
ctx I-problem O
. O O

Attending O O
: O O

He O O
had O O
no O O
oculocephalic B-problem B-problem
reflexes I-problem I-problem
. O O

9. O O
Magnesium B-treatment B-treatment
Oxide I-treatment I-treatment
800 O O
mg O O
p.o. O O
b.i.d. O O

No O O
lesions B-problem O
or O O
rashes B-problem O
. O O

Trental B-treatment B-test
400 O O
milligrams O B-treatment
t.i.d. O O
, O O
Cytotec B-treatment B-test
100 O O
milligrams O B-test
t.i.d. O O
, O O
Ativan B-treatment B-test
2 O O
milligrams O O
q.h.s. O O
Darvon B-treatment O
65 O O
milligrams O O
two O O
q.i.d O O
, O O
Relafen B-treatment B-test
500 O O
milligrams O O
b.i.d O O
, O O
Vitamin B-treatment B-treatment
E I-treatment O
, O O
Prilosec B-treatment B-treatment
20 O O
milligrams O O
once O O
a O O
day O O
, O O
Zantac B-treatment B-treatment
150 O O
milligrams O O
b.i.d O O
, O O
Lasix B-treatment B-treatment
120 O O
milligrams O O
every O O
other O O
day O O
PRN O O
edema B-problem O
. O O

Avoid O O
grapefruit O O
unless O O
MD O O
instructs O O
otherwise O O
. O O

No O O
alcohol O O
use O O
. O O

Reason O O
for O O
override O O
: O O

Richard O O
U. O O
Walker O O
, O O
M.D. O O

915093496 O O
RWH O O

Sternum O O
stable O O

None O O
. O O

- O O
Trauma O B-treatment
Surgery O I-treatment
Clinic O I-treatment
in O O
four O O
weeks O O
with O O
CT B-test B-problem
abdomen I-test I-problem
results O I-problem
. O O

Also O O
of O O
note O O
was O O
the B-problem B-problem
distal I-problem I-problem
lateral I-problem I-problem
wall I-problem I-problem
hypokinesis I-problem I-problem
. O O

Breath B-test O
sounds I-test O
, O O
clear O O
and O O
equal O O
, O O
without O O
retractions B-problem O
, O O
respiratory B-test B-treatment
rate I-test I-treatment
30 O O
s O O
to O O
60 O O
s. O O

3. O O
Gastroesophageal B-problem B-problem
reflux I-problem I-problem
disease I-problem I-problem
with O O
esophageal B-treatment O
dilatation I-treatment O
for O O
stricture B-problem O
. O O

HOSPITAL O O
COURSE O O
: O O

Discharge O O
Date O O
/ O O
Time O O
: O O

This O O
is O O
a O O
discharge O O
summary O O
addendum O O
for O O
Discharge O O
Summary O O
number O O
554108 O O
. O O

Removal B-treatment O
of I-treatment O
tunneled I-treatment O
cath I-treatment O
( O O
previously O O
used O O
for O O
tPN B-treatment O
) O O

Baby O O
1 O O

425680098 O O
SC O O

She O O
was O O
started O O
on O O
Ampicillin B-treatment B-treatment
, O O
Gentamycin B-treatment B-treatment
and O O
Flagyl B-treatment O
. O O

Small B-problem B-problem
right I-problem I-problem
pleural I-problem I-problem
effusion I-problem I-problem
is O O
stable O O
. O O

Pt O O
previously O O
diagnosed O O
with O O
hepatorenal B-problem B-treatment
and O O
was O O
started O O
on O O
midodrine B-treatment O
, O O
octreotide B-treatment O
and O O
albumin B-treatment B-treatment
; O O
these O O
were O O

Initial B-test O
newborn I-test O
exam I-test O
: O O

2013-12-24 O O
01:30 O O
AM O O

She O O
is O O
right-handed O O
. O O

ED O O
Discharge O O
Summary O O

TriCor B-treatment B-test
145 O O
mg O O
p.o. O O
every O O
day O O
. O O

The O O
abdomen O O
was O O
benign O O
. O O

Dropped O O
from O O
42.7 O O
to O O
36 O O
in O O
setting O O
of O O
anticoagulation B-treatment O
for O O
saddle B-problem O
PE I-problem O
and O O
IV B-treatment O
fluids I-treatment O
. O O

( O O
End O O
of O O
Report O O
) O O

See O O
PT O O
note O O
for O O
further B-test O
assessment I-test O
and O O
discussion O O
. O O

Followup O O
Instructions O O
: O O

2. O O
Lipitor B-treatment B-treatment
20 O O
milligrams O O
po O O
q O O
HS O O
. O O

HOSPITAL O O
COURSE O O
: O O

The O O
patient O O
was O O
given O O
printed O O
instructions O O
for O O
urinary B-problem B-problem
tract I-problem I-problem
infection I-problem I-problem
( O O
Portugese O O
) O O
. O O

Disposition O O
, O O
Follow O O
up O O
and O O
Instructions O O
to O O
Patient O O
: O O

RIEEA O B-test
ODEE O I-test
SAPMAL O I-test
, O O
M.D. O O
CEALME O B-treatment
LEOE O I-treatment
MARESSYTHE O I-treatment
Dr. O O
Tokbelb O O
Welle O O
Health O O
Sonsant O O
. O O

BUN B-test O
25 O O
and O O
creatinine B-test B-treatment
1.4 O O
. O O

In O O
the O O
past O O
, O O
he O O
had O O
biliary B-treatment O
stents I-treatment O
placed O O
which O O
clotted O O
off O O
. O O

Had O O
tubular B-problem O
breath I-problem O
sounds I-problem O
especially O O
in O O
the O O
lower O O
lung O O
fields O O
. O O

2015-10-26 O O
08:34 O O
PM O O

Report O O
Status O O
: O O

JOB O O
#: O O

G5 O O
, O O
P5 O O
normal O O
Pap O O
smears O O
, O O
sexual O B-problem
active O I-problem
without O I-problem
dyspareunia B-problem I-problem
. O O

1 O O
NOTE O O
NEW O O
NORMAL O O
RANGE O O
AS O O
OF O O
12 O O
AM O O
2013-05-04 O O

ALLERGIES O O
: O O

Discharge O O
Summary O O

There O O
was O O
no O O
nystagmus B-problem O
, O O
except O O
for O O
some B-problem B-problem
fine I-problem I-problem
fast I-problem I-problem
beat I-problem I-problem
nystagmus I-problem I-problem
bilateral I-problem I-problem
extremes I-problem I-problem
of I-problem I-problem
abduction I-problem I-problem
. O O

Disposition O O
, O O
Follow O O
up O O
and O O
Instructions O O
to O O
Patient O O
: O O

SALMETEROL B-treatment O
XINAFOATE I-treatment O
and O O
LEVOFLOXACIN B-treatment O

7. O O
h/o O O
clot B-problem O
in O O
AV B-treatment O
graft I-treatment O
x2 O O
( O O
March O O
and O O
2018-07-07 O O
) O O

Age O O
: O O

Father O O
and O O
brother O O
died O O
of O O
PE B-problem O
. O O

ADMISSION O O
DATE O O
: O O

ABD O O
: O O
soft O O
ND/NT B-problem O
+BS O O

A O O
34 O O
year O O
old O O
white O O
female O O
lying O O
in O O
bed O O
, O O
anxious B-problem B-treatment
; O O
blood B-test B-test
pressure I-test I-test
of O O
220/120 O O
, O O
afebrile B-problem B-treatment
. O O

HISTORY O O
OF O O
PRESENT O O
ILLNESS O O
: O O

Heart O O
was O O
regular O O
with O O
a B-problem B-problem
I I-problem I-problem
/ I-problem I-problem
VI I-problem I-problem
systolic I-problem I-problem
ejection I-problem I-problem
murmur I-problem I-problem
without O I-problem
jugular B-problem I-problem
venous I-problem I-problem
distention I-problem I-problem
. O O

While O O
her O O
discharge O O
summary O O
maintains O O
that O O
she O O
was O O
continued O O
on O O
Furosemide B-treatment O
/ O O
Spirinolactone B-treatment B-treatment
/ O I-treatment
Propranolol B-treatment I-treatment
, O O
the O O
patient O O
did O O
not O O
receive O O
any O O
scripts O O
on O O
discharge O O
and O O
as O O
a O O
result O O
did O O
not O O
take O O
these B-treatment O
medications I-treatment O
. O O

Formerly O O
smoked O O
3 O O
packs O O
per O O
day O O
x O O
25 O O
years O O
; O O
2 O O
cigars O O
per O O
day O O
x O O
approximately O O
6 O O
months O O
. O O

He O O
has O O
a O O
very O O
supportive O O
family O O
with O O
numerous O B-problem
siblings O I-problem
. O O

At O O
the O O
time O O
an B-treatment O
8 I-treatment O
Caucasian I-treatment B-treatment
catheter I-treatment I-treatment
was O O
placed O O
in O O
the O O
common O O
hepatic/bioduct O O
for O O
external B-treatment O
drainage I-treatment O
. O O

6. O O
Diabetes B-problem B-problem
mellitus I-problem I-problem
. O O

HOSPITAL O O
COURSE O O
AND O O
TREATMENT O O
: O O

You O O
may O O
resume O O
your O O
regular O O
diet O O
as O O
tolerated O O
. O O

Jacob O O
Montegut O O
MD O O
71-786 O O

4. O O
Aspirin B-treatment B-treatment
325 O O
mg O O
p.o. O O
q O O
day O O
. O O

DISCHARGE O O
STATUS O O
: O O

CONTINGENT O O
UPON O O

She O O
came O O
back O O
to O O
the O O
floor O O
on O O
10-14 O O
. O O

He O O
had O O
no O O
symptoms B-problem B-problem
of O I-problem
chest B-problem I-problem
pain I-problem I-problem
or O I-problem
myocardial B-problem I-problem
ischemia I-problem I-problem
. O O

Urgency O O
: O O

- O O
transfuse O O
2 O O
units O O
today O O
, O O
with O O
lasix B-treatment O

Batch O O
: O O

Volume B-problem O
overload I-problem O

He O O
received O O
Ancef B-treatment O
preoperatively O O
. O O

2013-12-24 O O
01:30 O O
AM O O

This O O
report O O
was O O
created O O
by O O
KOTEKOLL O O
, O O
CH O O
10/17/2001 O O
07:08 O O
PM O O

CONDITION O O
ON O O
DISCHARGE O O
: O O

Patient O O
was O O
gradually O O
put O O
back O O
on O O
her B-treatment O
outpatient I-treatment O
xanax I-treatment O
dose I-treatment O
of O O
1 O O
mg O O
qid O O
and O O
clozaril B-treatment B-treatment
was O O
restarted O O
. O O

Provider O O
: O O
Laurie O B-treatment
, O O
Paul O B-treatment
G. O O
( O O
858 O O
) O O
481-2816 O O
Call O O
to O O
schedule O O
appointment O O
. O O

Left B-test B-test
ventricular I-test I-test
systolic I-test I-test
function I-test I-test
is O O
hyperdynamic B-problem O
( O O
EF B-test O
> O O
75% O O
) O O
. O O

10. O O
Glucotrol B-treatment B-treatment
10 O O
mg O O
qam O O
. O O

ROS O O
otherwise O O
negative O O
. O O

Neurology O O
was O O
consulted O O
and O O
the O O
pt O O
also O O
had O O
MRI B-test O
which O O
was O O
negative O O
. O O

cc O O
: O O

4. O O
Glipizide B-treatment O
5 O O
mg O O
Tablet O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Tablet O O
PO O O
BID O O
( O O
2 O O
times O O
a O O
day O O
). O O

2013-12-24 O O
01:30 O O
AM O O

EXTREMITIES O O
: O O

Patient O O
placed O O
on O O
FiO2 B-treatment O
100% O O
. O O

Please O O
followup O O
with O O
your O O
primary O O
care O O
physician O O
Todd O O
12-30 O O
weeks O O
of O O
discharge O O
. O O

MEDICATIONS O O
ON O O
DISCHARGE O O
: O O

POTASSIUM B-test B-test
- O O
5.9* O O
CHLORIDE B-test B-test
- O O
108 O O
TOTAL B-test B-test
CO2 I-test I-test
- O O
23 O O
ANION B-test O
GAP I-test O
- O O
17 O O

You O O
will O O
need O O
to O O
conrtinue O O
with O O
your B-treatment O
Lovenox I-treatment O
injections I-treatment O
for O O
at O O
least O O
4-6 O O
weeks O O
as O O
instructed O O
by O O
Orthopedics O O

On O O
physical B-test B-treatment
exam I-test I-treatment
, O O
she O O
is O O
a O O
healthy-appearing O O
female O O
with O O
a O O
normal O O
voice O O
and O O
no O O
exophthalmos B-problem B-problem
. O O

There O O
were O O
post B-problem O
laparoscopic I-problem B-problem
incisions I-problem I-problem
without O O
erythema B-problem O
with O O
Steri-Strips B-treatment O
in O O
place O O
. O O

EKG B-test O
showed O O
atrial B-problem B-treatment
fibrillation I-problem I-treatment
, O O
left B-problem B-treatment
axis I-problem I-treatment
deviation I-problem I-treatment
, O O
LVH B-problem O
, O O
nonspecific B-problem B-treatment
ST-T I-problem I-treatment
changes I-problem I-treatment
either O O
due O O
to O O
digitalis B-problem O
affect I-problem O
. O O

TR O O
: O O

Discharge O O
Date O O
: O O

normal O O
sinus O O
rhythm O O
at O O
73 O O
beats O O
per O O
minute O O
. O O

He O O
underwent O O
a B-treatment O
joint I-treatment O
procedure I-treatment O
by O O
Otolaryngology O O
and O O
Plastic O B-problem
Surgery O I-problem
. O O

Patient O O
underwent O O
liver B-test O
biopsy I-test O
on O O
02/16/91 O O
and O O
the O O
results O O
of O O
this O O
were O O
pending O O
when O O
the O O
patient O O
died O O
. O O

No O O
Restrictions O O

PCP O O
Name O O
: O O

6. O O
Diverticulosis B-problem B-problem
within I-problem I-problem
the I-problem I-problem
right I-problem I-problem
remnant I-problem I-problem
sigmoid I-problem I-problem
colon I-problem I-problem
. O O

ALLERGIES O O
: O O

Aspirin B-treatment B-test
81 O O
mg O O
qd O O
, O O
Toprol B-treatment B-test
XL O I-test
50 O O
mg O O
qd O O
, O O
MVI B-treatment B-test
, O O
Flexeril B-treatment B-test
10 O O
mg O O
qhs O O
, O O
Plavix B-treatment B-test
75 O O
mg O O
qd O O
( O O
last O O
on O O
10-18 O O
) O O

Subcutaneous B-problem B-test
edema I-problem I-test
is O O
noted O O
in O O
the O O
lower O O
abdomen O O
and O O
pelvis O O
. O O

Trivial B-problem O
MR I-problem O
. O O

Endocrine O O
. O O

PCP O O
Name O O
: O O

The O O
patient O O
is O O
a O O
58 O O
year O O
old O O
right O O
hand O O
dominant O O
white O O
male O O
with O O
a O O
long O O
history O O
of O O
hypertension B-problem B-treatment
, O O
changed O O
his B-treatment O
medications I-treatment O
from O O
Aldomet B-treatment O
to O O
Clonidine B-treatment O
six O O
weeks O O
ago O O
. O O

NONE O O
, O O
PHYSICIAN O O

Unremarkable O O
. O O

The O O
extra O O
ocular O O
movements O O
are O O
full O O
. O O

Temperature B-test B-test
97.4 O O
, O O
heart B-test B-test
rate I-test I-test
100 O O
, O O
blood B-test B-test
pressure I-test I-test
142/89 O O
, O O
and O O
O2 B-test O
saturation I-test B-treatment
94% O O
on O O
room O O
air O O
. O O

That O O
test O O
was O O
negative O O
. O O

She O O
underwent O O
an B-test B-treatment
immediate I-test I-treatment
head I-test I-treatment
CT I-test I-treatment
and O O
Neuro O O
consult O O
and O O
was O O
transferred O O
back O O
to O O
the O O
CSRU O O
. O O

T O O
- O O
waves O O
were O O
also O O
noted O O
to O O
be O O
inverted O O
in O O
I O O
and O O
AVL O O
. O O

Occasionally O O
required O O
Haldol B-treatment O
/ O O
ativan B-treatment O
at O O
night O O
for O O
agitation B-problem O
. O O

10. O O
Senna B-treatment B-test
8.6 O O
mg O O
Tablet O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Tablet O O
PO O O
BID O O
( O O
2 O O
times O O
a O O
day O O
) O O
as O O
needed O O
. O O

Chest O O
was O O
clear O O
to O O
auscultation B-test B-problem
bilaterally O I-problem
. O O

The O B-test
right O I-test
superior O I-test
parathyroid O I-test
gland O O
was O O
found O O
to O O
be O O
markedly B-problem O
enlarged I-problem O
and O O
consistent O O
with O O
an B-problem B-problem
adenoma I-problem I-problem
. O O

Other O O
notable O O
tests O O
: O O

Shortness B-problem O
of I-problem O
breath I-problem O
. O O

CV O O
: O O
RRR O O
, O O
s1 O O
, O O
s2 B-problem O
distant I-problem O

DISCHARGE O O
DATE O O
: O O

DISPOSITION O O
: O O

Post-operatively O O
mental O O
status O O
improved O O
. O O

Discharge O O
Diagnosis O O
: O O
s/p O O
AVR B-treatment O
05-14 O O
( O O
tissue O O
) O O
readmitted O O
05-24 O O
w/ O O
pulmonary B-problem B-treatment
embolism I-problem I-treatment
, O O
RUE B-problem O
DVT I-problem O
, O O
HIT B-problem O
positive I-problem O

Attending O O
: O O

were O O
elevated B-problem O
. O O

Sensory O O
is O O
intact O O
to O O
soft O O
touch O O
throughout O O
. O O

Discharge O O
Date O O
: O O

8. O O
Coumadin B-treatment B-treatment
- O O
Dose O O
unknown O O

She O O
was O O
able O O
to O O
give O O
a O O
detailed O O
history O O
in O O
an O O
organized O O
manner O O
. O O

69 O O
y/o O O
female O O
wtih O O
PMH B-problem O
significant O O
for O O
ESRD B-problem O
on O O
HD B-treatment O
, O O
type B-problem O
2 I-problem O
DM I-problem O
, O O
and O O
recent B-problem O
PE I-problem O
resulting O O
in O O
PEA B-problem O
arrest I-problem O
admitted O O
through O O
the O O
Juan O O
with O O
sepsis B-problem O
of O O
unknown O O
etiology O O
. O O

He O O
has O O
a O O
ten O O
pack O O
year O O
history O O
of O O
smoking O O
, O O
quit O O
in O O
1990 O O
. O O

HEENT O O
: O O
PERRL O O
, O O
OP O O
clear O O
, O O
MMM O O

Discharge O O
Date O O
: O O

RECOMMENDATIONS O O
: O O

Soft O O
. O O

In O O
addition O O
, O O
she O O
is O O
to O O
follow O O
up O O
with O O
her O O
primary O O
care O O
physician O O
to O O
check O O
her B-test O
prothrombin I-test O
time I-test O
/ O O
INR B-test O
as O O
well O O
as O O
calcium B-test B-treatment
, I-test O
albumin I-test B-treatment
and I-test O
phosphate I-test B-problem
levels I-test I-problem
. O O

Pupils O O
were O O
2 O O
millimeters O O
down O O
to O O
1 O O
millimeter O O
by O O
direct B-test O
and I-test O
consensual I-test B-problem
stimuli I-test I-problem
. O O

An B-test B-test
echocardiogram I-test I-test
was O O
performed O O
, O O
which O O
showed O O
completely O B-problem
normal O I-problem
left O I-problem
ventricular O I-problem
systolic O I-problem
function O I-problem
with O O
an O B-problem
ejection O I-problem
fraction O I-problem
calculated O I-problem
at O O
.74 O O
. O O

Lungs O O
decreased B-problem O
breath I-problem O
sounds I-problem O
at I-problem O
bilateral I-problem O
bases I-problem O
with O O
minimal B-problem B-problem
expiratory I-problem I-problem
crackles I-problem I-problem
on I-problem O
the I-problem O
right I-problem O
. O O

Flagyl B-treatment O
. O O

absomen O O
soft O O
, O O
tender B-problem O
to O O
palpation B-test O
over I-test O
RUQ I-test O
, O O
but O O
no O O
guarding B-problem O
or O O
rebound B-problem O

ABD B-problem O
PAIN/ I-problem O
PELVIC B-problem O
PAIN I-problem O

- O O
Echo O O
: O O

Call O O
Trauma O O
Clinic O O
to O O
coordinate O O
the B-test O
study I-test O
, O O
result O O
and O O
appointment O O
dates O O
(( O O
289 O O
) O O
411-5387 O O
). O O

026350193 O O
RWH O O

This O O
gradually O O
increased O O
until O O
June O O
1992 O O
where O O
he O O
had O O
recurrent B-problem B-problem
severe I-problem I-problem
right I-problem I-problem
sided I-problem I-problem
sciatica I-problem I-problem
. O O

2. O O
Heparin B-treatment B-treatment
5000 O O
units O O
subcutaneously O O
twice O O
a O O
day O O
. O O

4. O O
Endocrine O O
. O O

PAST O O
MEDICAL O O
HISTORY O O
: O O

Given O O
no O O
other O O
risk O O
factors O O
or O O
likely O O
causes O O
, O O
the O O
most O O
likely O O
etiology O O
for O O
his B-problem O
embolus I-problem O
is O O
DVT B-problem O
from I-problem O
the I-problem O
left I-problem O
leg I-problem O
. O O

A B-test B-test
Swan I-test I-test
was O O
placed O O
and O O
initial O B-treatment
readings O I-treatment
were O O
CVP B-test O
of O O
6 O O
, O O
wedge B-test O
pressure I-test B-test
of O O
10 O O
to O O
12 O O
, O O
cardiac B-test B-test
index I-test I-test
of O O
4.7 O O
, O O
and O O
SVR B-test O
of O O
438 O O
all O O
consistent O O
with O O
a B-problem B-problem
Pseudomonas I-problem I-problem
sepsis I-problem I-problem
picture I-problem I-problem
. O O

PAST O O
MEDICAL O O
HISTORY O O
: O O

The B-test O
CA-125 I-test O
was O O
still O O
pending O O
and O O
alphafeto B-test O
protein I-test O
is O O
still O O
pending O O
. O O

CRP B-test B-test
- O O
46.2 O O
* O O

8. O O
2017-09-30 O O
EEG B-test O
: O O

_____________________________ O O
LATO O O
TIKFREIERM O O
, O O
M.D. O O

She O O
was O O
discharged O O
on O O
post-op O O
day O O
11 O O
. O O

Disp O O
:* O O
30 O O
Tablet O O
(s)* O O
Refills O O
:* O O
2 O O
* O O

As O O
the O O
patient O O
became O O
more O O
awake O O
, O O
he O O
still O O
remained O O
somewhat B-problem O
confused I-problem O
and O O
a B-problem O
little I-problem O
bit I-problem O
out I-problem O
of I-problem O
it I-problem O
. O O

CC O O
: O O

She O O
can O O
be O O
given O O
prn O O
lasix B-treatment O
for O O
weight B-problem O
gain I-problem O
or O O
shortness B-problem B-problem
of I-problem I-problem
breath I-problem I-problem
. O O

Discharge O O
Date O O
: O O

1. O O
Atonic B-problem O
bladder I-problem O
with O O
a B-treatment B-problem
suprapubic I-treatment I-problem
tube I-treatment I-problem
. O O

SOCIAL O O
HISTORY O O
: O O

The O O
patient O O
is O O
a O O
52 O O
year O O
old O O
Czech O O
speaking O O
gentleman O O
with O O
a O O
history O O
of O O
severe B-problem B-problem
mitral I-problem I-problem
regurgitation I-problem I-problem
. O O

She O O
remained O O
on O O
IV B-treatment B-test
antibiotics I-treatment I-test
x O O
14 O O
days O O
and O O
required O O
pressors B-treatment O
for O O
the O O
first O O
few O O
days O O
post-op O O
. O O

Report O O
Status O O
: O O

The O O
plan O O
is O O
for O O
alternating O O
feeds O O
. O O

He O O
did O O
not O O
sleep O O
at O O
all O O
the O O
night O O
before O O
and O O
was O O
extremely B-problem O
fatigued I-problem O
. O O

Major O O
Surgical O O
or O O
Invasive O O
Procedure O O
: O O

She O O
has O O
been O O
working O O
with O O
Speech B-treatment O
Therapy I-treatment O
, O O
occupational B-treatment B-treatment
therapy I-treatment I-treatment
and O O
physical B-treatment B-treatment
therapy I-treatment I-treatment
closely O I-treatment
and O O
should O O
continue O O
to O O
show O O
improvement O O
. O O

A B-test O
Holter I-test O
showed O O
atrial B-problem O
fibrillation I-problem O
with O O
period O O
of O O
ventricular B-problem B-problem
bigemini I-problem I-problem
. O O

Brief O O
Hospital O O
Course O O
: O O

At O O
that O O
time O O
, O O
his B-test B-treatment
oxygen I-test I-treatment
saturation I-test I-treatment
was O O
only O O
90% O O
on O O
room O O
air O O
and O O
his B-test B-treatment
chest I-test I-treatment
X-Ray I-test I-treatment
showed O O
no O O
change O O
. O O

Medications O O
on O O
Admission O O
: O O

DISCHARGE O O
SUMMARY O O
NAME O O
: O O

5. O O
Type B-problem O
2 I-problem O
DM I-problem O
- O O
Patient O O
was O O
initially O O
covered O O
with O O
an B-treatment B-problem
insulin I-treatment I-problem
drip I-treatment I-problem
while O I-problem
septic B-problem I-problem
and O O
then O O
transitioned O O
back O O
to O O
insulin B-treatment B-problem
sliding I-treatment I-problem
scale I-treatment I-problem
. O O

On O O
HD2 O O
, O O
cardiac B-test B-treatment
clearance I-test I-treatment
was O O
obtained O O
by O O
Dr. O O
Sanchez O O
. O O

MEDICATIONS O O
ON O O
ADMISSION O O
: O O

BELB O B-test
, O O
BRITHERL O B-treatment
, O O
M.D. O O
( O O
IL35 O O
) O O
12/10/05 O O
02:50 O O
PM O O

402389409 O O
WGH O O

Sex O O
: O O

3) O O
Anemia B-problem B-treatment
- O O
patient O O
transfusion B-problem O
dependant I-problem O
with O O
a O O
baseline O O
of O O
28 O O
. O O

His B-test B-test
complete I-test I-test
blood I-test I-test
count I-test I-test
showed O O
11% B-problem O
bandemia I-problem O
with O O
a B-test B-treatment
total I-test I-treatment
white I-test I-treatment
count I-test I-treatment
of O O
10 O O
. O O

Take O O
with O O
food O O
PRENATAL B-treatment O
MULTIVITAMINS I-treatment O
( I-treatment O
STUARTNATAL I-treatment O
) I-treatment O
1 O O
TAB O O
PO O O
QD O O
MAALOX-TABLETS B-treatment B-treatment
QUICK I-treatment I-treatment
DISSOLVE I-treatment I-treatment
/ I-treatment I-treatment
CHEWABLE I-treatment I-treatment
1-2 O O
TAB O O
PO O O
Q6H O O
PRN O O
Upset B-problem O
Stomach I-problem O

- O O
CAD B-problem B-problem
s/p B-treatment I-problem
LAD I-treatment I-problem
PTCA I-treatment I-problem
33 O O
years O O
ago O O

decision O O
was O O
made O O
by O O
the O O
family O O
and O O
the O O
medical O O
team O O
to O O
withdraw O O
care B-treatment O
. O O

A B-problem B-test
gastric I-problem I-test
ulcer I-problem I-test
was O O
found O O
and O O
this O O
was O O
biopsied O O
and O O
pathology B-test O
is O O
pending O O
at O O
this O O
time O O
. O O

15. O O
Nitroglycerin B-treatment B-treatment
SR I-treatment O
2.5 O O
mg O O
twice O O
a O O
day O O
. O O

SELCFARST O O
, O O
NAORLY O O

Override O O
Notice O O
: O O

The O O
patient O O
has O O
stable B-problem O
three-pillow I-problem O
orthopnea I-problem O
and O O
occasional B-problem B-problem
paroxysmal I-problem I-problem
nocturnal I-problem I-problem
dyspnea I-problem I-problem
. O O

In O O
order O O
to O O
facilitate O B-treatment
therapy B-treatment I-treatment
and O O
to O O
promote O O
mobility O O
, O O
an B-test B-test
MRI I-test I-test
of I-test O
the I-test O
knee I-test O
was O O
done O O
. O O

CVS O O
: O O
RRR O O
. O O
Normal O O
S1 O O
, O O
S2 O O
. O O

This O O
report O O
was O O
created O O
by O O
SHOULDER O O
, O O
RYBAM O O
06/05/2002 O O
04:26 O O
PM O O

Percocet B-treatment O
one O O
to O O
two O O
tablets O O
PO O O
q.4h. O O
to O O
6h.p.r.n. O O
pain B-problem B-treatment
. O O

There O O
were O O
some B-problem B-problem
very I-problem I-problem
rare I-problem I-problem
atrial I-problem I-problem
premature I-problem I-problem
contractions I-problem I-problem
. O O

Baby O O
is O O
presently O O
tolerating O O
mother O O
's O O
breastmilk O O
with O O
Enfamil B-treatment O
powder I-treatment O
to O O
make O O
24 O O
cal O O
/ O O
oz O O
at O O
130 O O
cc O O
/ O O
kg O O
/ O O
day O O
. O O

On O O
06-28 O O
, O O
the O O
patient O O
was O O
also O O
cleared O O
for O O
removal O O
of O O
her B-treatment B-problem
C-spine I-treatment I-problem
collar I-treatment I-problem
and O O
deemed O O
stable O O
for O O
transfer O O
to O O
the O O
Orthopedic O O
Service O O
under O O
the O O
direction O O
of O O
Dr. O O
Ronda O O
Lopez O O
. O O

Following O O
triage B-test O
, O O
the O O
patient O O
LEFT O O
WITHOUT O O
TREATMENT B-treatment O
. O O

A B-treatment B-test
thoracentesis I-treatment I-test
was O O
done O O
with O O
removal B-treatment O
of O O
1.5 O O
liters O O
of O O
fluid B-problem O
. O O

1. O O
Liver B-problem O
lesions I-problem O
: O O

He O O
was O O
loaded O O
with O O
IV B-treatment B-problem
Dilantin I-treatment I-problem
. O O

Pt O O
admitted O O
05-24 O O
from O O
ER O O
after O O
positive B-problem O
RUE I-problem O
DVT I-problem O
finding O O
in O O
vascular O O
lab O O
. O O

Resume O O
regular O O
exercise O O

Kimberly O O
was O O
born O O
in O O
Great O O
Britain O O
. O O

1. O O
Hydroxyzine B-treatment B-test
HCl I-treatment I-test
10 O O
mg O O
Tablet O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Tablet O O
PO O O
DAILY O O
( O O
Daily O O
) O O
. O O

Age O O
: O O

8. O O
PVD B-problem O
: O O

Chest O O
: O O

PRELIMINARY O O
REPORT O O

Mucous O O
membranes O O
are O O
moist O O
. O O

BLOOD B-test B-test
PT I-test I-test
- O O
39.1 O O
* O O
INR B-test O
( I-test O
PT I-test O
)- I-test O
4.4 O O
* O O

She O O
is O O
to O O
follow O O
up O O
with O O
her O O
primary O O
care O O
physician O O
in O O
one O O
week O O
. O O

She O O
had O O
normal O O
sensation O O
and O O
pulses O O
in O O
both O O
legs O O
. O O

2014-04-23 O O
07:56 O O
AM O O

2014-02-21 O O
12:20 O O
PM O O
BLOOD B-test B-test
Glucose B-test I-test
- O O
345 O O
* O O
UreaN B-test B-test
- O O
34 O O
* O O
Creat B-test B-test
- O O
1.0 O O
Na B-test B-test
- O O
137 O O
K B-test O
- O O
4.3 O O
Cl B-test B-test
- O O
99 O O
HCO3 B-test O
- O O
24 O O
AnGap B-test O
- O O
18 O O

An B-test O
MRI I-test O
was O O
performed O O
upon O O
admission O O
and O O
showed O O
an B-problem B-treatment
epidural I-problem I-treatment
mass I-problem I-treatment
at O I-treatment
the O I-treatment
right O I-treatment
posterior O I-treatment
lateral O I-treatment
T9 O O
to O O
T12 O O
area O B-problem
invading O I-problem
the O I-problem
neural O I-problem
foramina O I-problem
. O O

14. O O
Levofloxacin B-treatment B-test
500 O O
mg O O
p.o. O O
q.d. O O
for O O
10 O O
more O O
days O O
. O O

Dictated O O
By O O
: O O

DD O O
: O O

10/01/03 O O
09:06 O O
AM O O

9. O O
Hypertension B-problem B-problem

Diagnosis O O
: O O

6. O O
Norvasc B-treatment B-treatment
, O O
5 O O
mg O O
PO O O
daily O O
. O O

5. O O
Bile B-problem B-problem
leak I-problem I-problem
. O O

He O O
also O O
received O O
Kayexalate B-treatment O
for O O
hyperkalemia B-problem B-problem
. O O

Gastrointestinal O O
was O O
consulted O O
. O O

She O O
otherwise O O
had O O
normal O O
spontaneous O O
movements O O
and O O
facial O B-treatment
expression O I-treatment
and O O
did O O
not O O
appear O O
to O O
be O O
abulic B-problem O
. O O

PLT B-test B-test
COUNT I-test I-test
- O O
128 O O
* O O

KCl B-treatment B-test
20 O O
mg O O
p.o. O O
q. O O
day O O
for O O
one O O
week O O
. O O

No O O
ethanol O O
. O O

- O O
Grandfather O O
died O O
of O O
MI B-problem O
at O O
age O O
75 O O

The O O
cause O O
of O O
death B-problem O
was O O
a O B-treatment
combination O I-treatment
of O O
GI B-problem O
bleeding I-problem O
felt O O
to O O
be O O
ultimately O O
related O O
to O O
his B-problem B-problem
known I-problem I-problem
metastatic I-problem I-problem
pancreatic I-problem I-problem
cancer I-problem I-problem
. O O

Quit O O
tobacco O O
in O O
2003 O O
after O O
smoking O O
1 O O
ppd O O
for O O
" O O
a O O
very O O
long O O
time O O
". O O

Denies O O
any B-problem O
pain I-problem B-treatment
or O O
discomfort B-problem O
. O O

This O O
is O O
a O O
55-year-old O O
female O O
with O O
multiple O O
prior O O
admissions O O
for O O
pneumonia B-problem B-treatment
, O O
COPD B-problem B-treatment
, O O
asthma B-problem B-treatment
exacerbation I-problem I-treatment
, O O
over O O
3 O O
weeks O O
of O O
upper B-problem B-problem
respiratory I-problem I-problem
like I-problem I-problem
infection I-problem I-problem
unremitting O I-problem
with O O
increased B-treatment O
nebulizer I-treatment O
treatments I-treatment O
at O O
home O O
. O O

Reflexes B-test O
were O O
2+ O O
throughout O O
in O O
the O O
upper O O
and O O
lower O B-test
extremities O I-test
, O O
and O O
toes O O
were O O
downgoing O O
. O O

She O O
could O O
identify O O
her O O
siblings O O
. O O

No O O
Restrictions O O

No O O
driving O O
for O O
at O O
least O O
one O O
month O O
. O O

MRI B-test O
of I-test O
the I-test O
brain I-test O
revealed O O
multiple B-problem B-problem
foci I-problem I-problem
susceptibility I-problem I-problem
artifact I-problem I-problem
within I-problem I-problem
the I-problem I-problem
brain I-problem I-problem
. O O

MEDICATION O O
( O O
S O O
) O O
ON O O
DISCHARGE O O
: O O

The O O
patient O O
is O O
completely B-problem O
pacer-dependent I-problem O
, O O
being O O
epicardially B-treatment O
paced I-treatment O
at O O
70 O O
. O O

7. O O
Clonidine B-treatment B-treatment
0.2 O O
mg O O
Tablet O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Tablet O O
PO O O
TID O O
( O O
3 O O
times O O
a O O
day O O
). O O

These O O
findings O O
indicate O O
a B-problem O
widespread I-problem O
encephalopathic I-problem O
condition I-problem O
affecting O O
both O O
cortical O O
and O O
subcortical O B-problem
structures O I-problem
. O O

1. O O
Respiratory O B-treatment
- O O
Gerardo O O
was O O
initially O O
placed O O
in O O
nasal B-treatment O
cannula I-treatment O
oxygen I-treatment O
to O O
maintain O O
oxygen B-test O
saturation I-test O
greater O O
than O O
94 O O
. O O

2018-12-26 O O
08:28 O O
PM B-test O
URINE I-test O

Abdomen O O
had O O
decreased B-problem O
bowel I-problem O
sounds I-problem O
, O O
soft O O
, O O
nontender B-problem B-test
, O O
and O O
nondistended B-problem O
. O O

Vasotec B-treatment B-test
20 O O
mg O O
PO O O
b.i.d. O O
, O O
Clonidine B-treatment B-test
0.2 O O
mg O O
PO O O
b.i.d. O O
, O O
Nifedipine B-treatment B-test
20 O O
mg O O
PO O O
t.i.d. O O
, O O
Flexeril B-treatment B-test
10 O O
mg O O
PO O O
t.i.d. O O
, O O
Valium B-treatment B-test
5 O O
mg O O
PO O O
t.i.d. O O
, O O
Micronase B-treatment B-treatment
1.25 O O
mg O O
q.day O O
. O O

SHE O O
WAS O O
TRANSFERED O O
TO O O
THE O O
FLOOR O O
POST-OP O O
DAY O O
2 O O
WHERE O B-treatment
SHE O I-treatment
HAD O I-treatment
BEEN O I-treatment
AFEBRILE B-problem I-treatment
WITH O I-treatment
NORMAL O I-treatment
VITALS O I-treatment
, O O
MAKING O B-treatment
GOOD O I-treatment
URINE O I-treatment
, O O
AND O B-problem
TOLERATING O I-problem
A O I-problem
REGULAR O I-problem
DIET O I-problem
. O O

The O O
patient O O
became O O
constipated B-problem O
; O O
this O O
resolved O O
with O O
laxatives B-treatment O
. O O

CMED O O
: O O

The O O
following O O
day O O
, O O
she O O
remained O O
in O O
bed O O
through O O
essentially O O
all O O
of O O
the O O
day O O
due O O
to O O
malaise B-problem O
with O O
no O O
specific B-problem B-problem
deficits I-problem I-problem
being O O
noted O O
. O O

98.6 O O
, O O
104/50 O O
, O O
96 O O
, O O
20 O O
, O O
96% O O
RA O O

Metamucil B-treatment B-test
1 O O
teaspoon O B-treatment
q.d. O O
, O O
with O O
first O O
bolus O O
of O O
juice B-treatment O
, O O
juice B-treatment B-test
250 O O
cc. O O
down O O
nasogastric B-treatment B-treatment
tube I-treatment I-treatment
t.i.d. O O
, O O
tube B-treatment O
feeds I-treatment O
as O O
above O O
, O O
Lactinex B-treatment B-treatment
as O O
above O O
, O O
Tagamet B-treatment B-test
800 O O
mg. O O
nasogastric B-treatment B-treatment
tube I-treatment I-treatment
qhs O I-treatment
, O O
Nystatin B-treatment B-treatment
swish I-treatment I-treatment
and I-treatment O
spit I-treatment O
10 O O
cc. O O
five O O
times O O
a O O
day O O
, O O
Cardizem B-treatment B-treatment
slow I-treatment I-treatment
release I-treatment I-treatment
90 O O
mg. O O
PO O O
q.d. O O
, O O
Folic B-treatment B-test
Acid I-treatment I-test
1 O O
mg. O O
PO O O
q.d. O O
, O O
Ciprofloxacin B-treatment B-test
500 O O
mg. O O
PO O O
b.i.d. O O
, O O
discontinue O B-test
on O O
12/10/92 O O
KayCiel B-treatment B-test
30 O O
mEq. O O
down O O
nasogastric B-treatment B-test
tube I-treatment I-test
q.d. O O
, O O
Peridex B-treatment B-test
10 O O
cc. O O
swish O O
and O O
spit O O
q.i.d. O O
, O O
Coumadin B-treatment B-treatment
4 O O
mg. O O
nasogastric O B-treatment
tube O I-treatment
on O O
odd O O
days O O
, O O
alternating O B-treatment
with O O
5 O O
mg. O O
nasogastric O B-treatment
tube O I-treatment
on O O
even O O
days O O
, O O
once O O
daily O O
, O O
Tylenol B-treatment B-test
650 O O
mg. O O
PO O O
and O O
PR O B-treatment
q6hours O I-treatment
PRN O I-treatment
pain B-problem I-treatment
, O O
Nystatin B-treatment B-treatment
powder I-treatment O
to O O
axilla O O
and O O
groin O O
as O O
needed O O
. O O

Over O O
the O O
next O O
12 O O
hours O O
while O O
in O O
transit O O
to O O
the O O
hospital O O
, O O
the O O
patient O O
&apos;s O B-treatment
right O I-treatment
lower O I-treatment
extremity O I-treatment
became O I-treatment
red B-problem O
, O O
swollen B-problem O
, O O
and O O
increasingly B-problem B-problem
painful I-problem I-problem
. O O

Intermitent B-problem O
delirium I-problem O
throughout O O
admission O O
. O O

Treatment O O
Rendered O O
: O O

10/17/2001 O O
12:00:00 O O
AM O O

11. O O
Code O O
status O O
- O O
Initially O O
full O O
code O O
then O O
made O O
DNR O O
/ O O
DNI O O
after O O
family O O
meeting O O
on O O
02-27 O O
. O O

PPX O O
: O O
SC B-treatment O
heparin I-treatment O
, O O
bowel B-treatment O
regimen I-treatment O
, O O
nicotine B-treatment O
patch I-treatment O

ASSOCIATED O O
PROCEDURES O O
OR O O
OPERATIONS O O
: O O

This O O
was O O
thought O O
to O O
be O O
04-09 O O
the B-treatment O
large I-treatment O
volume I-treatment O
tap I-treatment O
verses O O
sepsis B-problem O
though O O
she O O
had O O
no O O
other O O
evidence O O
of O O
sepsis B-problem O
. O O

DISPOSITION O O
: O O

3. O O
Isosorbide B-treatment O
mononitrate I-treatment O
30 O O
q. O O
day O O
. O O

Rectal O O
: O O

PCP O O
Name O O
: O O

The O O
patient O O
contracted O O
HCV B-problem O
20 O O
years O O
ago O O
secondary O O
to O O
IV O O
drug O O
use O O
. O O

Major O O
Surgical O O
or O O
Invasive O O
Procedure O O
: O O

11. O O
C. B-problem O
difficile I-problem O
colitis I-problem O
treated O O
with O O
Flagyl B-treatment O
( O O
completed O O
08-10 O O
) O O

There O O
was O O
some O O
concern O O
that O O
the O O
patient O O
may O O
have O O
a B-problem B-problem
partial I-problem I-problem
biliary I-problem I-problem
obstruction I-problem I-problem
and O O
the O O
patient O O
was O O
sent O O
for O O
an B-test B-problem
magnetic I-test I-problem
resonance I-test I-problem
cholangiopancreatography I-test I-problem
to O O
further O O
evaluate O O
the O O
biliary O O
system O O
. O O

Rectal O O
normal O O
tone O O
, O O
guaiac B-problem B-treatment
positive I-problem I-treatment
brown I-problem I-treatment
stool I-problem I-treatment
, O O
no O O
perirectal B-problem B-problem
lesions I-problem I-problem
or O I-problem
erythema B-problem I-problem
. O O

It O O
is O O
associated O O
with O O
rest B-problem O
pain I-problem B-treatment
as O O
well O O
. O O

The O O
patient O O
was O O
afebrile O O
. O O

9. O O
Ascorbic B-treatment B-test
Acid I-treatment I-test
500 O O
mg O O
Tablet O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Tablet O O
PO O O
BID O O
( O O
2 O O
times O O
a O O
day O O
). O O

1. O O
Prematurity B-problem O
at O O
30-6/7 O O
weeks O O
. O O

Pulmonary B-problem O
embolus I-problem O

05/14/2005 O O
16:02 O O

FAMILY O O
HISTORY O O
: O O

21. O O
Metoprolol B-treatment B-treatment
Succinate I-treatment I-treatment
25 O O
mg O O
Tablet O O
Sustained O O
Release O O
24HR O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Tablet O O
Sustained O O
Release O O
24HR O O
PO O O
DAILY O O
( O O
Daily O O
) O O
. O O

TR O O
: O O

The O O
patient O O
gradually O O
lost O O
brain O B-treatment
systolic O I-treatment
ejection O I-treatment
murmur O I-treatment
function O I-treatment
and O O
was O O
pronounced O O
dead B-problem O
on O O
07/02/00 O O
. O O

5. O O
Borderline B-problem B-problem
splenomegaly I-problem I-problem
. O O

He O O
had O O
a O O
normal O O
head B-test O
, I-test O
eyes I-test O
, I-test O
ears I-test O
, I-test O
nose I-test O
and I-test O
throat I-test B-problem
exam I-test I-problem
. O O

Fever B-problem O
, O O
f/u O O
infiltrte B-problem O

not O O
given O O

Discharge O O
Disposition O O
: O O

Two O O
branches O O
of O O
an B-problem B-treatment
left I-problem I-treatment
anterior I-problem I-treatment
descending I-problem O
to I-problem O
PA I-problem O
fistula I-problem O
which O O
was O O
successfully O O
coiled O O
. O O

This O O
was O O
thought O O
to O O
be O O
related O O
to O O
musculoskeletal O O
. O O

His B-treatment B-test
central I-treatment I-test
line I-treatment I-test
and O O
chest B-treatment B-treatment
tubes I-treatment I-treatment
were O O
removed O O
on O O
post-op O O
day O O
#2 O O
and O O
was O O
transferred O O
to O O
the O O
floor O O
in O O
stable O O
condition O O
. O O

The O O
patient O O
had O O
a B-problem O
very I-problem O
firm I-problem O
nodule I-problem O
at O O
the O O
vertex O O
of O O
her O B-problem
calvarium O I-problem
. O O

Certified O O
Nurse O O
Midwife O O
: O O

ABDOMEN O O
: O O

INDICATION O O
: O O

IMPRESSION O O
: O O
Minimally B-problem O
displaced I-problem O
, I-problem O
comminuted I-problem B-treatment
fractures I-problem I-treatment
of I-problem I-treatment
the I-problem I-treatment
left I-problem I-treatment
C7 I-problem I-treatment
and I-problem O
T1 I-problem O
transverse I-problem O
processes I-problem O
. O O

Pupils B-problem O
minimally I-problem O
reactive I-problem O
. O O

AKOTE O O
, O O
NAO O O
630-65-64-5 O O
Q39 O O

9) O O
Amitriptyline B-treatment B-treatment
10 O O
mg O O
p.o. O O
q.h.s. O O

11/25/2000 O O
01:36 O O
AM O O

Sex O O
: O O

The O O
patient O O
was O O
also O O
told O O
to O O
continue O O
on O O
a B-treatment B-problem
neutropenic I-treatment I-problem
diet I-treatment O
. O O

In O O
the O O
meantime O O
, O O
Lasix B-treatment B-treatment
dosage O O
is O O
increased O O
. O O

Discharge O O
Diagnosis O O
: O O

The O O
patient O O
was O O
referred O O
to O O
the O O
Neurology O O
Service O O
for O O
further B-test O
workup I-test O
of O O
the B-problem O
mass I-problem O
. O O

3. O O
Severe B-problem O
autonomic I-problem O
dysfunction I-problem O
with O O
multiple O O
hospitalizations O O
for O O
hypertensive B-problem O
emergency I-problem O
, O O
gastroparesis B-problem B-treatment
, O O
and O O
orthostatic B-problem B-problem
hypotension I-problem I-problem
. O O

Discharge O O
Date O O
: O O

Admission O O
Date O O
: O O

You O O
may O O
remove O O
your B-treatment O
dressings I-treatment O
2 O O
days O O
after O O
your B-treatment O
surgery I-treatment O
if O O
they O O
were O O
not O O
removed O O
in O O
the O O
hospital O O
. O O

Local O O
Vaginal O O
delivery O O
: O O

EDC O O
: O O

COMPARISONS O O
: O O
None O O
. O O

White B-test B-test
blood I-test I-test
cell I-test I-test
count I-test I-test
9.8 O O
, O O
hematocrit B-test B-test
44.1 O O
, O O
platelets B-test B-test
262 O O
, O O
prothrombin B-test B-treatment
time I-test I-treatment
10.4/ O O
10.3 O O
, O O
partial B-test B-treatment
thromboplastin I-test I-treatment
time I-test O
25.9 O O
. O O

DISCHARGE O O
DATE O O
: O O

Prior O O
to O O
that O O
smoked O O
2 O O
packs O O
a O O
day O O
. O O

The O O
patient O O
had O O
coarse B-problem O
rhonchi I-problem O
on O O
examination B-test B-treatment
. O O

Her O B-test
previous O I-test
occupation O I-test
was O O
an O B-treatment
executive O I-treatment
secretary O I-treatment
, O O
home O O
trainer O O
/ O O
nurse O O
, O O
rental O O
aide O O
. O O

Monitor O O
wounds B-problem O
for O O
infection B-problem B-treatment
- O O
redness B-problem O
, O O
drainage B-problem O
, O O
or O O
increased B-problem B-problem
pain I-problem I-problem

He O O
is O O
a O O
39 O O
year-old O O
gentleman O O
with O O
hyperlipidemia B-problem B-treatment
and O O
smoking O O
who O O
presented O O
with O O
acute O O
onset O O
of O O
chest B-problem B-treatment
pain I-problem I-treatment
since O O
five O O
in O O
the O O
morning O O
with O O
radiation O O
to O O
the O O
left O O
arm O O
and O O
nausea B-problem B-problem
. O O

17. O O
Ferrous B-treatment B-test
Sulfate I-treatment I-test
325 O O
( O O
65 O O
) O O
mg O O
Tablet O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Tablet O O
PO O O
DAILY O O
( O O
Daily O O
) O O
. O O

ACTIVITY O O
: O O

He O O
needed O O
to O O
go O O
to O O
a B-treatment O
rehab I-treatment O
facility I-treatment O
for O O
continued B-treatment O
respiratory I-treatment O
therapy I-treatment O
and O O
for O O
Physical B-treatment O
Therapy I-treatment O
to O O
increase O O
his O O
muscle O O
strength O O
. O O

Chest B-test O
x-ray I-test O
was O O
remarkable O O
for O O
a O B-problem
questionable O I-problem
left B-problem I-problem
lower I-problem I-problem
lobe I-problem I-problem
infiltrate I-problem I-problem
. O O

His B-treatment B-test
Decadron I-treatment I-test
dose I-treatment O
was O O
titrated O O
down O O
to O O
5 O O
mg O O
IV O O
q6h O O
on O O
12/3/94 O O
. O O

HOSPITAL O O
COURSE O O
: O O

She O O
had O O
a B-problem B-problem
dominant I-problem I-problem
right I-problem I-problem
coronary I-problem I-problem
artery I-problem I-problem
with O O
minor B-problem B-problem
disease I-problem I-problem
. O O

Modifinal B-treatment B-test
100 O O
mg O O
po O O
qd O O

No O O
dictated O O
summary O O

POSTPARTUM O O
OTHER O O
DIAGNOSIS O O
; O O

RUTHU O B-test
PAIN O I-test
, O O
M.D. O O
KW25 O O

CONDITION O O
ON O O
DISCHARGE O O
: O O

Please O O
note O O
this O O
information O O
may O O
have O O
been O O
updated O O
on O O
the O O
inpatient O O
unit O O
. O O

She O O
was O O
oriented O O
to O O
person O O
, O O
place O O
, O O
time O O
and O O
purpose O B-treatment
, O O
she O O
recalled O O
three O O
out O O
of O O
three O O
objects O O
at O O
five O O
minutes O O
, O O
she O O
is O O
able O O
to O O
do O O
calculations O B-problem
. O O

TIB B-test O
/ I-test O
FIB I-test O
( I-test O
AP I-test O
& I-test O
LAT I-test O
) I-test O
SOFT O O
TISSUE O O

Blood B-test B-test
pressure I-test I-test
120/70 O O
, O O
temperature B-test B-test
97.8 O O
F O O
, O O
pulse B-test B-test
68 O O
, O O
respirations B-test B-test
22 O O
, O O
Sa02 B-test O
on O O
2 O O
L O O
94% O O
. O O

Patient O O
had O O
CTA B-test O
which O O
showed O O
bilateral B-problem B-problem
pulmonary I-problem I-problem
embolisms I-problem I-problem
. O O

There O O
is O O
opacification B-problem B-treatment
of I-problem I-treatment
the I-problem I-treatment
mastoid I-problem I-treatment
air I-problem I-treatment
cells I-problem I-treatment
, O O
greater O O
on O O
the O B-problem
left O I-problem
than O I-problem
the O I-problem
right O I-problem
. O O

Sigmoid B-problem O
diverticulosis I-problem O
with O O
focal B-problem O
narrowing I-problem O
of I-problem O
the I-problem O
sigmoid I-problem O
colon I-problem O
just O O
distal O O
to O O
the B-problem O
dilatation I-problem O
with O O
wall B-problem O
thickening I-problem O
, O O
due O O
to O O
diverticulitis B-problem O
. O O

On O O
the O O
night O O
of O O
05-13 O O
, O O
the O O
patient O O
continued O O
to O O
decline O O
. O O

Brother O O
w/ O O
CAD B-problem O
since O O
age O O
40 O O
and O O
died O O
in O O
70 O O
's O O
after O O
cardiac B-treatment B-problem
surgery I-treatment I-problem
. O O

Blood B-test O
pressure I-test B-treatment
was O O
98/64 O O
. O O

EKG B-test O
is O O
notable O O
for O O
sinus B-problem B-treatment
tachycardia I-problem I-treatment
at O O
100 O O
beats O O
per O O
minute O O
, O O
normal O O
axis O O
. O O

PRINCIPAL O O
PROCEDURE O O
: O O

NOTE O O
: O O
This B-test O
study I-test O
was O O
initially O O
performed O O
on O O
2014-10-21 O O
. O O

She O O
was O O
able O O
to O O
tolerate O O
diet O O
, O O
ambulate O B-treatment
, O O
having O O
a O O
bowel O O
movement O O
and O O
dischargo O O
home O O
in O O
good O O
conditions O O
. O O

ABDOMEN O O
: O O

DISCHARGE O O
FOLLOW-UP O O
: O O

LAYMIE O O
M O O
HE O O
, O O
M.D. O O

Pancreatic B-problem B-test
carcinoma I-problem I-test
. O O

Treatment O O
Rendered O O
: O O

Strength B-test O
5/5 O O
in O O
upper O O
and O O
lower O B-problem
extremities O I-problem
. O O

12/19/2006 O O
08:13 O O
PM O O

Room O O
: O O

Lactulose B-treatment O
30 O O
mg O O
q.i.d. O O

1. O O
Bucket B-problem O
handle I-problem O
medial I-problem O
meniscal I-problem O
tear I-problem O
with O O
flipped B-problem O
fragment I-problem O
in I-problem O
the I-problem O
intercondylar I-problem O
notch I-problem O
. O O

No O O
chest B-problem B-problem
pain I-problem I-problem
. O O

ED O O
Discharge O O
Summary O O

Memory O O
and O O
attention O O
span O O
good O O
. O O

Denies O O
any O O
abuse O O
of O O
alcohol O O
. O O

2018-10-25 O O
12:36 O O
PM O O
BLOOD B-test B-test
UreaN B-test I-test
- O O
17 O O
Creat B-test B-test
- O O
0.7 O O
Cl B-test B-test
- O O
111 O O
* O O
HCO3 B-test O
- O O
23 O O

3. O O
Baclofen B-treatment B-treatment
20 O O
mg O O
p.o. O O
t.i.d. O O

DISPOSITION O O
: O O

An B-test B-test
electroencephalogram I-test I-test
revealed O O
generalized B-problem O
slowing I-problem O
without I-problem O
ictal I-problem O
events I-problem O
. O O

The O O
diagnosis O O
of O O
Alzheimer B-problem O
&apos;s I-problem O
was O O
made O O
in O O
1998 O O
. O O

complications B-problem O
. O O

5. O O
Dehydration B-problem B-treatment
. O O

Wife O O
verbally O O
agrees O O
to O O
understanding O O
. O O

He O O
was O O
discharged O O
home O O
on O O
Percocet B-treatment O
and O O
Keflex B-treatment O
. O O

6/15/1994 O O
12:00:00 O O
AM O O

The O O
patient O O
at O O
that O O
time O O
noted O O
slight B-problem O
shortness I-problem O
of I-problem O
breath I-problem O
but O O
was O O
sent O O
home O O
anyway O O
. O O

Diagnosis O O
: O O

2. O O
Compazine B-treatment B-treatment
10 O O
mg O O
p.o. O O
q O O
6hours O O
p.r.n. O O
nausea B-problem B-problem
. O O

PHYSICAL O O
EXAMINATION O O
: O O

Major O O
Surgical O O
or O O
Invasive O O
Procedure O O
: O O

Monitor O O
wounds B-problem O
for O O
signs B-problem O
of I-problem O
infection I-problem B-treatment
. O O
Please O O
call O O
with O O
any O O
concerns O O
or O O
questions O O
. O O

DISCHARGE O O
PATIENT O O
ON O O
: O O

She O O
has O O
difficulty B-problem O
with I-problem O
shoes I-problem O
and I-problem O
socks I-problem O
and I-problem O
foot I-problem O
care I-problem O
. O O

She O O
described O O
the B-problem O
pain I-problem B-treatment
as O O
being O O
exacerbated O O
by O O
eating O O
and O O
described O B-problem
an B-problem I-problem
associated I-problem I-problem
weight I-problem I-problem
loss I-problem I-problem
. O O

While O O
at O O
home O O
, O O
the O O
patient O O
did O O
not O O
do O O
well O O
and O O
could O O
tolerate O O
minimal O O
food O O
intake O O
and O O
lost O O
about O O
20 O O
pounds O O
in O O
one O O
month O O
. O O

Disp O O
:* O O
30 O O
Tablet O O
, O O
Delayed O O
Release O O
( O O
E.C. O O
)(s)* O O
Refills O O
:* O O
2 O O
* O O

HOSPITAL O O
COURSE O O
: O O

Attending O O
: O O
James O O
F. O O
Bard O O
, O O
M.D. O O

PT B-test O
was O O
13.2 O O
. O O

In O O
the O O
Emergency O O
Department O O
at O O
the O O
Rehab O O
Hospital O O
of O O
the O O
Cape O O
& O O
Islands O O
Hospital O O
, O O
the O O
patient O O
was O O
noted O O
to O O
have O O
vomited O O
some O O
heme O O
positive O O
material O O
. O O

SVD O O
OTHER O O
DIAGNOSIS O O
; O O
Conditions O B-treatment
, O O
Infections O B-treatment
, O O
Complications O B-treatment
, O O
affecting O O
Treatment O O
/ O O
Stay O O

The O O
patient O O
&apos;s O O
hospitalization O O
was O O
uncomplicated O O
. O O

( O O
End O O
of O O
Report O O
) O O

Resting B-test O
WMA I-test O
include O O
mid B-problem O
to I-problem O
distal I-problem O
septal I-problem O
akinesis I-problem O
, O O
apical B-problem B-treatment
akinesis I-problem I-treatment
, O O
inferior B-problem B-treatment
akinesis/hypokinesis I-problem I-treatment
, O O
and O O
mid B-problem O
to I-problem O
distal I-problem B-problem
anterolateral I-problem I-problem
hypokinesis I-problem I-problem
/ O I-problem
akinesis B-problem I-problem
. O O

3. O O
Neurontin B-treatment B-treatment
300 O O
mg O O
taken O O
three O O
times O O
a O O
day O O
. O O

HOSPITAL O O
COURSE O O
: O O

1. O O
Docusate B-treatment B-test
Sodium I-treatment I-test
100 O O
mg O O
Capsule O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Capsule O O
PO O O
BID O O
( O O
2 O O
times O O
a O O
day O O
) O O
as O O
needed O O
for O O
constipation B-problem B-problem
. O O

Pelvic B-test B-test
exam I-test I-test
revealed O O
normal O O
vulva O O
, O O
vagina O O
normal O O
, O O
cervix O O
normal O O
, O O
uterus O O
anteverted O O
, O O
small O B-treatment
, O O
nontender B-problem O
. O O

carduac B-problem B-test
enzymes I-problem I-test
mildly I-problem I-test
elevated I-problem I-test
, O O
felt O O
02-08 O O
demand B-problem O
ischemia I-problem O
in O O
setting O O
of O O
hypertensive B-problem B-treatment
urgency I-problem I-treatment
, O O
CK B-test B-treatment
and O O
MB B-test O
trended O O
Mcewen O O
at O O
time O O
of O O
admission O O
to O O
medical O O
floor O O
. O O

HOSPITAL O O
COURSE O O
: O O

She O O
occasionally O O
drinks O O
alcohol O O
. O O

There O O
is O O
no O O
evidence O O
of O O
intraaxial B-problem O
or I-problem O
extraaxial I-problem B-treatment
hemorrhage I-problem I-treatment
, O O
mass B-problem B-treatment
effect I-problem I-treatment
, O O
shift B-problem O
of I-problem O
normally I-problem B-problem
midline I-problem I-problem
structures I-problem I-problem
, O O
or O O
acute B-problem O
major I-problem O
or I-problem O
minor I-problem B-problem
vascular I-problem I-problem
territorial I-problem I-problem
infarction I-problem I-problem
. O O

DICTATING O O
FOR O O
: O O

11. O O
Potassium B-treatment B-treatment
Chloride I-treatment I-treatment
10 O O
mEq O O
Capsule O O
, O O
Sustained O O
Release O O
Sig O O
: O O
Two O O
( O O
2 O O
) O O
Capsule O O
, O O
Sustained O O
Release O O
PO O O
Q12H O O
( O O
every O O
12 O O
hours O O
). O O

The B-test O
cranial I-test O
nerve I-test O
exam I-test O
: O O

11/26/2000 O O
12:00:00 O O
AM O O

Call O O
to O O
reschedule O O
. O O

This O O
report O O
was O O
created O O
by O O
HERDES O O
, O O
NEWSHALIE O B-treatment
04/21/2005 O O
06:47 O O
AM O O

Again O O
, O O
this O O
was O O
unsuccessful O O
. O O

NEUROLOGICAL O O
: O O

ASSOCIATED O O
DIAGNOSES O O
: O O

WBC B-test B-test
- O O
8.3 O O
RBC B-test B-test
- O O
3.64 O O
* O O
HGB B-test B-test
- O O
12.6 O O
HCT B-test B-test
- O O
36.1 O O
MCV B-test B-test
- O O
99 O O
* O O
MCH B-test B-test
- O O
34.7 O O
* O O
MCHC B-test B-test
- O O
35.0 O O
RDW B-test O
- O O
12.4 O O

12/26/1996 O O
12:00:00 O O
AM O O

No O O
known B-problem B-problem
drug I-problem I-problem
allergies I-problem I-problem
. O O

MEDICATIONS O O
: O O

During O O
the O O
hospital O O
course O O
, O O
the O O
patient O O
was O O
started O O
on O O
a B-treatment B-test
PPI I-treatment I-test
, O O
Nexium B-treatment B-treatment
, O O
for O O
concerns O B-problem
of O I-problem
acid B-problem I-problem
reflux I-problem I-problem
. O O

cc O O
: O O

Mrs. O O
Wisniewski O O
is O O
a O O
45-year-old O O
woman O O
with O O
multiple B-problem B-problem
familial I-problem I-problem
cavernous I-problem I-problem
hemangiomas I-problem I-problem
. O O

TRIEVA O O
, O O
WINGENE O O
R O O

7. O O
Lisinopril B-treatment B-treatment
5 O O
mg O O
Tablet O O
Sig O O
: O O
0.5 O O
Tablet O O
PO O O
DAILY O O
( O O
Daily O O
). O O

Dr O O
Royer O O
in O O
2-3 O O
weeks O O

Hepatitis B-problem B-problem
C I-problem I-problem
cirrhosis I-problem I-problem
. O O

HO B-test O
evaluation I-test O

However O O
he O O
was O O
transferred O O
to O O
the O O
Medical O O
Intensive O O
Care O O
Unit O O
where O O
he O O
received O O
continuous B-treatment O
respiratory I-treatment O
therapy I-treatment O
in O O
theway O O
of O O
Albuterol B-treatment B-treatment
nebulizers I-treatment I-treatment
as O O
well O O
as O O
nasal B-treatment O
oxygen I-treatment O
, O O
intravenous B-treatment B-problem
steroids I-treatment I-problem
and O O
intravenous B-treatment B-problem
antibiotics I-treatment I-problem
. O O

Lives O O
with O O
wife O O
, O O
retired O O
12 O O
years O O
ago O O
after O O
working O O
as O O
electrician O O
for O O
Attleboro O O
Donald O O

Social O O
History O O
: O O

LABORATORY O O
DATA O O
: O O

Dictated O O
By O O
: O O
Kenneth O O
O. O O
Hogan O O
, O O
M.D. O O

He O O
has O O
had O O
night B-problem O
sweats I-problem O
for O O
the O O
past O O
2 O O
weeks O O
. O O

LABORATORY O O
DATA O O
: O O

Physical O O
Exam O O
: O O

Motor B-test O
examination I-test B-treatment
revealed O O
5/5 O O
power O O
in O O
all O O
groups O O
in O O
the O O
proximal O O
and O O
distal O O
upper O O
and O O
lower O B-problem
extremities O I-problem
. O O

61 O O
yo O O
African-American-Hispanic O O
male O O
had O O
abnormal B-problem O
EKG I-problem O
found O O
as O O
part O O
of O O
pre-op B-test O
eval. I-test O
for O O
ventral B-treatment B-problem
hernia I-treatment I-problem
repair I-treatment I-problem
. O O

the O O
area O O
of O O
hemorrhage B-problem O
the O O
same O O
, O O
slightly B-problem B-treatment
more I-problem I-treatment
edema I-problem I-treatment
and I-problem O
mass I-problem B-problem
effect I-problem I-problem
. O O

The O O
patient O O
is O O
a O O
59 O O
year-old O O
female O O
status O O
post O O
endoscopic B-test O
retrograde I-test O
cholangiopancreatography I-test O
on O O
the O O
day O O
of O O
admission O O
, O O
which O O
had O O
been O O
done O O
to O O
evaluate O O
for O O
possible O O
bile B-problem O
leak I-problem O
after O O
cholecystectomy B-treatment O
was O O
performed O O
four O O
days O O
ago O O
. O O

GI O O
: O O

She O O
developed O O
congestive B-problem B-problem
heart I-problem I-problem
failure I-problem I-problem
and O O
required O B-problem
pressor B-treatment I-problem
support I-treatment I-problem
. O O

Nortriptyline B-treatment B-test
10 O O
mg O O
q. O O
h.s. O O
; O O
Flomax B-treatment B-test
0.4 O O
mg O O
q. O O
h.s. O O
; O O
Neurontin B-treatment B-treatment
600 O O
mg O O
three O O
times O O
a O O
day O O
. O O

Discharge O O
Date O O
: O O

Required O O
diuresis B-treatment O
of O O
> O O
9 O O
L O O
while O O
in O O
the O O
ICU O O
, O O
after O O
2nd B-treatment O
surgery I-treatment O
. O O

History O O
of O O
syncope B-problem O
. O O

Nebulizers B-treatment O
as O O
needed O O
, O O
weaning O O
from O O
ventilation B-treatment O
. O O

Disp O O
:* O O
90 O O
Tablet O O
(s)* O O
Refills O O
:* O O
2 O O
* O O

UNDERLYING O O
MEDICAL O O
CONDITION O O
: O O

For O O
blood B-treatment B-treatment
pressure I-treatment I-treatment
control I-treatment I-treatment
she O O
was O O
maintained O O
on O O
metoprolol B-treatment O
at O O
the O O
request O O
of O O
her O O
primary O O
care O O
physician O O
and O O
enalapril B-treatment O
was O O
discontinued O O
. O O

EKG B-test O
revealed O O
a O O
normal O O
sinus O O
rhythm O O
with O O
a O B-test
rate O I-test
of O O
69 O O
, O O
left B-problem B-treatment
ventricular I-problem I-treatment
hyper-trophy I-problem I-treatment
with O O
poor B-problem O
anterior I-problem O
progression I-problem O
of I-problem O
R-waves I-problem O
. O O

No O O
history O O
of O O
head B-problem O
trauma I-problem O
or O O
seizure B-problem O
disorder I-problem O

2014-03-09 O O
07:52 O O
PM O O
BLOOD B-test B-test
CK-MB B-test I-test
- O O
NotDone O B-test
cTropnT B-test I-test
- O O
0.55 O O
* O O

S1 O O
S2 O O
. O O

Seventh B-problem O
nerve I-problem O
weakness I-problem O
on O O
the O O
right O O
in O O
a O O
central O O
pattern O O
is O O
present O O
. O O

2018-12-26 O O
08:28 O O
PM B-test O
URINE I-test O

DOUETSHUFF O O
, O O
DE O O
CLEEE O B-test
, O O
M.D. O O
( O O
CP85 O O
) O O
01/24/05 O O
06:53 O O
PM O O

Discharge O O
Date O O
: O O

The O O
patient O O
was O O
consented O O
for O O
surgery B-treatment O
and O O
on O O
the O O
day O O
of O O
admission O O
was O O
taken O O
to O O
the O O
operating O O
room O O
for O O
transverse B-treatment O
colectomy I-treatment O
for O O
tumor B-problem O
. O O

He O O
does O O
not O O
smoke O O
. O O

If O O
you O O
need O O
additional O O
information O O
please O O
call O O
442-025-0303 O O
. O O

His B-test B-test
blood I-test I-test
sugar I-test I-test
at O O
10 O O
pm O O
was O O
low O O
at O O
22 O O
and O O
he O O
was O O
disoriented B-problem O
, O O
which O O
resolved O O
with O O
two O O
glasses O O
of O O
juice O O
; O O
he O O
did O O
not O O
receive O O
his O O
standing O O
dose O O
of O O
NPH B-treatment O
that O O
evening O O
. O O

Call O O
the O O
doctor O O
or O O
return O O
to O O
the O O
Thomas O O
for O O
: O O

CT B-test B-problem
HEAD I-test I-problem
W/O I-test I-problem
CONTRAST I-test I-problem

Discharge O O
Instructions O O
: O O

Chronic B-problem B-problem
muscle I-problem I-problem
spasms I-problem I-problem
. O O

His B-problem B-test
melanoma I-problem I-test
was O O
originally O O
diagnosed O O
last O O
fall O O
when O O
he O O
presented O O
with O O
lesions B-problem O
in I-problem O
the I-problem O
liver I-problem O
and I-problem O
spleen I-problem O
, O O
and O O
a B-test B-problem
chest I-test I-problem
CT I-test I-problem
showed O I-problem
left B-problem I-problem
upper I-problem I-problem
lobe I-problem I-problem
nodules I-problem I-problem
. O O

PRINCIPAL O O
DIAGNOSIS O O
: O O
: O O

Per O O
OMR O O
, O O
h/o O O
sporadic O B-problem
marijuana O I-problem
use O O
. O O

The O O
patient O O
remained O O
stable O O
during O O
the O O
rest O O
of O O
the O O
hospitalization O O
. O O

5. O O
osteoarthritis B-problem B-treatment
, O O

Markedly B-problem O
abnormal I-problem O
portable I-problem O
EEG I-problem O
due O O
to O O
the B-problem O
voltage I-problem O
suppression I-problem B-treatment
over I-problem I-treatment
the I-problem I-treatment
left I-problem I-treatment
hemisphere I-problem I-treatment
and O O
due O O
to O O
the B-problem O
bursts I-problem O
of I-problem O
generalized I-problem O
slowing I-problem O
and O O
right B-problem B-problem
hemisphere I-problem I-problem
slowing I-problem I-problem
. O O

It O O
is O O
not O O
clearly O O
outside O O
normal O O
limits O O
. O O

He O O
has O O
a O O
half-pack O O
per O O
day O O
smoking O O
history O O
and O O
drinks O O
approximately O O
three O O
to O O
four O O
alcoholic O O
beverages O O
per O O
day O O
. O O

1. O O
Augmentin B-treatment B-treatment
500 O O
mg O O
p.o. O O
three O O
times O O
a O O
day O O
times O O
ten O O
days O O
. O O

6. O O
Atorvastatin B-treatment B-treatment
10 O O
mg O O
Tablet O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Tablet O O
PO O O
DAILY O O
( O O
Daily O O
). O O

This O O
22 O O
year O O
old O O
Gravida O O
4 O O
Para O O
2012 O O
was O O
admitted O O
to O O
the O O
Naliheall O O
County O O
Memorial O O
Hospital O O
Obstetrical O O
service O O
on O O
10/29/2003 O O
at O O
11:14 O O
pm O O
for O O
the O O
indication O O
( O O
s O O
) O O
: O O
early B-problem O
labor I-problem O
/ O O
rule O O
out O O
labor B-problem O
. O O

Electronically O O
Signed O O
ERIN O O
KENGEKOTE O O
, O O
M.D. O O

VITA O B-test
THOSTERWEN O I-test
LINKEKOTEMONES O I-test
, O O
M.D. O O

OSH B-test O
IMAGING I-test O
: O O

Room O O
: O O

This O O
report O O
was O O
created O O
by O O
SHUFF O O
, O O
RONRIN O O
04/30/2005 O O
03:52 O O
PM O O

The O O
patient O O
will O O
be O O
discharged O O
to O O
an O O
outside O O
hospital O O
. O O

Manual O O
Condition O O
: O O

Followup O O
Instructions O O
: O O

ALLERGIES O O
: O O
He O O
had O O
no O O
known B-problem B-problem
drug I-problem I-problem
allergies I-problem I-problem
. O O

This O O
will O O
be O O
followed O O
by O O
a O O
trial O O
of O O
Coumadin B-treatment B-treatment
, O O
and O O
then O O
by O O
mitral B-treatment B-problem
commissurotomy I-treatment I-problem
or O O
replacement B-treatment O
and O O
probable O O
tricuspid B-treatment O
annuloplasty I-treatment O
by O O
Dr. O O
Riemund O O
C. O O
Wave O O
. O O

The O O
patient O O
ruled O O
out O O
for O O
an B-problem O
MI I-problem O
with O O
negative O O
CK O O
X4 O O
and O O
negative O O
troponin O O
X4 O O
. O O

The O O
patient O O
has O O
had O O
multiple B-problem O
myeloma I-problem O
since O O
1990 O O
. O O

Batch O O
: O O

PAST O O
SURGICAL O O
HISTORY O O
: O O

Discharge O O
Summary O O

The O O
patient O O
also O O
had O O
a O O
history O O
of O O
platelet B-problem B-problem
reaction I-problem I-problem
. O O

Disp O O
:* O O
60 O O
Tablet O O
( O O
s O O
)* O O
Refills O O
:* O O
2 O O
* O O

PHYSICAL O O
EXAMINATION O O
: O O

Cardiology O O
discussed O O
cath B-test O
however O O
, O O
patient O O
's O O
family O O
turned O O
down O O
. O O

Repeat B-test O
exam I-test O
one O O
month O O
later O O
showed O O
a B-problem B-problem
firm I-problem I-problem
left-sided I-problem I-problem
lobe I-problem I-problem
. O O

DICTATING O O
FOR O O
: O O

Report O O
any B-problem O
weight I-problem O
gain I-problem O
of O O
greater O O
than O O
2 O O
pounds O O
in O O
24 O O
hours O O
or O O
5 O O
pounds O O
in O O
a O O
week O O

Difficulty B-problem O
with I-problem O
word I-problem O
finding I-problem O
at O O
times O O
. O O

1. O O
Lopid B-treatment O
600 O O
mg O O
PO O O
b.i.d. O O
, O O

Extended O O
Care O O

Glipizide B-treatment O
10 O O
mg O O
bid O O

On O O
the O O
day O O
prior O O
to O O
admission O O
, O O
the O O
patient O O
&apos;s O O
family O O
noted O O
that O O
&quot; O O
he O O
looked O O
yellow B-problem O
&quot; O O
and O O
presented O O
to O O
the O O
Lorough O O
Medical O O
Center O O
&apos;s O O
Emergency O O
Department O O
this O O
after O O
noon O O
. O O

Until O O
then O O
, O O
his B-treatment O
foley I-treatment O
should O O
remain O O
in O O
place O O
. O O

The O O
patient O O
was O O
admitted O O
to O O
the O O
Neurologic O O
Service O O
for O O
workup B-test O
of O O
his B-problem B-problem
tumor I-problem I-problem
. O O

DISCHARGE O O
DIAGNOSES O O
: O O

Aspirin B-treatment B-test
81 O O
mg O O
p.o. O O
q. O O
day O O
. O O

Trace B-problem O
edema I-problem O
without O O
cyanosis B-problem O
or O O
clubbing B-problem O
. O O

2015-03-26 O O
10:10 O O
AM O O
BLOOD B-test B-test
Hypochr B-test I-test
- O O
1 O O
+ O O
Anisocy B-test B-test
- O O
2 O O
+ O O
Poiklo B-test B-test
- O O
2 O O
+ O O
Macrocy B-test B-test
- O O
2 O O
+ O O
Microcy B-test B-test
- O O
NORMAL O O
Polychr B-test O
- O O
NORMAL O O
Ovalocy B-test O
- O O
OCCASIONAL O B-treatment
Target B-test I-treatment
- O O
OCCASIONAL O B-treatment
Schisto B-test I-treatment
- O O
OCCASIONAL O B-problem
Tear O I-problem
Dr O I-problem
Clark O I-problem

Medications O O
on O O
Admission O O
: O O

You O O
may O O
shower O O
. O O

11. O O
Fragmin B-treatment B-treatment
2500 O O
units O O
subcut O O
every O O
day O O
. O O

ABG B-test O
: O O

Social O O
History O O
: O O

Her B-test O
O2 I-test O
sat I-test O
was O O
stable O O
at O O
94-97% O O
on O O
2.5L O O
of O O
supplemental B-treatment O
O2 I-treatment O
. O O

She O O
is O O
anicteric B-problem O
without O O
rash B-problem O
or O O
HEENT O O
. O O

Once O O
he O O
was O O
coherent O O
enough O O
, O O
the O O
patient O O
was O O
evaluated O O
by O O
the O O
swallow O O
team O O
who O O

In O O
the O O
lower O O
extremities O O
on O O
the O O
left O O
hip O O
flexor O O
is O O
1/5 O O
, O O
knee O B-test
flexion O I-test
and O O
extension O O
is O O
3/5 O O
and O O
4/5 O O
respectively O O
and O O
plantar O O
and O O
dorsiflexion O O
is O O
4/5 O O
. O O

Reason O O
: O O
follow B-test O
up I-test O
ct I-test O

OK O O
to O O
shower O O
, O O
no O O
bathing O O
or O O
swimming O O
. O O

CV O O
: O O
Reg O O
, O O
tachy B-problem O
Nml O O
S1 O O
, O O
S2 O O
, O O
no O O
M/R/G B-problem O

Atorvastatin B-treatment O
10 O O
' O O

Alb B-treatment O
nebs I-treatment O

Mr. O O
Breutzfarstxei O B-treatment
was O O
recently O O
diagnosed O O
with O O
acquired B-problem B-problem
immunodeficiency I-problem I-problem
syndrome I-problem I-problem
when O O
he O O
had O O
Pneumocystis B-problem B-problem
carinii I-problem I-problem
pneumonia I-problem I-problem
on O O
01/17/91 O O
. O O

Do O O
no O O
strenuous O O
activity O O
or O O
heavy O O
lifting O O
for O O
the O O
next O O
few O O
days O O
. O O

Provider O O
: O O

GLUCOSE B-test B-test
- O O
101 O O
LACTATE B-test B-test
- O O
2.9 O O
* O O
NA+ B-test B-test
- O O
142 O O
K+ B-test O
- O O
3.6 O O
CL- B-test B-test
- O O
102 O O
TCO2 B-test O
- O O
26 O O

Allowing O O
for O O
the O O
limitations O O
of O O
this B-test O
noncontrast I-test O
study I-test O
, O O
the O O
liver O O
, O O
pancreas O B-treatment
, O O
adrenals O O
, O O
stomach O O
are O O
unremarkable O O
. O O

He O O
was O O
admitted O O
on O O
06/07/00 O O
for O O
a B-treatment O
matched I-treatment O
, I-treatment O
unrelated I-treatment B-problem
donor I-treatment I-problem
bone I-treatment I-problem
marrow I-treatment I-problem
transplant I-treatment I-problem
. O O

Cesarean B-treatment B-test
section I-treatment I-test
x O O
2 O O
, O O
spontaneous B-problem B-treatment
abortion I-problem I-treatment
x O O
1 O O
. O O

3. O O
End B-problem O
stage I-problem B-problem
renal I-problem I-problem
disease I-problem I-problem
, O O
status O O
post O O
kidney B-treatment O
transplantation I-treatment O
. O O

OPERATIONS O O
AND O O
PROCEDURES O O
: O O

A B-test B-test
neurologic I-test I-test
work-up I-test I-test
was O O
undertaken O O
which O O
included O O
a B-test B-test
CT I-test I-test
scan I-test I-test
of I-test O
the I-test O
head I-test O
which O O
revealed O O
no O O
acute B-problem O
bleed I-problem O
and O O
a B-test B-treatment
lumbar I-test I-treatment
puncture I-test I-treatment
which O O
revealed O O
a B-test B-test
glucose I-test I-test
of O O
72 O O
, O O
protein B-test B-test
65 O O
, O O
white B-test B-test
blood I-test I-test
cell I-test I-test
count I-test I-test
19 O O
, O O
red B-test B-test
blood I-test I-test
cell I-test I-test
count I-test I-test
11,500 O O
with O O
no O O
evidence O O
of O O
xanthrochromasia B-problem B-problem
. O O

Included O O
normal O O
CBC O B-treatment
, O O
BUN B-test O
47 O O
, O O
creatinine B-test B-treatment
2.4 O O
up O O
from O O
baseline O O
of O O
about O O
1.5 O O
. O O

RADIOLOGY O O
: O O

Currently O O
pt O O
denies O O
sensory B-problem O
deficits I-problem O
or O O
weakness B-problem O
. O O

The O O
patient O O
is O O
allergic B-problem O
to O O
Ciprofloxacin B-treatment B-treatment
, O O
morphine B-treatment B-problem
sulfate I-treatment I-problem
and O O
Droperidol B-treatment O
. O O

OPERATION O O
: O O

Discharge O O
Date O O
/ O O
Time O O
: O O

However O O
after O O
the B-treatment O
procedure I-treatment O
, O O
the B-problem O
patient I-problem O
&apos;s I-problem O
hematocrit I-problem O
dropped I-problem O
to O O
24 O O
and O O
he O O
was O O
transfused O O
two B-treatment O
units I-treatment O
of I-treatment O
packed I-treatment B-problem
red I-treatment I-problem
blood I-treatment I-problem
cells I-treatment I-problem
. O O

The O O
patient O O
was O O
initially O O
started O O
on O O
D10 B-treatment O
/ I-treatment O
W I-treatment O
at O O
80 O O
cc O O
/ O O
kg O O
/ O O
day O O
. O O

The O O
patient O O
was O O
referred O O
back O O
to O O
Dr. O O
Pop O O
for O O
the O O
possibility O O
of O O
a B-treatment B-problem
revascularization I-treatment I-problem
procedure I-treatment I-problem
. O O

Major O O
Surgical O O
or O O
Invasive O O
Procedure O O
: O O

Throughout O O
hospital O O
course O O
patient B-test O
's I-test O
troponin I-test O
trended O O
down O O
to O O
less O O
than O O
0.3 O O
. O O

She O O
was O O
referred O O
to O O
the O O
Emergency O O
Department O O
. O O

2014-04-23 O O
01:38 O O
PM O O

On O O
postoperative O O
day O O
two O O
, O O
the O O
patient O O
remained O O
hemodynamically O O
stable O O
. O O

HOSPITAL O O
COURSE O O
: O O

2. O O
Protonix B-treatment B-treatment
40 O O
mg O O
po O O
qd O O
. O O

She O O
was O O
never O O
on O O
an B-treatment O
anticonvulsant I-treatment O
due O O
to O O
her O O
former O O
beliefs O O
as O O
N. O O
Derk O O
Scientist O O
. O O

Subsequently O O
, O O
the B-problem O
mass I-problem O
continued O O
to O O
increase O O
in O O
size O O
. O O

Upper O O
lungs O O
are O O
clear O O
. O O

6) O O
Coumadin B-treatment B-treatment
2 O O
mg O O
p.o. O O
q.h.s. O O

Transfer O O
from O O
Rehab O O
Hospital O O
of O O
the O O
Cape O O
& O O
Islands O O
Hospital O O
for O O
an B-test B-problem
endoscopic I-test I-problem
retrogram I-test I-problem
cholangiopancreatography I-test I-problem
. O O

Neck O O
with O O
cervical B-treatment B-problem
collar I-treatment I-problem
. O O

pt O O
with O O
2/4 O O
bottles O O
coag B-problem O
neg I-problem O
staph I-problem O
on O O
01-19 O O
and O O
again O O
on O O
01-20 O O
. O O

He O O
used O O
Ativan B-treatment O
in O O
the O O
hospital O O
, O O
which O O
helped O O
him O O
. O O

PRELIMINARY O O
REPORT O O

After O O
that O O
, O O
he O O
was O O
on O O
Lupron B-treatment O
and O O
Nilandron B-treatment B-problem
hormone I-treatment I-problem
therapy I-treatment I-problem
. O O

OTHER O O
POSTPARTUM O O
THERAPIES O O
: O O

The O O
patient O O
is O O
a O O
47 O O
- O O
year-old O O
male O O
with O O
a O O
past O O
medical O O
history O O
of O O
coronary B-problem B-problem
artery I-problem I-problem
disease I-problem I-problem
, O O
status B-treatment O
post I-treatment O
2-vessel I-treatment O
percutaneous I-treatment B-treatment
transluminal I-treatment I-treatment
coronary I-treatment I-treatment
angioplasty I-treatment I-treatment
in O O
2005 O O
, O O
3-vessel B-treatment B-treatment
percutaneous I-treatment I-treatment
transluminal I-treatment I-treatment
coronary I-treatment I-treatment
angioplasty I-treatment I-treatment
in O O
2009 O O
, O O
hypertension B-problem B-treatment
, O O
new B-problem O
onset I-problem O
type I-problem O
2 I-problem O
diabetes I-problem B-treatment
, O O
and O O
hypercholesterolemia B-problem B-treatment
who O O
presents O O
with O O
the O O
sudden O O
onset O O
of O O
substernal B-problem B-problem
chest I-problem I-problem
pain I-problem I-problem
status O O
post O O
exercise O O
. O O

ADMISSION O O
DATE O O
: O O

PRELIMINARY O O
REPORT O O

ALLERGIES O O
: O O

The B-test O
LH I-test O
was O O
4.9 O O
, O O
FSH B-test O
3.3 O O
. O O

She O O
has O O
not O O
received O O
prior B-treatment O
radiation I-treatment O
exposure I-treatment O
. O O

She O O
was O O
then O O
transferred O O
to O O
Ro O O
Woodma O O
Healthcare O O
for O O
further B-treatment O
management I-treatment O
. O O

MEDICATIONS O O
ON O O
DISCHARGE O O
: O O

The O O
patient O O
has O O
steroid B-problem O
induced I-problem O
diabetes I-problem B-problem
mellitus I-problem I-problem
. O O

1. O O
One B-problem O
vessel I-problem B-problem
coronary I-problem I-problem
artery I-problem I-problem
disease I-problem I-problem
. O O

Regular O O
menses O O
, O O
on O O
Ortho-Tri-Cyclen B-treatment O
. O O

No O O
thyromegaly B-problem O
. O O

were O O
clear O O
to O O
auscultation B-test B-problem
. O O

HISTORY O O
OF O O
PRESENT O O
ILLNESS O O
: O O

17. O O
Ibuprofen B-treatment B-treatment
100 O O
mg/5 O O
mL O O
Suspension O O
Sig O O
: O O
Twenty O O
( O O
20 O O
) O O
mL O O
PO O O
Q8H O O
( O O
every O O
8 O O
hours O O
) O O
as O O
needed O O
. O O

Mr. O O
Mcelveen O O
51 O O
year-old O O
male O O
with O O
metastatic B-problem B-treatment
RCC I-problem I-treatment
on O O
Sutent B-treatment O
since O O
2018-12-21 O O
, O O
admitted O O
with O O
fever B-problem O
, O O
hypoxemia B-problem B-treatment
, O O
and O O
bibasilar B-problem B-problem
pneumonia I-problem I-problem
. O O

Discharge O O
Date O O
: O O

Discharge O O
Date O O
: O O

History O O
of O O
Present O O
Illness O O
: O O

Allergies O O
: O O

4) O O
Prostate B-problem O
CA I-problem O
. O O

2013-10-29 O O
01:09 O O
PM O O
BLOOD B-test B-test
Glucose B-test I-test
- O O
172 O O
* O O
UreaN B-test B-test
- O O
11 O O
Creat B-test B-test
- O O
0.9 O O
Na B-test B-test
- O O
142 O O
Cl B-test B-test
- O O
111 O O
* O O
HCO3 B-test O
- O O
22 O O

Benefits O O
Assigned O O
: O O

2015-10-26 O O
08:34 O O
PM O O

LABORATORY O O
DATA O O
: O O

Disposition O O
, O O
Follow O O
up O O
and O O
Instructions O O
to O O
Patient O O
: O O

Cardiology O O
recommended O O
that O O
in O O
addition O O
to O O
the B-treatment O
medications I-treatment O
already O O
stated O O
above O O
, O O
his B-test B-treatment
hematocrit I-test I-treatment
be O O
kept O O
greater O O
than O O
30 O O
. O O

Index O O
No. O O

Neurological B-test B-test
exam I-test I-test
was O O
grossly O O
intact O O
. O O

As O O
a O O
result O O
, O O
you O O
were O O
started O O
on O O
thyroid B-treatment O
supplements I-treatment O
. O O

655358166 O O
WGH O O

2014-10-21 O O
08:10 O O
PM O O

He O O
gets O O
cold B-problem O
easily O O
but O O
denies O O
fevers B-problem O
. O O

A B-test B-test
biopsy I-test I-test
showed O O
moderately B-problem O
to I-problem O
poorly I-problem O
differentiated I-problem O
Grade I-problem O
III-IV I-problem O
adenocarcinoma I-problem O
on I-problem O
the I-problem O
left I-problem O
. O O

LABS O O
: O O

Discharge O O
Instructions O O
: O O

Labs O O
on O O
admit O O
: O O

An O O
endocrine O O
consult O O
was O O
obtained O O
to O O
help O B-problem
manage O I-problem
his B-test I-problem
serum I-test I-problem
electrolytes I-test I-problem
. O O

Erythromycin B-treatment O
Base I-treatment O

During O O
that O O
period O O
of O O
time O O
he O O
received O O
nebulizer B-treatment O
treatments I-treatment O
with O O
Albuterol B-treatment B-problem
. O O

Neck O O
was O O
supple O O
. O O

TA O O
KO O O
FOSSA O O
, O O
M.D. O O

Home O O
With O O
Self-Care O O
( O O
Routine O O
Discharge O O
) O O

Laboratory O O
results O O
: O O

renal B-problem O
calculi I-problem O

On O O
sensory B-test O
exam I-test O
there O O
was O O
a B-problem B-treatment
mild I-problem I-treatment
diminution I-problem I-treatment
of I-problem O
light I-problem O
touch I-problem O
, I-problem O
pinprick I-problem B-treatment
, I-problem O
position I-problem B-treatment
, I-problem O
and I-problem O
vibration I-problem O
sense I-problem O
in I-problem O
the I-problem O
left I-problem O
side I-problem O
. O O

Gag B-test O
was O O
symmetric O O
. O O

Respiratory B-test O
rate I-test O
20 O O
. O O

10/31/2004 O O
12:00:00 O O
AM O O

The B-test B-test
abdominal I-test I-test
and I-test O
pelvic I-test B-treatment
CT I-test I-treatment
scans I-test I-treatment
showed O O
no O O
suspicious B-problem B-treatment
GI I-problem I-treatment
masses I-problem I-treatment
, O O
no O O
pancreatic B-problem B-treatment
mass I-problem I-treatment
; O O
a B-problem O
2 I-problem O
cm I-problem O
ovarian I-problem O
cyst I-problem O
. O O

Override O O
added O O
on O O
01/23/05 O O
by O O
DAINSAYLESNOORT O O
, O O
AGER O O
, O O
M.D. O O
, O O
PH.D. O O

New B-problem O
lower I-problem B-problem
left I-problem I-problem
lateral I-problem I-problem
CW I-problem I-problem
opacity I-problem I-problem
, O O
likely O B-problem
loculated B-problem I-problem
pleural I-problem I-problem
fluid I-problem I-problem
. O O

The O O
patient O O
also O O
had O O
a B-test O
shoulder I-test O
film I-test O
done O O
on O O
10/10/97 O O
that O O
showed O O
a B-problem B-problem
severely I-problem I-problem
comminuted I-problem I-problem
fracture I-problem I-problem
of I-problem I-problem
the I-problem I-problem
proximal I-problem I-problem
left I-problem I-problem
humerus I-problem I-problem
with O O
proximal B-problem B-problem
distraction I-problem I-problem
. O O

Initial B-test O
newborn I-test O
exam I-test O
: O O

Override O O
added O O
on O O
12/07/05 O O
by O O
BELB O O
, O O
BRITHERL O B-treatment
, O O
M.D. O O
on O O
order O O
for O O
ATORVASTATIN B-treatment O
PO I-treatment O
( O O
ref O O
# O O
33823759 O O
) O O

Active B-problem O
Labor I-problem O

5. O O
Placement O O
of O O
a B-treatment B-problem
right I-treatment I-problem
femoral I-treatment I-problem
arterial I-treatment I-problem
line I-treatment I-problem
. O O

Right B-test B-test
upper I-test I-test
extremity I-test I-test
examination I-test I-test
demonstrated O O
intact O O
motor O O
, O O
sensory O O
, O O
and O O
vascular O B-problem
function O I-problem
. O O

- O O
CAD B-problem B-treatment
s/p O I-treatment
CABG B-treatment I-treatment
x4 O O
in O O
' O O
03 O O
. O O

(4) O O
Coronary B-problem B-problem
artery I-problem I-problem
disease I-problem I-problem
as O O
above O O
. O O

Postpartum O O
she O O
encountered O O
the O O
following O O
complication O O
( O O
s O O
) O O
: O O

D O O
: O O
2012-08-01 O O
12:27:33 O O

Glucose B-test B-test
- O O
120* O O
UreaN B-test B-test
- O O
30* O O
Creat B-test B-test
- O O
1.2* O O
Na B-test B-test
- O O
134 O O
K B-test O
- O O
4.2 O O
Cl B-test B-test
- O O
100 O O
HCO3 B-test O
- O O
25 O O

4 O O
days O O
of O O
worsening B-problem O
SOB I-problem O
with O O
sore B-problem O
throat I-problem O
and O O
cough B-problem O
productive I-problem O
of I-problem O
yellow I-problem O
/ I-problem O
green I-problem O
sputum I-problem O
. O O

Catheterization B-test B-test
results I-test I-test
showed O O
100% B-problem O
occlusion I-problem B-treatment
of I-problem I-treatment
the I-problem I-treatment
proximal I-problem I-treatment
left I-problem I-treatment
anterior I-problem I-treatment
descending I-problem I-treatment
artery I-problem I-treatment
and O O
50% B-problem O
stenosis I-problem B-problem
of I-problem I-problem
first I-problem I-problem
diagonal I-problem I-problem
. O O

Disp O O
:* O O
30 O O
Capsule O O
, O O
Sust. O O
Release O O
24 O O
HR O O
(s)* O O
Refills O O
:* O O
0 O O
* O O

Vascular B-problem B-test
calcifications I-problem I-test
are O O
seen O O
in O O
the O O
abdominal O O
aorta O O
and O O
iliac O B-problem
arteries O I-problem
. O O

Physical O O
Exam O O
: O O

3. O O
Prior B-problem B-problem
transient I-problem I-problem
ischemic I-problem I-problem
attacks I-problem I-problem
. O O

CPK B-test O
was O O
tracked O O
, O O
but O O
was O O
totally O O
normal O O
. O O

ID O O
- O O
afebrile B-problem B-treatment
, O O
no O O
wbc B-test O
, O O
started O O
on O O
Azithromycin B-treatment O
for O O
COPD B-problem O
flare I-problem O

On O O
hospital O O
day O O
number O O
three O O
, O O
her B-test B-problem
blood I-test I-problem
cultures I-test I-problem
came O I-problem
back O I-problem
positive B-problem I-problem
in O I-problem
the B-test I-problem
anaerobic I-test I-problem
culture I-test I-problem
for O O
gram-positive B-problem O
cocci I-problem O
in I-problem O
pairs I-problem O
and I-problem O
clusters I-problem O
. O O

Sex O O
: O O

12. O O
Chronic B-problem B-problem
muscle I-problem I-problem
spasms I-problem I-problem
. O O

ED O O
Discharge O O
Summary O O

2. O O
Born O B-test
between O I-test
32 O O
and O O
35 O O
weeks O O
with O O
plans O O
for O O
daycare O B-treatment
during O I-treatment
respiratory O I-treatment
syncytial O I-treatment
virus O I-treatment
season O I-treatment
, O O
with O O
a O O
smoker O O
in O O
the O O
household O O
or O O
with O O
preschool O O
siblings O O
; O O
or O O

VS B-test O
: O O
65 O O
20 O O
160/100 O O
5 O O
' O O
7 O O
" O O
180 O O
# O O

The O O
patient O O
will O O
see O O
his O O
PCP O O
in O O
one O O
to O O
two O O
weeks O O
. O O

He O O
also O O
required O O
FFP B-treatment O
initially O O
to O O
reverse O B-problem
his B-problem I-problem
coagulopathy I-problem I-problem
. O O

This O O
is O O
to O O
notify O O
you O O
that O O
your O O
patient O O
, O O
FYFEUARDFEL O O
, O O
TADE O O
arrived O O
in O O
the O O
Emergency O O
Department O O
at O O
Ph O O
University O O
Of O O
Medical O O
Center O O
on O O
09/20/2000 O O
12:41 O O
PM O O
. O O

Back O O
: O O
+ O O
ttp B-problem O
of I-problem O
lumbar I-problem O
spine I-problem O
and I-problem O
paraspinal I-problem B-treatment
muscles I-problem I-treatment
, O O
R O O
> O O
L O O
. O O

The O O
patient O O
was O O
admitted O O
to O O
the O O
O-CMED O O
Service O O
for O O
further B-treatment O
management I-treatment O
. O O

72 O O
male O O
s/p O O
fall O O
down O O
20 O O
stairs O O

No O O
Restrictions O O

DISCHARGE O O
DIAGNOSIS O O
: O O

As O O
for O O
the O O
patient O O
's O O
ALL B-problem O
and O O
AML B-problem O
, O O
the O O
patient O O
was O O
started O O
on O O
a B-treatment B-treatment
new I-treatment I-treatment
chemotherapy I-treatment I-treatment
protocol I-treatment I-treatment
called O I-treatment
hyper-CVAD B-treatment I-treatment
on O O
2012-03-06 O O
. O O

Recent B-problem O
weight I-problem O
loss I-problem O
associated O O
with O O
the B-problem B-problem
pneumonia I-problem I-problem
. O O

Pt O O
discharged O O
with O O
instructions O O
to O O
continue O B-test
coumadin B-treatment I-test
1.5 O O
mg O O
po O O
q O O
daily O O
with O O
goal B-test O
INR I-test O
02-09 O O
. O O

KOORSKOTE O O
, O O
RETCO O O

( O O
The B-treatment O
tunneled I-treatment O
catheter I-treatment O
later O O
came O O
back O O
for O O
negative O O
for O O
culture. B-test O
) O O

K-Dur B-treatment O
20meq O O
PO O O
QD O O

The B-test O
MRA I-test O
showed O O
mild B-problem O
narrowing I-problem O
of I-problem O
the I-problem O
left I-problem O
ICA I-problem O
just O O
distal O O
to O O
the O O
bifurcation O O
. O O

Transrectal B-test B-test
ultrasound I-test I-test
showed O O
a B-problem O
hypoechoic I-problem O
left-sided I-problem O
mass I-problem O
in I-problem O
the I-problem O
peripheral I-problem O
zone I-problem O
. O O

S1 O O
normal O O
. O O

Homan B-test O
&apos;s I-test O
sign I-test O
negative O O
. O O

The O O
pregnancy O O
was O O
unremarkable O O
until O O
2015-06-01 O O
when O O
the O O
mother O O
presented O O
to O O
Shriner O O
's O O
Hospital O O
for O O
Crippled O O
Children O O
for O O
increased B-problem B-problem
blood I-problem I-problem
pressure I-problem I-problem
and O O
proteinuria B-problem B-problem
. O O

MENTAL B-problem O
STATUS I-problem O
CHANGE I-problem O
, O O
CELLULITIS B-problem O

She O O
has O O
had O O
at B-problem O
least I-problem O
two I-problem O
generalized I-problem O
seizures I-problem O
in O O
the O O
past O O
, O O
but O O
she O O
has O O
not O O
had O O
one O O
since O O
she O O
was O O
26 O O
years O O
old O O
. O O

Vetrano O O
probably O O
does O O
not O O
need O O
Synagis B-treatment O
at O O
least O O
until O O
her O O
sibling O O
is O O
discharged O O
from O O
the O O
hospital O O
. O O

Sodium B-test B-test
138 O O
, O O
potassium B-test B-test
4.9 O O
, O O
chloride B-test B-test
102 O O
, O O
CO2 B-test B-test
25 O O
, O O
BUN B-test B-test
24 O O
, O O
creatinine B-test B-treatment
0.9 O O
, O O
glucose B-test B-treatment
309 O O
. O O

urinalysis B-test O
: O O

Disp O O
:* O O
24 O O
Capsule O O
(s)* O O
Refills O O
:* O O
0 O O
* O O

Please O O
see O O
original O O
Discharge O O
Summary O O
for O O
discharge B-treatment O
medications I-treatment O
. O O

sw O O
/ O O
bmot O O

Alkaline B-test B-test
phosphatase I-test I-test
1148 O O
. O O

Attending O O
: O O

She O O
is O O
guaiac O O
negative O O
on O O
rectal B-test B-problem
examination I-test I-problem
. O O

The O O
patient O O
became O O
agitated B-problem O
with O O
both O O
tent B-treatment O
and O O
Bi-PAP B-treatment B-treatment
machine I-treatment I-treatment
, O O
although O O
continued O O
to O O
saturate O O
well O O
. O O

He O O
continued O O
to O O
progress O O
until O O
two O O
weeks O O
prior O O
to O O
admission O O
when O O
he O O
was O O
found O O
in O O
the O O
bathtub O O
, O O
unsteady B-problem O
and O O
fell O O
trying O O
to O O
steady O O
himself O O
. O O

It O O
decreased O O
to O O
30 O O
in O O
the O O
setting O O
of O O
aggressive B-treatment B-problem
hydration I-treatment I-problem
. O O

Unclear O O
etiology O O
headache B-problem O
over O O
the O O
three O O
days O O
prior O O
to O O
admission O O
in O O
association O O
with O O
fever B-problem O
was O O
concerning O O
for O O
a O O
CNS O O
etiology O O
. O O

3. O O
Prilosec B-treatment B-treatment
20 O O
mg O O
p.o. O O
q. O O
day O O
. O O

HOSPITAL O O
COURSE O O
( O O
include O O
complications O O
if O O
any O O
) O O
: O O

The O O
patient O O
presented O O
with O O
a O O
chief O O
complaint O O
of O O
SDH B-problem O
. O O

Report O O
Status O O
: O O

MRN O O
: O O

They O O
felt O O
that O O
there O O
was O O
obstruction B-problem O
and O O
possible O O
obstruction B-problem O
to I-problem O
airflow I-problem B-problem
generating O I-problem
some B-problem I-problem
obstructive I-problem I-problem
apnea I-problem I-problem
, O O
as O O
well O O
as O O
partial B-problem O
obstructive I-problem O
events I-problem O
. O O

Attending O O
: O O
Dona O O
J. O O
O. O O
Anderson O O
, O O
M.D. O O

Social O O
History O O
: O O

active B-problem O
labor I-problem O
. O O

Admission O O
Date O O
: O O

regular O O
rate O O
and O O
rhythm O O
with O O
normal O O
S1 O O
and O O
S2 O O
, O O
no O O
murmurs B-problem B-problem
. I-problem O

She O O
also O O
has O O
new B-problem O
changes I-problem O
on I-problem O
EKG I-problem O
. O O

On O O
admission B-test O
examination I-test B-treatment
she O O
was O O
a O O
well O O
developed O O
, O O
well O O
nourished O O
female O O
in O O
no O O
apparent B-problem B-problem
distress I-problem I-problem
. O O

3. O O
Occipital B-problem B-problem
scalp I-problem I-problem
laceration I-problem I-problem
. O O

His O O
voice O O
became O O
slurred B-problem O
and O O
he O O
had O O
a B-problem B-problem
mild I-problem I-problem
central I-problem I-problem
dull I-problem I-problem
headache I-problem I-problem
. O O

ED O O
Discharge O O
Summary O O

1) O O
Digoxin B-treatment B-treatment
0.125 O O
mg O O
p.o. O O
q. O O
day O O
. O O

Room O O
: O O

His B-treatment B-test
Jackson-Pratt I-treatment I-test
drained O O
about O O
35-40 O O
cc O O
per O O
day O O
and O O
was O O
discontinued O O
on O O
postoperative O O
day O O
# O O
3 O O
. O O

General O O
: O O

Past O O
Medical O O
History O O
: O O

The O O
patient O O
was O O
given O O
respiratory B-treatment O
therapy I-treatment O
in O O
the O O
way O O
of O O
nebulizer B-treatment O
treatments I-treatment O
in O O
the O O
Oaksgekesser/ O O
Memorial O O
Hospital O O
Emergency O O
Room O O
because O O
of O O
a O O
longstanding O O
desire O O
by O O
patient O O
and O O
family O O
to O O
refrain O O
from O O
intubation B-treatment O
to O O
be O O
considered O O
Do O O
Not O O
Resuscitate O O
. O O

06/11/2005 O O
12:00:00 O O
AM O O

DISCHARGE O O
DATE O O
: O O

Her B-treatment O
Foley I-treatment O
was O O
removed O O
. O O

Neck O O
was O O
supple O O
without O O
masses B-problem O
or O O
defects B-problem O
. O O

Because O O
of O O
the B-problem O
increasing I-problem O
creatinine I-problem O
to O O
8.0 O O
on O O
February O B-test
28 O O
, O O
1999 O O
, O O
a B-treatment B-treatment
left I-treatment I-treatment
nephrostomy I-treatment I-treatment
tube I-treatment I-treatment
was O O
placed O O
. O O

MRN O O
: O O

The O O
patient O O
is O O
a O O
68 O O
year O O
old O O
, O O
right O B-treatment
handed O I-treatment
caucasian O I-treatment
female O I-treatment
, O O
former O O
R.N. O O
who O O
complained O O
of O O
several O O
days O O
of O O
vertigo B-problem O
, O O
one O O
day O O
of O O
double B-problem O
vision I-problem O
, O O
dysarthria B-problem B-treatment
and O O
worsening O O
of O O
vertigo B-problem O
. O O

12. O O
Communication O B-treatment
- O O
With O O
pt O O
's O O
son O O
. O O

Crackles B-problem O
at I-problem O
base I-problem O
and I-problem O
mid-lungs I-problem O
bilaterally I-problem O

Cardiac B-test O
exam I-test O
: O O

Dictated O O
By O O
: O O
John O O
V.E. O O
Jameson O O
, O O
M.D. O O

NEUTS B-test B-test
- O O
78.0 O O
* O O
LYMPHS B-test B-test
- O O
17.0 O O
* O O
MONOS B-test B-test
- O O
4.6 O O
EOS B-test O
- O O
0.3 O O
BASOS B-test O
- O O
0.1 O O

Social O O
History O O
: O O

Extremities O O
are O O
warm O O
, O O
well O O
perfused O O
, O O
no O O
cyanosis B-problem B-treatment
, O O
clubbing B-problem O
or O O

1) O O
No O O
acute B-problem B-problem
cervical I-problem I-problem
spine I-problem I-problem
fracture I-problem I-problem
. O O

He O O
does O O
drink O O
alcohol O O
three O O
drinks O O
per O O
day O O
, O O
denies O O
any O O
current O O
tobacco O O
use O O
. O O

PHYSICAL O O
EXAMINATION O O
: O O

JOB O O
#: O O

Vancomycin B-test B-test
levels I-test I-test
should O O
be O O
checked O O
every O O
third O O
day O O
for O O
four O O
to O O
six O O
weeks O O
, O O
according O O
to O O
IMD O O
. O O

The O O
patient O O
's O O
appetite O O
improved O O
significantly O O
, O O
and O O
at O O
the O O
time O O
of O O
discharge O O
the O O
patient O O
was O O
on O O
a O O
regular O O
diet O O
with O O
no O O
tube B-treatment O
feed I-treatment O
supplements I-treatment O
deemed O O
necessary O O
. O O

Diabetes B-problem O
mellitus I-problem O
for O O
approximately O O
40 O O
years O O
. O O

CHIEF O O
COMPLAINT O O
: O O

TR O O
: O O

Patient O O
tolerated O O
procedure B-treatment O
on O O
2018-03-05 O O
and O O
was O O
transferred O O
to O O

His B-test B-test
chest I-test I-test
X-ray I-test I-test
was O O
normal O O
. O O

He O O
was O O
subsquently O O
admitted O O
to O O
the O O
ICU O O
for O O
further B-treatment O
care I-treatment O
. O O

5) O O
PLASMACYTOMA B-problem B-treatment
. O O

The O O
patient O O
expressed O O
a O O
desire O O
to O O
be O O
full O O
code O O
, O O
so O O
he O O
was O O
transferred O O
to O O
the O O
Intensive O O
Care O O
Unit O O
. O O

DISCHARGE B-treatment O
MEDICATIONS I-treatment O
are O O
the O O
same O O
with O O
the O O
addition O O
of O O
viscous B-treatment O
lidocaine I-treatment O
jelly I-treatment O
to O O
be O O
applied O O
to O O
buttock O O
prn O O
and O O
viscous B-treatment B-treatment
lidocaine I-treatment I-treatment
swish I-treatment I-treatment
and I-treatment O
swallow I-treatment O
tid O O
prn O O
before O O
meals O O
. O O

His B-test B-test
most I-test I-test
recent I-test I-test
bilirubin I-test I-test
was O O
6.6 O O
on O O
day O O
of O O
life O O
six O O
, O O
the O O
day O O
of O O
discharge O O
, O O
and O O
his B-treatment B-treatment
phototherapy I-treatment I-treatment
was O O
discontinued. O O
He O O
will O O
need O O
a B-test O
rebound I-test O
bilirubin I-test O
level I-test O
in O O
am O O
. O O

OTHER O O
PROCEDURES O O
: O O

His O O
lungs O O
are O O
clear O O
to O O
auscultation B-test B-problem
bilaterally O I-problem
. O O

ACTIVITY O O
: O O

David O O
Thomas O O
MD O O
60-008 O O

An B-test B-test
electrocardiogram I-test I-test
showed O O
no O O
evidence O O
of O O
QT B-problem O
prolongation I-problem O
prior O O
to O O
discharge O O
, O O
and O O
pulmonary B-test B-treatment
function I-test I-treatment
tests I-test O
will O O
be O O
performed O O
before O O
the O O
patient O O
goes O O
home O O
today O O
. O O

06/07/2000 O O
12:00:00 O O
AM O O

He O O
is O O
married O O
. O O

INR B-test O
was O O
elevated O O
at O O
2.5 O O
. O O

Her O B-test
right O I-test
superior O I-test
parathyroid O I-test
gland O O
was O O
removed O O
and O O
the O O
rest O O
of O O
her O O
parathyroid O O
glands O O
were O O
left O O
in O O
place O O
. O O

Wash O B-test
incision B-problem I-test
with O O
mild O B-treatment
soap O I-treatment
and O O
water O O
, O O
then O O
pat O O
dry O O
. O O

HOSPITAL O O
COURSE O O
: O O

2017-08-14 O O
07:30 O O
PM O O
TYPE O B-test
- O O
ART B-test B-test
PO2 I-test I-test
- O O
468 O O
* O O
PCO2 B-test B-test
- O O
44 O O
PH B-test B-test
- O O
7.50 O O
* O O
TOTAL B-test B-test
CO2 I-test I-test
- O O
36 O O
* O O
BASE B-test B-test
XS I-test I-test
- O O
10 O O
INTUBATED B-treatment B-treatment
- O O
INTUBATED B-treatment O

The O O
motor O O
tone O O
was O O
within O O
normal O O
limits O O
in O O
the O O
upper O O
and O O
lower O B-problem
extremities O I-problem
. O O

The O O
patient O O
is O O
allergic B-problem O
to O O
MSG O O
from O O
which O O
he O O
gets O O
hives B-problem O
. O O

Admission O O
Date O O
: O O

Brief O O
Hospital O O
Course O O
: O O

HOSPITAL O O
COURSE O O
( O O
include O O
complications O O
if O O
any O O
) O O
: O O

During O O
entire O O
post-op O O
course O O
she O O
was O O
followed O O
by O O
physical O O
therapy O O
for O O
strength O O
and O O
mobility O O
. O O

ADMISSION O O
DATE O O
: O O

Patient O O
States O O
Complaint O O
: O O

7. O O
Calcium B-treatment B-treatment
Acetate I-treatment I-treatment
667 O O
mg O O
Tablet O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Tablet O O
PO O O
TID O O
W/ O O
MEALS O O
( O O
3 O O
TIMES O O
A O O
DAY O O
WITH O O
MEALS O O
) O O
. O O

Pneumonia B-problem O
one O O
and O O
a O O
half O O
years O O
ago O O
. O O

Sex O O
: O O

No O O
known B-problem B-problem
drug I-problem I-problem
allergies I-problem I-problem
. O O

Laser B-treatment O
surgery I-treatment O
for O O
retinopathy B-problem O
. O O

Disp O O
:* O O
90 O O
Tablet O O
Sustained O O
Release O O
(s)* O O
Refills O O
:* O O
0 O O
* O O

6. O O
Tiotropium B-treatment B-treatment
Bromide I-treatment I-treatment
18 O O
mcg O O
Capsule O O
, O O
w/ O O
Inhalation B-treatment O
Device I-treatment O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Cap O O
Inhalation O O
DAILY O O
( O O
Daily O O
) O O
. O O

3. O O
Levothyroxine B-treatment B-treatment
125 O O
mcg O O
Tablet O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Tablet O O
PO O O
DAILY O O
( O O
Daily O O
). O O

He O O
was O O
transferred O O
to O O
CSRU O O
for O O
evaluation B-test B-problem
. O O

HOUGHTBREUN O B-test
, O O
TESANT O B-test
E. O O
, O O
M.D. O O
( O O
EV89 O O
) O O
01/20/03 O O
12:26 O O
PM O O

The O O
patient O O
was O O
doing O O
relatively O O
at O O
home O O
until O O
one O O
day O O
prior O O
to O O
admission O O
he O O
complained O O
discomfort B-problem O
over O O
a B-treatment B-problem
suprapubic I-treatment I-problem
catheter I-treatment I-problem
area I-treatment I-problem
. O O

Some B-problem O
rashes I-problem O
on I-problem O
ACW I-problem O
around O O
EKG B-treatment O
leads I-treatment O

In O O
addition O O
, O O
the O O
patient O O
did O O
have O O
slightly B-problem B-treatment
elevated I-problem I-treatment
blood I-problem I-treatment
sugars I-problem I-treatment
over O O
the O O
last O O
couple O O
of O O
days O O
and O O
has O O
required O O
an B-treatment O
insulin I-treatment O
sliding I-treatment O
scale I-treatment O
and O O
basal B-treatment O
insulin I-treatment O
to O O
maintain O B-problem
his B-test I-problem
blood I-test I-problem
sugars I-test I-problem
at O I-problem
a O I-problem
more O I-problem
appropriate O I-problem
level O I-problem
. O O

D O O
: O O
2012-03-10 O O
22:44 O O

Discharge O O
Instructions O O
: O O

The O O
results O O
of O O
this B-test O
study I-test O
indicated O O
that O O
this O O
structure O O
at O O
the O O
head O O
of O O
his O O
pancreas O O
is O O
most O O
likely O O
a B-problem O
forming I-problem O
pseudocyst I-problem O
; O O
however O O
, O O
the O O
suspicion O O
of O O
malignancy B-problem O
is O O
still O O
possible O O
and O O
the O O
patient O O
underwent O O
an B-test O
ultrasound I-test O
guided I-test O
biopsy I-test O
of O O
this B-problem O
mass I-problem O
on O O
2011-01-20 O O
. O O

The O O
patient O O
is O O
fully O O
paced O O
. O O

Please O O
see O O
operative O O
report O O
for O O
surgical O B-problem
details O I-problem
. O O

15. O O
Pamidronate B-treatment B-treatment
30 O O
mg O O
IV O O
every O O
month O O
. O O

Optimization O O
of O O
his B-test B-treatment
fluid I-test I-treatment
balance I-test I-treatment
was O O
managed O O
by O O
the O O
medical O O
service O O
in O O
consultation O O
with O O
hepatology O O
and O O
renal O O
. O O

Medications O O
on O O
Admission O O
: O O

He O O
is O O
also O O
on O O
Reglan B-treatment B-test
, O O
10 O O
mg O O
p.o. O O
q O O
h O O
; O O
Miracle B-treatment O
topical I-treatment O
cream I-treatment O
to O O
affected B-problem O
area I-problem O
; O O
also O O
Sarna B-treatment O
, I-treatment O
topical I-treatment B-problem
cream I-treatment I-problem
, O O
b.i.d. O O

MMM O O
, O O
OP O O
clear O O

HEENT O O
- O O
normocephalic O B-treatment
/ O I-treatment
atraumatic B-problem I-treatment
, O O
extraocular O O
movements O O
are O O
intact O O
, O O
pupils O B-treatment
equal O I-treatment
, O O
round O O
and O O
reactive O O
to O O
light O O
and O O
accommodation O B-problem
. O O

In O O
2003 O O
, O O
he O O
had O O
a B-problem B-treatment
non I-problem I-treatment
ST I-problem I-treatment
elevation I-problem I-treatment
MI I-problem O
, O O
came O O
to O O
the O O
RWH O O
, O O
and O O
had O O
a B-test B-test
cath I-test I-test
done O O
, O O
which O O
showed O O
a B-problem O
40% I-problem O
RCA I-problem O
, O O
which O O
was O O
hazy B-problem O
. O O

1. O O
Sepsis B-problem B-treatment
/ O O
ID- O O
Started O O
on O O
sepsis B-treatment B-problem
protocol I-treatment I-problem
. O O

Her O O
thyroid O O
was O O
within O O
normal O O
limits O O
. O O

Please O O
follow O O
up O O
in O O
1 O O
month O O
. O O

Neurological O O
: O O

MEDICATIONS O O
ON O O
ADMISSION O O
: O O
He O O
takes O O
Imodium B-treatment O
and O O
Lomotil B-treatment O
while O O
on O O
Sutent B-treatment O
for O O
diarrhea B-problem O
. O O

Ct B-test O
scan I-test O
shows O O
ovarian B-problem O
cyst I-problem O

PLT B-test B-test
COUNT I-test I-test
- O O
207 O O

( O O
End O O
of O O
Report O O
) O O

503651854 O O
WGH O O

She O O
received O O
4units O O
of O O
FFP B-treatment O
which O O
decreased O O
her B-test O
INR I-test O
to O O
2.2 O O
and O O
then O O
2 O O
more O O
units O O
during O O
the B-treatment O
tap I-treatment O
. O O

These O O
were O O
thought O O
to O O
be O O
consistent O O
either O O
with O O
pneumonia B-problem B-problem
or O I-problem
asymmetric B-problem I-problem
pulmonary I-problem I-problem
edema I-problem I-problem
. O O

Transcranial B-test B-test
Dopplers I-test I-test
were O O
checked O O
following O O
surgery B-treatment O
and O O
the O O
patient O O
was O O
started O O
on O O
Decadron B-treatment O
4 O O
mg O O
q6 O O
to O O
prevent O O
swelling B-problem O
. O O

# O O
bacteremia B-problem O
: O O

No O O
pneumothorax B-problem B-treatment
. O O

Reports O O
that O O
he O O
has O O
suffered O O
from O O
anxiety B-problem O
since O O
childhood O O
and O O
needed O O
to O O
drop O O
out O O
of O O
college O O
. O O

Chest B-treatment O
tubes I-treatment O
were O O
removed O O
on O O
post-op O O
day O O
two O O
and O O
epicardial B-treatment O
pacing I-treatment O
wires I-treatment O
on O O
post-op O O
day O O
three O O
. O O

The O O
patient O O
was O O
treated O O
with O O
a B-treatment B-problem
Lidocaine I-treatment I-problem
patch I-treatment I-problem
and O O
Percocet B-treatment O
prn O O
. O O

left O B-test
hip O I-test
110 O O
degrees O O
of O O
flexion B-test B-test
, O O
0 O O
degrees O O
of O O
extension B-test B-test
, O O
30 O O
degrees O O
of O O
abduction B-test B-test
, O O
45 O O
degrees O O
of O O
adduction B-test B-treatment
, O O
10 O O
degrees O O
of O O
internal B-test B-treatment
rotation I-test I-treatment
and I-test O
flexion I-test B-treatment
, O O
45 O O
degrees O O
of O O
external B-test B-problem
rotation I-test I-problem
and I-test O
flexion I-test O
. O O

The O O
strength O O
was O O
5 O O
out O O
of O O
5 O O
. O O

The O O
patient O O
&apos;s O O
mother O O
is O O
alive O O
at O O
the O O
age O O
of O O
114y O O
. O O

Date O O
of O O
Birth O O
: O O

Responsible O O
After O O
Study O O
for O O
Causing O O
Admission O O
) O O

pregnancy B-problem O
, I-problem O
term I-problem O

Security O O
was O O
notified O O
who O O
then O O
arrived O O
to O O
the O O
room O O
and O O
helped O O
to O O
place O O
the O O
patient O O
in O O
four-point O O

16. O O
Furosemide B-treatment B-treatment
40 O O
mg O O
Tablet O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Tablet O O
PO O O
BID O O
( O O
2 O O
times O O
a O O
day O O
) O O
. O O

Post B-problem O
dates I-problem O

The O O
patient O O
presented O O
to O O
Bri O O
Health O O
in O O
order O O
to O O
be O O
evaluated O O
for O O
preoperative B-test B-problem
clearance I-test I-problem
. O O

Pulmonary O O
: O O

RPR B-test O
card I-test O
test I-test O
was O O
negative O O
. O O

HEART O O
: O O

She O O
presents O O
for O O
cadaveric B-treatment B-problem
pancreas I-treatment I-problem
transplantation I-treatment I-problem
. O O

He O O
was O O
successfully O O
weaned O O
off O O
this B-treatment O
support I-treatment O
. O O

Head B-test O
computerized I-test B-treatment
tomography I-test I-treatment
scan I-test I-treatment
on O O
10/19 O O
: O O
3 B-problem O
centimeter I-problem B-problem
hyperdensity I-problem I-problem
within O I-problem
the O I-problem
right O I-problem
putamenal O I-problem
area O I-problem
in O I-problem
the O I-problem
right O I-problem
external O I-problem
capsusle O I-problem
consistent O O
with O O
intra-parenchymal B-problem B-problem
hematoma I-problem I-problem
with O O
mild B-problem B-problem
local I-problem I-problem
mass I-problem I-problem
effect I-problem I-problem
and O O
surrounding B-problem B-problem
edema I-problem I-problem
. O O

The O O
patient O O
was O O
admitted O O
to O O
the O O
hospital O O
on O O
July O O
12th O O
for O O
a B-treatment O
chole I-treatment O
with O O
a O B-problem
principle O I-problem
diagnosis O I-problem
of O I-problem
recurrent B-problem I-problem
biliary I-problem I-problem
colic I-problem I-problem
. O O

ALENDRONATE B-treatment O
70 O O
MG O O
PO O O
QWEEK O O

ALLERGIES O O
: O O

5. O O
Chronic B-problem B-treatment
constipation I-problem I-treatment
from O O
laxative B-problem O
abuse I-problem O
. O O

Admission O O
Date O O
: O O

HEENT O O
: O O
Flushed B-problem O
cheeks I-problem O
. O O

Provider O O
: O O

Trazodone B-treatment B-test
25 O O
mg O O
p.o. O O
q O O
h.s. O O
as O O
needed O O
for O O
sleep O O
. O O

A B-test B-test
chest I-test I-test
x-ray I-test I-test
in O O
the O O
Oaksgekesser/ O O
Memorial O O
Hospital O O
Emergency O O
Room O O
showed O O
new B-problem O
changes I-problem O
on O O
his B-test B-treatment
chest I-test I-treatment
x-ray I-test I-treatment
on O O
top O O
of O O
his B-problem B-problem
usual I-problem I-problem
severe I-problem I-problem
bilateral I-problem I-problem
emphysema_____ I-problem I-problem
with O O
scarring B-problem O
in I-problem O
both I-problem O
lungs I-problem O
. O O

Timothy O O
E O O
Woolfolk O O
, O O
M.D. O O

Report O O
Status O O
: O O

On O O
HD#5 O O
flexible B-test O
sigmoidoscopy I-test O
was O O
performed O O
for O O
colonic B-treatment B-problem
decompression I-treatment I-problem
. O O

He O O
was O O
also O O
given O O
5mg O O
of O O
glucagon B-treatment O
and O O
started O O
on O O
a B-treatment B-treatment
glucagon I-treatment I-treatment
drip I-treatment I-treatment
with O O
good O O
response O O
. O O

MRN O O
: O O

Abdomen O O
: O O

Patient O O
was O O
alert O O
, O O
oriented O O
x3 O O
. O O

She O O
also O O
described O O
sob B-problem O
, O O
nausea B-problem B-treatment
, O O
worsening B-problem B-problem
lower I-problem I-problem
ext I-problem I-problem
edema I-problem I-problem
. O O

The O O
chest O O
is O O
clear O O
to O O
auscultation B-test B-problem
bilaterally O I-problem
. O O

22. O O
Finasteride B-treatment B-treatment
5 O O
mg O O
Tablet O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Tablet O O
PO O O
DAILY O O
( O O
Daily O O
) O O
. O O

DISCHARGE O O
DATE O O
: O O

AKOTEBONTKAYS O O
, O O
JUANQUINTLEO O O

There O O
was O O
no O O
evidence O O
of O O
pericardial B-problem B-problem
effusion I-problem I-problem
. O O

Patient O O
was O O
also O O
found O O
to O O
have O O
abnormal B-problem O
TFTs I-problem O
on O O
Sutent B-treatment O
and O O
was O O
started O O
on O O
replacement B-treatment O

Discharge O O
Instructions O O
: O O

2017-09-03 O O
PT B-test B-test
- O O
13.8 O O
* O O
PTT B-test B-test
- O O
33.1 O O
INR B-test O
( I-test O
PT I-test O
)- I-test O
1.2 O O
* O O

The O O
patient O O
was O O
initially O O
admitted O O
for O O
likely O B-problem
CHF B-problem I-problem
exacerbation I-problem I-problem
. O O

In O O
the O O
absence O O
of O O
history O O
of O O
malignancy B-problem O
, O O
this O O
is O O
statistically O O
benign O O
. O O

Liver B-problem O
slightly I-problem O
pulsatile I-problem O
but O O
no O O
enlarged B-problem O
. O O

The B-test O
patient I-test O
&apos;s I-test O
liver I-test O
function I-test O
tests I-test O
began O O
to O O
rise O O
and O O
she O O
began O O
to O O
experience O B-problem
pulmonary B-problem I-problem
symptoms I-problem I-problem
including O I-problem
increased B-problem I-problem
crackles I-problem I-problem
. O O

Discharge O O
Date O O
: O O

PHYSICAL O O
EXAMINATION O O
ON O O
ADMISSION O O
: O O

General O O
: O O

STEROID B-problem O
PSYCHOSIS I-problem O
NO O O
BENZOS B-treatment O

The O B-test
chest O I-test
was O O
clear O O
to O O
auscultation B-test B-treatment
and O O
percussion B-test B-problem
. O O

Right O O
arm O O
neurovascularly O O
intact O O
. O O

they O O
will O O
call O O
you O O
to O O
set O O
up O O
appt O O
. O O

Bilateral B-problem B-test
crackles I-problem I-test
at I-problem O
bases I-problem O
and I-problem O
midlungs I-problem O
, O O
elevated B-problem O
JVP I-problem O
, O O
trace B-problem B-treatment
bilateral I-problem I-treatment
ankle I-problem I-treatment
edema I-problem I-treatment
, O O
and O O
CXR B-test O
with O O
diffuse B-problem B-problem
opacities I-problem I-problem
suggest O I-problem
possible O I-problem
pulmonary B-problem I-problem
edema I-problem I-problem
, O O
likely O O
secondary O O
to O O
acute B-problem O
MI I-problem O
. O O

Robert O O
the B-problem O
shortness I-problem O
of I-problem O
breath I-problem O
gets O O
worse O O
please O O
return O O
to O O
emergency O O
room O O
. O O

The O O
patient O O
is O O
a O O
49-year-old O O
gravida O O
III O O
, O O
para O O
II O O
, O O
who O O
was O O
sent O O
from O O
her O O
primary O O
care O O
physician O O
's O O
office O O
secondary O O
to O O
lower B-problem B-problem
abdominal I-problem I-problem
pain I-problem I-problem
. O O

- O O
persistent B-problem O
R I-problem O
foot I-problem O
ulcer I-problem O

S1 O O
and O O
S2 O O
. O O

XARAH O O
RATIA O O
SERVICE O O

Functionally O B-test
, O O
she O O
was O O
at O O
the O O
level O O
of O O
pre-gait B-treatment O
training I-treatment O
and O O
able O O
to O O
stand O O
and O O
take O O
several O O
steps O O
with O O
upper B-treatment O
body I-treatment O
support I-treatment O
. O O

Vital O O
signs O O
: O O

Intramuscular B-treatment O
as O O
well O O
as O O
intravenous B-treatment B-treatment
Haldol I-treatment I-treatment
were O O
ordered O O
p.r.n. O O
for O O
emergency O O
use O O
should O O
he O O
become O O
acutely B-problem O
agitated I-problem O
. O O

Date O O
of O O
Birth O O
: O O

diabetic B-problem O
gastropathy I-problem O
causing O O
inability B-problem O
to I-problem O
toleral I-problem O
oral I-problem O
antihypertensive I-problem O
medication I-problem O
prompting O O
repeated O O
Donald O O
presentation O O
for O O
hypertensive B-problem B-problem
urgency I-problem I-problem
. O O

An B-test B-test
echocardiogram I-test I-test
performed O O
at O O
the O O
outside O O
hospital O O
while O O
he O O
was O O
septic B-problem O
showed O O
decreased B-problem O
global I-problem O
EF I-problem O
. O O

Approved O O
: O O
FRI O O
2013-05-24 O O
4:01 O O
PM O O

Admitting B-test O
labs I-test O
were O O
: O O

NC/AT O O
. O O

White B-test B-test
blood I-test I-test
cell I-test I-test
12.9 O O
, O O
hemoglobin B-test B-test
11.5 O O
, O O
hematocrit B-test B-test
32.8 O O
, O O
platelet B-test B-test
count I-test I-test
197,000 O O
, O O
sodium B-test B-test
141 O O
, O O
potassium B-test B-test
3.6 O O
, O O
chloride B-test B-test
110 O O
, O O
bicarbonate B-test B-test
21 O O
, O O
BUN B-test B-test
20 O O
, O O
creatinine B-test B-test
0.7 O O
, O O
glucose B-test B-test
189 O O
, O O
PT B-test B-test
13.3 O O
, O O
INR B-test B-test
1.2 O O
, O O
PTT B-test B-test
30.0 O O
, O O
amylase B-test B-test
57 O O
, O O
arterial B-test B-test
blood I-test I-test
gas I-test I-test
7.32 O O
, O O
35 O O
, O O
159 O O
, O O
19 O O
, O O
-7 O O
. O O

Provider O O
Number O O
: O O

Prednisone B-treatment O
taper I-treatment O
as O O
above O O
. O O

The O O
pregnancy O O
was O O
complicated O O
by O O
twin B-problem O
gestation I-problem O
and O O
by O O
polyhydramnios B-problem O
with O O
apparent O B-problem
duodenal B-problem I-problem
atresia I-problem I-problem
and O O
nuchal O O

Give O O
on O O
an O O
empty O O
stomach O O
( O O
give O O
1hr O O
before O O
or O O
2hr O O
after O O
food O O
) O O

On O O
presentation O O
to O O
Providence O O
Behavioral O O
Health O O
Hospital O O
Amanda O O
, O O
her B-test B-test
vitals I-test I-test
were O O
HR B-test O
68 O O
, O O
BP B-test B-test
142/68 O O
, O O
RR B-test O
28 O O
, O O
O2 B-test O
sat I-test O
100% O O
RA O O
. O O

2. O O
Captopril B-treatment B-treatment
12.5 O O
mg O O
po O O
tid O O
. O O

Upon O O
further O O
review O O
of O O
CT B-test B-treatment
and O O
angiography B-test O
results O O
with O O
Neuroradiology O O
and O O
Neurology O O
service O O
, O O
it O O
was O O
decided O O
that O O
CT B-test B-treatment
myelography I-test I-treatment
was O O
not O O
indicated O O
at O O
this O O
time O O
. O O

Soft O O
, O O
nontender B-problem O
, O O
nondistended B-problem O
. O O

Subdural B-problem O
hematoma I-problem O

T O O
: O O
2016-03-22 O O
12:23 O O

He O O
was O O
instructed O O
to O O
hold O O
the O O
following O O
three O O
medications B-treatment O
that O O
he O O
took O O
prior O O
to O O
admission O O
: O O

5. O O
Atorvastatin B-treatment B-treatment
10 O O
mg O O
Tablet O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Tablet O O
PO O O
DAILY O O
( O O
Daily O O
). O O

Minimal B-problem O
bleeding I-problem O
. O O

There O O
were O O
diffuse B-problem O
ST I-problem O
segment I-problem O
and I-problem O
T-wave I-problem O
abnormalities I-problem B-treatment
, O O
which O O
were O O
nonspecific O B-problem
. O O

6. O O
Atrovent B-treatment B-treatment
multiple I-treatment I-treatment
dose I-treatment I-treatment
inhalers I-treatment I-treatment
, O O
one O O
to O O
two O O
puffs O O
q. O O
six O O
hours O O
as O O
needed O O
. O O

At O O
the O O
time O O
, O O
blood O B-test
, O O
urine O B-treatment
and O O
bile O O
was O O
sent O O
for O O
culture B-test B-treatment
, O O
which O O
were O O
all O O
negative O O
. O O

Heart O O
: O O

She O O
was O O
started O O
on O O
clear O O
fluids O O
with O O
a B-treatment B-problem
nasogastric I-treatment I-problem
clamped O I-problem
. O O

5. O O
Fluticasone B-treatment B-test
- O O
Salmeterol B-treatment B-treatment
100-50 O O
mcg O O
/ O O
Dose O O
Disk O O
with O O
Device O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Disk O O
with O O
Device O O
Inhalation O O
BID O O
( O O
2 O O
times O O
a O O
day O O
) O O
. O O

GUABENFRANDA O B-test
PATIENT O I-test
, O O
M.D. O O

Rare O O
. O O

He O O
works O O
as O O
a O O
jeweler O O
. O O

6. O O
Morphine B-treatment B-treatment
15 O O
mg O O
Tablet O O
Sustained O O
Release O O
Sig O O
: O O
Three O O
( O O
3 O O
) O O
Tablet O O
Sustained O O
Release O O
PO O O
Q12H O O
( O O
every O O
12 O O
hours O O
). O O

ENTERED O O
BY O O
: O O

Lidocaine B-treatment O
patch I-treatment O

There O O
was O O
only O O
diffuse B-problem B-problem
small I-problem I-problem
vessel I-problem I-problem
disease I-problem I-problem
noted O O
. O O

1. O O
Chronic B-problem B-problem
obstructive I-problem I-problem
pulmonary I-problem I-problem
disease I-problem I-problem
exacerbation I-problem I-problem
. O O

Dictated O O
By O O
: O O

Provider O O
: O O

CSF B-test O
grm I-test O
stn I-test O
/ O O
cx B-test O
: O O
negative O O

He O O
was O O
treated O O
with O O
Octreotide B-treatment O
to O O
try O O
to O O
slow O O
down O O
the B-problem O
bleeding I-problem O
. O O

Date O O
of O O
Birth O O
: O O

CH O O
KOTEKOLL O O

CREDKOTE O O
, O O
ALEN O O

PAST O O
SURGICAL O O
HISTORY O O
: O O

2019-06-14 O O
06:03 O O
PM O O
BLOOD O B-treatment
CK-MB B-test I-treatment
-4 O I-treatment
cTropnT B-test I-treatment
- O O
0.03 O O
* O O

PRELMINARY O O
REPORT O O

She O O
will O O
continue O O
on O O
her B-treatment B-problem
previous I-treatment I-problem
outpatient I-treatment I-problem
medical I-treatment I-problem
regimen I-treatment I-problem
. O O

ALLERGIES O O
: O O

Senna B-treatment O
PRN O O

A B-test B-test
lumbar I-test I-test
puncture I-test I-test
was O O
considered O O
, O O
although O O
not O O
performed O O
due O O
to O O
the O O
fact O O
that O O
the O O
cerebrospinal O O
fluid O O
was O O
not O O
breached O O
during O O
the B-treatment O
procedure I-treatment O
. O O

She O O
is O O
discharged O O
to O O
rehab O O
on O O
POD# O O
27/18 O O
. O O

MEDICATIONS O O
: O O

2) O O
Calcium B-treatment B-treatment
gluconate I-treatment I-treatment
1000 O O
mg O O
p.o. O O
q O O
day O O
. O O

Restared O O
coumadin B-treatment O
on O O
12-29 O O
. O O

IMPRESSION O O
: O O

Discharge O O
Date O O
: O O

Index O O
No. O O

WBC B-test B-test
- O O
13.8* O O
RBC B-test B-test
- O O
3.39* O O
Hgb B-test B-test
- O O
10.7* O O
Hct B-test B-test
- O O
30.2* O O
MCV B-test B-test
- O O
89 O O
MCH B-test B-treatment
- O O
31.5 O O

2. O O
Vocal B-problem B-problem
cord I-problem I-problem
polyps I-problem I-problem

Severe B-problem O
chronic I-problem B-problem
obstructive I-problem I-problem
pulmonary I-problem I-problem
disease I-problem I-problem
. O O

Abdominal B-test O
ultrasound I-test O
was O O
unremarkable O O
. O O

Report O O
Status O O
: O O

6. O O
Nystatin B-treatment B-treatment
100,000 O O
unit O O
/ O O
g O O
Cream O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Appl O O
Topical O O
BID O O
( O O
2 O O
times O O
a O O
day O O
) O O
. O O

Twenty-four B-test O
urine I-test O
for O O
catecholamine B-test B-treatment
, O O
metanephrines B-test B-treatment
, O O
and O O
VMA B-test O
pending O O
at O O
the O O
time O O
of O O
discharge O O
. O O

BUN B-test O
was O O
34 O O
and O O
creatinine B-test B-treatment
was O O
2.6 O O
, O O
up O O
from O O
his O O
baseline O O
of O O
1.0 O O
. O O

HOSPITAL O O
COURSE O O
BY O O
SYSTEM O O
: O O

She O O
has O O
no O O
history O O
of O O
liver B-problem B-problem
disease I-problem I-problem
, O O
hepatitis B-problem B-problem
. O O

PHYSICAL O O
EXAMINATION O O
: O O

Note O O
, O O
please O O
draw O O
blood O O
for O O
vancomycin B-test B-treatment
levels I-test I-treatment
on O O
25 O O
May O O
1998 O O
, O O
before O O
the O O
next O O
dose O O
, O O
to O O
get O O
the B-test O
trough I-test O
level I-test O
. O O

DISCHARGE O O
DIAGNOSIS O O
: O O

2. O O
Ovoid B-problem O
18 I-problem O
- I-problem O
mm I-problem O
density I-problem O
within I-problem O
the I-problem O
atrium I-problem O
of O O
the O B-problem
right O I-problem
lateral O I-problem
ventricle O I-problem
. O O

ADDITIONAL O O
COMMENTS O O
: O O

Chem-7 B-test O
revealed O O
sodium B-test O
of O O
136 O O
, O O
potassium B-test B-test
4.7 O O
, O O
chloride B-test B-test
103 O O
, O O
bicarbonate B-test B-test
22 O O
, O O
BUN B-test B-test
16 O O
, O O
creatinine B-test B-treatment
0.8 O O
, O O
glucose B-test B-treatment
284 O O
. O O

Total B-test B-test
bilirubin I-test I-test
was O O
2.1 O O
. O O

13. O O
Potassium B-treatment B-treatment
Chloride I-treatment I-treatment
20 O O
mEq O B-treatment
Tab O I-treatment
Sust O I-treatment
. O O
Rel O O
. O O
Particle O B-treatment
/ O O
Crystal O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Tab O O
Sust O O
. O O
Rel O O
. O O
Particle O O
/ O O
Crystal O O
PO O O
once O O
a O O
day O O
. O O

G4 O O
T2 O O
P0 O O
A1 O O
L2 O O
Estimated O O

She O O
is O O
a O O
nonsmoker O O
. O O

He O O
was O O
then O O
transferred O O
to O O
the O O
Retelk O O
County O O
Medical O O
Center O O
for O O
further B-treatment O
management I-treatment O
. O O

Hurtado B-problem O
Colon I-problem O

Discharge O O
Date O O
: O O

The B-test O
study I-test O
and O O
the O O
report O O
were O O
reviewed O O
by O O
the O O
staff O O
radiologist O O
. O O

No O O
heavy O O
lifting O O
or O O
driving O O
until O O
follow O O
up O O
with O O
Dr. O O
Mullins O B-problem
. O O

Cardiac O O
: O O
RRR O O
, O O
no O O
murmurs B-problem B-problem

Elinor O B-test
Nicole O I-test
, O O
New O O
York O O
12428 O O

Varicella B-test B-test
antibody I-test I-test
positive O I-test
, O O
CMV B-test B-treatment
antibody I-test I-treatment
positive O I-treatment
, O O
toxo B-test O
negative O O
, O O
RPR B-test O
non O O
reactive O O
. O O

MEDICATION O O
( O O
S O O
) O O
ON O O
DISCHARGE O O
: O O

1. O O
Quetiapine B-treatment B-treatment
300 O O
mg O O
QHS O O

Tracheostomy B-treatment O
2014-11-11 O O

Staff O O
Obstetrician O O
( O O
supervising O O
) O O
: O O

OTHER O O
PROCEDURE O O
: O O

His B-test B-treatment
hemoglobin I-test I-treatment
A1C I-test I-treatment
levels I-test I-treatment
actually O I-treatment
came O I-treatment
back O I-treatment
within O I-treatment
normal O I-treatment
limits O I-treatment
, O O
however O O
, O O
the B-problem O
wide I-problem O
excursions I-problem O
of O O
his B-test O
sugars I-test O
were O O
consistent O O
with O O
possible O O
diabetes B-problem O
. O O

States O O
he O O
first O O
developed O O
back B-problem O
pain I-problem B-treatment
5 O O
weeks O O
ago O O
but O O
was O O
still O O
able O O
to O O
ambulate O O
with O O
his B-treatment B-problem
cane I-treatment I-problem
. O O

NIACIN B-treatment O
, O O
VIT B-treatment O
. O O

There O O
was O O
no O O
significant B-problem O
change I-problem O
in I-problem O
size I-problem O
of O O
the B-problem O
subacute I-problem O
pontine I-problem O
hemorrhage I-problem O
. O O

2014-03-11 O O
02:00 O O
AM O O
BLOOD B-test B-test
cTropnT B-test I-test
- O O
0.45 O O
* O O

Amylase B-test O
was O O
2304 O O
with O O
lipase B-test O
being O O
7116 O O
. O O

MEDICATIONS O O
ON O O
DISCHARGE O O
: O O

The O O
past O O
medical O O
history O O
is O O
significant O O
for O O
hypertension B-problem B-problem
. O O

The O O
patient O O
required O O
supplemental B-treatment O
oxygen I-treatment O
to O O
keep O O
his B-test O
oxygen I-test O
saturation I-test O
greater O O
than O O
93% O O
. O O

extubated O O
. O O

His B-treatment B-test
Avandia I-treatment I-test
was O O
discontinued O O
secondary O O
to O O
the B-problem O
side I-problem O
effect I-problem O
profile I-problem O
. O O

WBC B-test O
12.91 O O

DISCHARGE O O
DIAGNOSES O O
: O O

3. O O
Gastrointestinal B-problem B-treatment
adenocarcinoma I-problem I-treatment
( O O
as O O
noted O O
in O O
History O O
of O O
Present O O
Illness O O
) O O
. O O

WBC B-test B-test
8.4 O O
, O O
hematocrit B-test B-treatment
32.6 O O
, O O
platelet B-test B-treatment
count I-test I-treatment
194,000 O O
. O O

Mr. O O
Anders O O
was O O
admitted O O
for O O
anticoagulation B-treatment O
and O O
hemodynamic B-test O
monitoring I-test O
in O O
the O O
setting O O
of O O
saddle B-problem O
pulmonary I-problem B-problem
embolus I-problem I-problem
and O O
left B-problem B-problem
knee I-problem I-problem
injury I-problem I-problem
. O O

PHYSICAL O O
EXAM O O
: O O

2. O O
80-99% B-problem O
stenosis I-problem B-problem
of I-problem I-problem
the I-problem I-problem
left I-problem I-problem
internal I-problem I-problem
carotid I-problem I-problem
artery I-problem I-problem
. O O

DISCHARGE O O
DATE O O
: O O

Service O O
: O O

Regular O B-test
rate O I-test
and O O
rhythm O O
, O O
S1 O O
, O O
S2 O O
, O O
with O O
soft B-problem O
systolic I-problem B-problem
ejection I-problem I-problem
murmur I-problem I-problem
. O O

Her B-test B-test
cholesterol I-test I-test
was O O
350 O O
here O O
. O O

Cardiac B-test O
Enzymes I-test O

OTHER O O
DIAGNOSIS O O
; O O
Conditions O B-treatment
, O O
Infections O B-treatment
, O O
Complications O B-treatment
, O O
affecting O O
Treatment O O
/ O O
Stay O O
s O O
/ O O
p O O
cesarean B-treatment O

Echo B-test O
showed O O
ef B-test O
45-50% O O
, O O
with O O
mild B-problem B-test
dilatation I-problem I-test
and O O
no O O
significant B-problem B-treatment
valvular I-problem I-treatment
disease I-problem I-treatment
, O O
and O O
nl O O
PAP O O
. O O

He O O
was O O
most O O
recently O O
discharged O O
from O O
Oaksgekesser/ O O
Memorial O O
Hospital O O
on O O
03/06/99 O O
and O O
was O O
then O O
transferred O O
to O O
Linghs O O
County O O
Medical O O
Center O O
from O O
which O O
he O O
was O O
discharged O O
on O O
03/20/99 O O
. O O

The O O
patient O O
periodically O O
required O O
transfusions B-treatment O
of O O
fresh B-treatment O
frozen I-treatment O
plasma I-treatment O
, O O
as O O
well O O
as O O
platelets B-treatment O
and O O
red B-treatment O
cells I-treatment O
. O O

The O O
lungs O O
were O O
clear O O
to O O
auscultation B-test B-problem
. O O

Pt O O
will O O
finish O O
course O O
of O O
H. B-treatment O
pylori I-treatment B-problem
treatment I-treatment I-problem
as O O
well O O
. O O

Pertinent O O
Results O O
: O O

Percocet B-treatment O
1 O O
tab O O
PRN O O

WBC B-test B-test
- O O
9.4 O O
# O O
RBC B-test B-test
- O O
4.75 O O
HGB B-test B-test
- O O
14.7 O O
HCT B-test B-test
- O O
42.2 O O
MCV B-test B-test
- O O
89 O O
MCH B-test B-test
- O O
30.9 O O
MCHC B-test B-test
- O O
34.8 O O
RDW B-test O
- O O
13.6 O O

He O O
is O O
on O O
Amiodarone B-treatment O
for O O
post-op B-problem O
afib I-problem O
and O O
this O O
was O O
continued O O
this O O
entire O O
admission O O
. O O

Attending B-test O
evaluation I-test O

reach O O
six O O
months O O
of O O
age O O
, O O
before O O
this O O
age O O
the O O
family O O
and O O
other O O
caregivers O O
should O O
be O O
considered O O
for O O
immunization B-treatment O
against O O

5. O O
Multivitamin B-treatment B-treatment
one O O
p.o. O O
q. O O
day O O
. O O

Back O O
without O O
CVA B-problem O
or I-problem O
spinal I-problem B-problem
tenderness I-problem I-problem
. O O

Take O O
with O O
8 O O
oz O O
of O O
plain O B-treatment
water O I-treatment
ALBUTEROL B-treatment I-treatment
INHALER I-treatment I-treatment
2 O O
PUFF O O
INH O O
QID O O
Starting O O
Today O O
( O O
12/09 O O
) O O
ATROVENT B-treatment O
INHALER I-treatment O
( I-treatment O
IPRATROPIUM I-treatment O
INHALER I-treatment O
) I-treatment O
2 O O
PUFF O O
INH O O
QID O O
Starting O O
Today O O
( O O
12/09 O O
) O O

In O O
emergency O O
room O O
, O O
he O O
was O O
noted O O
to O O
be O O
afebrile O O
with O O
stable O O
vital O O
signs O O
, O O
was O O
treated O O
with O O
IV B-treatment O
fluids I-treatment O
, O O
azithromycin B-treatment B-treatment
, O O
and O O
cefuroxime B-treatment B-problem
. O O

The O O
patient O O
is O O
a O O
42 O O
year O O
old O O
with O O
recurrent B-problem B-problem
biliary I-problem I-problem
colic I-problem I-problem
. O O

ON O O
admission O O
she O O
was O O
taking O O
Quetiapine B-treatment O
300 O O
mg O O
QHS O O
and O O
Clonazepam B-treatment B-test
1 O O
mg O O
QAM O O
, O O
1 O O
mg O O
Q3PM O O
, O O
2 O O
mg O O
PO O O
QHS O O
. O O

Left O O
arm O O
shows O O
a B-problem O
flexor I-problem O
contracture I-problem O
and O O
markedly B-problem O
increased I-problem O
tone I-problem O
. O O

Prochlorperazine B-treatment O
10 O O
mg O O
IV O O
Q6H O O
prn O O

Neck O O
: O O
No O O
LAD B-problem O
. O O

POSTPARTUM O O
DIAGNOSTIC O O
PROCEDURES O O
: O O

Abdomen O O
, O O
soft O O
, O O
non-tender B-problem O
, O O
non-distended B-problem O
, O O
normal O O
active O O
bowel O O
sounds O O
. O O

During O O
her O O
delivery O O
she O O
encountered O O
the O O
following O O
complication O O
( O O
s O O
) O O
: O O

The B-test B-test
neurological I-test I-test
examination I-test I-test
revealed O O
that O O
the O O
patient O O
was O O
awake O O
, O O
alert O O
and O O
oriented O O
to O O
person O O
, O O
place O O
and O O
time O O
. O O

morbid B-problem O
obesity I-problem O

2. O O
Oxycodone B-treatment O
5 O O
mg O O
Tablet O O
Sig O O
: O O
Two O O
( O O
2 O O
) O O
Tablet O O
PO O O
Q4H O O
( O O
every O O
4 O O
hours O O
) O O
as O O
needed O O
for O O
pain B-problem B-treatment
. O O

Drug B-problem O
toxicity I-problem O
would O O
be O O
a O B-problem
consideration O I-problem
, O O
although O O
somewhat O O
less O O
likely O O
given O O
the O O
unilaterality O O
of O O
the O O
findings O O
. O O

Gen O O
: O O
NAD B-problem O

It O O
is O O
recommended O O
that O O
you O O
receive O O
follow-up O O
care O O
with O O
the O O
Department O O
of O O
Orthopaedics O B-treatment
if O I-treatment
your B-problem I-treatment
symptoms I-problem I-treatment
are O O
not O O
improved O O
in O O
5-7 O O
days O O
. O O

The O O
patient O O
underwent O O
a B-treatment O
percutaneous I-treatment O
sphincterotomy I-treatment O
extended O O
to O O
a B-treatment B-problem
full I-treatment I-problem
sphincterectomy I-treatment I-problem
. O O

Blood B-test B-test
pressure I-test I-test
150/82 O O
, O O
heart B-test B-test
rate I-test I-test
88 O O
, O O
respiratory B-test B-treatment
rate I-test I-treatment
18 O O
. O O

This O O
was O O
restarted O O
post O O
extubation B-treatment O
. O O

Speech B-treatment O
and O O
Swallow B-treatment O
evaluated O O
the O O
patient O O
at O O
bedside O O
and O O
recommended O O
advancing O O
to O O
regular O O
diet O O
with O O
regular O O
consistency O O
and O O
saw O O
no O O
evidence O O
of O O
any B-problem O
dysphagia I-problem O
. O O

6. O O
Digoxin B-treatment B-treatment
125 O O
mcg O O
Tablet O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Tablet O O
PO O O
DAILY O O
( O O
Daily O O
). O O

no O O
heavy O O
lifting O O
; O O
nothing O O
in O O
the O O
vagina O O
for O O
6 O O
weeks O O
-- O O
no O O
intercourse O B-test
, O O
no O O
douching O O
, O O
no O O
tampons O O
; O O
call O O
for O O
fever B-problem O
above I-problem O
100.5 I-problem O
, O O
worsening B-problem B-test
abdominal I-problem I-test
pain I-problem I-test
, O O
heavy B-problem O
bleeding I-problem O
, O O
or O O
any B-problem O
other I-problem O
concern I-problem O
; O O
no O O
driving O O
while O O
taking O O
percocet B-treatment O

Followup O O
Instructions O O
: O O

MRN O O
: O O

Cr B-test O
0.8 O O
, O O
stress B-problem O
incontinence I-problem O
by O O
symptoms B-problem O
with O O
increased B-problem O
cough I-problem O
, O O
no O O
evidence O O
of O O
uti B-problem O
, O O
cont O O
to O O
closely O O
monitor O O

Negative O O
. O O

SLENTPEASEBUMPS O O
, O O
LISSSOND O O

1. O O
Aortic B-problem B-problem
stenosis I-problem I-problem

Report O O
Status O O
: O O

FREIERMDREPS O O
, O O
RI O O

no O O
evidence O O
of O O
pulmonary B-problem B-problem
emboli I-problem I-problem
. O O

6. O O
Nystatin B-treatment B-treatment
06-18 O O
mL O O
swish O O
and O O
swallow O O
q.6. O O
prn O O
. O O

Raymond O O
William O O
MD O O
50-154 O O

Treatment O O
Rendered O O
: O O

3. O O
Urinary B-problem O
frequency I-problem O
secondary O O
to O O
interstitial B-problem B-problem
cystitis I-problem I-problem
. O O

The O O
patient O O
has O O
had O O
low B-problem O
sodiums I-problem O
during O O
this B-treatment O
hospitalization I-treatment O
. O O

This O O
is O O
an O O
83-year-old O O
female O O
with O O
a O O
history O O
of O O
hypertrophic B-problem B-treatment
obstructive I-problem I-treatment
cardiomyopathy I-problem I-treatment
, O O
status O O
post O O
mitral B-treatment B-treatment
valve I-treatment I-treatment
replacement I-treatment I-treatment
in O O
1988 O O
, O O
chronic B-problem B-treatment
atrial I-problem I-treatment
fibrillation I-problem I-treatment
, O O
hypertension B-problem B-treatment
, O O
who O O
presents O O
for O O
parathyroidectomy B-treatment O
. O O

The O O
patient O O
was O O
evaluated O O
by O O
the O O
Surgical O O
Service O O
who O O
felt O O
that O O
the B-problem O
wound I-problem O
was O O
clean O O
with O O
some B-problem O
erythema I-problem O
but O O
without O O
evidence O O
of O O
true B-problem B-problem
cellulitis I-problem I-problem
. O O

The O O
cranial O O
nerves O O
showed O O
pupils O O
were O O
bilaterally O O
active O O
from O O
3 O O
to O O
2 O O
mm O O
. O O

It O O
was O O
felt O O
that O O
he O O
may O O
have O O
had O O
some O O
component O O
of O O
vascular B-problem B-problem
congestion I-problem I-problem
from O I-problem
his B-problem I-problem
congestive I-problem I-problem
heart I-problem I-problem
failure I-problem I-problem
as O O
well O O
as O O
possibly O B-problem
some B-problem I-problem
mild I-problem I-problem
cirrhotic I-problem I-problem
changes I-problem I-problem
secondary O O
to O O
his O O
previous O O
alcohol O O
use O O
. O O

Influenza B-treatment O
immunization I-treatment O
should O O
be O O
considered O O
annually O O
in O O
the O O
fall O O
for O O
preterm O O
infants O O
with O O
chronic B-problem B-problem
lung I-problem I-problem
disease I-problem I-problem
once O O
they O O

3. O O
Posttraumatic B-problem B-problem
stress I-problem I-problem
disorder I-problem I-problem
. O O

However O O
, O O
given O O
his B-problem B-treatment
rapid I-problem I-treatment
clinical I-problem I-treatment
decline I-problem I-treatment
, O O
this O O
was O O
deferred O O
and O O
I O O
do O O
not O O
suspect O O
that O O
he O O
will O O
be O O
a O O
candidate O O
for O O
this O O
, O O
as O O
the O O
degree O O
of O O
his B-problem B-treatment
decline I-problem I-treatment
bodes O I-treatment
a O I-treatment
poor O I-treatment
prognosis O I-treatment
for O O
him O O
. O O

Discharge O O
Disposition O O
: O O

FOLLOW O O
UP O O
APPOINTMENT O O
( O O
S O O
) O O
: O O

There O O
was O O
mild B-problem O
enhancement I-problem O
of I-problem O
the I-problem O
pontine I-problem O
hemorrhagic I-problem O
mass I-problem O
but O O
none O O
elsewhere O O
. O O

Status O O
post O O
coronary B-treatment B-problem
bypass I-treatment I-problem
surgery I-treatment I-problem
. O O

06/11/2005 O O
12:08 O O
PM O O

Skin O O
intact O O
. O O

This O O
is O O
to O O
notify O O
you O O
that O O
your O O
patient O O
, O O
BREUNDAIL O B-treatment
, O O
NETFA O O
arrived O O
in O O
the O O
Emergency O O
Department O O
at O O
Fairm O O
of O O
Ijordcompmac O O
Hospital O O
on O O
11/20/2002 O O
02:02 O O
AM O O
. O O

01-23 O O
PICC B-treatment B-problem
placement I-treatment I-problem
. O O

A B-test B-test
head I-test I-test
CT I-test I-test
scan I-test I-test
and O O
cervical B-test B-treatment
spine I-test I-treatment
series I-test I-treatment
were O O
negative O O
. O O

No O O
observed B-problem O
abnormalities I-problem O

Mother O O
died O O
of O O
MI B-problem O
at O O
age O O
55 O O
. O O

Normal O O
S1 O O
, O O
S2 O O
. O O

appears O O
younger O O
than O O
stated O O
age O O

Chronic B-problem B-test
blood I-problem I-test
loss I-problem I-test
anemia I-problem I-test
and O O
chronic B-treatment B-problem
RBC I-treatment I-problem
transfusion I-treatment I-problem
. O O

Restrictive B-problem B-test
lung I-problem I-test
disease I-problem I-test
. O O

MEDICATIONS O O
ON O O
ADMISSION O O
FROM O O
TRANSFER O O
: O O

Discharge O O
Medications O O
: O O

PCP O O
Name O O
: O O

GRENDZISKLEEB O O
, O O
DELMRU O B-problem
CENI O I-problem
, O O
M.D. O O

The O O
patient O O
expired O O
at O O
6 O O
p.m. O O
on O O
05-14 O O
. O O

2. O O
Respiratory O B-treatment
- O O
Intubated B-treatment O
for O O
airway B-treatment O
protection I-treatment O
due O O
to O O
change B-problem O
in I-problem O
mental I-problem O
status I-problem O
. O O

His B-test B-test
SBP I-test I-test
s I-test O
ranged O O
140 O O
s- O O
170 O O
s O O
. O O

Again O O
, O O
this O O
was O O
a O O
47-year-old O O
female O O
admitted O O
with O O
Berkitt's B-problem B-problem
lymphoma I-problem I-problem
. O O

98.4 O O
, O O
94 O O
, O O
22 O O
, O O
120/96 O O
, O O
98% O O
on O O
2L. O O
NAD B-problem O
, O O
using O B-test
scalenes B-test I-test
, O O
AT O O
/ O O
NC O O
, O O
no O O
oral B-problem B-treatment
lesions I-problem I-treatment
, O O
Bibasilar B-problem B-treatment
rales I-problem I-treatment
otherwise O I-treatment
clear O I-treatment
, O O
good O O
air O B-test
movement O I-test
, O O
RRR O O
, O O
no O O
MRG O O
, O O
NTND O O
+BS O O
, O O
no O O
CCE O B-treatment
, O O
2+ O O
DPs O O
. O O

The O O
patient O O
was O O
an O O
alert O O
, O O
jaundiced O O
gentleman O O
in O O
no O O
acute B-problem B-problem
distress I-problem I-problem
. O O

Therefore O O
, O O
directional B-treatment B-treatment
coronary I-treatment I-treatment
atherectomy I-treatment I-treatment
was O O
performed O O
with O O
an O B-treatment
excellent O I-treatment
angiographic O I-treatment
outcome O I-treatment
, O O
and O O
a B-problem O
less I-problem O
than I-problem O
10% I-problem O
residual I-problem B-problem
narrowing I-problem I-problem
. O O

ADMISSION O O
DATE O O
: O O

HOSPITAL O O
COURSE O O
: O O

Her B-test B-test
pulse I-test I-test
is O O
72 O O
, O O
irregularly O B-treatment
irregular O I-treatment
, O O
blood B-test B-test
pressure I-test I-test
96/60 O O
, O O
temperature B-test B-treatment
97.9 O O
, O O
respirations B-test B-treatment
18 O O
. O O

BREUNCLONTSTREAUAYLES O O
, O O
BINTRIREE O O

Gastroc. B-test O
3 O O
on O O
the O O
left O O
and O O
4+ O O
on O O
the O O
right O O
. O O

No O O
spontaneous B-problem O
echo I-problem O
contrast I-problem O
or O O
thrombus B-problem O
is O O
seen O O
in O O
the O O
body O O
of O O
the O O
left O O
atrium O O
or O O
left O B-problem
atrial O I-problem
appendage O I-problem
. O O

Ext O O
- O O
2 O O
+ O O
edema B-problem B-test
to I-problem O
knees I-problem O
, O O
warm O O
2 O O
+ O O
pulses B-test O
, O O
pain B-problem B-treatment
in I-problem O
R I-problem O
arm I-problem O
and I-problem O
R I-problem O
hip I-problem O

Echo B-test O
02-09 O O

His B-test B-test
liver I-test I-test
span I-test I-test
was O O
8 O O
cm O O
. O O

The O O
patient O O
was O O
maintained O O
on O O
IV B-treatment B-test
Solu I-treatment I-test
- I-treatment O
Medrol I-treatment O
60 O O
mg O O
q. O O
8 O O
h. O O

Date O O
of O O
Birth O O
: O O

PHYSICAL O O
EXAMINATION O O
: O O

She O O
was O O
continued O O
on O O
Demerol B-treatment O
50 O O
mg O O
q O O
6-8 O O
hours O O
p.r.n. O O
for O O
left B-problem B-problem
arm I-problem I-problem
and I-problem I-problem
leg I-problem I-problem
pain I-problem I-problem
. O O

Her B-test B-test
PT I-test I-test
drifted O O
down O O
to O O
a O O
level O O
of O O
12.9 O O
by O O
7/3 O O
and O O
therefore O O
she O O
will O O
be O O
discharged O O
with O O
4 O O
mg O O
of O O
Coumadin B-treatment B-treatment
per O O
day O O
to O O
be O O
followed O O
by O O
the O O
Coumadin O O
Clinic O O
at O O
Cowerin O O
Tonli O O
Medical O O
Center O O
. O O

10/17/2001 O O
16:28 O O

NEAR B-problem O
SYNCOPE I-problem O
Standardized O O
Discharge O O
Instructions O O
: O O

2. O O
Hypercholesterolemia B-problem B-treatment
. O O

4. O O
RISS B-treatment O

The O O
patient O O
was O O
admitted O O
to O O
the O O
hospital O O
for O O
further B-test B-problem
evaluation I-test I-problem
and O O
work B-test O
up I-test O
. O O

Age O O
: O O

Admission O O
Date O O
: O O

Two B-problem O
major I-problem B-treatment
fracture I-problem I-treatment
fragments I-problem I-treatment
were O O
seen O O
at O O
the O O
humeral O O
head O O
, O O
articulating O O
with O O
the O O
glenoid O O
fossa O O
. O O

R O O
/ O O
O O O
HEMMOROIDS B-problem O

SOCIAL O O
HISTORY O O
: O O

ED O O
Discharge O O
Summary O O

After O O
one O O
hour O O
his O O
eyes O O
were O O
midline O O
and O O
he O O
remained O O
unresponsive B-problem O
. O O

2) O O
Cxray B-test O
( O O
06-14 O O
): O O
New B-problem O
bibasilar I-problem O
consolidations I-problem O
are O O
demonstrated O O
accompanied O O
by O O
bilateral B-problem B-problem
small I-problem I-problem
pleural I-problem I-problem
effusion I-problem I-problem
. O O

The O O
patient O O
remained O O
intubated B-treatment O
until O O
postoperative O O
day O O
number O O
five O O
. O O

He O O
was O O
seen O O
by O O
Dr. O O
Seen O O
and O O
Dr. O O
Seen O O
as O O
an O O
out-patient O O
. O O

He O O
has O O
no O O
bleeding B-problem O
or O O
clotting B-problem B-problem
problems I-problem I-problem
. O O

An B-test B-test
ECHO I-test I-test
showed O O
that O O
she O O
had O O
preserved O O
EF O O
and O O
no O O
wall B-problem B-problem
motion I-problem I-problem
abnormalities I-problem I-problem
. O O

In O O
the O O
postoperative O O
recovery O O
room O O
the O O
patient O O
had O O
a B-test B-test
hematocrit I-test I-test
of O O
29.2 O O
with O O
low B-problem O
urine I-problem O
output I-problem O
. O O

No O O
lifting O O
more O O
than O O
10 O O
lbs O O
for O O
at O O
least O O
10 O O
weeks O O
from O O
the O O
date O O
of O O
surgery B-treatment O
. O O

HEIGHT B-test O
66 O O
HEENT B-test O
NORMAL O O
NECK O O
NORMAL O O
BREASTS O O
NORMAL O O
NIPPLES O O
NORMAL O O
CHEST O O
NORMAL O O
COR O O
NORMAL O O
ABDOMEN O O
NORMAL O O
EXTREM O O
NORMAL O O
SKIN O O
NORMAL O O
NODES O O
NORMAL O O
VULVA O O
NORMAL O O
VAGINA O O
NORMAL O O
CERVIX O O
NORMAL O O
OS O O
NORMAL O O
ADNEXAE O O
NORMAL O O
UTERUS O O
NORMAL O O
UTERINE O O
SIZE O O
IN O O
WEEKS O O
NORMAL O O
12 O O

MRN O O
: O O

Condition O O
on O O
Discharge O O
: O O

NOTIFIED O O
Y. O O
Welch O O
- O O
TSICU O O
140 O O
AM O O
2013-05-24 O O

Thrush B-problem O
. O O

4. O O
Os-Cal B-treatment B-treatment
500 O O
mg O O
PO O O
q.i.d. O O
, O O

1. O O
Gastrointestinal B-problem B-treatment
adenocarcinoma I-problem I-treatment
; O O
primary O O
unknown O O
( O O
likely O O
hepatobiliary O O
) O O
. O O

Plan O O
is O O
for O O
surveillance B-test B-problem
cultures I-test I-problem
to O O
be O O
drawn O O
at O O
dialysis B-treatment O
. O O

2. O O
History O O
of O O
multiple B-problem B-problem
urinary I-problem I-problem
tract I-problem I-problem
infections I-problem I-problem
. O O

She O O
was O O
sent O O
to O O
New O O
England O O
Sinai O O
Hospital O O
& O O
Rehab O O
Center O O
for O O
an B-test B-problem
endoscopic I-test I-problem
retrograde I-test I-problem
cholangiopancreatography I-test I-problem
and O O
possible O O
stent B-treatment O
placement I-treatment O
. O O

Father O O
and O O
mother O O
died O O
in O O
their O O
eighties O O
of O O
heart B-problem B-problem
disease I-problem I-problem
. O O

Hematology O O
was O O
consulted O O
. O O

Yes O O
- O O
Direct O O
contact O O
with O O
PCP O O

Duloxetine B-treatment O
20 O O
mg O O
PO O O
QHS O O

2013-05-18 O O
06:00 O O
PM O O
CK-MB B-test O
- O O
NotDone O O

She O O
works O O
at O O
TackyMart O O
, O O
is O O
single O O
. O O

Completed O O
by O O
: O O
Opal O O
Anne O O
MD O O
40-158 O O
2017-08-23 O O
@ O O
2054 O O

Dictated O O
By O O
: O O
Annie O O
D. O O
Martinez O O
, O O
M.D. O O

Dicatated O O
By O O
: O O

He O O
had O O
no O O
cervical B-problem B-treatment
adenopathy I-problem I-treatment
and O O
his O O
neck O O
was O O
supple O O
. O O

Follow O O
up O O
with O O
Dr. O O
Melendez O O
, O O
Neurosurgery O O
in O O
4 O O
weeks O O
; O O
call O O
745 O O
8256 O O
ext O O
- O O
6468 O O
for O O
an O O
appointment O O
. O O

Further B-test O
work-up I-test O
of O O
his B-problem B-problem
neurologic I-problem I-problem
conditions I-problem I-problem
were O O
planned O O
as O O
an O O
outpatient O O
. O O

No O O
anorexia B-problem B-treatment
. O O

CMED O O
CSRU O O
and O O
Plastic O B-treatment
Surgery O I-treatment
flap B-test I-treatment
checks I-test I-treatment
, O O
tracheostomy B-treatment O
care I-treatment O
, O O
and O O
Westwood-Pocasset B-treatment O
management. I-treatment O

History O O
of O O
multinodular B-problem O
goiter I-problem O
; O O
history O O
of O O
hypertension B-problem B-treatment
; O O
history O O
of O O
subtotal B-treatment B-problem
thyroidectomy I-treatment I-problem
. O O

There O O
was O O
no O O
pronator B-problem O
drift I-problem O
. O O

ALT B-test O
44 O O
. O O

The O O
patient O O
has O O
seen O O
his O O
primary O O
care O O
physician O O
who O O
referred O O
him O O
to O O
physical O O
therapy O O
for O O
his B-problem B-treatment
gait I-problem I-treatment
weakness I-problem I-treatment
but O I-treatment
his B-problem I-treatment
symptoms I-problem I-treatment
failed O O
to O O
improve O O
. O O

She O O
was O O
started O O
on O O
_________ O O
with O O
excellent O B-treatment
diuresis O I-treatment
, O O
however O O
, O O
her B-problem B-problem
renal I-problem I-problem
functioning I-problem I-problem
worsening I-problem I-problem
. O O

Symptoms B-problem O
lasted O O
about O O
five O O
hours O O
and O O
then O O
gradually O O
resolved O O
except O O
for O O
the B-problem O
change I-problem O
in I-problem O
vision I-problem O
. O O

6. O O
Neoral B-treatment B-treatment
100 O O
mg O O
twice O O
a O O
day O O
. O O

Discharge O O
Status O O
: O O

Echo B-test O
prior O O
to O O
scheduled B-test O
cath I-test O
showed O O
mild B-problem B-test
LVH I-problem I-test
, O O
inferior B-problem B-test
HK I-problem I-test
, O O
EF B-test O
40% O O
, O O
mild B-problem B-test
MR I-problem I-test
, O O
mild B-problem B-problem
LAE I-problem I-problem
. O O

Neurologic B-test B-test
examination I-test I-test
revealed O O
alert O O
and O O
oriented O O
times O O
three O O
. O O

No O O
evidence O O
for O O
pulmonary B-problem B-problem
embolism I-problem I-problem
. O O

DR. O O
John O O
S. O O
Beauchamp O O

There O O
is O O
a B-problem B-problem
small I-problem I-problem
subdural I-problem I-problem
hematoma I-problem I-problem
with O O
components O O
of O O
pneumocephalus B-problem O
tracking O O
from O O
the O O
mastoid O O
air O O
cells O O
. O O

1. O O
Familial B-problem B-problem
cavernous I-problem I-problem
hemangiomas I-problem I-problem
, O O
status O O
post O O
a B-problem B-problem
subacute I-problem I-problem
pontine I-problem I-problem
hemorrhage I-problem I-problem
. O O

The B-test O
air- I-test O
fluid I-test O
level I-test O
in I-test O
the I-test O
right I-test O
sphenoid I-test O
sinus I-test O
and O O
bilateral B-problem B-problem
opacification I-problem I-problem
of I-problem O
the I-problem O
mastoid I-problem O
air I-problem O
cells I-problem O
are O O
unchanged O O
. O O

The O O
patient O O
was O O
also O O
given O O
instructions O O
to O O
be O O
prudent O O
and O O
stay O O
away O O
from O O
public O O
places O O
as O O
well O O
as O O
small O O
children O O
. O O

Laceration B-problem O
: O O

An B-test B-test
angiogram I-test I-test
on O O
11/3 O O
was O O
consistent O O
with O O
thrombosis B-problem O
at I-problem O
the I-problem O
mid I-problem O
basilar I-problem B-problem
artery I-problem I-problem
. O O

The O O
family O O
was O O
present O O
. O O

5. O O
Immunizations B-treatment B-treatment
received O O
- O O
Hepatitis B-treatment B-treatment
B I-treatment I-treatment
vaccine I-treatment I-treatment
given O O
2009-01-22 O O
. O O

Denies O O
. O O

No O O
Restrictions O O

If O O
you O O
have O O
continued O O
fevers B-problem O
, O O
worsening B-problem B-problem
abdominal I-problem I-problem
pain I-problem I-problem
, O O
discharge B-problem O
or O O
other B-problem O
worrisome I-problem O
symptoms I-problem O
, O O
please O O
return O O
to O O
the O O
emergency O O
department O O
. O O

4) O O
Colace B-treatment B-treatment
100 O O
mg O O
p.o. O O
b.i.d. O O

PAST O O
SURGICAL O O
HISTORY O O
: O O

Cardiovascular B-test B-test
examination I-test I-test
revealed O O
tachycardic B-problem O
first I-problem O
heart I-problem O
sound I-problem O
and I-problem O
second I-problem O
heart I-problem O
sound I-problem O
. O O

Report O O
Status O O
: O O

none O O
. O O

Service O O
: O O

Fluids O O
, O O
electrolytes O O
and O O
nutrition O O
: O O

7. O O
2017-09-29 O O
CT B-test B-treatment
Head I-test O
: O O

NIREGE O O
MEMORY O O
, O O
M.D. O O

11/18/05 O O
AT O O
02:00 O O
PM O O

1. O O
Miconazole B-treatment O
nitrate I-treatment O
powder I-treatment O
tid O O
prn O O
for O O
groin B-problem O
rash I-problem O
. O O

Cholangiogram B-test O
on O O
postoperative O O
day O O
number O O
two O O
showed O O
no O O
evidence O O
of O O
leakage B-problem O
at I-problem O
the I-problem O
anastomosis I-problem O
site I-problem O
. O O

please O O
follow O O
up O O
with O O
your O O
primary O O
care O O
doctor O O
within O O
4 O O
weeks O O
. O O

Motor O O
vehicle O O
accident O O

Date O O
of O O
Birth O O
: O O

Urine B-test O
lytes I-test O
with O O
Na B-test O
of O O
10 O O
indicating O O
either O O
pre-renal B-problem O
or O O
hepatorenal B-problem O
. O O

NSR B-test O
at O O
62 O O
, O O
nl O B-test
axis O I-test
, O O
nl O B-test
intervals O I-test
, O O
Q B-problem O
waves I-problem O
in I-problem O
III I-problem O
, O O
avR B-test O
, I-test O
V1 B-test O
. O O

This O O
27 O O
year O O
old O O
Gravida O O
1 O O
Para O O
0000 O O
was O O
admitted O O
to O O
the O O
Life O O
Valley O O
Medical O O
Center O O
Obstetrical O O
service O O
on O O
10/31/2004 O O
at O O
08:45 O O
pm O O
for O O
the O O
indication O O
( O O
s O O
) O O
: O O

Her B-test B-test
oxygen I-test I-test
saturations I-test I-test
were O O
greater O O
than O O
94% O O
at O O
the O O
time O O
. O O

Admission O O
Date O O
: O O

1 O O
VERIFIED O O

The O O
patient O O
was O O
also O O
started O O
on O O
a O O
clear O O
diet O O
. O O

Prednisone B-treatment O
5 O O
every O O
other O O
day O O
, O O
alternating O O
with O O
ten O O
every O O
other O O
day O O
. O O

Date O O
of O O
Birth O O
: O O

The O B-test
right O I-test
lower O I-test
extremity O I-test
shows O O
a O O
3/5 O O
on O O
hip O B-test
flexion O I-test
, O O
4/5 O O
at O O
knee O O
flexion O O
and O O
extension O B-treatment
and O O
full O O
power O O
on O O
dorsi O O
and O O
plantar O B-problem
flexion O I-problem
. O O

Admission O O
Date O O
: O O

Urine B-test O
and I-test O
serum I-test O
toxicology I-test O
screen I-test O
negative O O
. O O

T O O
: O O

She O O
knows O O
to O O
return O O
to O O
her O O
local O O
physician O O
for O O
her B-treatment O
routine I-treatment O
care I-treatment O
with O O
her B-problem O
condition I-problem O
unchanged O O
at O O
the O O
time O O
of O O
discharge O O
. O O

Batch O O
: O O

* O O
CV O O
: O O

He O O
works O O
in O O
real O O
estate O O
development O O
and O O
invests O O
in O O
stockmarket O O
. O O

There O O
was O O
no O O
CSF B-problem O
density I-problem O
. O O

His O O
mental O O
status O O
did O O
clear O O
somewhat O O
with O O
the O O
addition O O
of O O
standing B-treatment O
lactulose I-treatment O
; O O
he O O
was O O
discharged O O
on O O
this B-treatment O
medication I-treatment O
. O O

Signed O O
electronically O O
by O O
: O O
DR. O O
Antonio O O
Hall O O
on O O
: O O
FRI O O
2012-05-04 O O
7:48 O O
AM O O

Brief O O
Hospital O O
Course O O
: O O

HISTORY O O
OF O O
PRESENT O O
ILLNESS O O
: O O

The O O
patient O O
is O O
a O O
37 O O
year O O
old O O
lady O O
with O O
type B-problem O
1 I-problem O
diabetes I-problem B-treatment
mellitus I-problem I-treatment
, O O
who O O
is O O
four O O
months O O
postcadaveric B-treatment B-treatment
kidney I-treatment I-treatment
transplantation I-treatment I-treatment
and O O
now O O
has O O
good O O
graft O B-problem
function O I-problem
. O O

On O O
2010-07-01 O O
, O O
the O O
patient O O
was O O
discharged O O
from O O
the O O
hospital O O
with O O
instructions O O
for O O
follow O O
up O O
care O O
on O O
return O O
to O O
the O O
United O O
Kingdom O O
. O O

Electronically O O
Signed O O
OIE O O
LIMOR O O
WARM O O
, O O
M.D. O O
05/18/2004 O O
11:28 O O

PRINCIPAL O O
PROCEDURE O O
: O O
: O O

The O O
left O O
ventricular O O
cavity O O
size O O
is O O
normal O O
. O O

SOCIAL O O
HISTORY O O
: O O

No O O
murmurs B-problem B-treatment
, O O
rubs B-problem O
or O O
gallops B-problem O
. O O

Report O O
Status O O
: O O

Past O O
Medical O O
History O O
: O O

3. O O
Right B-treatment B-problem
hip I-treatment I-problem
replacement I-treatment I-problem

Discharge O O
Date O O
: O O

1. O O
Pancreatitis B-problem O
status O O
post O O
endoscopic B-test B-problem
retrogram I-test I-problem
cholangiopancreatography I-test I-problem
and O O
sphincterotomy B-treatment O
. O O

These O O
recommendations O O
were O O
followed O O
throughout O O
the O O
admission O O
. O O

17. O O
Pepcid B-treatment O
20 O O
mg O O
Tablet O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Tablet O O
PO O O
once O O
a O O
day O O
. O O

He O O
was O O
admitted O O
to O O
the O O
Surgical O O
Intensive O O
Care O O
Unit O O
where O O
his O B-problem
respiratory O I-problem
and O O
cardiac O O
status O O
was O O
monitored O O
carefully O O
. O O

Magnetic B-test B-test
resonance I-test I-test
cholangiopancreatography I-test I-test
did O O
not O O
reveal O O
any O O
evidence O O
of O O
biliary B-problem O
dilatation I-problem O
or O O
of O O
any B-problem O
obstructing I-problem B-problem
pancreatic I-problem I-problem
mass I-problem I-problem
. O O

HEENT O O
- O O
NC O O
AT O O
. O O

DISPOSITION O O
: O O

3. O O
ARF B-problem O
: O O

ENTERED O O
BY O O
: O O

Her B-treatment O
Doxepin I-treatment O
has O O
recently O O
been O O
increased O O
. O O

Postpartum O O
she O O
encountered O O
the O O
following O O
complication O O
( O O
s O O
) O O
: O O

24. O O
Warfarin B-treatment B-treatment
1 O O
mg O O
Tablet O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Tablet O O
PO O O
at O O
bedtime O O
: O O
Please O O
monitor O O
INR B-test O
with O O
goal O O
02-24 O O
. O O

He O O
had O O
been O O
admitted O O
to O O
the O O
St. O O
Margaret O O
's O O
Center O O
for O O
Women O O
& O O
Infants O O
multiple O O
times O O
early O O
in O O
2013 O O
for O O
management B-treatment O
of O O
encephalopathy B-problem O
and O O
ascites B-problem O
. O O

By O O
systems O O
: O O

He O O
was O O
treated O O
with O O
broad B-treatment O
spectrum I-treatment B-problem
antibiotics I-treatment I-problem
for O O
a O O
14 O O
day O O
course O O
for O O
clinical B-problem B-problem
SBP I-problem I-problem
. O O

She O O
has O O
undergone O O
full O O
teaching O O
in O O
regards O O
to O O
immunosuppressant B-treatment B-problem
medications I-treatment I-problem
. O O

Major O O
Surgical O O
or O O
Invasive O O
Procedure O O
: O O

3/13/2006 O O
12:00:00 O O
AM O O

Conditions O O
, O O
Infections O B-treatment
, O O
Complications O B-treatment
, O O
affecting O O
Treatment O O
/ O O
Stay O O

Followup O O
Instructions O O
: O O

During O O
her O O
labor O O
she O O
encountered O O
the O O
following O O
complication O O
( O O
s O O
) O O
: O O

COMPARISON O O
: O O
None O O
. O O

*********** O O
HOSPITAL O O
COURSE O O
**************** O O

SOCIAL O O
HISTORY O O
: O O

Abd O O
: O O
normal O O
size O O
, O O
nd B-problem O
, O O
no O O
scars B-problem B-test
, O O
nl O O
bs O O
, O O
soft O O
, O O
nt B-problem O
, O O
palp O O
liver O O

Sex O O
: O O

Routine B-treatment O
Post I-treatment O
Partum I-treatment O
Care I-treatment O

Medications B-treatment O
per O O
gastrostomy B-treatment O
tube I-treatment O
on O O
postoperative O O
day O O
one O O
. O O

CONDITION O O
ON O O
DISCHARGE O O
: O O

8. O O
Prednisone B-treatment B-treatment
10 O O
mg O O
q. O O
day O O
. O O

Diabetic B-problem O
retinopathy I-problem O
with O O
the O O
patient O O
blind B-problem O
in I-problem O
right I-problem O
eye I-problem O
. O O

10) O O
Buspar B-treatment B-treatment
5 O O
mg O O
p.o. O O
t.i.d. O O

As O O
the B-treatment O
patient I-treatment O
&apos;s I-treatment O
diuresis I-treatment O
continued O O
his B-problem O
respiratory I-problem O
status I-problem O
improved O O
. O O

PAST O O
SURGICAL O O
HISTORY O O
: O O

On O O
physical B-test B-treatment
examination I-test I-treatment
she O O
was O O
afebrile B-problem O
with O O
a O B-test
blood B-test I-test
pressure I-test I-test
of O O
170/100 O O
, O O
heart B-test B-treatment
rate I-test I-treatment
of O O
70 O O
. O O

10. O O
Trusopt B-treatment O
1gtt O O
in O O
left O O
eye O O
three O O
times O O
a O O
day O O
. O O

Disp O O
:* O O
60 O O
Capsule O O
(s)* O O
Refills O O
:* O O
2 O O
* O O

Treatment O O
Rendered O O
: O O

PHYSICAL O O
EXAMINATION O O
: O O

Please O O
return O O
to O O
the O O
hospital O O
if O O
you O O
experience O B-problem
chest B-problem I-problem
pain I-problem I-problem
, O O
shortness B-problem B-treatment
of I-problem I-treatment
breath I-problem I-treatment
, O O
lightheadedness B-problem B-problem
or O I-problem
dizziness B-problem I-problem
. O O

Patient O O
was O O
started O O
on O O
Lactulose B-treatment O
and O O
Rifaximine B-treatment O
which O O
improved O O
his O O
mental O O
status O O
. O O

Had O O
Chest B-test B-test
CT I-test I-test
to O O
r O O
/ O O
o O O
dissection B-problem O
( O O
due O O
to O O
back B-problem B-problem
pain I-problem I-problem
) O O
which O O
was O O
neg. O O

CONDITION O O
ON O O
DISCHARGE O O
: O O

Disp O O
:* O O
60 O O
Capsule O O
(s)* O O
Refills O O
:* O O
0 O O
* O O

TCA B-problem O
overdose I-problem O

HEENT O O
: O O
Clear O O
OP O O
, O O
MM B-problem O
very I-problem O
dry I-problem O
. O O

CONTRAINDICATIONS O O
for O O
IV O O
CONTRAST O O
: O O
None O O
. O O

INDICATION O O
: O O
Intraparenchymal B-problem O
hemorrhage I-problem O
after O O
fall O O
. O O

BOORMKAYSSCAJE O B-test
, O O
PA O O
A. O O
, O O
M.D. O O
( O O
TI84 O O
) O O
12/10/05 O O
02:58 O O
AM O O

Calcium B-test B-test
was O O
7.6 O O
. O O

The O O
patient O O
's O O
father O O
died O O
of O O
a B-problem B-treatment
myocardial I-problem I-treatment
infarction I-problem I-treatment
at O O
age O O
40 O O
, O O
and O O
a O B-test
brother O I-test
who O O
died O O
of O O
a B-problem B-treatment
myocardial I-problem I-treatment
infarction I-problem I-treatment
at O O
age O O
40 O O
. O O

Please O O
r/o O O
acute B-problem B-problem
process I-problem I-problem
. O O

He O O
also O O
became O O
short B-problem O
of I-problem O
breath I-problem O
with O O
climbing O B-problem
a O I-problem
flight O I-problem
of O I-problem
stairs O I-problem
. O O

Age O O
: O O

Ativan B-treatment B-test
0.5 O O
mg O O
p.o. O O
b.i.d. O O
p.r.n. O O
anxiety B-problem O
. O O

PRINCIPAL O O
DIAGNOSIS O O
: O O

Atrial B-problem O
fibrillation I-problem O
( O O
on O O
Coumadin B-treatment O
) O O

Attending O O
: O O

Pulse B-test O
60 O O
. O O

Cranial O O
nerves O O
2 O O
through O O
12 O O
intact O O
. O O

LABORATORY O O
EXAMINATION O O
: O O

Gen O O
: O O

He O O
also O O
began O O
to O O
develop O B-problem
noticeably B-problem I-problem
increasing I-problem I-problem
bilateral I-problem I-problem
lower I-problem I-problem
extremity I-problem I-problem
weakness I-problem I-problem
and O O
possibly O O
numbness B-problem O
in I-problem O
the I-problem O
lower I-problem O
extremities I-problem O
. O O

01/12/2005 O O
06:07 O O
AM O O

The O O
patient O O
subsequently O O
underwent O O
a B-test B-problem
CT I-test I-problem
scan I-test I-problem
angiogram I-test I-problem
with O O
Pancreas B-test O
protocol I-test O
to O O
assess O O
the O O
pseudocyst B-problem O
versus O O
enlarged B-problem O
pancreas I-problem O
head I-problem O
. O O

The O O
patient O O
had O O
considerable B-problem O
difficulty I-problem O
with I-problem O
left I-problem B-problem
finger-to-nose I-problem I-problem
movement I-problem I-problem
, O O
most O O
likely O O
secondary O O
to O O
hemianopsia B-problem B-problem
. O O

PRINCIPAL O O
DIAGNOSIS O O
: O O

DD O O
: O O

This O O
report O O
was O O
created O O
by O O
CHIRDKOTEKERTH O B-treatment
, O O
LICHEREANYVE O B-treatment
10/24/2001 O O
10:09 O O
AM O O

4. O O
History O O
of O O
hyperkalemia B-problem B-problem
. O O

HOSPITAL O O
COURSE O O
: O O

Standardized O O
Discharge O O
Instructions O O
: O O

PT B-test B-test
- O O
15.0 O O
* O O
PTT B-test B-test
- O O
107.1 O O
* O O
INR B-test O
( I-test O
PT I-test O
)- I-test O
1.3 O O
* O O

Follow O O
up O O
Service O O
: O O

t97.5 O O
, O O
hr B-test O
117 O O
, O O
bp156/81 O O
, O O
rr28 O O
, O O
o2 B-test O
sats I-test O
87% O O
RA O O
; O O
95% O O
4L O O

Age O O
: O O

Chest B-test B-test
x-ray I-test I-test
showed O O
left B-problem B-problem
atrial I-problem I-problem
, I-problem O
right I-problem B-problem
ventricular I-problem I-problem
and I-problem O
pulmonary I-problem B-problem
arterial I-problem I-problem
enlargement I-problem I-problem
and O O
interstitial B-problem B-problem
edema I-problem I-problem
with O O
small B-problem O
, I-problem O
bilateral I-problem B-problem
effusions I-problem I-problem
. O O

Admission O O
Date O O
: O O

12. O O
Levofloxacin B-treatment B-treatment
500 O O
mg O O
Tablet O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Tablet O O
PO O O
Q24H O O
( O O
every O O
24 O O
hours O O
) O O
for O O
3 O O
days O O
. O O

OTHER O O
DIAGNOSIS O O
; O O

He O O
will O O
also O O
require O O
close O O
follow O O
up O O
with O O
his O O
primary O O
care O O
provider O O
for O O
coumadin B-treatment B-problem
management I-treatment I-problem
. O O

She O O
had O O
an O O
intact O O
gag O O
reflex O O
. O O

Vital O O
signs O O
: O O

Brief O O
Hospital O O
Course: O O

3. O O
Ezetimibe B-treatment B-treatment
10 O O
mg O O
Tablet O O
Sig O O
: O O
One O O
( O O
1 O O
) O O
Tablet O O
PO O O
DAILY O O
( O O
Daily O O
) O O
. O O

Sensory O O
: O O

CHIEF O O
COMPLAINT O O
AND O O
HISTORY O O
OF O O
PRESENT O O
ILLNESS O O
: O O

Date O O
of O O
Birth O O
: O O

She O O
has O O
had O O
no O O
motor B-problem O
weakness I-problem O
, O O
abnormal B-problem B-treatment
sensation I-problem I-treatment
, O O
numbness B-problem B-treatment
, O O
tingling B-problem O
or O O
incontinence B-problem O
of I-problem O
bowel I-problem O
or I-problem O
bladder I-problem O
. O O

He O O
was O O
started O O
on O O
Pyridium B-treatment B-problem
. O O

Signed O O
electronically O O
by O O
: O O
DR. O O
Clara O B-treatment
M. O O
Odell O O
on O O
: O O
WED O O
2013-06-26 O O
9:58 O O
AM O O

The O O
patient O O
became O O
hypotensive B-problem O
into O O
the O O
70 O O
s O O
without O O
any B-problem O
symptoms I-problem O
. O O

She O O
also O O
complained O O
of O O
some B-problem O
loose I-problem O
stools I-problem O
on O O
the O O
day O O
of O O
admission O O
, O O
no O O
nausea B-problem B-problem
or O I-problem
vomiting B-problem I-problem
. O O
